Sentence,class,file
Available at http://www.jis.,Non-OADS,/arxiv_data1/oa_pdf/16/84/11105_2009_Article_115.PMC3881568.pdf
The expression level of the GmUBQ gene was used as an internal control to normalize and calculaterelative expression levels of genes tested using ImageJ software ( http://rsb.info.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/5f/9b/11105_2010_Article_201.PMC3881571.pdf
Results Cloning the GAL2 Gene We used the sequence of AGL11 (At4g09960) as a query in a tBLASTn sequence search ( http://www.ncbi.nlm.nih.gov/ ).,OADS,/arxiv_data1/oa_pdf/5f/9b/11105_2010_Article_201.PMC3881571.pdf
The deduced amino acid sequence was analyzed with the Predict Protein Analysis System(http://www.predictprotein.org/ ).,OADS,/arxiv_data1/oa_pdf/5c/2a/11105_2011_Article_410.PMC3881572.pdf
We constructed the secondary structure of ASS8P20 using NNPREDICT ( http://alexander.compbio.,OADS,/arxiv_data1/oa_pdf/61/fe/11105_2009_Article_159.PMC3881576.pdf
"Also, using the website ( http://alexander.compbio.ucsf.edu/~nomi/nnpredict.",Non-OADS,/arxiv_data1/oa_pdf/61/fe/11105_2009_Article_159.PMC3881576.pdf
"OncoImmunology 2013; 2:e26512;  http://dx.doi.org/10.4161/onci.26512Dendritic cell-based vaccines Shining the spotlight on signal 3 Gerald P Linette and Beatriz M Carreno* Department of Medicine; Division of Oncology; w ashington u niversity s chool of Medicine; s t. Louis, MO usa Keywords:  CD8+ T cells, CD40L, dendritic cells, IL-12, melanoma, vaccines Abbreviations:  DC, dendritic cell; IFN, interferon; mDC, mature DC Dendritic cell (DC)-based anticancer vaccines have yielded disappointing results in a multitude of clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
Blood 2013; 121:2836- 44; PMID:23390195 ; http://dx.doi.org/10.1182/ blood-2012-09-452078 2.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
Immunol Rev 2006; 211:81-92;  PMID:16824119 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
J Immunol 2009; 183:1695- 704; PMID:19592655 ; http://dx.doi.org/10.4049/ jimmunol.09005924.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
J Immunol 2010; 185:4988- 92; PMID:20935204 ; http://dx.doi.org/10.4049/ jimmunol.1002042 5.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
J Clin Invest  2013; 123:3383-94;  PMID:23867552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
J Immunol  2013; 191:1011-5;  PMID:23804712 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
Blood 2013; 122:932- 42; PMID:23794066 ; http://dx.doi.org/10.1182/ blood-2013-04-495424Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/22/c6/onci-2-e26512.PMC3881596.pdf
"OncoImmunology 2013; 2:e26536; http://dx.doi.org/10.4161/onci.26536Immunogenic cell death in radiation therapy Lorenzo Galluzzi1,2,3,*,†, Oliver Kepp3,4,5, and Guido Kroemer2,3,4,5,6,*,† 1Gustave r oussy; Villejuif, France; 2Université Paris d escartes/Paris V; s orbonne Paris Cité; Paris, France;   3equipe 11 labellisée par la Ligue n ationale contre le Cancer; Centre de r echerche des Cordeliers; Paris, France; 4Inser M, U848; Villejuif, France;   5Metabolomics and Cell Biology Platforms; Gustave r oussy; Villejuif, France; 6Pôle de Biologie; Hôpital e uropéen Georges Pompidou; a P-HP; Paris, France †These authors share senior co-authorship.",Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Nat Rev Clin Oncol  2013; 10:52-60;  PMID:23183635 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Oncoimmunology  2013 ; 2:e25396 ;  PMID:23894726 ; http://dx.doi.org/10.4161/ onci.253963.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
OncoImmunology  2013 ;  2:e24238 ; http://dx.doi.org/10.4161/onci.24238 4.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Lancet Oncol  2003 ; 4:529-36;  PMID:12965273 ; http://dx.doi.org/10.1016/ S1470-2045(03)01191-45.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
J Natl  Cancer Inst 2012 ; 104:357-70; PMID:22312134 ;  http://dx.doi.org/10.1093/jnci/djr533 6.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Nat Rev Mol Cell Biol 2011 ; 12:385- 92; PMID :21527953 ; http://dx.doi.org/10.1038/ nrm3115,OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Cancer Treat Rev 2005 ; 31:159- 72; PMID:15923088 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Oncoimmunology  2012 ; 1:407- 8; PMID:22754758 ; http://dx.doi.org/10.4161/ onci.20074 12.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Oncoimmunology  2013 ; 2:e22731 ; PMID:23525138 ;  http://dx.doi.org/10.4161/onci.22731 13.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Cancer Metastasis Rev  2011 ; 30:61- 9; PMID:21249425 ; http://dx.doi.org/10.1007/ s10555-011-9273-4 14.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-10000815.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Immunity  2013 ; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Nature   2010 ; 467:863-7 ; PMID:20944749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Oncoimmunology  2013 ; 2:e24568 ;  PMID:23894718 ; http://dx.doi.org/10.4161/ onci.24568 18.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
EMBO J 2009 ; 28:578-90; PMID:19165151 ;  http://dx.doi.org/10.1038/emboj.2009.1 19.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Immunity  2013 ;  39:211-27; PMID:23973220 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Science  2011 ; 334:1573 -7; PMID:22174255 ;  http://dx.doi.org/10.1126/science.120834721.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Oncoimmunology   2012 ; 1:393-5; PMID:22737627 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Science  2011 ; 333:1109 -12;  PMID:21868666 ; http://dx.doi.org/10.1126/ science.1201940 24.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Mol Cell  2010 ; 40:280- 93; PMID:20965422 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Nat Rev Cancer   2012 ; 12:401-10; PMID:22534666 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
Cell Death Differ  2013 ; In press ; PMID:24037090 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/onci-2-e26536.PMC3881599.pdf
"OncoImmunology 2013; 2:e26383; http://dx.doi.org/10.4161/onci.26383Tumor-derived lactate   and myeloid-derived suppressor cells Linking metabolism to cancer immunology Zaheed h usain1,2, Pankaj s eth1,2, and Vikas P s ukhatme1,2,* 1Division of Interdisciplinary Medicine and Biotechnology; Beth-Israel Deaconess Medical h ospital; h arvard Medical s chool; Boston, M a usa ;   2Department of Medicine; Beth-Israel Deaconess Medical h ospital; h arvard Medical s chool; Boston, M a usa Keywords:  glycolysis, ketogenic diet, lactate, MDSCs, NK cells Many malignant cells produce increased amounts of lactate, which promotes the development of myeloid-derived  suppressor cells (MD sCs).",Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
Nat Rev Immunol 2012; 12:253-68;  PMID:22437938 ; http://dx.doi.org/10.1038/ nri3175 2.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
BMC Biol  2010 ; 8:88-90; PMID:20598111 ;  http://dx.doi.org/10.1186/1741-7007-8-884.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
Cancer Res  2011 ; 71:6921 -5; PMID:22084445 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
Blood   2006 ; 107:2013 -21; PMID:16278308 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
J Immunol  2013 ; 191:1486 - 95; PMID:23817426 ; http://dx.doi.org/10.4049/ jimmunol.1202702,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
Nutr Cancer   2013 ; 65:843-9; PMID:23909728 ; http://dx.doi.org /10.1080/01635581.2013.80457910.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
Cancer Res  2012 ; 72:2746 -56; PMID:22593198 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/onci-2-e26383.PMC3881600.pdf
"JAK-STAT 2013; 2:e24911; http://dx.doi.org/10.4161/jkst.24911The function of steroid receptors is not only regulated by  steroid hormones, but also by multiple cellular signaling cascades activated by membrane-bound receptors which are  stimulated by growth factors or cytokines.",OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Mammary Gland Biol Neoplasia  1997; 2:7-17; PMID:10887515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Proc Natl Acad Sci U S A  2003; 100:1016-21; PMID:12552091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Endocrinology 2007; 148:2417-23; PMID:17272397; http://dx.doi.org/10.1210/en.2006-1305 39.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Reproduction 2007; 133:361-9; PMID:17307904;  http://dx.doi.org/10.1530/REP-06-0299 40.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
T rends Endocrinol Metab  2003; 14:118-23; PMID:12670737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Endocrinol 2001; 15:1941-52; PMID:11682625;  http://dx.doi.org/10.1210/me.15.11.1941 42.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Steroid Biochem Mol Biol 2008; 108:203- 12; PMID:17964138; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Endocrinol 1999; 13:829-36; PMID:10379882;  http://dx.doi.org/10.1210/me.13.6.829 45.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Cell Biol  2005; 25:4826-40; PMID:15923602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Andrologia  2013; 45:178-86; PMID:22748021; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Biol Reprod  2011; 85:1222-31; PMID:21880948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Clin Oncol 2002; 20:3001-15; PMID:12089231;  http://dx.doi.org/10.1200/JCO.2002.10.018 50.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 2002; 277:7076-85; PMID:11751884;  http://dx.doi.org/10.1074/jbc.M10825520019.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cell 1995; 83:841-50;  PMID:8521508; http://dx.doi.org/10.1016/0092- 8674(95)90200-7 20.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Cell Endocrinol 2005; 236:1- 7; PMID:15876478; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Endocrinol 2010; 204:105-14; PMID:19767412;  http://dx.doi.org/10.1677/JOE-09-0242 23.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Lancet  1896; 2:104-7; http://dx.doi.org/10.1016/S0140- 6736(01)72307-0 24.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Crit Rev  Oncol Hematol 2004; 51:55-67; PMID:15207254;  http://dx.doi.org/10.1016/j.critrevonc.2004.02.001 25.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Mol Med (Berl)  1998; 76:469-79; PMID:9660165; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Endocrinol 2007; 21:2311-9; PMID:17536004;  http://dx.doi.org/10.1210/me.2007-0101 28.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Steroid Biochem Mol Biol  2010; 118:219-30; PMID:19815064; http://dx.doi.org/10.1016/j.jsbmb.2009.09.018 29.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
"Cell Signal 2012; 24:151-61; PMID:21907792;  http://dx.doi.org/10.1016/j.cellsig.2011.08.016 30. de Souza Rocha Simonini P , Breiling A, Gupta N,  Malekpour M, Youns M, Omranipour R, et al.",OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cancer Res 2010; 70:9175-84;  PMID:20978187; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1318 31.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Cell Biochem 2008; 105:956- 64; PMID:18821585; http://dx.doi.org/10.1002/ jcb.21911 34.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Endocr Rev 1987;  8:115-31; PMID:3301316; http://dx.doi.org/10.1210/ edrv-8-2-115References 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Annu Rev Immunol 1998; 16:293-322;  PMID:9597132; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Oncogene 2000; 19:5662- 79; PMID:11114747; http://dx.doi.org/10.1038/ sj.onc.1203925 4.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Cell Sci 2004; 117:1281- 3; PMID:15020666; http://dx.doi.org/10.1242/ jcs.00963 5.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cancer Metastasis  Rev 2003; 22:423-34; PMID:12884916; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Mammary Gland Biol Neoplasia 2008; 13:93-103; PMID:18228120; http://dx.doi.org/10.1007/s10911- 008-9062-z 8.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
T rends  Pharmacol Sci 2012; 33:574-82; PMID:22995223;  http://dx.doi.org/10.1016/j.tips.2012.08.005 9.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cell 1995; 83:835- 9; PMID:8521507; http://dx.doi.org/10.1016/0092- 8674(95)90199-X 13.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Genome  Res 2004; 14:580-90; PMID:15059999; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Endocrinology 2009; 150:2537-42; PMID:19372199; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cell 1999; 97:161-3; PMID:10219237;  http://dx.doi.org/10.1016/S0092-8674(00)80726-6 16.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Curr Drug Targets Inflamm Allergy  2004; 3:335-46; PMID:15584884; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Endocrinol  2011; 25:377-84; PMID:20861220; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 2002;  277:34879-84; PMID:12107179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
"Wahli W, Braissant O, Desvergne B. Peroxisome pro-liferator activated receptors: transcriptional regulators  of adipogenesis, lipid metabolism and more… Chem  Biol 1995; 2:261-6; PMID:9383428; http://dx.doi.org/10.1016/1074-5521(95)90045-4 81.",OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Prog Lipid Res 2006; 45:120-59; PMID:16476485;  http://dx.doi.org/10.1016/j.plipres.2005.12.002 82.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Carcinogenesis 1997; 18:2029-33; PMID:9395198;  http://dx.doi.org/10.1093/carcin/18.11.2029 83.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Biochem Pharmacol 1994; 47:918- 21; PMID:8135869; http://dx.doi.org/10.1016/0006-2952(94)90494-4 85.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Arch  Biochem Biophys 1994; 315:555-7; PMID:7986103;  http://dx.doi.org/10.1006/abbi.1994.1536 87.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 1999; 274:2672-81; PMID:9915797; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Nephrol Dial T ransplant  2008; 23:3776-85; PMID:18596134; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Steroid  Biochem Mol Biol 2002; 82:369-76; PMID:12589944;  http://dx.doi.org/10.1016/S0960-0760(02)00223-6 67.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Circ Res 2007; 101:545- 59; PMID:17872473; http://dx.doi.org/10.1161/ CIRCRESAHA.107.156596 68.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Diabetes 1997; 46:717-9;  PMID:9075817; http://dx.doi.org/10.2337/diabe - tes.46.4.717 69.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 2004; 279:19658-64; PMID:14993217; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Leukemia 2002;  16:1896-905; PMID:12357341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Blood 2002; 100:4401-9;  PMID:12393611; http://dx.doi.org/10.1182/blood- 2001-12-0374 74.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem  2010; 285:38915-22; PMID:20876578; http://dx.doi.org/10.1074/jbc.M110.170274 75.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
FEBS Lett 2005; 579:3669-73; PMID:15963505; http://dx.doi.org/10.1016/j.febs- let.2005.05.052 76.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Mol Aspects Med 2008; 29:388-96; PMID:18755215; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
BMC Genomics 2010; 11:26; PMID:20070897;  http://dx.doi.org/10.1186/1471-2164-11-26 78.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Neurosci Res  2006; 83:1299-309; PMID:16547967; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Virol 2008; 82:11066-72; PMID:18768969;  http://dx.doi.org/10.1128/JVI.01300-08 52.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 2011; 286:32976- 85; PMID:21808064; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
J Biol Chem 2003; 278:52355- 62; PMID:14565954; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Endocrinology 2005; 146:3900-6; PMID:15932931;  http://dx.doi.org/10.1210/en.2004-1674 59.,Non-OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Cell Tissue  Res 2012; 348:71-80; PMID:22331364; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Proc Am Thorac Soc 2004; 1:239- 46; PMID:16113441; http://dx.doi.org/10.1513/ pats.200402-005MS 62.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
Proc Natl Acad Sci U S A 2000; 97:9573- 8; PMID:10920190; http://dx.doi.org/10.1073/ pnas.160099797 63.,OADS,/arxiv_data1/oa_pdf/b1/78/jkst-2-e24911.PMC3881601.pdf
"OncoImmunology 2013; 2:e26586http://dx.doi.org/10.4161/onci.26586The interplay between regulatory T cells   and metabolism in immune regulation Hu Zeng and Hongbo Chi* Department of Immunology; St. Jude Children’s r esearch Hospital; Memphis, TN US a Keywords:  Treg, metabolism, mTOR, FOXP3, lipid metabolism regulatory T cells (Tregs) are crucial for peripheral toler - ance and are intimately involved in immunological diseases  and cancer.",Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunol Rev 2012; 249:5-13; PMID:22889211 ;  http://dx.doi.org/10.1111/j.1600-065X.2012.01158.x 2.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Cell  2008; 133:775-87;  PMID:18510923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Am J Cardiol 1990; 65:168-72; PMID:2296885 ;  http://dx.doi.org/10.1016/0002-9149(90)90079-G 4.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat  Rev Immunol 2011; 11:738-49; PMID:21984069 ;  http://dx.doi.org/10.1038/nri3071 8.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Clin Invest 2006; 116 :3015-25;  PMID:17053832 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Lipid Res  2012; 53:2002-13;  PMID:22766885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Biol Chem 2001; 276:16683- 9; PMID:11278967 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Biol Chem 2004;  279:16971-9;  PMID:14966134 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A 2011;  108:15324-9;  PMID:21876127 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol 2011; 12:408- 15; PMID:21478880 ; http://dx.doi.org/10.1038/ ni.202215.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity 2013; 38:1154- 63; PMID:23809162 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Lipid Res  2008; 49:1894-903;  PMID:18503031 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Med  2012; 18:1407-12;  PMID:22863787 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Med 2009; 15:940-5; PMID:19633655 ;  http://dx.doi.org/10.1038/nm.1994 19.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Med 2009; 15:914- 20; PMID:19633658 ; http://dx.doi.org/10.1038/ nm.1964 20.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Med 2009; 15:930- 9; PMID:19633656 ; http://dx.doi.org/10.1038/ nm.2002,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
EMBO Mol Med 2012; 4:1112- 25; PMID:23027613 ; http://dx.doi.org/10.1002/ emmm.201201272 22.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Med 2011; 17:610- 7; PMID:21499269 ; http://dx.doi.org/10.1038/ nm.2353 23.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Immunol 2010; 185:6947-59;  PMID:21037091 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Science 2011; 332:243-7; PMID:21436399 ;  http://dx.doi.org/10.1126/science.1201475 25.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Exp Med 2013; 210:535- 49; PMID:23420878 ; http://dx.doi.org/10.1084/ jem.20121964 26.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
PLoS One 2011; 6:e16376;  PMID:21298111 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Diabetes 2011; 60:2954-62; PMID:21911743 ;  http://dx.doi.org/10.2337/db11-0358 28.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A 2010; 107:9765- 70; PMID:20445103 ; http://dx.doi.org/10.1073/ pnas.0908771107 29.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Annu Rev Biochem  2008; 77:289-312;  PMID:18518822 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity 2011; 35:337-48; PMID:21924928 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Clin Invest 2011; 121:4503-15; PMID:21965331 ;  http://dx.doi.org/10.1172/JCI5745633.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Rev Immunol 2008; 8:523- 32; PMID:18566595 ; http://dx.doi.org/10.1038/ nri2343 35.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol  2003; 4:1206-12;  PMID:14578884 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A 2009; 106:12055-60;  PMID:19567830 ; http://dx.doi.org/10.1073/ pnas.0903919106 38.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity 2007; 26:241-55; PMID:17307705 ;  http://dx.doi.org/10.1016/j.immuni.2007.01.011 39.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Int Immunol 1998; 10:1969-80;  PMID:9885918 ; http://dx.doi.org/10.1093/ intimm/10.12.1969 40.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity 2010; 33:929-41; PMID:21145759 ;  http://dx.doi.org/10.1016/j.immuni.2010.11.024 41.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A 2013; 110:6193-8; PMID:23530205 ; http://dx.doi.org/10.1073/ pnas.1210644110 42.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Cell 2012; 149:274- 93; PMID:22500797 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Curr Opin Immunol 2013; 25:347-55;  PMID:23722114 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Annu Rev Immunol 2012; 30:39-68;  PMID:22136167 ; http://dx.doi.org/10.1146/ annurev-immunol-020711-075024 45.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol 2013; 14:307-8;  PMID:23507634 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Exp Med 2008; 205:565- 74; PMID:18283119 ; http://dx.doi.org/10.1084/ jem.20071477 48.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A 2008; 105:7797-802;  PMID:18509048 ; http://dx.doi.org/10.1073/ pnas.0800928105 49.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol 2010; 11:1047-56;  PMID:20852647 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity  2009; 30:832-44;  PMID:19538929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol  2011; 12:295-303;  PMID:21358638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Blood 2005; 105:4743-8; PMID :15746082 ;  http://dx.doi.org/10.1182/blood-2004-10-3932 53.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Sci Transl Med 2011; 3:83ra41; PMID:21593401 ;  http://dx.doi.org/10.1126/scitranslmed.3001809 55.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Proc Natl Acad Sci U S A  2008; 105:17414-9;  PMID:18955708 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Nat Immunol 2009; 10:769-77;  PMID:19483717 ; http://dx.doi.org/10.1038/ni.1743 59.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Exp Med 2005; 201:723- 35; PMID:15753206 ; http://dx.doi.org/10.1084/ jem.20041982 61.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J Exp Med 2011; 208:1367-76;  PMID:21708926 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunity 2010; 32:54-66; PMID:20060329 ;  http://dx.doi.org/10.1016/j.immuni.2009.12.003 64.,OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
J  Immunol 2011; 186:3299-303;  PMID:21317389 ;  http://dx.doi.org/10.4049/jimmunol.100361365.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
Immunology 2009; 127:18-25;  PMID:19191903 ;  http://dx.doi.org/10.1111/j.1365-2567.2008.03011.x,Non-OADS,/arxiv_data1/oa_pdf/91/ad/onci-2-e26586.PMC3881602.pdf
"Mobile Genetic Elements 2013; 3:e27313; http://dx.doi.org/10.4161/mge.27313Foreign gene recruitment to the fatty acid  biosynthesis pathway in diatoms cheong Xin c han,1,* Francesca L Baglivi,2 christina e  Jenkins,2,† and Debashish Bhattacharya3 1Institute for Molecular Bioscience, and a Rc centre of e xcellence in Bioinformatics; The University of Queensland; Brisbane, QLD australia; 2Department of Biology;   University of Iowa; Iowa c ity, I a Usa; 3Department of e cology, e volution and Natural Resources, and Institute of Marine and c oastal s ciences; Rutgers University;   New Brunswick, NJ U sa †current affiliation: s chool of Biological s ciences; Washington s tate University; Pullman, W a Usa Keywords:  diatoms, fatty acid biosynthesis, horizontal gene transfer, lipid metabolism, phylogenomics, endosymbiosis Diatoms are highly successful marine and freshwater algae that contribute up to 20% of global carbon fixation.",Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
"For each of the protein  sequences, we searched for putative homologs within a local  database similar to the one used a earlier study23 but with the  updated NCBI RefSeq release 51 (http://www.ncbi.nlm.nih.gov/RefSeq).",OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
"17 million protein sequences, include other genomic sources of predicted proteins (http://www.jgi.doe.gov/) and EST data (http://www.ncbi.nlm.nih.gov/dbEST/; http://tbestdb.bcm.umontreal.ca/) from other algae and protists.",OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Plant Physiol 2005;  137:500-13;  PMID:15665249 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Science  1998; 281:237-40;  PMID:9657713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Annu Rev Genet  2008; 42:83-107;  PMID:18983255 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Adv Funct Mater 2008; 18:369- 74; http://dx.doi.org/10.1002/adfm.200700609 5.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Curr  Opin Biotechnol 2008; 19:235-40; PMID:18539450 ;  http://dx.doi.org/10.1016/j.copbio.2008.05.007 6.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Annu Rev Biochem 1995; 64:315-43; PMID:7574485 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Endocr Rev 1988; 9:295-318; PMID:3061784 ; http://dx.doi.org/10.1210/ edrv-9-3-295 9.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Microbiol Mol Biol Rev 2004; 68:501-17; PMID:15353567 ; http://dx.doi.org/10.1128/ MMBR.68.3.501-517.200411.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
J Biol Chem 2005; 280:12422-9;  PMID:15668256 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Annu Rev Biochem 2005; 74:791-831; PMID :15952903 ; http://dx.doi.org/10.1146/ annurev.biochem.74.082803.133524 13.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Annu Rev Plant Biol 2008; 59:491-517; PMID :18315522 ; http://dx.doi.org/10.1146/ annurev.arplant.59.032607.092915 14.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Annu Rev Genet 2007; 41:147-68;  PMID:17600460 ; http://dx.doi.org/10.1146/ annurev.genet.41.110306.130134 15.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Science  2009; 324:1724-6;  PMID:19556510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Nature 2010; 465:617-21;  PMID:20520714 ;  http://dx.doi.org/10.1038/nature09016 17.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
J Phycol  2012; 48:1130-42;  PMID:23066170 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Nature 2012; 492:59- 65; PMID:23201678 ; http://dx.doi.org/10.1038/ nature11681 19.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Nature 2013; 499:209-13; PMID:23760476 ; http://dx.doi.org/10.1038/ nature12221 20.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Genome Biol Evol 2012; 4:738-47;  PMID:22593553 ; http://dx.doi.org/10.1093/gbe/ evs049 21.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Genome Biol Evol  2012; 4:795-800;  PMID:22684208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Mol Biol Evol 2008; 25:2653-67; PMID:18799712 ; http://dx.doi.org/10.1093/ molbev/msn206 23.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
PLoS One 2011; 6:e29138; PMID:22195008 ;  http://dx.doi.org/10.1371/journal.pone.0029138 24.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Mob Genet Elements 2012; 2:101- 5; PMID:22934244 ; http://dx.doi.org/10.4161/ mge.20110,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
BMC Evol Biol  2007; 7:173;  PMID:17894863 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Science  2012; 335:843-7;  PMID:22344442 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Mob Genet Elements  2013; 3:e25845;  PMID:24195014 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Planta  2006; 223:550-7;  PMID:16133206 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Plant Physiol 1997; 113:75-81;  PMID:9008389 ; http://dx.doi.org/10.1104/ pp.113.1.75 32.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Prog Lipid Res 2002; 41:407-35; PMID:12121720 ; http://dx.doi.org/10.1016/ S0163-7827(02)00007-3 33.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Biosci Biotechnol Biochem  2004; 68:1175-84;  PMID :15215578 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Plant Cell Physiol  1996; 37:117-22;  PMID:8665091 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
J Biol Chem 1996; 271:1833- 6; PMID:8567624 ; http://dx.doi.org/10.1074/ jbc.271.4.183336.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Proc Natl Acad Sci U S A 1997; 94:4872-7; PMID :9144157 ; http://dx.doi.org/10.1073/ pnas.94.10.4872 39.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
J Lipid Res 2008; 49:183-91;  PMID :17921532 ; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Plant Physiol 2003; 131:1648- 60; PMID:12692324 ; http://dx.doi.org/10.1104/ pp.102.018317 42.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Prostaglandins Leukot Essent  Fatty Acids 2003; 68:73-95; PMID:12538072 ;  http://dx.doi.org/10.1016/S0952-3278(02)00258-2 43.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Science 2004; 306:79-86; PMID :15459382 ; http://dx.doi.org/10.1126/ science.110115647.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Curr Biol 2011; 21:328- 33; PMID :21315598 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Nature 2004; 428:653-7; PMID :15071595 ;  http://dx.doi.org/10.1038/nature02398 49.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Nat Commun 2013; 4:1941; PMID:23770768 ;  http://dx.doi.org/10.1038/ncomms2931 50.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Proc Natl Acad Sci U S A 2013; 110:5247-52;  PMID:23503846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Science 2013; 339:1207- 10; PMID:23471408 ; http://dx.doi.org/10.1126/ science.1231707 52.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
Bioinformatics 2006;  22:2688-90;  PMID:16928733 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
BMC Bioinformatics 2008; 9:393; PMID:18811941 ;  http://dx.doi.org/10.1186/1471-2105-9-393,Non-OADS,/arxiv_data1/oa_pdf/68/b9/mge-3-e27313.PMC3881603.pdf
"7, July 2013 , pp.652-664                                                             Review Article   652   Available at:    http://ijph.tums.ac.ir        Clinical Research Involving Minors in International and Serbian  Regulations     *Nina PLANOJEVIĆ, Dragica ŽIVOJINOVIĆ     Faculty of Law, University of Kragujevac, Kragujevac, Republic of Serbia     *Corresponding Author:  Email: nplanojevic@jura.kg.ac.rs     (Received 24 Mar 2013; accepted 11 May 2013)        Introduction     Informed consent is minimum term to be fulfilled  today in order to access clinical research involving  human subjects.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               653 ing research involving children if, instead of them,  consent is given by an authorized person for that.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  654                                                                                                        Available at:    http://ijph.tums.ac.ir  those is necessity, having in mind differences b e- tween international and Ser bian solutions.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               655 consent cannot be justified mini mally  by possible  usefulness for minor's health, we cannot recognize  proper justification of his participation in research  leading to promotion of the health of population  he belongs to if minor personally has no benefits,  and may even suffer damage.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  656                                                                                                        Available at:    http://ijph.tums.ac.ir  nor is possible both in therapeutic and non -thera - peutic research under different terms.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               657 2008 for participation of minors in non-therapeutic   research.,Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  658                                                                                                        Available at:    http://ijph.tums.ac.ir  fore, they should enjoy the position pre scribed for  the cate gory of healthy minors.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               659 lating also actions in the case of minor's disagree - ment with representative’s position to partici pate in  the research.,Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  660                                                                                                        Available at:    http://ijph.tums.ac.ir  portant also for the fact that Serbia is a poor  coun try, with low population’ education level; a l- together this can result in representative's con sent  to participation of a child in research more for  offered benefit and less for his assessment that it  is in the interest of a child.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"As - sessment that some group of patients will  have  benefit from minors participation does not mean  special protection of the minor himself; therefore,  this term is not in accordance to the title of the  article prescribing it ( „Protection of minor sub - jects in conducting of clinical research“ ) and it                                                                                    http://www.infoplease.com/world/statistics/most - corrupt -countries -2009.html  (access: March 2013)   4Guideline 7 of the Guide contains particularly detailed  regulation of this issue contains under the title „Inducement  to participate in research“.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               661 minors' protection; therefore, we con sider that is  the direction for their amendment, including the  term of minimal risk of the research in minor, as  required by international regulations only for non - therapeutic research.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  662                                                                                                        Available at:    http://ijph.tums.ac.ir  filled.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"Planojević  and Živojinović  : Clinical Research Involving Minors  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               663 tional regulations are grounded on principle of  allowed both therapeutic and non -therapeutic re - searches in minors, or similar or even equal terms,  infringing the  principle that subject’s welfare has  to be above the interest of society and science.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
http://news.bbc.,Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"42, No.7,  July 2013, pp .652-664  664                                                                                                        Available at:    http://ijph.tums.ac.ir  22.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijph-42-652.PMC3881611.pdf
"665-672                                                                       Review Article   665                                                                                                          Available at: http://ijph.tums.ac.ir      Imbalance between Goals and Organizational Structure in Pri - mary Health Care in Iran - a Systematic Review      Mehdi ZANGANEH BAYGI, *Hesam SEYEDIN     International Campus , Tehran University of Medical Sciences, Tehran, Iran     *Corresponding Author:  Email: hseyedin@tums.ac.ir     (Received 20 Feb 2013; accepted 27 May 2013)        Introduction     Health is a universal  right and responsibility of  every government to provide for communities.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
"Zanganeh Baygi & Seyedin  : Imbalance between Goals and Organizational Structure  …  Available at:    http://ijph.tums.ac.ir                                                                                                        666 plays a very effective role to achieve the goal of  health for all, the system was neglected in Iran.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
"42, No.7,  July 2013, pp .665-672  667   Available at:    http://ijph.tums.ac.ir  or even were dubious were retrieved and assessed  for relevance by one investigator (SHS) and a re - search assistant.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
Zanganeh Baygi & Seyedin  : Imbalance between Goals and Organizational Structure  …  Available at:    http://ijph.tums.ac.ir                                                                                                        668 Table 1:  Findings of researches in organizational structure in Iran’s health system     Author(s)   or title  Reference num - ber.,Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
"42, No.7,  July 2013, pp .665-672  669   Available at:    http://ijph.tums.ac.ir    Based on authors, proper  conduct of decentral i- zation  process will  bring  quality  and justice  but  without  considering to  prerequi sites can lead to   consequences  for health system (15) .",Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
Zanganeh Baygi & Seyedin  : Imbalance between Goals and Organizational Structure  …  Available at:    http://ijph.tums.ac.ir                                                                                                        670 forms in health system were carried out in other  countries with different impacts.,Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
"42, No.7,  July 2013, pp .665-672  671   Available at:    http://ijph.tums.ac.ir  needed to design the system to adjust goals and   strategies .",Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
Zanganeh Baygi & Seyedin  : Imbalance between Goals and Organizational Structure  …  Available at:    http://ijph.tums.ac.ir                                                                                                        672 prehensive  and scientific health map (2009).,Non-OADS,/arxiv_data1/oa_pdf/39/3e/ijph-42-665.PMC3881612.pdf
"7, July 2013, pp .673-680                                                       Original Article   673   Available at:    http://ijph.tums.ac.ir        Associations of Hypertension Status with Physical Fitness   Variables in Korean Women     Jin-Ho YOON  1, *Wi -Young SO  2    1.",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
Yoon & So: Associations of Hypertension Status  …  Available at:    http://ijph.tums.ac.ir   674 fitness  is subdivided into 2 categories: c ardiova s- cular respiratory fitness  and m otor- and coor dina- tion-related physical fitness .,Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"42 , No.7, July 2013 , pp.673 -680  675   Available at:    http://ijph.tums.ac.ir  Table 1:  The characteristics of the subjects (n = 9,216)     Variables  Mean ± standard deviation  or n (%)   Age (yr)  46.83 ± 10.32   Anthropometry  Height (cm)  156.79 ± 5.23   Weight (kg)  57.94 ± 7.60   Body mass index (kg/m2) 23.58 ± 2.92   SBP (mm Hg)  118.70 ± 17.05   DBP (mm Hg)  73.22 ± 10.62   Cardiovascular respiratory  fitness  VO 2max (ml/kg/min)  26.39 ± 5.17   RHR (beats/min)  74.08 ± 9.50   Double product (HR  SBP)  8,816.15 ± 1,841.42   Vital capacity (ℓ)  2.75 ± 0.58   Motor - and Coordination - related physical fitness  Grip strength (kg)  28.32 ± 3.77   Sit-ups (repetitions/min)  12.87 ± 5.97   Sit-and-reach (cm)  17.38 ± 7.99   Vertical jump height (cm)  24.42 ± 7.44   Side steps (repetitions/30 s)  30.62 ± 5.60   1-leg standing with eyes open (s)  42.31 ± 37.64   Body mass index (kg/m2) Normal  <23 4237 (46.0%)   Overweight  ≥23 to <25  2397 (26.0%)   Obese  ≥25 2582 (28.0%)   Smoking  Nonsmoker  9,013 (97.8%)   <1 pack of cigarettes per day  164 (1.8%)   ≥1 pack of cigarettes per day  39 (0.4%)   Drinking  Nondrinker  7,918 (85.9%)   1 or 2 times per week  1,078 (11.7%)   ≥3 times per week  220 (2.4%)   Exercise  No exercise  4,432 (48.1%)   1 or 2 times per week  2,849 (30.9%)   ≥3 times per week  1,935 (21.0%)   HR, heart rate; RHR, resting heart rate; DBP, diastolic blood pressure; SBP; systolic blood pressure     Motor - and coordination -related physical fitness  statuses were evaluated based on muscular  strength, muscular endurance, flexibility, power,  agility, and ability to maintain balance, as deter - mined using grip strength (kilogra ms), number of  sit-ups completed (repetitions/minute), sit -and- reach score (centimeters), vertical jump height  (centimeters), number of side steps performed  (repetitions/30 seconds), and 1 -leg standing with eyes open (seconds), respectively.",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"Yoon & So: Associations of Hypertension Status  …  Available at:    http://ijph.tums.ac.ir   676 SH-9600N; Korea), bend their knees to 90 de - grees, grab their necks with both hands, and raise  their upper body and bend forward,  using only  their abdominal muscles.",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"42 , No.7, July 2013 , pp.673 -680  677   Available at:    http://ijph.tums.ac.ir  Table 2:  Anthropometry, c ardiovascular respiratory fitness, motor - and coordination -related physical fitness,  and  lifestyle according to prehypertension and hypertension in Korean women (n = 9,216)     Variables  Normal   (n = 5,237)  Pre-HT  (n = 2,794)  HT  (n = 1,185)  F P  Age (yr)  43.72 ± 9.38  49.51 ± 9.91  54.23 ± 9.72  737.308  <0.001***   Anthropometry  Height (cm)  157.25 ± 5.09  156.55 ± 5.28  155.31 ± 5.40  72.137  <0.001***   Weight (kg)  56.36 ± 6.93  59.52 ± 7.77  61.24 ± 8.13  305.470  <0.001***   Body mass index (kg/m2) 22.79 ± 2.60  24.29 ± 2.95  25.37 ± 2.92  558.060  <0.001***   SBP (mm Hg)  106.96 ± 7.98  127.39 ± 5.83  150.10 ± 11.23  16,751.873  <0.001***   DBP (mm Hg)  66.54 ± 6.22  78.25 ± 5.54  90.91 ± 7.95  8,567.063  <0.001***   Cardiovascular  respiratory fit - ness VO 2max (mL/kg/min)  27.14 ± 4.95  25.59 ± 5.28  24.45 ± 5.22  141.760  <0.001***   RHR (beats/min)  72.97 ± 8.79  75.19 ± 9.79  76.34 ± 10.99  90.054  <0.001***   Double product   (HR  SBP)  7,812.11 ±  1,160.08  9,578.61 ±  1,327.69  11,458.33 ±  1,859.77  4,336.106  <0.001***   Vital capacity ( ℓ) 2.83 ± 0.59  2.68 ± 0.57  2.53 ± 0.53  148.215  <0.001***   Motor - and C o- ordination - related physical  fitness  Grip strength (kg)  28.43 ± 3.73  28.25 ± 3.76  27.98 ± 3.99  7.329  0.001**   Sit-ups (reps/min)  13.60 ± 5.81  12.14 ± 5.97  11.03 ± 6.11  97.309  <0.001***   Sit-and-reach (cm)  17.33 ± 8.02  17.51 ± 8.14  17.31 ± 7.99  0.479  0.619   Vertical jump height (cm)  25.73 ± 7.21  23.09 ± 7.42  21.15 ± 7.04  212.143  <0.001***   Side steps (reps/30sec)  31.62 ± 5.30  29.90 ± 5.57  27.41 ± 5.61  268.326  <0.001***   1-leg standing with eyes  open (s)  48.84 ± 39.05  36.52 ± 35.17  26.09 ± 28.55  213.083  <0.001***   Body mass in - dex (kg/m2) Normal  <23 3,013 (71.1%)  992 (23.4%)  232 ( 5.5%)   890.103  <0.001***  Overweight  ≥23 to <25  1,277 (53.3%)  761 (31.7%)  359 (15.0%)   Obese  ≥25 947 (36.7%)  1,041 (40.3%)  594 (23.0%)   Smoking  Non-smoker  5,127 (56.9%)  2,728 (30.3%)  1,158 (12.8%)   4.204  0.379  1 or 2 times per week  94 (57.3%)  49 (29.9%)  21 (12.8%)   ≥3 times per week  16 (41.0%)  17 (43.6%)  6 (15.4%)   Drinking  Non-drinker  4,493 (56.7%)  2,415 (30.5%)  1,010 (12.8%)   18.618  0.001**  1 or 2 times per week  636 (59.0%)  315 (29.2%)  127 (11.8%)   ≥3 times per week  108 (49.1%)  64 (29.1%)  48 (21.8%)   Exercise  No exercise  2,350 (53.0%)  1,442 (32.5%)  640 (14.4%)   76.960  <0.001***  1 or 2 times per week  1,640 (57.6%)  877 (30.8%)  332 (11.6%)   ≥3 times per week  1,247 (64.4%)  475 (24.5%)  213 (11.0%)   Data are expressed as mean ± standard deviation or n (%).",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"Yoon & So: Associations of Hypertension Status  …  Available at:    http://ijph.tums.ac.ir   678 pacity in creased by 1 ℓ, pre hypertension  preva- lence de creased 0.850 times (0.777 –0.930, P <  0.001).",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"42 , No.7, July 2013 , pp.673 -680  679   Available at:    http://ijph.tums.ac.ir  Myocardial infarction is known to be closely re - lated to hypertension, and RHR is closely related t o  myocardial infarction (21).",Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
Yoon & So: Associations of Hypertension Status  …  Available at:    http://ijph.tums.ac.ir   680 Reference     1.,Non-OADS,/arxiv_data1/oa_pdf/df/b5/ijph-42-673.PMC3881613.pdf
"681-690                                                          Original Article   681   Available at:    http://ijph.tums.ac.ir        Type 2 Diabetes Family Histories , Body Composition and Fast- ing Glucose Levels: A Cross -Section Analysis in Healthy Se - dentary Male and Female     *Antonino BIANCO  1, Francesco POMARA  2, Ewan  THOMAS  1, Antonio PAOLI  3, Gi- useppe BATTAGLIA  1, Marco PETRUCCI  1, Patrizia PROIA  1, Marianna BELLAFI ORE  1,  Antonio PALMA  1    1.",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
: Type 2 Diabetes Family Histories  …  Available at:    http://ijph.tums.ac.ir   682 crease in  body weight and a tendency towards  obesity and visceral adiposity  (12-16).,Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"42 , No.7, July 2013 , pp.681-690  683   Available at:    http://ijph.tums.ac.ir  test); participants were not  allowed to eat (4 hours  prior to test); partici pants were not allowed to  drink water (1 hour prior to test) participants did  not have to be cov ered in sweat or soaked in urine   (35).",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
: Type 2 Diabetes Family Histories  …  Available at:    http://ijph.tums.ac.ir   684     Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"42 , No.7, July 2013 , pp.681-690  685   Available at:    http://ijph.tums.ac.ir  Table 3:  Body composition (BIA) of male subjects     Variables  FH+   (n = 35)  FH++   (n = 32)  FH-  (n = 116)  P  H2O, litres  39.06 ± 8.26  37.60 ± 7.50  36.95 ± 5.57  NS  FM, %  29.10 ± 5.41  25.46 ± 7.97  28.59 ± 5.43  0.0191   FFM, %  70.90 ± 5.41  74.54 ± 7.97  71.41 ± 5.43  0.0191   FM, kg  24.37 ± 7.83  19.23 ± 6.87  22.35 ± 5.85  0.0052   FFM, kg  58.59 ± 12.40  56.40 ± 11.25  55.43 ± 8.36  NS  FFM/FM  2.63 ± 1.10  3.51 ± 1.94  2.72 ± 1.20  0.0085   NS: no significance         Table 4:  Body composition (BIA) of female subjects     Variables  FH+   (n = 44)  FH++   (n = 58)  FH-  (n = 135)  P  H2O, litres 28.33 ± 3.48  27.33 ± 3.20  27.96 ± 3.31  NS  FM, %  35.28 ± 11.12  31.76 ± 9.82  29.90 ± 8.32  0.0039   FFM, %  64.72 ± 11.12  68.24 ± 9.82  70.10 ± 8.32  0.0039   FM, kg  25.08 ± 13.86  20.51 ± 11.19  18.81 ± 8.49  0.0026   FFM, kg  42.50 ± 5.22  40.99 ± 4.80  41.94 ± 4.97  NS  FFM/FM  2.09 ± 0.90  2.43 ± 1.00  2.60 ± 0.97  0.0102   NS: no significance         Table 5:  Fasting blood glucose levels of male subject in absolute and relative values     Glucose levels  FH+   (n = 35)  FH++   (n = 32)  FH-  (n = 116)  P  mg/dl  73.86 ± 10.14  71.72 ± 9.81  74.30 ± 9.31  NS  mg/dl · kg BW-1 0.93 ± 0.24  0.97 ± 0.20  0.97 ± 0.18  NS  mg/dl · kg FFM-1 1.32 ± 0.36  1.33 ± 0.34  1.37 ± 0.29  NS  mg/dl · kg FM-1 3.36 ± 1.18  4.28 ± 1.88  3.58 ± 1.08  0.0076   mg/dl · kg BSA-1 38.15 ± 6.81  38.15 ± 6.60  38.91 ± 5.59  NS  NS: no significance         Table 6:  Fasting blood glucose levels of female subject in absolute and relative values     Glucose levels  FH+     (n = 44)  FH++   (n = 58)  FH-  (n = 135)  P  mg/dl  73.61 ± 8.93  73.09 ± 8.75  75.33 ± 9.29  NS  mg/dl · kg BW-1 1.13 ± 0.23  1.24 ± 0.28  1.27 ± 0.23  0.0046   mg/dl  · kg FFM-1 1.75 ± 0.29  1.81 ± 0.32  1.82 ± 0.29  NS  mg/dl · kg FM-1 3.61 ± 1.52  4.39 ± 1.93  4.67 ± 1.78  0.0031   mg/dl · kg BSA-1 43.25 ± 6.40  45.22 ± 7.32  46.75 ± 6.30  0.0081   NS: no significance         Discussion     The development of TD2 during years has rele - vantly increased in occidental countries as shown  by WHO (32, 36 -38).",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
": Type 2 Diabetes Family Histories  …  Available at:    http://ijph.tums.ac.ir   686 un-healthy life styles, obesity and physical inacti v- ity (10, 34, 39, 40) .",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"42 , No.7, July 2013 , pp.681-690  687   Available at:    http://ijph.tums.ac.ir  Acknowledgements       The study was supported by the MEDEOR Re - search Institute – Palermo, with the grant code  AED -SELINO -S6/2011 -2012.",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
: Type 2 Diabetes Family Histories  …  Available at:    http://ijph.tums.ac.ir   688 15.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"42 , No.7, July 2013 , pp.681-690  689   Available at:    http://ijph.tums.ac.ir  nutritional calcium intake assessment in Italian  women .",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"42 , No.7, July 2013 , pp.681-690  Available at:    http://ijph.tums.ac.ir      690 54.",Non-OADS,/arxiv_data1/oa_pdf/37/a2/ijph-42-681.PMC3881614.pdf
"691-699                                                            Original Article   691   Available at:    http://ijph.tums.ac.ir      Effect of Pregnancy on the Levels of Blood Cadmium and Lead:   analysis of 2006 -2011 Nanjing Maternity and Child Health Care  Hospital Survey Data     Kangsheng LIU 1, Pingqing GU  1, Wenjun CHEN 2,Juan SHI 3,Chuan SHI 4, *Li XIA  5    1.",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
: Effect of Pregnancy on the Levels of Blood  …  Available at:    http://ijph.tums.ac.ir   692 some neurological disorder s including hyperactiv - ity and increased aggressiveness in humans (4).,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
"42 , No.7, July 2013 , pp.691-699  693   Available at:    http://ijph.tums.ac.ir  There were in total 18884 female participants in  Nanjing Maternity and Child Health Care Hos - pital Gynecology  and Obstetrics Clinic during the  years of 2006 -2011 for survey.",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
: Effect of Pregnancy on the Levels of Blood  …  Available at:    http://ijph.tums.ac.ir   694 kept in the final model.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
"42 , No.7, July 2013 , pp.691-699  695                                                                                                        Available at:    http://ijph.tums.ac.ir  Table 2:  Final fitted regression models with f statistics for main and interaction effects regression slopes for conti - nuous variables and their P values     Parameter  log(Blood Cadmium)  log(Blood Lead)   F or β P-value  F or β  P-value   Race/Ethnicity  7.45 0.04 30.12  0.05  Pregnancy Status  5.89 <0.01  5.47 <0.01   Iron Storage Status  8.14 <0.01  5.14 <0.01   Smoking Status  789.470  <0.01  78.91  <0.01   Fish/Shellfish Consumption during the  last 30 days (F /S) 0.351  0.41 N/A  410.12   Pregnancy X Iron Storage Status  5.147  <0.01  NIM    Pregnancy X Smoking Status  NIM   NIM    Iron Storage Status X Smoking Status  8.478  <0.01   NIM   Age 0.006  <0.01  0.007  <0.01   Body Mass Index  -0.004  <0.01  -0.006  <0.01  Parity  0.004  0.25 0.005  0.91  Survey cycle  0.007  0.07 -0.041  <0.01   Serum Albumin  -0.028  0.04 0.027  0.02  Serum Hemoglobin   Serum Creatinine  0.020   0.014  <0.01   0.45 0.021   0.071  <0.01   <0.01   NIM:  Not in the model     The results of regression   Blood Pb leve ls for those Fe was absent were si g- nificantly higher than those either deficient or r e- plete (3.968 μg/dl vs. 3.804 μg/dl and 3.801 μg/dl, Table 3).",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
: Effect of Pregnancy on the Levels of Blood  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              696 The data of compari sons of AGM among differ - ent groups within each category were provided in  Table 3.Irrespective of whether or not main ef - fects were both interpretable.,OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
"42 , No.7, July 2013 , pp.691-699  697                                                                                                        Available at:    http://ijph.tums.ac.ir  status when addressing occupational or environ - mental exposure to lead and related toxic effects.",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
": Effect of Pregnancy on the Levels of Blood  …  Available at:    http://ijph.tums.ac.ir   698 national health levels, the lead levels of pregnant  women should be monitored and  lead prevention  should be prioritized in health care.",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
"42 , No.7, July 2013 , pp.691-699  699                                                                                                       Available at:    http://ijph.tums.ac.ir  (2011).",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/ijph-42-691.PMC3881615.pdf
"7, July 2013 , pp.700-706                                                    Original Article   700   Available at:    http://ijph.tums.ac.ir      Efficacy and Safety of Dimeticone in the Treatment of Lice Infe s- tation through Prophylaxis of Classmates     *Pietro FERRARA  1, Francesca DEL BUFALO  2, Valerio ROMANO  1, Eloisa TIBERI  1,  Giorgia BOTTARO  2, Lorenza ROMANI  2, Monica MALAMISURA  2, Francesca IAN - NIELLO  1, Laura CENI  3, Giovanni MOTTINI  3, Antonio GATTO  1    1.",Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
: Efficacy and Safety of Dimeticone  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             701 to evaluate a new approach to treat head lice  aimed to prevent reinfestation after cure.,Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
"42 , No.7, July 2013 , pp.700-706  702                                                                                                        Available at:    http://ijph.tums.ac.ir  We fixed two end points: after 7 and 30 days  from the first application of dimeticone.",Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
: Efficacy and Safety of Dimeticone  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             703 resistances.,Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
"42 , No.7, July 2013 , pp.700-706  704                                                                                                        Available at:    http://ijph.tums.ac.ir  malathion was twice as effective as combing (23).",Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
: Efficacy and Safety of Dimeticone  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             705 Acknowledgements     The authors declare that there is no conflict of  interests and that this study was not funded.,Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
"42 , No.7, July 2013 , pp.700-706  706                                                                                                        Available at:    http://ijph.tums.ac.ir  matic randomised controlled trial .",Non-OADS,/arxiv_data1/oa_pdf/2a/ec/ijph-42-700.PMC3881616.pdf
"7, Jul 2013 , pp.707-725                                                            Original Article   707   Available at:    http://ijph.tums.ac.ir       The Potential Financial Costs of Climate Change on Health of Urban  and Rural Citizens: A Case Study of Vibrio cholerae  Infections at Bu - kavu Town, South Kivu Province, Eastern of Democratic Republic of   Congo     *MB Théodore MUNYULI 1, 2, 3, J-M Mbaka KAVUVU 2, 4, Guy MULINGANYA  5,    G Mulinganya BWINJA 5, 6    1.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
": The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   708 Introuduction     In East and central Africa, a cholera epidemic was  first reported in 1836 along the Indian Ocean  coast, killing as many as 20 000 people in Zanzi - bar alone.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   709   Available at:    http://ijph.tums.ac.ir  to act on existing knowledge about prevention is  likely to prove the most desirable intervention  over the longer term   There is increasing emphasis on quantifying the  health impacts from climate change (WHO 2008).",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
: The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   710 The main source of secondary health data in this  study was obtained from the weekly epidemio logi- cal review as supplied by local hospit als to the  provincial health inspection of South -Kivu Prov- ince that has reliable patients’ health records.,Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   711   Available at:    http://ijph.tums.ac.ir  minimum temperature and years as predic tor va - riables (covariates).",OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
: The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   712 climato logica l characteristics to precipitate a cho - lera outbreak.,Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   713   Available at:    http://ijph.tums.ac.ir   (B) Annual rainfall stability (1992-2012) per month of the  year, Lwiro meterological station 00.511.522.533.544.5 JanuaryFebruaryMarchApril MayJuneJuly August SeptemberOctober November December Month of the yearStability (1/CV) in (%)   (D) Monthy stability in rainfall (January to December)  per annum, Lwiro meterological station 00.511.522.5 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 YearStability (1/CV) in (%)   (H).",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
": The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   714 In addition, high rainfall and consequent floods  (soil/water erosion) are needed to disperse the  cho- lera pathogen in the lake basin area including in  some artesian water sources.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   715   Available at:    http://ijph.tums.ac.ir  Males and females have different perceptions.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
": The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   716 Table 3:  Community perception of illnesses and diseases suffered by residents of Bukavu from 2010 to 2011         Frequency of households indicating the disease among those interviewed during the study period                                                                 Diseases   Households opinion  Diarrhea  Typhoid  Inter worms  Cholera  Bilharziose  Hepatitis  Filariasis  Dysentery  Malaria   Rarely  345 121 267 45 33 17 11 19 167  Often  45 16 123 12 12 8 7 23 156  Frequent  12 23 56 8 7 11 18 45 87  Very Frequent  24 6 45 24 19 9 21 28 67  Statistics   DF 1 1 1 2 1 1 1 1 2  χ2-test  4566.34  179070  8.25843  73.5324  8.28938  0.9345  5.40822  3.82941  2211.88   P <0.0001  <0.0001  <0.0001  <0.0001  0.004  0.345  0.020  0.050  <0.0001     Table 4:  Mutiple regression to estimate the relationships between the number of new Cholera  cases and climatic factors  (maximum temperature, minimum temperature, average temperature, monthly rainfall) from 1992 to 2011,Bukavu ,South -Kivu  province, eastern Congo      Un-standarized coefficients    Full model   Terms  Regression   Coefficient  SE coefficient  T-statistic  P-value   Constant  -16573.1  6381.87  -2.5969  0.010   Years (1992 -2011)  8.7 3.23 2.69796  0.007   Rainfall (mm) Lwiro  0.5 0.10 4.74386  0.000   Maximum temperature  5.2 6.17 0.83794  0.403   Minimum temperature  -4.1 6.04 -0.67651  0.499   Mean temperature  -43.6 20.21  -2.15795  0.032    Whole model: Model F(5,246)=22.678; Model P<0.0001; Multiple R2= 25.33%     These results suggested over years, increase in rain fall  indirectly induced an increase in new cho lera cases.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   717   Available at:    http://ijph.tums.ac.ir     0.0050.00100.00150.00200.00250.00300.00350.00400.00 01002003004005006007008009001000 JM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSN 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Rainfall(mm)Monthly numbr of new cases of Cholera Years Cholera new cases Rainfall (mm) Lwiro    Fig.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
": The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   718 The negative sign of the coefficient of variable  average temperature (indirectly “droug ht”) con - firms that cholera cases decrease in months with  less rainfall, as expected.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   719   Available at:    http://ijph.tums.ac.ir     y = -1E-05x3+ 0.0016x2-0.0237x + 24.834 R2= 0.7273, P<0.001 05101520253035 050100150200250300350400 JM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSNJM MJSN 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 TemperatureMonthly number of new cases of Cholera Years Cholera new cases Temperature Min Temperature Max Poly.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
: The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   720 The type of food and frequency of meals that a  household has is a good measure of household  food security.,Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   721   Available at:    http://ijph.tums.ac.ir  not include an uncertainty analysis and rely on  preliminary analysis (19).",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
": The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   722 inpatient costs for diarrhea are estimated to by  US$78 p er bed day, while for Congo, inpatient  costs are estimated in the range of USD 1 to15  dollars per day.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   723   Available at:    http://ijph.tums.ac.ir  because of the cos ts involved and instead relied  on those that were distributed during such  epidem ics.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
: The Potential Financial Costs of Climate Change …    Available at:    http://ijph.tums.ac.ir   724 of governance need t o be improved.,Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"4 2, No.7, July 2013, pp.707-725   725   Available at:    http://ijph.tums.ac.ir  intervention in Zambia.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/ijph-42-707.PMC3881617.pdf
"726-736                                                          Original Article   726   Available at:    http://ijph.tums.ac.ir       Prevalence and Predictors of Anxiety and Depression among Fe male  Medical Students in King Abdulaziz University, Jeddah, Saudi Arabia     *Nahla IBRAHIM 1, 2, Dania  AL- KHARBOUSH 3, Lamis EL-KHATIB 3,  Ahd AL -HABIB 3,  Dana ASALI 3    1.",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
: Prevalence and Predictors of Anxiety  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               727 cross -sectional study conducted in Malaysia re - ported that 41.9% of the medical students have  psychological stress ( 8).,Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"42 , No.7, July 2013 , pp.726-736  728                                                                                                       Available at:    http://ijph.tums.ac.ir  HADS scoring is grouped for each of anxiety and  depression as following:   1.",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
": Prevalence and Predictors of Anxiety  …  Available at:    http://ijph.tums.ac.ir                                                                                                                           729 Table 1:  Relationship between personal, socioeconomic condition & anxiety among female medical students in King Abdulaziz  University     OR X2 Total  No Anxiety  Anxiety   Variables                               (95%CI)  (P)  % n % n  Nationality   0.43 (0.19 -0.98) 4.14 426 66.2 282 33.8 144 Saudi   Reference  (0.04)  24 45.8 11 54.2 13 Non Saudi    Age  1.19 (0.67 - 2.08) 0.36 60 61.7 37 38.3 23 < 20 years   Reference  (0.5) 390 65.6 256 34.4 134 ≥ 20 years   Marital status   1.36(0.58 -3.17)  0.52 422 64.7 273 35.3 149 Single   Reference  (0.46)  28 71.4 20 28.6 8 Non-single   Educational year   0.78 (0.4 -1.5)  111 66.7 74 33.3 37 Second   0.56 (0.3 -1.3) 2.5 91 70.3 64 29.7 27 Third   0.99 (0.5-1.9) (0.62)  100 61.0 61 39.0 39 Fourth   0.79 (0.4 -1.6)  74 66.2 49 33.8 25 Fifth   Reference   74 60.8 45 39.2 29 Six (RC)  Residual status   Reference  0.2 400 64.8 259 35.2 141 With family (RC)  0.86 (0.3 -2.2) (0.9) 25 68.0 17 32.0 8 A private resident   0.86 (0.3 -2.2)  25 68.0 17 32.0 8 College dormitory   Father's education   0.79 (0.52 -1.22) 1.07 140 68.6 96 31.4 44 Less than university   Reference  (0.3) 310 63.5 197 36.5 113 University and above   Mother's education   0.79 (0.52 -1.22) 2.1 190 68.9 131 31.1 59 Less than university   Reference  (0.08)  260 62.3 162 37.7 98 University and above   Father occupation:   0.92 (0.61 -1.38) 0.196   0.6 250 66.0 165 34.0 85 Professional   Reference  200 64.0 128 36.0 72 Non-professional   Mother occupation:   1.60(1.06 -2.42) 5.57  (0.01)  187 58.8 110 41.2 77 Professional   Reference  263 69.6 183 30.4 80 Non-professional   Crowding index:   1.5 (60.84 -2.86) 2.1  (0.15)  249 63.8 249 36.2 141 < 2 person / room   Reference  44 73.3 44 26.7 16 ≥ 2 person / room   Income:   1.61 (0.16 -15.64)  0.174  446 65.0 290 35.0 156 Sufficient   Reference  0.677  4 75.0 3 25.0 1 Non-sufficient     450 65.1 293 34.9 157 Total   RC: Referent category     Regarding depression, Table 4 shows that Saudis  had a lower prevalence of depression (13.6%) than  non- Saudis (33.3%), with highly statistical signif i- cant difference ( X2=7.06, P=0.006).",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"42 , No.7, July 2013 , pp.726-736  730                                                                                                        Available at:    http://ijph.tums.ac.ir  Table 2:  Relationship between faculty environment conditions & anxiety among female medical students in                King Abdula ziz University     OR  X2 Total  No Anxiety  Anxiety   Variables                               (95%CI)  (P)  % n % n  Academic failure   2.05  (1.28 -3.26)   9.4  0.002  93 51.6 48 48.4 45 Yes  Reference    357 68.6 245 31.4 112 No   Exam anxiety   2.75 (1.68 -4.53)   15.26   0.000  315 59.4 187 41.2 128 Yes  Reference    135 78.5 106 21.5 29 No  Condensed course   2.27  (1.44 -3.58)    14.06  289 58.8 170 41.2 119 Yes  0.000  161 76.4 123 23.6 38 No  No cooperation   2.04  (1.30 -3.20)    10.87  121 52.9 64 47.1 57 Yes  0.001  329 69.6 229 30.4 100 No  No encouragement   1.88  (1.19 -2.98)    8.23 113 54.0 61 46.0 52 Yes  0.004  337 86.8 232 31.2 105 No   450 65.1 293 34.9 157 Total     Table 3:  Relationship between events in 6 months preceded the study & anxiety among female medical students in  King Abdulaziz University     OR X2 Total  No Anxiety  Anxiety   Variables                               (95%CI)  (P)  % n % n  Emotional failure   2.09 (1.41 - 3.10)  13.68  199 55.8 111 44.2 88 Yes  Reference  0.000  251 72.5 182 27.5 69 No   Death of relative   1.41  (0.87 -2.26)  2.2 105 59.0 62 41.0 43 Yes  Reference  0.13 345 67.0 231 33.0 114 No  Death of a close friend   1.92 (0.68 -5.40)  1.88 18 50 9 50.0 9 Yes  Reference  0.17 432 65.7 284 34.3 148 No  Loss of a close friend   2.18 (1.36 -3.49)  11.92  104 51 53 49 51 Yes  Reference  0.001  346 69.4 240 30.6 106 No  Marriage of a close friend   1.24 (0.82 -1.87)  1.15 254 63.0 160 37.0 94 Yes  Reference  0.28 196 67.9 133 32.1 63 No  Family psychological problem   1.78 (1.11 -2.83)  0.81 137 62.0 58 38.0 52 Yes  Reference  0.63 313 66.5 208 33.5 105 No   450 65.1 293 34.9 157 Total",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
": Prevalence and Predictors of Anxiety  …  Available at:    http://ijph.tums.ac.ir   731 Table 4:  Relationship between personal, socioeconomic condition & depression among female medical students in     King Abdulaziz University     OR X2 Total  No Depression  Depression   Variables                               (95%CI)  (P)  % n % n  Nationality   0.32 (0.12 -0.85)  7.06 426 86.4 368 13.6 58 Saudi   Reference  0.006  24 66.6 16 33.3 8 Non Saudi   Age  0.88 (0.37 -2.05)  0.09 60 68.7 52 13.3 8 < 20 years   Reference  0.74 390 85.1 332 14.9 58 ≥ 20 years   Marital status   0.40 (0.16 -1.04)  4.61 422 86.3 364 13.7 58 Single   Reference  0.03 28 71.4 20 28.6 8 Non-single   Educational year   Reference   111 85.6 95 14.4 16 Second   0.73  (0.29 -1.38)  4.07 91 89.0 81 11.0 10 Third   0.89  (0.38 -2.08)  0.39 100 87.0 87 13.0 13 Fourth   1.04  (0.42 -2.56)   74 85.1 63 14.9 11 Fifth   1.64  (0.71 -3.77)   74 78.4 58 21.6 16 Six  Residential status   Reference   400 85.5 342 14.5 58 With family (RC)  1.12  (0.46 -2.65)  5.8 25 72.0 18 28.0 7 Private resident   0.25  (0.01 -1.76)  0.05 55 96.0 24 4.0 1 College dormitory   Father's education   1.43 (0.80 -2.45)  1.65 115 82.1 115 17.9 25 Less than university   Reference  0.19 310 86.8 269 13.2 41 University and above   Mother's education   1.17 (0.67 -2.05)  0.33 190 84.2 160 15.8 30 Less than university   Reference  0.56 260 86.2 224 13.8 36 University and above   Father occupation:   0.58 (0.33 -1.01)  4.23 250 88.4 221 11.6 29 Professional   Reference  0.64 200 81.5 163 18.5 37 Non-professional   |Mother occupation:   0.97 (0.80 -2.45)  0.01 187 85.6 160 14.4 27 Professional   Reference  0.9 263 85.2 224 14.8 39 Non-professional   Crowding index:   0.97(0.55 -1.07)  0.09 390 85.1 332 14.9 58 < 2 persons / room   Reference  0.75 60 86.7 52 13.3 8 ≥ 2 persons / room   Income:   0.17 (0.02 -1.70)  4.02*  446 85.7 382 14.3 64 Sufficient   Reference  0.04 4 50.0 2 50.0 2 Non-sufficient     450 85.3 384 14.7 66 Total          RC: Referent category",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"42 , No.7, July 2013 , pp.726-736   http://ijph.tums.ac.ir Available at:                                                                                                         732 Table 5 shows the effect of educational enviro n- ment on depression, students who had academic failure had significantly ( P < 0.05) higher rate of  depression (24.6%) compared to others (13.1%).",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
": Prevalence and Predictors of Anxiety  …   733                                                                                                                             http://ijph.tums.ac.ir Available at:     Students who felt that there no cooperation in the  faculty were about two -times more prone to d e- pression compared to others (OR= 2.14; 9 5% CI:  1.24-3.67, P = 0.005 ).",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"42 , No.7, July 2013 , pp.726-736  734                                                                                                       Available at:    http://ijph.tums.ac.ir  disorders was 54% and 48%, among the c linically  non -active and clinically active students, respec - tively ( 24) .This difference may be because Fin - land study screened many mental health prob - lems, but the current one screened anxiety and  depression only.",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
: Prevalence and Predictors of Anxiety  …  735                                                                                                                         http://ijph.tums.ac.ir Available at:     depression.,Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"42 , No.7, July 2013 , pp.726-736   http://ijph.tums.ac.ir Available at:    736                                                                                                         14.",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/ijph-42-726.PMC3881618.pdf
"7, July 2013 , pp.737 -747                                                                     Original Article   737   Available at:    http://ijph.tums.ac.ir       What Is To Be Expected from an Ethics Audit Integrated Within  the Accreditation Process of Hospitals from Romania?",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
": What Is To Be Expected From An Ethics Audit  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               738 instrument in the b uild-up of organizational integr i- ty, García -Marzá (4) a key factor in the manag e- ment of trust, and Weber (5) an instrument for e n- hancing the perfor mance of the organization.",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
"737-747  739                                                                                                        Available at:    http://ijph.tums.ac.ir   ployees and clients and to conflicts of interests,  defamation of character, monitoring, consultation,  clients’ complaints, providing training, prevention  of fraud, completion of services, ethics of deci - sion-making.",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
": What Is To Be Expected From An Ethics Audit  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               740 Similar initiatives (but more limited) in the ethical  assessment of hospital facilities can be given as  examples: auditing values applied to Calvary Hos - pital, Bronx, New York (22) in ensuring the eth - ics program; the national survey on ethics issues  in healthcare, commissioned by the St. Joseph’s  Hospital, Phoenix (ethics of allocating resources  and treatment efficacy) (23).",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
"737-747  741                                                                                                        Available at:    http://ijph.tums.ac.ir   ing the ethics audit within the accreditation sys - tem of hospit als from Romania, as well as co n- cerning its possible structure.",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
": What Is To Be Expected From An Ethics Audit  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               742 lected after consulting the scholarly literature  availa ble and on the basis of the good practices  enacted in the healthcare domain, both of which  are focused on the organizationa l ethics.",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
"737-747  743                                                                                                        Available at:    http://ijph.tums.ac.ir   cused on the respect of the moral rights of the  patients (M= 5.89, σ= 0.31), a percentage of 89.4%  of respondents (N = 42) expressing a complete  agreement for their inclusion in an ethics audit,  and 10.6%  (N = 5) a simple agreement.",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
: What Is To Be Expected From An Ethics Audit  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               744 σ= 0.64).,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
: What Is To Be Expected From An Ethics Audit  …  745   Available at:    http://ijph.tums.ac.ir     Table 1: Mean and standards deviation; issues in a hospital ethics audit      Variables  Mean  Minimum  Maximum  Standard  deviation  Sum  Part.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
": What Is To Be Expected From An Ethics Audit  …  Available at:    http://ijph.tums.ac.ir                                                                                                                               746 The p reoccupation from an ethical point of view  with the mission/vision of the organization se - cures a “moral guaranty” because the mission  itself is based on values, shapes the character and  the good reputation of the institution (31).",Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
Available from:    http://brainmass.com/business/business -law/164472     14.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
737-747  747                                                                                                      Available at:    http://ijph.tums.ac.ir  Publications Faculty Books and Publications .,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
Available from:   http://digitalcommons.ric.edu/cgi/viewcontent.cgi?arti cle=1172&context=facultypublications   16.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
Available from:   http://ethicssa.intoweb.co.za/UserFiles/ethicssaintow eb.co.za/CHBHFinalReport.pdf   22.,Non-OADS,/arxiv_data1/oa_pdf/3b/93/ijph-42-737.PMC3881619.pdf
"7, July 2013 , pp.748-757                                                       Original Article   748   Available at:    http://ijph.tums.ac.ir         Association of Smoking Habits of Mother during Pregnancy with  Pregnancy Outcome     *Cyrus AZIMI 1, Mahshid LOTFI 2    1.",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"Azimi & Lotfi : Association of Smoking Habits  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              749 myocardial infarction, and stroke) and pulmonary  disorders (bronchitis, asthma, pneumonia, in - fluenza) than non -smokers.",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"748-757  750                                                                                                       Available at:    http://ijph.tums.ac.ir  Table 1:  Distribution of smoking habits with respect to previous stillbirths and abortions         Non -smokers*  < 10 cigs/day  10 - 19 cigs/day  ≥ 20 cigs/day   No Previous Stillbirths   Odds Ratios     1 Previous Stillbirth   Odds Ratios   (95% CI)     2 or more Previous Still - births Odds Ratios   (95% CI)    28093 (98.07)   1.00    514 (1.80)   1.00      38 (0.13)   1.00 5154 (97.76)   1.00    111 (2.11)   1.18  (0.96 – 1.45)     7 (0.13)   1.00  (0.45 – 2.24)  8007 (97.07)   1.00    229 (2.77)   1.56  (1.33 – 1.83)     13 (0.16)   1.20  (0.64 – 2.25)  4683 (96.58)   1.00    157 (3.24)   1.83  (1.53 – 2.19)     9 (0.18)   1.42  (0.69 – 2.94)   Total/category  28645 (100.0)  5272 (100.0)  8249 (100.0)  4849 (100.0)   Non-smokers and light smokers 30.0 ,38.22 P  (see text)   All categories 0001.0 ,98.602 P   (see text)   No Previous Abortions   Odds Ratios     1 Previous Abortion   Odds ratios   (95% CI)     2 Previous Abortions   Odds Ratios   (95% CI)     3 or more Previous Abor - tions   Odds Ratios   (95% CI)    23397 (81.68)   1.00    4146 (14.47)   1.00      821 (2.87)   1.00      281 (0.98)   1.00     4296 (81.49)   1.00    810 (15.36)   1.06  (0.98 – 1.15)     127 (2.41)   0.84  (0.69 – 1.02)     39 (0.74)   0.76  (0.54 – 1.06)    6513 (78.96)   1.00    1330 (16.12)   1.15  (1.07 – 1.23)     292 (3.54)   1.28  (1.12 – 1.47)     114 (1.38)   1.46  (1.17 – 1.82)    3524 (72.67)   1.00    961 (19.82)   1.54  (1.42 – 1.67)     243 (5.01)   1.97  (1.70 – 2.28)     121 (2.50)   2.86  (2.30 – 3.55)     Total/category  28645 (100.0)  5272 (100.0)  8249 (100.0)  4849 (100.0)   Non-smokers and light smokers 036.0 ,51.82 P  (see text)   All categories 0001.0 ,77.2902  P   (see text)   Cigs: cigarettes /*Reference category     The frequency of previous neonatal deaths in rela - tion to smoking habits is given in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"Azimi & Lotfi : Association of Smoking Habits  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              751 Table 2:  Distribution of Smoking Habits with Respect to Previous Neonatal Deaths         Non -smokers*  < 10 cigs/day  10 -19 cigs/day  ≥ 20 cigs/day   No Neonatal Death   Odds Ratios     1 Neonatal Death   Odds Ratios   (95% CI)     2 or more Neonatal  Deaths   Odds Ratios   (95% CI)  28107 (98.12)   1.00    486 (1.70)   1.00      52(0.18)   1.00   5178 (98.22)   1.00    88 (1.67)   0.98  (0.78 – 1.23)     6(0.11)   0.63  (0.27 – 1.47)  8026 (97.29)   1.00    201 (2.44)   1.45  (1.23 – 1.71)     22(0.27)   1.48  (0.90 – 2.44)  4702 (96.97)   1.00    131 (2.70)   1.61  (1.32 – 1.96)     16(0.33)   1.84  (1.05 – 3.23)     Total/category    28645(100.0)    5272(100.0)    8249(100.0)    4849(100.0)   Non-smokers and light smokers 50.0 ,22.12 P  (see text) / All categories  0001.0 ,02.452  P  (see text) / Cigs: ciga - rettes /*Reference category     Table 3:  Distribution of Smoking Habits in Relation to Birth Weights        Birth Weight  Non -smokers*  < 10 cigs/day  10 -19 cigs/day  ≥ 20 cigs/day   2.5 kg or less   Odds  Ratios     2.6 – 2.9 kg   Odds  Ratios   (95% CI)     3.0 – 3.3 kg   Odds  Ratios   (95% CI)     3.4 – 3.7 kg   Odds Ratio   (95% CI)     3.8 – 4.1 kg   Odds Ratios   (95% CI)     4.2 or more   Odds Ratios   (95% CI)  2247(7.85)   1.00    4255(14.87)   1.00      8625(30.14)   1.00      8257(28.85)   1.00      3954(13.81)   1.00      1281(4.48)   1.00 580(11.02)   1.00    1041(19.78)   0.95  (0.85 – 1.06)     1679(31.90)   0.75  (0.68 – 0.84)     1261(23.96)   0.59  (0.53 – 0.66)     568(10.79)   0.56  (0.49 – 0.64)     134(2.55)   0.41  (0.34 – 0.50)  1225(14.87)   1.00    1884(22.87)   0.81  (0.74 – 0.88)     2669(32.39)   0.57  (0.53 – 0.62)     1725(20.94)   0.37  (0.34 – 0.40)     594(7.21)   0.28  (0.25 – 0.31)     142(1.72)   0.20  (0.17 – 0.24)  792(16.36)   1.00    1147(23.70)   0.76  (0.68 - 0.84)     1502(31.03)   0.49  (0.44 – 0.54)     983(20.31)   0.34  (0.31 – 0.38)     333(6.88)   0.24  (0.21 – 0.28)     83(1.72)   0.18  (0.14 – 0.23)     Total/category  28619(100.0)  5263(100.0)  8239(100.0)  4840(100.0)   All categories 0001.0 ,11.",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
748-757  752                                                                                                       Available at:    http://ijph.tums.ac.ir  The data from the present study suggest that  moth ers who smoke have ligh ter babies than  moth ers who do not smoke.,Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"Azimi & Lotfi : Association of Smoking Habits  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              753 Discussion     1) Smoking Habits and Previous Stillbirths  and Previous Abortions   Källen (8) reported that maternal smoking during  pregnancy is associated with a number of effects  such as pre -term birth, intrauterine growth  retarda tion, a small head circumference, and still - births and neonata l deaths.",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"748-757  754                                                                                                       Available at:    http://ijph.tums.ac.ir  The present results show that there is no signifi - cant difference between non -smokers and light  smokers with < 10 cigarettes per day  ( 50.0 ,22.12 P ).",Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
Azimi & Lotfi : Association of Smoking Habits  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              755 5) Smoking Habits and Outcomes on the 28th  Day of Life   The perinatal mortality (PNM) has been defined  (28) as the total number of stillbirths and deaths in  the first week of life (early neonatal deaths).,Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
748-757  756                                                                                                       Available at:    http://ijph.tums.ac.ir  experiment.,Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
Azimi & Lotfi : Association of Smoking Habits  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              757 25.,Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
Availa - ble from:  http://www.who.int/ceh/indicators/perinatal mortality.pdf   28.,Non-OADS,/arxiv_data1/oa_pdf/ac/0f/ijph-42-748.PMC3881620.pdf
"7, Jul 2013 , pp.758-766                                                     Original Article   758        Available at:    http://ijph.tums.ac.ir       Model for Implementing Evidence Based Health Care System in  Iran    Saeed MANAVI  1, *Alireza OLYAEE MANESH  1,2, Shahram YAZDANI  3, Lida SHAMS  4,  Taha NASIRI  5, Armin SHIRVANI  1, Hasan EMAMI RAZAVI  2    1.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
: Model for Implementing Evidence Based Health  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              759 Trans lation of knowledge into routine practice  process is a difficult task (6).,Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
758-766  760                                                                                                        Available at:    http://ijph.tums.ac.ir  for the best practice is insuring refer ence to the  best local evidence in different parts of the health  care.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
": Model for Implementing Evidence Based Health  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              761 dimen sions of organization and stewardship,  know ledge prod ucts, distribution and support of  evidence applica tion and the way of performa nce  monitor ing.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
"758-766  762                                                                                                        Available at:    http://ijph.tums.ac.ir       Fig.1:  National Clinical Knowledge Management System (NCKMS)     According to studies, insuring an evidence based  practice culture in the country requires a system  called national evidence -based health care system  which consists of three subsystems as follows:   a.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
": Model for Implementing Evidence Based Health  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              763 country, leads to products which are called Know - ledge Products.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
"758-766  764                                                                                                        Available at:    http://ijph.tums.ac.ir  Table 4:  Characteristics of the knowledge products produced by CKMs and EBCPs     Product characteristics  Evidence based care providers  Clinical knowledge managers   Objectives  Improvement of the personal  practice by care provider   direct benefiting to patients  benefiting to the community   development and expansion of the  knowledge boundaries   Product inclusion  the individual and in rare cases,  some of the available colleagues  all provides of the product target   Evidence production process  search method: nonsystematic   search sources: secondary sources  (based on evidence)   time allocated to finding evi dence:  very little time   criticism criteria: not available or  very simple criticism criteria   documentation of the stages: it is  not done often and if it is don e, it  is least used by others  search method: systematic (struc tured,  broad and documented)   search sources: primary sources   time allocated to finding evidence: too  much time (about for finding all rele - vant evidence)   criticism criteria: very accurate   documentation of the stages: accu rate  method for documentation at publisha - ble at national level   Production considerations  regarding values, considerations  and condition at patient level  at community proprieties and values  level  Organizing people for pr od- uct production  usually individually and perso nally in the form of multi -disciplinary  teams   Product type  provision of knowledge for evi - dence based decision making  through semi structured process  types of qualitative knowledge prod - ucts which are reviews by peers and are  bases for practice in the community   Financial resources needed for  production  usually very small  Production and updating it requires  considerable resources     Traditional care pro viders have the least  self- learn ing and there fore effort.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
: Model for Implementing Evidence Based Health  …  Available at:    http://ijph.tums.ac.ir                                                                                                                              765 medical education and other in volved organiza - tions in health policy making.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
758-766  766                                                                                                        Available at:    http://ijph.tums.ac.ir  9.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
"Ghajar -Zadeh M. Evidence based medicine, Stu- dent Research Center , Tehran University of Medi - cal Sciences, Available from:     http://etdctums.ir /  13.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
"http://www.ahrq.gov/clinic/epc/   17. anonymous, http://www.cebm.net/   18. anonymous:  http://www.nettingtheevidence.org.uk/   19. anonymous:  http://hlwiki.slais .ubc.ca/index.php/Evi - dence -based_health_care   20.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
Available from:   http://www.nhmrc.gov.au/   23.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/ijph-42-758.PMC3881621.pdf
"767-774                                                            Original Article   767   Available at:    http://ijph.tums.ac.ir      Correlation of Serum Free Carnitine with Serum Ferritin and Vi t- amin C Levels in Type II Diabetic Men     Ahmad POURABBAS 1, *Farnoush FALLAH 2, Reza MAHDAVI 3, Akbar   ALIASGARZA DEH 4    1.",Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
": Correlation of Serum Free Carnitine  …    Available at:    http://ijph.tums.ac.ir   768 concentrations are asso ciated with increased risk  of developing  type II diabetes (7 -9), causality can - not be concluded from these cross -sectional stu - dies, since the possi bility of reverse causality  through which type II diabetes mellitus may cause  elevated serum ferri tin levels rather than the con - verse, should not be neglected (1,10 -11)   Dyslipidemia in diabetes melli tus with a characte r- istic feature of elevated plasma triglyce ride and  LDL -Cholesterol concentrations is well esta b- lished (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
"42 , No.7, July 2013 , pp.767-774  769   Available at:    http://ijph.tums.ac.ir  meters.",Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
: Correlation of Serum Free Carnitine  …    Available at:    http://ijph.tums.ac.ir   770     Fig.,Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
"42 , No.7, July 2013 , pp.767-774  771   Available at:    http://ijph.tums.ac.ir  current study was lower than those observed in  these patients in USA (28) (520±166 µg/l), and  Singapore (4) (231 µg/l).",Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
: Correlation of Serum Free Carnitine  …    Available at:    http://ijph.tums.ac.ir   772 which are part of the whole L -carnitine pool ; so  we could not assess the possi ble associations b e- tween vitamine C or ferri tin with carnitine deriv a- tives and total carnitine levels.,Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
"42 , No.7, July 2013 , pp.767-774  773   Available at:    http://ijph.tums.ac.ir  11.",Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
: Correlation of Serum Free Carnitine  …    Available at:    http://ijph.tum s.ac.ir   774 tabolism in dia betes mellitus.,Non-OADS,/arxiv_data1/oa_pdf/f1/05/ijph-42-767.PMC3881622.pdf
"775-782                                                                Original Article   775   Available at:    http://ijph.tums.ac.ir      Polymorphism in Exon 2 of CD1 Genes in Southwest of Iran     Hossein GOLMOGHADDAM  1, Nargess ARANDI  1, Abbas GHADERI  1,2, *Mehrnoosh  DOROUDCHI  1,2    1.",Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
: Polymorphism in Exon 2 of CD1  Genes  …  Available at:    http://ijph.tums.ac.ir   776 has been under investigation during the past two  decades (12-17).,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
"775-782  777   Available at:    http://ijph.tums.ac.ir  PCR Condition   The PCR reaction was performed in a total vo - lume of 25 µl including 13.5 µL DW, 2.5 µl of  PCR buffer 10X, 0.75 µl MgCl2 (50 mM), 0.75 µl  dNTP (10 mM), 1 µl of each primer (20 pm), 1  µL of each internal control primers , 1 µl of ge - nomic DNA (0.3 ng/ml), 0.5 µl Tween -20 and 2  µl Taq polymerase (1U).",Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
: Polymorphism in Exon 2 of CD1  Genes  …  Available at:    http://ijph.tums.ac.ir   778     Fig.1: Gel electrophoresis of PCR products of CD1a and CD1e alleles.,OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
775-782  779   Available at:    http://ijph.tums.ac.ir  Our findings also indicate that the CD1a and  CD1e gene polym orphisms in exon 2 are largely  different among various ethnic groups in Asia.,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
: Polymorphism in Exon 2 of CD1  Genes  …  Available at:    http://ijph.tums.ac.ir                                                                                   780 5.,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
775-782     781                                                                                                    Available at:    http://ijph.tums.ac.ir                                                                                     26.,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
: Polymorphism in Exon 2 of CD1  Genes  …    Available at:    http://ijph.tums.ac.ir                                                                                                                              782 46.,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/ijph-42-775.PMC3881623.pdf
"7, Jul 2013 , pp.783-784                                       Letter to the Editor   783   Available at:    http://ijph.tums.ac.ir         On the Effectiveness of Primary Health Care System in  Control ling HIV/AIDS in Iran     Mohammad KARAMOUZIAN  1, Shahrzad MOTAGHIPISHEH  2, *Ali -Akbar   HAGH DOOST  1    1 Regional Knowledge Hub for HIV/AIDS Surveillance, Institute for Futures Studies in Health, Kerman University of  Medical Sciences, Kerman, Iran   2 Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences,  Kerman, Iran     *Corresponding Author:  Email: ahaghdoost@kmu.ac.ir     (Received 25 May 2013; accepted 10 June 2013)     Dear Editor -in-Chief     We very much enjoyed reading a letter by Drs Joulaei  and Motazedian published in an earlier issue of your  journal (1).",Non-OADS,/arxiv_data1/oa_pdf/1f/a3/ijph-42-783.PMC3881624.pdf
: On the Effectiveness of Primary Health Care  …    Available at:    http://ijph.tums.ac.ir   784 Iran.,Non-OADS,/arxiv_data1/oa_pdf/1f/a3/ijph-42-783.PMC3881624.pdf
"7, July 2013 , pp.785-786                                          Letter to the Editor    785   Available at:    http://ijph.tums.ac.ir         The Concept of Liver Disease Diagnosis in Avicenna’s Canon  of Medicine     ٭Efat SHAHKARAMI  1, Bagher MINAEI  1, 2 ,Efat JAFARI DEHKORDI  1    1.",Non-OADS,/arxiv_data1/oa_pdf/fc/7a/ijph-42-785.PMC3881625.pdf
: The Concept of Liver Disease Diagnosis  …    Available at:    http://ijph.tums.ac.ir   786 i.,Non-OADS,/arxiv_data1/oa_pdf/fc/7a/ijph-42-785.PMC3881625.pdf
"7, July 2013 , pp.787-788                                           Letter to the Editor   787   Available at:    http://ijph.tums.ac.ir       Avicenna Aspect of Cardiac Risk Factors     *Marzieh -Baygom SIAHPOOSH  1, Fatemeh NEJATBAKHSH  2,3    1.",Non-OADS,/arxiv_data1/oa_pdf/e9/7c/ijph-42-787.PMC3881626.pdf
Siahpoosh  &  Nejatbakhsh : Avicenna Aspect of Cardiac  …    Available at:    http://ijph.tums.ac.ir   788 References     1.,Non-OADS,/arxiv_data1/oa_pdf/e9/7c/ijph-42-787.PMC3881626.pdf
"7, July 2013 , pp.789-790                                             Letter to the Editor   789   Available at:    http://ijph.tums.ac.ir         Avicenna and Oral Lithotripters     *Reza ILKHANI  1, Abdolrasoul MEHRSAI  2, Hossein MORADI  3    1.",Non-OADS,/arxiv_data1/oa_pdf/05/54/ijph-42-789.PMC3881627.pdf
: Avicenna and Oral  …    Available at:    http://ijph.tums.ac.ir   790 among Eastern and Western intellectuals.,Non-OADS,/arxiv_data1/oa_pdf/05/54/ijph-42-789.PMC3881627.pdf
"7, July 2013 , pp.791-792                                          Letter to the Editor   791   Available at:    http://ijph.tums.ac.ir        Public Health Surveillance and Hajj Pilgrimage as a Mass  Gather ing    Manoochehr KARAMI     Research Center for Health Sciences and Department of Biostatistics & Epidemiology, School of Public Health,  Hamadan  University of Medical Sciences, Hamadan, Iran     *Corresponding Author:  Email : ma.karami@umsha.ac.ir     (Received 15 Mar 2013; accepted 30 May 2013)    Dear Editor -in-Chief     A mass gathering (MG) is defined by World  Health Organization (WHO) as “any occasion,  either organized or spontaneous, that attracts  sufficient numbers of people  to strain the plan - ning and response resources of the community,  city or nation hosting the event”  (1).",Non-OADS,/arxiv_data1/oa_pdf/69/0b/ijph-42-791.PMC3881628.pdf
Karami : Public Health Surveillance and Hajj  …    Available at:    http://ijph.tums.ac.ir   792 erings.,Non-OADS,/arxiv_data1/oa_pdf/69/0b/ijph-42-791.PMC3881628.pdf
Geneva: World Health Organization;  Available from:   http://www.who.int/csr/resources/publicatio ns/WHO_HSE_.,Non-OADS,/arxiv_data1/oa_pdf/69/0b/ijph-42-791.PMC3881628.pdf
"7, July 2013 , pp.793-794                                         Letter to the Editor   793   Available at:    http://ijph.tums.ac.ir        Impact of Emotional Intelligence towards Leadership among  IT/ITES employees in Coimbatore Region                     Srividhya  SEETHAPATHY 1, 2, Venkatesh RADHAKRISHNAN 3    1.",Non-OADS,/arxiv_data1/oa_pdf/01/2b/ijph-42-793.PMC3881629.pdf
Seethapathy  & Radhakrishnan : Impact of Emotional Intelligence …    Available at:    http://ijph.tums.ac.ir   794 that there is very least significant variance on Ot h- er Emotion Appraisal (OEA) on the fact in sector  and gender.,Non-OADS,/arxiv_data1/oa_pdf/01/2b/ijph-42-793.PMC3881629.pdf
Available from: <http://www.bsac.org.uk/_db/_documents/version_7_1_february_2008.pdf>4- Brook I. Microbiology and principles of antimicrobial therapy for head and neck infections.,Non-OADS,/arxiv_data1/oa_pdf/98/10/jaos-18-06-0551.PMC3881752.pdf
"Available from: <http://storkview.storksmt.com/specsite/newspecdetail.asp?topic=ASTM_G154(G53)&sid=320>.4- Anil N, Hekimoglu C, Sahin S. Color stability of heat-polymerized  and autopolymerized soft denture liners.",Non-OADS,/arxiv_data1/oa_pdf/9e/0b/jaos-18-06-0641.PMC3881761.pdf
"We also invite all  readers, contributors and reviewers to visit our free complete online collection at http://www.scielo.br/jaos.",Non-OADS,/arxiv_data1/oa_pdf/3d/da/jaos-18-06-0000.PMC3881764.pdf
The teeth were randomly (http://www.random.org) divided into 3 experimental groups (n=11).,Non-OADS,/arxiv_data1/oa_pdf/c8/e7/jaos-20-03-0329.PMC3881782.pdf
"68ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302295 Marginal adaptation of class V composite  restorations submitted to thermal and mechanical cycling Denise Sá Maia CASSELLI1, André Luis FARIA-E-SILVA2, Henrique CASSELLI3, Luis Roberto Marcondes MARTINS4 1- DDS, MSc, PhD, Department of Dentistry, Federal University of Ceará, Sobral, CE, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/b9/12/jaos-21-01-0068.PMC3881802.pdf
"48ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302312 Polyspecies biofilm formation on implant surfaces  with different surface characteristics Patrick R. SCHMIDLIN1, Phillip MÜLLER2, Thomas ATTIN3, Marco WIELAND4, Deborah HOFER5, Bernhard  GUGGENHEIM6 1- PD Dr. med.",Non-OADS,/arxiv_data1/oa_pdf/34/4a/jaos-21-01-0048.PMC3881803.pdf
85ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302147 Do blood contamination and haemostatic agents  affect microtensile bond strength of dual cured resin cement to dentin?,Non-OADS,/arxiv_data1/oa_pdf/54/93/jaos-21-01-0085.PMC3881804.pdf
"20ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302124 Mechanical testing of thin-walled zirconia  abutments Luigi CANULLO1, Paulo G. COELHO2,3, Estevam A. BONFANTE4 1- DDS, Private Practice, Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/jaos-21-01-0020.PMC3881805.pdf
"56ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302370 effect of phosphoric acid etching on the shear  bond strength of two self-etch adhesives Camila SABATINI1 1- DDS, MS, Assistant Professor, SUNY at Buffalo, School of Dental Medicine Department of Restorative Dentistry, Buffalo, NY, USA.",Non-OADS,/arxiv_data1/oa_pdf/10/c3/jaos-21-01-0056.PMC3881806.pdf
"32ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302200 Biocompatibility and setting time of CPM-MTA  and white Portland cement clinker with or without calcium sulfate Clovis Monteiro BRAMANTE1, Marcia Magro KATO2, Gerson Francisco de ASSIS3, Marco Antonio Hungaro DUARTE4,  Norberti BERNARDINELI1, Ivaldo Gomes de MORAES1, Roberto Brandão GARCIA4, Ronald ORDINOLA-ZAPATA2,  Alexandre Silva BRAMANTE2 1- DDS, PhD, Full Professor, Discipline of Endodontics, Department of Operative Dentistry, Endodontics and Dental Materials, Bauru School of Dentistry,  University of São Paulo, Bauru, SP Brazil.2- DDS, PhD in Endodontics, Department of Operative Dentistry, Endodontics and Dental Materials, Bauru School of Dentistry, University of São Paulo, Bauru, SP Brazil.",Non-OADS,/arxiv_data1/oa_pdf/eb/a7/jaos-21-01-0032.PMC3881807.pdf
"25ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302129 effect of Zingiber officinale and propolis on  microorganisms and endotoxins in root canals Lilian Eiko MAEKAWA1, Marcia Carneiro VALERA2,Luciane Dias de OLIVEIRA3, Cláudio Antonio Talge CARVALHO4,  Carlos Henrique Ribeiro CAMARGO4, Antonio Olavo Cardoso JORGE5 1- DDS, MSc, PhD, Department of Restorative Dentistry, UNESP - Univ Estadual Paulista, São José dos Campos, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/55/42/jaos-21-01-0025.PMC3881809.pdf
"63ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302168 Chemical treatment of the intra-canal dentin  surface: a new approach to modify dentin hydrophobicity Cesar GAITAN-FONSECA1, Pierre-Yves COLLART-DUTILLEUL2, Vincent SEMETEY3, Olivier ROMIEU4, Roel CRUZ5,  Hector FLORES6, Frédéric CUISINIER7, Elías PÉREZ8, Amaury POZOS-GUILLEN9 1- DDS, MSc, Institutional Doctorate in Engineering and Science Materials, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.",Non-OADS,/arxiv_data1/oa_pdf/84/84/jaos-21-01-0063.PMC3881810.pdf
"1ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302106 Periodontal disease and diabetes mellitus Carlos Antonio NEGRATO1, Olinda TARZIA2, Lois JOVANOVIČ3, Luiz Eduardo Montenegro CHINELLATO4 1- PhD in Medical Sciences, Research Support Center, Diabetics Association of Bauru, São Paulo, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/b4/c9/jaos-21-01-0001.PMC3881811.pdf
"13ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302280 2013;21(1):13-9Water fluoridation in 40 Brazilian cities: 7 year  analysis Suzely Adas Saliba MOIMAZ1, Nemre Adas SALIBA1, Orlando SALIBA1, Doris Hissako SUMIDA2, Neila Paula de  SOUZA3, Fernando Yamamoto CHIBA4, Cléa Adas Saliba GARBIN5 1- DDS, MsC, PhD, Full Professor, Preventive and Social Dentistry Post-Graduation Program, Univ.",Non-OADS,/arxiv_data1/oa_pdf/88/b7/jaos-21-01-0013.PMC3881812.pdf
"Available  from: http://www.ibge.gov.br/home/presidencia/noticias/noticia_ visualiza.php?id_noticia=2017&id_pagina=1.12- Lodi CS, Ramires I, Buzalaf MA, Bastos JR. Fluoride concentration in water at the area supplied by the Water Treatment Station of Bauru, SP.",Non-OADS,/arxiv_data1/oa_pdf/88/b7/jaos-21-01-0013.PMC3881812.pdf
Available from: http://www.un.org/en/documents/udhr/ 24- United Nations.,Non-OADS,/arxiv_data1/oa_pdf/88/b7/jaos-21-01-0013.PMC3881812.pdf
"43ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302304 Long-term cytotoxic effects of contemporary root  canal sealers Emmanuel João Nogueira Leal da SILVA1, Carolina Carvalho SANTOS1, Alexandre Augusto ZAIA2 1- DDS, MSc, PhD student, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/1d/47/jaos-21-01-0043.PMC3881813.pdf
"37ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302138 Synthesis and cytotoxicity evaluation of granular  magnesium substituted β-tricalcium phosphate Débora dos Santos TAVARES1, Leticia de Oliveira CASTRO2, Gloria Dulce de Almeida SOARES3, Gutemberg Gomes  ALVES4, José Mauro GRANJEIRO5 1- DDS, MSc, PhD, Professor, Sergipe Federal University, Lagarto, SE, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/93/ad/jaos-21-01-0037.PMC3881814.pdf
"80ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302329 Six-month evaluation of a resin/dentin interface  created by methacrylate and silorane-based materials Renata Kirita Doi SAMPAIO1, Linda WANG2, Rodrigo Varella de CARVALHO3, Eugenio José GARCIA4, Andréa Mello  de ANDRADE4, Celso Afonso KLEIN-JÚNIOR5, Rosa Helena Miranda GRANDE6, Sandra Kiss MOURA3 1- DDS, MSc, University North of Paraná, Londrina, PR, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/16/50/jaos-21-01-0080.PMC3881815.pdf
Gustavo Pompermaier Garlet Co-Editor-in-Chief Journal of Applied Oral Science http://dx.doi.org/10.1590/1678-77572013ed001,Non-OADS,/arxiv_data1/oa_pdf/46/87/jaos-21-01-0000.PMC3881816.pdf
"74ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302322 Ex vivo microbial leakage after using different  final irrigation regimens with chlorhexidine Esther NAVARRO-ESCOBAR1, Pilar BACA2, María Paloma GONZÁLEZ-RODRÍGUEZ3, María Teresa ARIAS-MOLIZ4,  Matilde RUIZ5, Carmen María FERRER-LUQUE6 1- PhD, Postgraduate Student, Department of Operative Dentistry, School of Dentistry.",Non-OADS,/arxiv_data1/oa_pdf/74/65/jaos-21-01-0074.PMC3881817.pdf
"Available from: http://fnic.nal.usda.gov/nal_display/index.php?info_ center=4&tax_level=1  5- Gerrard WA, Winter PJ.",OADS,/arxiv_data1/oa_pdf/74/2b/jaos-20-04-0410.PMC3881819.pdf
"Available from: <http://www.matweb.com.br>.17- McDonald AV, King PA, Setchell DJ.",Non-OADS,/arxiv_data1/oa_pdf/62/3c/jaos-20-04-0427.PMC3881830.pdf
"482ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130014 The modified Ottawa method to establish the  update need of a systematic review: glass-ionomer versus resin sealants for caries prevention Steffen MICKENAUTSCH1, Veerasamy YENGOPAL1 1- SYSTEM Initiative/Department of Community Dentistry, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/c3/da/jaos-21-05-0482.PMC3881834.pdf
"Fixed effects meta-analysis for the identification  of quantitative signals was conducted, using  RevMan Version 4.2 statistical software of the Nordic Cochrane Centre, The Cochrane Collaboration  Citations  includedArticles accepted Expanded Academic ASAP PLUS search strategy: 26.04.12 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) BMC search strategy: 2009 – 2012 (Boolean search) Online: http://www.biomedcentral.com/search/ (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) Cochrane Oral Health Reviews search strategy: 2009 – 2012  (Advanced search) Online: http://www.thecochranelibrary.com/view/0/index.html4 0 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay)DOAJ search strategy: Date of search 26.04.12 Online: http://www.doaj.org5 0 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) Meta Register Of Controlled Trials search strategy: Date of search 26.04.12 Online: http://www.controlled-trials.com/isrctn/search.html 0 0 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) Science-Direct search strategy: 2009 – present/26.04.12  (Expert search) Online: http://www.sciencedirect.com 0 0 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) PubMed search strategy: 26.08.09 - 26.04.12Online: http://www.pubmed.org 8 0 (GIC sealant* OR glass ionomer cement sealant) AND (caries OR tooth decay) 29 1 * fissure sealant AND glass ionomer AND resin 28 2 Reference check: 26.04.12 0 Ad-hoc hand search: 26.04.12  1 Total articles included: 4 *Additional PubMed search Figure 2- Details of applied search strategyMICKENAUTSCH S, YENGOPAL V 2013;21(5):482-9",Non-OADS,/arxiv_data1/oa_pdf/c3/da/jaos-21-05-0482.PMC3881834.pdf
Available from: http://www.cochrane-net.org/openlearning/html/mod19-2.htm.,OADS,/arxiv_data1/oa_pdf/c3/da/jaos-21-05-0482.PMC3881834.pdf
Available from: http://effectivehealthcare.ahrq.gov/ehc/products/265/702/Updating-Systematic-Reviews_Final-Report_20110614.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c3/da/jaos-21-05-0482.PMC3881834.pdf
"475ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130204 Abrasion of 6 dentifrices measured by vertical  scanning interference microscopy Florence PASCARETTI-GRIZON1, Guillaume MABILLEAU1,2, Daniel CHAPPARD1 1- LUNAM University, Groupe Études Remodelage Osseux et bioMatériaux (GEROM – LHEA), Institut de Biologie en Santé, Centre Hospitalier Universitaire  d'Angers, Angers, France.2- LUNAM University, Service Commun d'Imagerie et Analyses Microscopiques (SCIAM), Institut de Biologie en Santé, Centre Hospitalier Universitaire d'Angers, Angers, France.",Non-OADS,/arxiv_data1/oa_pdf/8d/62/jaos-21-05-0475.PMC3881835.pdf
"460ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130317 Oral squamous cell carcinoma: clinicopathological  features from 346 cases from a single Oral Pathology service during an 8-year period Fábio Ramôa PIRES1, Amanda Barreto RAMOS1, Jade Bittencourt Coutinho de OLIVEIRA1, Amanda Serra TAVARES1,  Priscilla Silva Ribeiro da LUZ1, Teresa Cristina Ribeiro Bartholomeu dos SANTOS1 1- Department of Oral Pathology, School of Dentistry, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/32/0b/jaos-21-05-0460.PMC3881836.pdf
"409ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130201 etidronate from Medicine to endodontics: effects  of different irrigation regimes on root dentin  roughness Talita TARTARI1, Anivaldo Pereira DUARTE JUNIOR2, José Otávio Carrera SILVA JÚNIOR2, Eliza Burlamaqui  KLAUTAU3, Mario Honorato SILVA E SOUZA JUNIOR4, Patrícia de Almeida Rodrigues SILVA E SOUZA1  1- Department of Endodontics, Dental School, Federal University of Pará, Belém, PA, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/15/9f/jaos-21-05-0409.PMC3881837.pdf
"392ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130046  2013;21(5):392-6Impact of removable partial denture prosthesis  on chewing efficiency Marion BESSADET, Emmanuel NICOLAS, Marine SOCHAT, Martine HENNEQUIN, Jean-Luc VEYRUNE Clermont Université, Université d'Auvergne, Centre de Recherche en Odontologie Clinique; CHU Clermont-Ferrand, Service d'Odontologie, Hôtel-Dieu France,  Clermont-Ferrand, France.",Non-OADS,/arxiv_data1/oa_pdf/28/01/jaos-21-05-0392.PMC3881838.pdf
"443ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130160 Bone remodeling at microscrew interface near  extraction site in the beagle dog mandible-histologic and immunohistochemical analyses Guangxi WEI1,2,3, Yun HU2,3,4, Leilei ZHENG1,2, Jinfeng HUO1,2, Tian TANG5, Feng DENG1,2,3 1- Department of Orthodontics, the Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing, P. R. China.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/jaos-21-05-0443.PMC3881839.pdf
"430ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130252 Leukotoxicity of Aggregatibacter   actinomycetemcomitans  in generalized aggressive  periodontitis in Brazilians and their family members Virginia Régia Souza SILVEIRA1, Márcia Viana Bessa NOGUEIRA1, Nádia Accioly Pinto NOGUEIRA2, Vilma LIMA3,  Flávia Aparecida Chaves FURLANETO4, Rodrigo Otávio REGO5 1- Graduate Program in Dentistry, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, CE, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3c/31/jaos-21-05-0430.PMC3881840.pdf
"Available from: http://www.ibge.gov.br/home/ estatistica/populacao/condicaodevida/indicadoresminimos/sinteseindicsociais2010/SIS_2010.pdf.4- Brogan JM, Lally eT, Poulsen K, Kilian M, Demuth DR. Regulation  of Actinobacillus actinomycetemcomitans leukotoxin expression:  analysis of the promoter regions of leukotoxic and minimally  leukotoxic strains.",OADS,/arxiv_data1/oa_pdf/3c/31/jaos-21-05-0430.PMC3881840.pdf
"403ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130184 Coronal microleakage of endodontically treated  teeth with intracanal post exposed to fresh human saliva Simone Gomes Dias de OLIVEIRA1, Denise Jornada GOMES2, Marcelo Hissé das Neves COSTA3, Ezilmara Rolim  de SOUSA4, Rafael Guerra LUND5 1- Laboratory of Microbiology, School of Dentistry, Federal University of Pelotas, Pelotas, RS, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/8d/84/jaos-21-05-0403.PMC3881841.pdf
"452ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130120 evaluation of bond strength of silorane and  methacrylate based restorative systems to dentin  using different cavity models Stephano Zerlottini ISAAC, Ana Claudia Pietrobom BERGAMIN, Cecília Pedroso TURSSI, Flávia Lucisano Botelho do AMARAL, Roberta Tarkany BASTING, Fabiana Mantovani Gomes FRANÇA 1- Department of Restorative Dentistry, São Leopoldo Mandic Institute and Research Center, Campinas, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/29/87/jaos-21-05-0452.PMC3881842.pdf
"416ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130206 Low expression of MSH2 DNA repair protein is  associated with poor prognosis in head and neck squamous cell carcinoma Camila Santos PEREIRA1, Marcos Vinícius Macedo de OLIVEIRA1, Lucas Oliveira BARROS1, Gabriela Alencar  BANDEIRA1, Sérgio Henrique Sousa SANTOS1,2, John R. BASILE3, André Luiz Sena GUIMARÃES1,4, Alfredo Maurício  Batista DE PAULA1,4 1- Nucleus of Epidemiological and Molecular Research Catrumano.",Non-OADS,/arxiv_data1/oa_pdf/8e/88/jaos-21-05-0416.PMC3881843.pdf
2013;21(5):460-7.http://dx.doi.org/10.1590/1678-77572013ed005 2013;21(5):391,Non-OADS,/arxiv_data1/oa_pdf/93/94/jaos-21-05-0391.PMC3881844.pdf
"422ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130113 Clinical and radiographic evaluation of Bio-Gen  with biocollagen compared with Bio-Gen with connective tissue in the treatment of class II furcation defects: a randomized clinical trial Niloofar JENABIAN1, Sina HAGHANIFAR2, Avideh MABOUDI3, Ali BIJANI4 1- Department of  Periodontics, Dental Faculty, Dental Materials Research Center, Babol University of Medical Sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/41/74/jaos-21-05-0422.PMC3881845.pdf
"490ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130148 Mandibular metastasis of adenocarcinoma  from prostate cancer: case report according to epidemiology and current therapeutical trends of the advanced prostate cancer Juliana Dreyer da Silva de MENEZES1, Pietro Franchon Marques CAPPELLARI2, Marcos Maurício CAPELARI3,Paulo  Zupelari GONÇALVES4, Gustavo Lopes TOLEDO5, João Lopes TOLEDO FILHO6, Arsenio SALES-PERES7, Clóvis  MARZOLA8 1- Hospital for Rehabilitation of Craniofacial Anomalies, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/jaos-21-05-0490.PMC3881846.pdf
Available from: http://www.inca.gov.br/conteudo_view.asp?id=339.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/jaos-21-05-0490.PMC3881846.pdf
"468ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130229 Wizard CD Plus and ProTaper Universal: analysis  of apical transportation using new software Daiana GIANNASTASIO1, Ricardo Abreu da ROSA2, Bernardo Urbanetto PERES3, Mirela Sangoi BARRETO4, Gustavo  Nogara DOTTO4, Milton Carlos KUGA5, Jefferson Ricardo PEREIRA6, Marcus Vinícius Reis SÓ7 1- Department of Endodontics, Pontifical Catholic University of Rio Grande do Sul - PUCRS, Porto Alegre, RS, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/11/fe/jaos-21-05-0468.PMC3881847.pdf
Available from: http://tede.pucrs.br/tde_busca/arquivo.php?codArquivo=4185.7- Dotto GN.,OADS,/arxiv_data1/oa_pdf/11/fe/jaos-21-05-0468.PMC3881847.pdf
"437ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130091 evaluation of the intercanine distance in newborns  with cleft lip and palate using 3D digital casts Bianca Zeponi Fernandes MELLO1, Viviane Mendes FERNANDES2, Cleide Felício Carvalho CARRARA2, Maria  Aparecida Andrade Moreira MACHADO3, Daniela Gamba GARIB4, Thais Marchini OLIVEIRA4 1- Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/af/f5/jaos-21-05-0437.PMC3881848.pdf
"397ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130049 Importance of a distal proximal contact on load  transfer by implant-supported single adjacent crowns in posterior region of the mandible: a photoelastic study Fábio Afrânio de AGUIAR JÚNIOR, Rodrigo TIOSSI, Ana Paula MACEDO, Maria da Gloria Chiarello de MATTOS, Ricardo Faria RIBEIRO, Renata Cristina Silveira RODRIGUES Department of Dental Materials and Prosthodontics, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP , Brazil.",Non-OADS,/arxiv_data1/oa_pdf/4e/cf/jaos-21-05-0397.PMC3881849.pdf
"We also invite all readers,  contributors and reviewers to visit our free complete  online collection at http://www.scielo.br/jaos.",Non-OADS,/arxiv_data1/oa_pdf/09/ef/jaos-20-06-0000.PMC3881854.pdf
"163ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302308 efficacy of HPA Lanolin® in treatment of lip  alterations related to chemotherapy Paulo Sérgio da Silva SANTOS1, José Endrigo TINÔCO-ARAÚJO2, Lucas Monteiro de Vasconcelos Alves de  SOUZA3, Rafael FERREIRA3, Maura Rosane Valério IKOMA4, Ana Paula Ribeiro RAZERA5, Márcia Mirolde Magno  de Carvalho SANTOS6 1- DDS, PhD, Professor, Department of Stomatology, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ee/5c/jaos-21-02-0163.PMC3881864.pdf
"150ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302270 Prevalence of long face pattern in Brazilian  individuals of different ethnic backgrounds Mauricio de Almeida CARDOSO1, Renata Cristina Faria Ribeiro de CASTRO1, Tien LI AN2, David NORMANDO3,  Daniela Gamba GARIB4, Leopoldino CAPELOZZA FILHO1 1- DDS, PhD, Professor of Orthodontics, University of Sagrado Coração - USC, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/79/43/jaos-21-02-0150.PMC3881865.pdf
"177ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302362 effect of ozone gas on the shear bond strength  to enamel Patrícia Teixeira PIRES1, João Cardoso FERREIRA1, Sofia Arantes OLIVEIRA2, Mário Jorge SILVA3, Paulo Ribeiro  MELO4 1- DDS, MS, PhD student, Dental School, Department of Operative Dentistry, University of Porto, Porto, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/c6/67/jaos-21-02-0177.PMC3881866.pdf
"196ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302136 effect of the application time of phosphoric acid  and self-etch adhesive systems to sclerotic dentin Alexandra Patricia MENA-SERRANO1, Eugenio Jose GARCIA2, Miguel Muñoz PEREZ3, Gislaine Cristine MARTINS4,  Rosa Helena Miranda GRANDE5, Alessandro Dourado LOGUERCIO6, Alessandra REIS7 1- DDS, MSc, PhD student, School of Dentistry, Department of Restorative Dentistry, State University of Ponta Grossa, Ponta Grossa, PR, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/5a/03/jaos-21-02-0196.PMC3881867.pdf
"124ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302185 Surface hardness evaluation of different composite  resin materials: influence of sports and energy drinks immersion after a short-term period Ugur ERDEMİR1, Esra yİLDİZ2, Meltem Mert EREN3, Sevda OZEL4 1- DDS, PhD, Department of Operative Dentistry, School of Dentistry, Istanbul University, Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/be/db/jaos-21-02-0124.PMC3881868.pdf
"208ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302366 Photodynamic therapy associated with full-mouth  ultrasonic debridement in the treatment of severe chronic periodontitis: a randomized-controlled clinical trial Maybel Lages BALATA1, Lyla Prates de ANDRADE2, David Barros Nunes SANTOS3, Andrea Nóbrega CAVALCANTI4,  Urbino da Rocha TUNES4, Érica Del Peloso RIBEIRO4, Sandro BITTENCOURT4 1- MS, Specialist in Periodontics, Bahiana School of Medicine and Public Health, Salvador, BA, Brazil  2- Specialist in Periodontics, Bahiana School of Medicine and Public Health, Salvador, BA, Brazil 3- Graduate student, Bahiana School of Medicine and Public Health, Salvador, BA, Brazil4- DDS, MSc, PhD, Bahiana School of Medicine and Public Health, Salvador, BA, Brazil  Corresponding address: Sandro Bittencourt  - Avenida Silveira Martins, n. 3386 - Cabula - 41150-100 - Salvador - BA - Brazil - Phone: 71-9156-1998 - Fax  number: 71-3257-8230 - e-mail: sandrobittencourt@yahoo.com Received: May 7, 2012 - Modification: January 4, 2013 - Accepted: January 31, 2013 Background: Photodynamic therapy (PDT) is a method of microbial reduction which can  benefit periodontal treatment in areas of difficult access, such as deep pockets and  furcations.",Non-OADS,/arxiv_data1/oa_pdf/58/9f/jaos-21-02-0208.PMC3881869.pdf
"112ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302117 Minimal alterations on the enamel surface by  micro-abrasion: in vitro roughness and wear  assessments Marcela Charantola RODRIGUES1, Rafael Francisco Lia MONDELLI2, Gabriela Ulian OLIVEIRA3, Eduardo Batista  FRANCO4, Wagner BASEGGIO5, Linda WANG2 1- MSc, PhD student, Department of Operative Dentistry, Dental Materials and Endodontics, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/80/86/jaos-21-02-0112.PMC3881870.pdf
"106ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302116 Cellular proliferation markers in peripheral and  central fibromas: a comparative study Bruna Gonçalves GARCIA1, Patrícia Carlos CALDEIRA1, Aline Cristina Batista Rodrigues JOHANN2, Suzana  Cantanhede Orsini Machado de SOUSA3, Marcelo Vidigal CALIARI4, Maria Auxiliadora Vieira do CARMO5, Ricardo  Alves MESQUITA6 1- MSc, Department of Oral Surgery and Pathology, School of Dentistry, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.",OADS,/arxiv_data1/oa_pdf/13/1c/jaos-21-02-0106.PMC3881872.pdf
"190ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302380 Post-curing conversion kinetics as functions of  the irradiation time and increment thickness Nicola SCOTTI1, Alberto VENTURELLO2, Francesco Andrea Coero BORGA3, Damiano PASQUALINI4, Davide Salvatore  PAOLINO5, Francesco GEOBALDO6, Elio BERUTTI7 1- DDS, Assistant Professor, Department of Surgical Sciences, Dental School Lingotto, University of Turin, Turin, Italy.",Non-OADS,/arxiv_data1/oa_pdf/7d/7e/jaos-21-02-0190.PMC3881873.pdf
"118ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302135 In vitro antimicrobial activity of auxiliary chemical  substances and natural extracts on Candida albicans and Enterococcus faecalis  in root canals Marcia Carneiro VALERA1, Lilian Eiko MAEKAWA2, Luciane Dias de OLIVEIRA3, Antonio Olavo Cardoso JORGE4,  Érika SHyGEI5, Cláudio Antonio Talge CARVALHO6 1- DDS, MSc, PhD, Chair Professor, Restorative Dentistry Department, Univ.",Non-OADS,/arxiv_data1/oa_pdf/ba/75/jaos-21-02-0118.PMC3881874.pdf
"145ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302256 Influence of different beverages on the force  degradation of intermaxillary elastics: an in vitro  study Jorge César Borges LEÃO FILHO1, Daphine Beatriz GALLO2, Regis Meller SANTANA1, Odilon GUARIZA-FILHO3,  Elisa Souza CAMARGO4, Orlando Motohiro TANAKA5 1- DDS, Dentistry Graduate Program - Orthodontics, Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/26/00/jaos-21-02-0145.PMC3881875.pdf
"203ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302430 Catechin-incorporated dental copolymers inhibit  growth of Streptococcus mutans Alexandra MANKOVSKAIA1, Céline M. LÉVESQUE2, Anuradha PRAKKI3 1- Undegraduate Student, Human Biology Department, Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.",Non-OADS,/arxiv_data1/oa_pdf/9f/be/jaos-21-02-0203.PMC3881876.pdf
2011;19(3):189-94.http://dx.doi.org/10.1590/1678-77572013ed002,Non-OADS,/arxiv_data1/oa_pdf/72/44/jaos-21-02-0000.PMC3881877.pdf
"99ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201300004 2013;21(2):99-105CCL3 and CXCL12 production in vitro by dental  pulp fibroblasts from permanent and deciduous teeth stimulated by Porphyromonas gingivalis LPS Carla Renata SIPERT1, Ana Carolina de Faria MORANDINI1, Karin Cristina da Silva MODENA2, Thiago José DIONÍSIO3,  Maria Aparecida Andrade Moreira MACHADO4, Sandra Helena Penha de OLIVEIRA5, Ana Paula CAMPANELLI6,  Carlos Ferreira SANTOS7 1- DDS, PhD, Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/17/36/jaos-21-02-0099.PMC3881878.pdf
"183ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302338 Alteration of the oral environment in patients  undergoing esophagectomy during the perioperative period Masami yOSHIOKA1, Daisuke HINODE2, yota yAMAMOTO3, yoshihito FURUKITA4, Akira TANGOKU5 1- DDS, PhD, Associate Professor, Department of Oral Health and Welfare, Institute of Health Biosciences, The University of Tokushima Graduate School,  Tokushima, Japan.2- DDS, PhD, Professor, Department of Hygiene and Oral Health Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.",Non-OADS,/arxiv_data1/oa_pdf/d6/ba/jaos-21-02-0183.PMC3881879.pdf
"132ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302188 Accuracy of five electronic foramen locators with  different operating systems: an ex vivo  study Bruno Carvalho de VASCONCELOS1, Michelli de Medeiros BUENO2, Suyane Maria LUNA-CRUZ3, Marco Antonio  Hungaro DUARTE4, Carlos Augusto de Oliveira FERNANDES5 1- DDS, MSc, PhD, Sobral School of Dentistry, Federal University of Ceará and School of Pharmacy, Dentistry and Nursing, Federal University of Ceará,  Fortaleza, CE, Brazil.2- DDS, Brazilian Dental Association, Ceará Section, Fortaleza, CE, Brazil.3- DDS, MSc, Sobral School of Dentistry, Federal University of Ceará, Fortaleza, CE, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/1f/d9/jaos-21-02-0132.PMC3881880.pdf
"157ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302298 Temperature and curing time affect composite  sorption and solubility Fabrício Luscino Alves de CASTRO1, Bruno Barbosa CAMPOS2, Kely Firmino BRUNO3, Rogério Vieira REGES1 1- PhD, Professor, Dental Materials and Operative Dentistry, Paulista University, Goiânia, GO, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/77/40/jaos-21-02-0157.PMC3881881.pdf
"167ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-7757201302326 Comparison of manual, digital and lateral CBCT  cephalometric analyses Ricardo de Lima NAVARRO1, Paula Vanessa Pedron OLTRAMARI-NAVARRO2, Thais Maria Freire FERNANDES2,  Giovani Fidelis de OLIVEIRA3, Ana Cláudia de Castro Ferreira CONTI2, Marcio Rodrigues de ALMEIDA2, Renato  Rodrigues de ALMEIDA2 1- DDS, MSc, PhD, Oral and Maxillofacial Surgery Division, Saint Francis Hospital, Cambé, PR, Brazil; Area of Oral and Maxillofacial Surgery, Department of  Oral and Maxillofacial Surgery, Post Graduate Program State University of Maringá, PR, Brazil.2- DDS, MSc, PhD, Assistant Professor, Department of Orthodontics, University of North Paraná (UNOPAR), Londrina, PR, Brazil.3- DDS, MSc, Department of Orthodontics, University of North Paraná (UNOPAR), Londrina, PR, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/07/20/jaos-21-02-0167.PMC3881882.pdf
"358ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130022  Validation of a physical anthropology methodology using mandibles for gender estimation in a Brazilian population Suzana Papile Maciel CARVALHO1, Liz Magalhães BRITO2, Luiz Airton Saavedra de PAIVA3, Lucilene Arilho Ribeiro  BICUDO4, Edgard Michel CROSATO5, Rogério Nogueira de OLIVEIRA6 1- DDS, PhD, Department of Social Dentistry, School of Dentistry, University of São Paulo, São Paulo, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/68/20/jaos-21-04-0358.PMC3881884.pdf
"There are international efforts for normalization of the quality of techniques and methods applied in different countries, with utilization of better and /g80/g82/g85/g72/g3/g72/g73/g191/g70/g76/g72/g81/g87/g3/g80/g72/g87/g75/g82/g71/g86/g15/g3/g86/g88/g70/g75/g3/g68/g86/g3/g87/g75/g72/g3/g39/g76/g86/g68/g86/g87/g72/g85/g3/g57/g76/g70/g87/g76/g80/g3Identification Guide (DVI – Inter http://www.interpol.int/INTERPOL-expertise/Forensics/DVIpol) and the creation of forensic databanks as the Forensic Data Bank (http://fac.utk.edu/databank.html) and the Howells (kttp://konig.la.edu/hoells.htm) 4,5,8,14.",Non-OADS,/arxiv_data1/oa_pdf/68/20/jaos-21-04-0358.PMC3881884.pdf
"Available from: http://www.medigraphic.com/pdfs/adm/od-2003/0d035c.pdf.19- Silva M, Galvão LCC, Barros GB, Marques JAM.",OADS,/arxiv_data1/oa_pdf/68/20/jaos-21-04-0358.PMC3881884.pdf
"Available from: http://revistapesquisa2.fapesp.br/?art=3193&bd=1&pg=1.CARVALHO SPM, BRITO LM, PAIVA LAS, BICUDO LAR, CROSATO EM, OLIVEIRA RN 2013;21(4):358-62",OADS,/arxiv_data1/oa_pdf/68/20/jaos-21-04-0358.PMC3881884.pdf
"335ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130012  Heat treatment following surface silanization in rebonded tribochemical silica-coated ceramic brackets: shear bond strength analysis Emilia Adriane SILVA1, Flávia Zardo TRINDADE2, Hélcio Nagib José Feres RESKALLA1, José Renato Cavalcanti de  QUEIROZ3 1- DDS, MSc, Department of Restorative Dentistry, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/67/84/jaos-21-04-0335.PMC3881885.pdf
"376www.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130165 ABSTRACTHigh and specialty-related musculoskeletal %g71%g76%g86%g82%g85%g71%g72%g85%g86%g3%g68%g73%g192%g76%g70%g87%g3%g71%g72%g81%g87%g68%g79%g3%g83%g85%g82%g73%g72%g86%g86%g76%g82%g81%g68%g79%g86%g3%g72%g89%g72%g81%g3%g86%g76%g81%g70%g72%g3early training years Jianru YI1, Xiangxiang HU1, Boxi YAN1, Wei ZHENG2, Yu LI3, Zhihe ZHAO4 1- DDS, Department of Orthodontics, State Key Laboratory of Oral Diseases, West China School and Hospital of Stomatology, Sichu an University, Sichuan, China.",Non-OADS,/arxiv_data1/oa_pdf/88/7b/jaos-21-04-0376.PMC3881886.pdf
"320ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130134  Factors affecting the bond strength of denture base and reline acrylic resins to base metal materials Naomi TANOUE1, Yasuhiro MATSUDA2, Hiroaki YANAGIDA3, Hideo MATSUMURA4, Takashi SAWASE5 1- DDS, PhD, Assistant Professor, Division of Fixed Prosthodontics, Nagasaki University Hospital, Nagasaki, Japan.",Non-OADS,/arxiv_data1/oa_pdf/3f/80/jaos-21-04-0320.PMC3881887.pdf
"346ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130034  /g55/g75/g72/g3/g72/g73/g191/g70/g68/g70/g92/g3/g82/g73/g3/g87/g75/g72/g3/g86/g72/g79/g73/g16/g68/g71/g77/g88/g86/g87/g76/g81/g74/g3/g191/g79/g72/g3/g68/g81/g71/g3/g51/g85/g82/g55/g68/g83/g72/g85/g3for removal of calcium hydroxide from root canals Gisele FARIA1, Milton Carlos KUGA1, Alessandra Camila RUY2, Arturo Javier ARANDA-GARCIA3, Idomeo BONETTI- FILHO4, Juliane Maria GUERREIRO-TANOMARU1, Renato Toledo LEONARDO4 1- DDS, MSc, PhD, Assistant Professor, Department of Restorative Dentistry, Araraquara Dental School, UNESP - Univ.",Non-OADS,/arxiv_data1/oa_pdf/96/a0/jaos-21-04-0346.PMC3881888.pdf
"300ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130066  effect of silica coating and silane surface treatment  on the bond strength of soft denture liner to  denture base material Saadet ATSÜ1, Yasemin KESKİN2 1- Professor, Department of Prosthodontics, Kırıkkale University, Faculty of Dentistry, Kırıkkale, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/6c/00/jaos-21-04-0300.PMC3881889.pdf
"369www.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130114 ABSTRACT/g37/g82/g81/g71/g3/g86/g87/g85/g72/g81/g74/g87/g75/g3/g87/g82/g3/g85/g82/g82/g87/g3/g71/g72/g81/g87/g76/g81/g3/g68/g81/g71/g3/g192/g88/g76/g71/g3/g191/g79/g87/g85/g68/g87/g76/g82/g81/g3test of AH Plus/gutta-percha, EndoREZ and  RealSeal systems Alaa Abdul MAHDI1, Victoria BOLAÑOS-CARMONA2, Santiago GONZALEZ-LOPEZ3 1- PhD student, Department of Stomatology, School of Dentistry, University of Granada, Granada, Spain.",Non-OADS,/arxiv_data1/oa_pdf/8f/99/jaos-21-04-0369.PMC3881891.pdf
"307ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130077  Load-bearing capacity of screw-retained CAD/ CAM-produced titanium implant frameworks (I-Bridge ®2) before and after cyclic mechanical  loading Marc Philipp DITTMER1, Moritz NENSA2, Meike STIESCH3, Philipp KOHORST4 1- PD Dr, Private Practice, Hannover, Germany.",Non-OADS,/arxiv_data1/oa_pdf/e5/e8/jaos-21-04-0307.PMC3881892.pdf
"314ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130097  Comparison of static friction with self-ligating,  modified slot design and conventional brackets Raquel Morais CASTRO1, Perrin SMITH NETO2, Martinho Campolina Rebello HORTA3, Matheus Melo PITHON4,  Dauro Douglas OLIVEIRA5 1- Former resident in Orthodontics, Pontifical Catholic University of Minas Gerais, Belo Horizonte, MG, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/0c/13/jaos-21-04-0314.PMC3881893.pdf
"341ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130023  The sealing ability of MTA apical plugs exposed to a phosphate-buffered saline Josiane de ALMEIDA1, Ana Maria Hecke ALVES2, Roberto Ferreira de MELO3, Mara Cristina Santos FELIPPE2,  Eduardo Antunes BORTOLUZZI2, Cleonice da Silveira TEIXEIRA2, Wilson Tadeu FELIPPE2 1- DDS, MSc, PhD student in Endodontics, Department of Endodontics, School of Dentistry, Federal University of Santa Catarina, Florianópolis, SC, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/jaos-21-04-0341.PMC3881894.pdf
"383www.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130290 ABSTRACTRehabilitative treatment of cleft lip and palate: experience of the Hospital for Rehabilitation of Craniofacial Anomalies/USP (HRAC/USP) – Part 5: Institutional outcomes assessment and the role of the Laboratory of Physiology José Alberto de Souza FREITAS1, Ivy Kiemle TRINDADE-SUEDAM2, Daniela Gamba GARIB3, Lucimara Teixeira  das NEVES4, Ana Lúcia Pompéia Fraga de ALMEIDA5, Renato Yassukata Faria YAEDÚ6, Thaís Marchini OLIVEIRA7,  Simone SOARES5, Rita de Cássia Moura Carvalho LAURIS8, Renata Paciello YAMASHITA9, Alceu Sergio TRINDADE  JR10, Inge Elly Kiemle TRINDADE11, João Henrique Nogueira PINTO12 1- DDS, MSc, PhD, Superintendent, Hospital for Rehabilitation of Craniofacial Anomalies and Full Professor, Department of Stoma tology, Bauru School of  Dentistry, University of São Paulo, Bauru, SP, Brazil.2- DDS, MSc, PhD, Assistant Professor, Department of Biological Sciences, Bauru School of Dentistry and Laboratory of Physiolog y, Hospital for Rehabilitation  of Craniofacial Anomalies, University of São Paulo, Bauru, SP, Brazil.3- DDS, MSc, PhD, Associate Professor, Department of Pediatric Dentistry, Orthodontics and Community Health, Bauru School of De ntistry and Hospital for  Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, SP, Brazil.4- DDS, MSc, PhD, Assistant Professor, Department of Biological Sciences, Bauru School of Dentistry and Hospital for Rehabilita tion of Craniofacial Anomalies,  University of São Paulo, Bauru, SP, Brazil.5- DDS, MSc, PhD, Assistant Professor, Department of Prosthodontics, Bauru School of Dentistry and Hospital for Rehabilitation of Craniofacial Anomalies,  University of São Paulo, Bauru, SP, Brazil.6- DDS, MSc, PhD, Assistant Professor, Department of Stomatology, Bauru School of Dentistry and Hospital for Rehabilitation of Craniofacial Anomalies,  University of São Paulo, Bauru, SP, Brazil.7- DDS, MSc, PhD, Assistant Professor, Department of Pediatric Dentistry, Orthodontics and Community Health, Bauru School of De ntistry and Hospital for  Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, SP, Brazil.8- DDS, MSc, Orthodontist of the Dental Division of the Hospital for Rehabilitation of Craniofacial Anomalies, University of Sã o Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/c8/15/jaos-21-04-0383.PMC3881895.pdf
Available from http://www1.folha.uol.com.br/fsp/opiniao/fz1807200408.htm.,Non-OADS,/arxiv_data1/oa_pdf/c8/15/jaos-21-04-0383.PMC3881895.pdf
"Available from: https://uspdigital.usp.br/anuario/.28- Yamashita RP, Carvalho ELL, Fukushiro AP, Zorzetto NL, Trindade IEK.",Non-OADS,/arxiv_data1/oa_pdf/c8/15/jaos-21-04-0383.PMC3881895.pdf
editorial http://dx.doi.org/10.1590/1678-77572013ed004 Multi-purpose materials in dentistry - is it possible to match  maximum mechanical and biological properties/performance?,Non-OADS,/arxiv_data1/oa_pdf/53/ae/jaos-21-04-0000.PMC3881896.pdf
"351ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130047  Human tooth germ stem cell response to calcium-silicate based endodontic cements Esra PAMUKÇU GÜVEN1, Mehmet Emir YALVAÇ2, Mehmet Baybora KAYAHAN3/g15/g3/g43/g68/g78/g78/g213/g3/g54/g56/g49/g36/g603/g15/g3/g41/g76/g78/g85/g72/g87/g87/g76/g81/g3/g249/g36/g43/g248/g494,  Gündüz BAYIRLI5 /g20/g16/g3/g3(/g3(/g54/g15/g3/g51/g75/g3(/g15/g3/g3(/g72/g+3/g6+/g+5/g+7/g+0/g72/g+1/g+7/g3/g+2/g73/g3/g40/g+1/g71/g+2/g71/g+2/g+1/g+7/g76/g70/g+6/g15/g3/g41/g6+/g70/g++/g7(/g+7/g(2/g3/g+2/g73/g3/g3(/g72/g+1/g+7/g76/g+6/g+7/g+5/g(2/g15/g3/g60/g72/g71/g76/g+7/g72/g+3/g72/g3/g56/g+1/g76/g+(/g72/g+5/g+6/g76/g+7/g(2/g15/g3/g24+/g+6/g+7/g6+/g+1/g6(/g++/g7(/g15/g3/g55/g++/g+5/g7+/g72/g(2/g17 2- PhD, Center for Gene Therapy, Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA./g22/g16/g3/g3(/g3(/g54/g15/g3/g51/g75/g3(/g15/g3/g36/g+6/g+6/g+2/g70/g76/g6+/g+7/g72/g3/g51/g+5/g+2/g73/g72/g+6/g+6/g+2/g+5/g15/g3/g3(/g72/g+3/g6+/g+5/g+7/g+0/g72/g+1/g+7/g3/g+2/g73/g3/g40/g+1/g71/g+2/g71/g+2/g+1/g+7/g76/g70/g+6/g15/g3/g41/g6+/g70/g++/g7(/g+7/g(2/g3/g+2/g73/g3/g3(/g72/g+1/g+7/g76/g+6/g+7/g+5/g(2/g15/g3/g60/g72/g71/g76/g+7/g72/g+3/g72/g3/g56/g+1/g76/g+(/g72/g+5/g+6/g76/g+7/g(2/g15/g3/g24+/g+6/g+7/g6+/g+1/g6(/g++/g7(/g15/g3/g55/g++/g+5/g7+/g72/g(2/g17/g23/g16/g3/g51/g75/g3(/g15/g3/g51/g+5/g+2/g73/g72/g+6/g+6/g+2/g+5/g15/g3/g3(/g72/g+3/g6+/g+5/g+7/g+0/g72/g+1/g+7/g3/g+2/g73/g3/g42/g72/g+1/g72/g+7/g76/g70/g+6/g3/g6+/g+1/g71/g3/g37/g76/g+2/g72/g+1/g74/g76/g+1/g72/g72/g+5/g76/g+1/g74/g15/g3/g3+/g+2/g7(/g7(/g72/g74/g72/g3/g+2/g73/g3/g40/g+1/g74/g76/g+1/g72/g72/g+5/g76/g+1/g74/g3/g6+/g+1/g71/g3/g36/g+5/g70/g75/g76/g+7/g72/g70/g+7/g++/g+5/g72/g15/g3/g60/g72/g71/g76/g+7/g72/g+3/g72/g3/g56/g+1/g76/g+(/g72/g+5/g+6/g76/g+7/g(2/g15/g3/g24+/g+6/g+7 /g6+/g+1/g6(/g++/g7(/g15/g3/g55/g++/g+5/g7+/g72/g(2/g17 /g24/g16/g3/g3(/g3(/g54/g15/g3/g51/g75/g3(/g15/g3/g51/g+5/g+2/g73/g72/g+6/g+6/g+2/g+5/g15/g3/g3(/g72/g+3/g6+/g+5/g+7/g+0/g72/g+1/g+7/g3/g+2/g73/g3/g40/g+1/g71/g+2/g71/g+2/g+1/g+7/g76/g70/g+6/g15/g3/g41/g6+/g70/g++/g7(/g+7/g(2/g3/g+2/g73/g3/g3(/g72/g+1/g+7/g76/g+6/g+7/g+5/g(2/g15/g3/g60/g72/g71/g76/g+7/g72/g+3/g72/g3/g56/g+1/g76/g+(/g72/g+5/g+6/g76/g+7/g(2/g15/g3/g24+/g+6/g+7/g6+/g+1/g6(/g++/g7(/g15/g3/g55/g++/g+5/g7+/g72/g(2/g17 Corresponding address: /g3/g3(/g+5/g17/g3/g40/g+6/g+5/g6+/g3/g51/g6+/g+0/g++/g7+/g70/g++/g3/g42/g++/g+(/g72/g+1/g3/g16/g3/g3(/g72/g+3/g6+/g+5/g+7/g+0/g72/g+1/g+7/g3/g+2/g73/g3/g40/g+1/g71/g+2/g71/g+2/g+1/g+7/g76/g70/g+6/g15/g3/g41/g6+/g70/g++/g7(/g+7/g(2/g3/g+2/g73/g3/g3(/g72/g+1/g+7/g76/g+6/g+7/g+5/g(2/g15/g3/g60/g72/g71/g76/g+7/g72/g+3/g72/g3/g56/g+1/g76/g+(/g72/g+5/g+6/g76/g+7/g(2/g3/g16/g3/g37/g6+/g247/g71/g6+/g+7/g3/g3+/g6+/g71/g17/g3/g4(/g+2/g2(/g21/g22/g27/g3/g16/g3/g55/g53/g16/g22/g23/g26/g21/g27/g3 - Istanbul - Turkey - Phone: +(90)2163636044-6481 - Fax: +(90)2163636211 - e-mail: esrapamukcu@gmail.com /g54/g88/g69/g80/g76/g87/g87/g72/g71/g29/g3/g45/g68/g81/g88/g68/g85/g92/g3/g20/g23/g15/g3/g21/g19/g20/g22/g3/g16/g3/g48/g82/g71/g76/g191/g70/g68/g87/g76/g82/g81/g29/g3/g45/g88/g81/g72/g3/g25/g15/g3/g21/g19/g20/g22/g3/g16/g3/g36/g70/g70/g72/g83/g87/g72/g71/g29/g3/g45/g88/g81/g72/g3/g20/g20/g15/g3/g21/g19/g20/g22 Objective: The aim of this study was to compare the cytotoxic effects of endodontic  cements on human tooth germ stem cells (hTGSCs).",Non-OADS,/arxiv_data1/oa_pdf/bf/86/jaos-21-04-0351.PMC3881897.pdf
"363www.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130092 ABSTRACTSupplementation of soft drinks with metallic ions reduces dissolution of bovine enamel Heloisa Aparecida Barbosa da Silva PEREIRA1, Aline de Lima LEITE1, Flávia de Moraes ITALIANI2, Melissa Thiemi  KATO3 , Juliano Pelim PESSAN4, Marília Afonso Rabelo BUZALAF5 1- MSc, Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/20/a8/jaos-21-04-0363.PMC3881898.pdf
"293ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130036  2013;21(4):293-9Thermal analysis of bulk filled composite resin  polymerization using various light curing modes according to the curing depth and approximation to the cavity wall Hoon-Sang CHANG1, Kyu-Jeong CHO2, Su-Jung PARK3, Bin-Na LEE4, Yun-Chan HWANG1, Won-Mann OH5, In-Nam  HWANG5 1- DDS, MS, PhD, Associate Professor, Department of Conservative Dentistry and Dental Science Research Institute, School of Dentistry, Chonnam National  University, Gwangju, Korea.2- DDS, MS, Postgraduate student, Department of Conservative Dentistry, School of Dentistry, Chonnam National University, Gwangju, Korea.3- DDS, MS, Assistant Professor, Department of Conservative Dentistry, Dental Research Institute, College of Dentistry, Wonkwang University, Iksan, Jeonbuk,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/71/89/jaos-21-04-0293.PMC3881899.pdf
"250ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130008 Morphological characterization of the nasopalatine  region in human fetuses and its association to pathologies Saulo Gabriel Moreira FALCI1, Flaviana Dornela VERLI2, Alberto CONSOLARO3, Cássio Roberto Rocha dos SANTOS4 1- DDS, MSc in Dental Clinic, School of Dentistry, Federal University of Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/48/26/jaos-21-03-0250.PMC3881900.pdf
"256ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130079 PAX9 polymorphism and susceptibility to sporadic  non-syndromic severe anodontia: a case-control study in southwest China Jing WANG1,2, Yuanzhi XU1, Jing CHEN3, Feiyu WANG4, Renhuan HUANG4, Songtao WU4, Linjing SHU4, Jingyi QIU4,  Zhi YANG5, Junjie XUE3, Raorao WANG1, Jilin ZHAO6, Wenli LAI2 1- PhD, Department of Stomatology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/5e/a0/jaos-21-03-0256.PMC3881902.pdf
"Available from: http://www.omim.org/.20- Paixao-Côrtes VR, Braga T, Salzano FM, Mundstock K,  Mundstock CA, Bortolini MC.",Non-OADS,/arxiv_data1/oa_pdf/5e/a0/jaos-21-03-0256.PMC3881902.pdf
"235ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130089 effect of MTA-based sealer on the healing of  periapical lesions João Eduardo GOMES-FILHO1, Simone WATANABE2, Luciano Tavares Angelo CINTRA1, Mauro Juvenal NERY1, Eloi  DEZAN-JÚNIOR1, India Olinta Azevedo QUEIROZ2, Carolina Simonetti LODI2, Maria Daniela BASSO2 1- DDS, MSc, PhD, Associate Professor, Department of Endodontics, Araçatuba School of Dentistry, UNESP – Univ.",Non-OADS,/arxiv_data1/oa_pdf/40/56/jaos-21-03-0235.PMC3881903.pdf
"278ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130112 effect of different disinfecting procedures on the  hardness and color stability of two maxillofacial elastomers over time Panagiota N. ELENI1, Magdalini K. KROKIDA2, Gregory L. POLYZOIS3, Lawrence GETTLEMAN4 1- MSc, PhD, Junior Researcher, Laboratory of Process Analysis and Design, Department of Chemical Engineering, National Technical University of Athens,  Zografou Campus, Athens, Greece.2- MSc, PhD, Assistant Professor, Laboratory of Process Analysis and Design, Department of Chemical Engineering, National Technical University of Athens, Zografou Campus, Athens, Greece.",Non-OADS,/arxiv_data1/oa_pdf/36/1c/jaos-21-03-0278.PMC3881904.pdf
"215ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130001 2013;21(3):215-8Oral granuloma gravidarum: a retrospective study  of 41 cases in Southern Brazil Juliana Andrade CARDOSO1, Juliana Cassol SPANEMBERG1, Karen CHERUBINI2, Maria Antonia Zancanaro de  FIGUEIREDO2, Fernanda Gonçalves SALUM3 1- MSc, Oral Medicine Division, São Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3c/12/jaos-21-03-0215.PMC3881906.pdf
"284ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130127 Rehabilitative treatment of cleft lip and palate:  experience of the Hospital for Rehabilitation of Craniofacial Anomalies/USP (HRAC/USP) – Part 4: Oral Rehabilitation José Alberto de Souza FREITAS1, Ana Lúcia Pompéia Fraga de ALMEIDA2, Simone SOARES2, Lucimara Teixeira  das NEVES3, Daniela Gamba GARIB4, Ivy Kiemle TRINDADE-SUEDAM3, Renato Yassutaka Faria YAEDÚ5, Rita de  Cássia Moura Carvalho LAURIS6, Thais Marchini OLIVEIRA7, João Henrique Nogueira PINTO8 1- DDS, MSc, PhD, Superintendent, Hospital for Rehabilitation of Craniofacial Anomalies and Full Professor, Department of Stomatology, Bauru School of  Dentistry, University of São Paulo, Bauru, SP, Brazil.2- DDS, MSc, PhD, Assistant Professor, Department of Prosthodontics, Bauru School of Dentistry and Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/81/3a/jaos-21-03-0284.PMC3881907.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/3a/jaos-21-03-0284.PMC3881907.pdf
"Available from: http://dx.doi.org/10.1597/11-200 25- Verdi FJ Jr, Lanzi GL, Cohen SR, Powell R. Use of the Brånemark implant in the cleft palate patient.",Non-OADS,/arxiv_data1/oa_pdf/81/3a/jaos-21-03-0284.PMC3881907.pdf
"Guest editorial http://dx.doi.org/10.1590/1678-77572013ed003 Genetics of tooth agenesis: how to move the field forward Alexandre R. VIEIRA1 1- DDS, MSc, PhD, Department of Oral Biology, School of Dental Medicine, University of Pittsburgh, Pittisburgh, USA.",Non-OADS,/arxiv_data1/oa_pdf/71/ad/jaos-21-03-0000.PMC3881908.pdf
Available from:http://wwwncbi.nlm.nih.gov/projects/SNPsnp_ref cgi?rs=4904210 Figure 1- Allele and genotype frequencies of the PAX9  A240P mutation,Non-OADS,/arxiv_data1/oa_pdf/71/ad/jaos-21-03-0000.PMC3881908.pdf
"225ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130030 Prediction of the mesiodistal size of unerupted  canines and premolars for a group of Romanian children: a comparative study Cornel Gheorghe BOITOR1, Florin STOICA2, Hamdan NASSER3 1- PhD Lecturer, Department of Preventive Dentistry, College of Medicine V. Papilian, Lucian Blaga University of Sibiu, Sibiu, Romania.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/jaos-21-03-0225.PMC3881909.pdf
"265ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130016 High-efficiency tooth bleaching using non- thermal atmospheric pressure plasma with low concentration of hydrogen peroxide Seoul Hee NAM1, Hyun Woo LEE2, Soo Hyun CHO3, Jae Koo LEE2, Young Chan JEON4, Gyoo Cheon KIM5 1- MSc, PhD student, Department of Oral Anatomy, School of Dentistry, Pusan National University, Yangsan, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/78/jaos-21-03-0265.PMC3881910.pdf
"231ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-7757201300063 Opening and closure forces of sliding mechanisms  of different self-ligating brackets Paola GANDINI1, Linda ORSI2, Maria Francesca SFONDRINI3, Andrea SCRIBANTE4 1- MD, DDS, Professor and Chairman, Unit of Orthodontics, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, School of Dentistry, University  of Pavia, Pavia, Italy.2- DDS, Postgraduate fellow, Unit of Orthodontics, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, School of Dentistry, University of Pavia, Pavia, Italy.",Non-OADS,/arxiv_data1/oa_pdf/56/0f/jaos-21-03-0231.PMC3881911.pdf
"271ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130026 Long-term degradation of resin-based cements  in substances present in the oral environment: influence of activation mode Eduardo Moreira da SILVA1, Jaime Dutra NORONHA-FILHO2, Cristiane Mariote AMARAL3, Laiza Tatiana POSKUS3,  José Guilherme Antunes GUIMARÃES1 1- DDS, MSc, PhD, Associate Professor, Analytical Laboratory of Restorative Biomaterials - LABiom-R, School of Dentistry, Federal Fluminense University,  Niterói, RJ, Brazil.2- MSc, PhD student, Analytical Laboratory of Restorative Biomaterials - LABiom-R, School of Dentistry, Federal Fluminense University, Niterói, RJ, Brazil.3- DDS, MSc, PhD, Assistant Professor, Analytical Laboratory of Restorative Biomaterials - LABiom-R, School of Dentistry, Federal Fluminense University,  Niterói, RJ, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/9d/25/jaos-21-03-0271.PMC3881912.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/88/jir-7-001.PMC3881980.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2014:7 1–7Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  1ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S5272 8circulating levels of monocyte chemoattractant  protein-1 and interleukin-7 in women who have  undergone bilateral salpingo-oophorectomy anna Tani1 T oshiyuki Yasui2 sumika Matsui1 Takeshi Kato1 naoko Tsuchiya3 Mitsutoshi Yuzurihara3 Y oshio Kase3 Minoru Irahara1 1Department of Obstetrics and  gynecology, 2Department of  Reproductive Technology, Institute   of health Biosciences, The University  of T okushima graduate school,   T okushima, Japan; 3Pharmacology  Research Department, Tsumura  central Research Institute,    Ibaraki, Japan correspondence: anna Tani   Department of Obstetrics and   gynecology, Institute of health  Biosciences, The University of   Tokushima graduate school,   Kuramoto-cho 3-18-15,   Tokushima 770-8503, Japan   Tel +81 88 633 7177   Fax +81 88 631 2630   email tani.anna@tokushima-u.ac.j pPurpose:  The aim of the study reported here was to determine the effect of surgical menopause  by bilateral salpingo-oophorectomy (BSO) on circulating levels of cytokines and chemokines  related to the pathogenesis of atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/1b/88/jir-7-001.PMC3881980.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/1b/88/jir-7-001.PMC3881980.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/88/jir-7-001.PMC3881980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/e0/tacg-7-001.PMC3882136.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 1–13The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S3557 1Gene mutations that promote adrenal   aldosterone production, sodium retention,   and hypertension Andreas G Moraitis1 william e Rainey1,2 Richard J Auchus1 1Division of Metabolism,   endocrinology, and Diabetes,   Department of internal Medicine,   2Department of Physiology, University  of Michigan, Ann Arbor, M i, USA Correspondence: Richard J Auchus   Division of Metabolism, endocrinology,   and Diabetes, Department of internal   Medicine, University of Michigan,   Room 5560A, MSRBii, 1150w Medical   Center Drive, Ann Arbor, Mi 48109, USA   email rauchus@med.umich.ed uAbstract:  Primary aldosteronism (PA) is the most common form of secondary hypertension,  found in about 5% of all hypertension cases, and up to 20% of resistant hypertension cases.",Non-OADS,/arxiv_data1/oa_pdf/3e/e0/tacg-7-001.PMC3882136.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/3e/e0/tacg-7-001.PMC3882136.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/e0/tacg-7-001.PMC3882136.pdf
"Repeat dose data from subjects receiving individualized regimens was used to select FpV/R tV BID repeat dosage regimens for sub- sequently enrolled subjects; final dose regimens were 45/7 mg/kg  in the 6 months to <2 years and 45/10 mg/kg in the 4 weeks to <6  months cohorts is provided (see table, supplemental Digital Con- tent 1, http://links.lww.com/INF/B630, showing range of individu- alized doses and revised regimens).",Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
"twenty-nine subjects discontinued treatment; 15 (28%) sub- jects discontinued treatment ≤ 48 weeks and 14 discontinued after  week 48 (see table, supplemental Digital Content 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
"Reasons for discontinuation included Aes (n = 3 ≤ week 48, n = 1 after week 48) and insufficient VL response (n = 2 ≤ week 48, n = 1 after week 48) (see table, supplemental Digital Content 2, http://links.lww.com/INF/B631, showing disposition of  subjects).",Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
"subjects in the 6 months to <2 years age cohort who received  FpV with R tV 7 mg/kg BID had 63% higher plasma R tV AUC(0– τ), 62% higher Cmax and 80% higher Cτ values compared with the historical adult population receiving FpV/R tV 700/100 mg BID  (see table, supplemental Digital Content 4, http://links.lww.com/ INF/B633, showing plasma R tV pharmacokinetic parameters).",Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
"In the snapshot analysis,  the proportion of subjects achieving HIV -1 RNA <400 copies/mL  up to week 36 was similar between age cohorts, whereas at week  48 the proportions were 71% (20/28) in the 6 months to <2 years age cohort and 58% (15/26) in the 4 weeks to <6 months age cohort (see Fig., supplemental Digital Content 6, http://links.lww.com/INF/B635, showing virologic response).",Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
Available at: http://www.niaid.nih.gov/LabsAndResources/resources/DAIDsClinRsrch/ Documents/daidsaegradingtable.pdf.,OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
Available at: http://www.iasusa.org/resist-ance_mutations/index.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/b4/inf-33-57.PMC3882303.pdf
"1, Supplementary Data 1, http://links.lww.com/ QAD/A411).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"1, Supplementary Data 2, http://links.lww.com/QAD/A412).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Lists of collated deﬁnitions for all terms can be found in Supplementary Data 3 and4, http://links.lww.com/QAD/A414, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Unauthorized reproduction of this article is prohibited.Supplementary Tables 1–9, http://links.lww.com/ QAD/A415.",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"4, Supplementary Table 10, http://links.lww.com/QAD/ A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"In general, the duration of follow-up needed to deﬁne slow progressors was lower than that for LTNPs (Supplementary Table 10, http://links.lww.com/QAD/A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"As with LTNPs, a CD4þcell threshold of 500 cells/ ml was most common, with thresholds ranging from 200 to 1000 cells/ ml (Supple- mentary Table 10, http://links.lww.com/QAD/A415).",OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"The frequency of various component thresholds can be found in Supplementary Table 10, http://links.lww.com/ QAD/A415.",OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Unauthorized reproduction of this article is prohibited.Table 10, http://links.lww.com/QAD/A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"4, Supplementary Table 10, http://links.lww.com/QAD/A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Duration thresholds varied from 6 months to 16 years, with a threshold of 1 year being most frequent (Supplementary Table 10, http://links.lww.com/QAD/ A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"HIV-RNA thresholds varied from 40 to 10 000 copies/ml, with 400and 2000 copies/ml both being common thresholds applied (Supplementary Table 10, http://links.lww.com/ QAD/A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"CD4þcell thresholds appeared as components in ﬁve of 30 deﬁnitions, and there was marked variability in thresholds used (Supple- mentary Table 10, http://links.lww.com/QAD/A415).",OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Unauthorized reproduction of this article is prohibited.Supplementary Table 11, http://links.lww.com/QAD/ A415).",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"5, Supplementary Table 11, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"5, Supplementary Table 11, http://links.lww.com/QAD/A415), but no clinical endpoints appeared in any deﬁnition.",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"There was marked overlap between components and thresholds/categories used across all slow progression terms, with substantial overlap between components of LTNPs, slow progressors and nonprogressors, and between viremic controller and HICs (Supplementary Table 10, http://links.lww.com/ QAD/A415).",OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"In general, slow progressors represented a less stringent phenotype, and thresholds for duration of follow-up required tended to be lower (Supplementary Table 10, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c3/92/aids-28-149.PMC3882304.pdf
"Drugs and Doses Doses tested are summarized (see table, supplemental Dig- ital Content 1, http://links.lww.com/INF/B636).",Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
"ApV pK parameters for all age groups  administered FpV/R tV doses are displayed (see Fig., supplemen- tal Digital Content 2, http://links.lww.com/INF/B637).",Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
"RtV 3 mg/kg BID, in combination with FpV , delivered  higher plasma R tV Cτ across the age groups (see table, supple- mental Digital Content 3, http://links.lww.com/INF/B638).",Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
"the overall incidence of treatment-emergent grade 3/4 labo- ratory abnormalities was 21% (22/107) (see table, supplemental  Digital Content 4, http://links.lww.com/INF/B639).",Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
"HIV-1 RNA and CD4+ Cell Responses In the snapshot analysis, the response at week 48 was  higher among the AR t-naïve subjects (83%) than pI-naïve/NR tI- experienced subjects (65%) and pI-experienced subjects (48%)  within the FpV/R tV treatment group and subjects within the FpV  treatment group (60%) (see Fig., supplemental Digital Content 5, http://links.lww.com/INF/B640).",Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
Available at: http://aidsinfo.nih.,Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
Available at: http://tucson2008.go-acop.org/pdfs/48_fisher.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
Available at: http://www.niaid.nih.gov/LabsAndResources/resources/DAIDs ClinRsrch/Documents/daidsaegrad- ingtable.pdf.,OADS,/arxiv_data1/oa_pdf/47/05/inf-33-50.PMC3882305.pdf
http://seer.cancer.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/b0/86/520_2013_Article_1991.PMC3882558.pdf
http://www-dep.iarc.fr/ .A c c e s s e d2 5 February 2013 4.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/520_2013_Article_1991.PMC3882558.pdf
ClinicalTrials.gov IdentiﬁerNCT00401466 ( http://www.clinicaltrials.gov/ct2/show/NCT00401466 ).,OADS,/arxiv_data1/oa_pdf/e2/89/eht207.PMC3882723.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/89/eht207.PMC3882723.pdf
"This is an Open Access article distributed unde r the terms of the Creative CommonsAttribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use,distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/81/eht411.PMC3882724.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3592 | DOI: 10.1038/srep03592 5",Non-OADS,/arxiv_data1/oa_pdf/60/f7/srep03592.PMC3882743.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/f1/srep03586.PMC3882744.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3586 | DOI: 10.1038/srep03586 5",Non-OADS,/arxiv_data1/oa_pdf/02/f1/srep03586.PMC3882744.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3584 | DOI: 10.1038/srep03584 5",Non-OADS,/arxiv_data1/oa_pdf/26/22/srep03584.PMC3882747.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3590 | DOI: 10.1038/srep03590 7",Non-OADS,/arxiv_data1/oa_pdf/9e/11/srep03590.PMC3882748.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201305157/DC1.,Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1093/nar/gkq55 2 Arakawa, H., D. Lodygin, and J.M.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"1:7. http://dx.doi.org/10.1186/1472-6750-1- 7 Baumann, C., R. Körner, K. Hofmann, and E.A.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1016/j.cell.2006.11.04 1 Brill, S.J., S. DiNardo, K. Voelkel-Meiman, and R. Sternglanz.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1038/326414a 0 Buerstedde, J.M., and S. Takeda.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1016/0092-8674(91)90581- I Chan, K.L., and I.D.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.4161/cc.8.19.951 3 Chan, K.L., and I.D.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1016/j.semcdb.2011.07.00 1PURO cassettes were subcloned from pLOX-BSR, pLOX-NEO, and pLOX- PURO, respectively.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1007/BF0298608 0 Liberi, G., G. Maffioletti, C. Lucca, I. Chiolo, A. Baryshnikova, C. Cotta- Ramusino, M. Lopes, A. Pellicioli, J.E.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1101/gad.32260 5 Lindsey-Boltz, L.A., and A. Sancar.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1074/jbc.M111.23795 8 Lisby, M., J.H.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1016/j.cell.2004.08.01 5 Lopes, M., C. Cotta-Ramusino, G. Liberi, and M. Foiani.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1016/S1097-2765(03)00473- 8 Lucas, I., and O. Hyrien.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1093/nar/   28.10.218 7 Lukas, C., V. Savic, S. Bekker-Jensen, C. Doil, B. Neumann, R.S.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/ncb220 1 Mäkiniemi, M., T. Hillukkala, J. Tuusa, K. Reini, M. Vaara, D. Huang, H.  Pospiech, I. Majuri, T. Westerling, T.P.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1074/jbc.M10224520 0 Matos, J., M.G.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.05.03 9 Meister, P., A. Taddei, L. Vernis, M. Poidevin, S.M.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1083/jcb.20041000 6 Mendoza, M., C. Norden, K. Durrer, H. Rauter, F. Uhlmann, and Y. Barral.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/ncb185 5 Mordes, D.A., E.A.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1073/pnas.080662110 5 Naim, V., and F. Rosselli.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/ncb188 3 Naim, V., T. Wilhelm, M. Debatisse, and F. Rosselli.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/ncb279 3 Nishimura, K., T. Fukagawa, H. Takisawa, T. Kakimoto, and M. Kanemaki.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1038/nmeth.140 1 Ormö, M., A.B.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1126/   science.273.5280.139 2 Pfander, B., and J.F.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/emboj.2011.34 5 Porter, A.C., and C.J.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1023/B:CHRO.0000036608.91085.d 1 Reini, K., L. Uitto, D. Perera, P.B.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/   10.1007/s00412-004-0277- 5 Schramke, V., H. Neecke, V. Brevet, Y. Corda, G. Lucchini, M.P.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1101/gad.19390 1Chan, K.L., P.S.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/   10.1038/sj.emboj.760177 7 Chan, K.L., T. Palmai-Pallag, S. Ying, and I.D.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/ncb188 2 Chanoux, R.A., B. Yin, K.A.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1074/jbc.M80673920 0 Clerici, M., V. Paciotti, V. Baldo, M. Romano, G. Lucchini, and M.P.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1093/emboj/20.22.648 5 Corda, Y., S.E.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1128/MCB.25.23.10652-10664.200 5 Durkin, S.G., and T.W.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1146/annurev.genet.41.042007.16590 0 Eckert-Boulet, N., R. Rothstein, and M. Lisby.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1038/onc.2009.50 2 Germann, S.M., V.H.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"10:210– 224. http://dx.doi.org/10.1016/j.dnarep.2010.11.00 1 Goedhart, J., L. van Weeren, M.A.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1038/nmeth.141 5 Goedhart, J., D. von Stetten, M. Noirclerc-Savoye, M. Lelimousin, L. Joosen, M.A.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"3:751. http://dx.doi.org/10.1038/ncomms173 8 Heim, R., and R.Y .",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)00450- 5 Hirano, T., S. Funahashi, T. Uemura, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1093/nar/gkp48 0 Kaulich, M., F. Cubizolles, and E.A.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1007/s00412-012-0370- 0 Kegel, A., H. Betts-Lindroos, T. Kanno, K. Jeppsson, L. Ström, Y. Katou, T.  Itoh, K. Shirahige, and C. Sjögren.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1534/genetics.108.08708 0 Kumagai, A., J. Lee, H.Y.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/ 10.1016/   j.cell.2005.12.04 1 Lahkim Bennani-Belhaj, K., S. Rouzeau, G. Buhagiar-Labarchède, P.  Chabosseau, R. Onclercq-Delic, E. Bayart, F. Cordelières, J. Couturier,  and M. Amor-Guéret.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1158/1541-7786.MCR-09-053 4 Laulier, C., A. Cheng, and J.M.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
http://dx.doi.org/10.1093/   nar/gkr18 7,Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/nbt103 7 Sherman, F. 2002.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1016/S0076-6879(02)50954- X Sikorski, R.S., and P. Hieter.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1007/978-1-61779-998-3_3 0 Smith, J., and R. Rothstein.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1093/nar/gkr34 0 Spence, J.M., H.H.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1242/jcs.01373 0 Steigemann, P., C. Wurzenberger, M.H.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.12.02 0 Struhl, K., D.T.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.1073/pnas.76.3.103 5 Szakal, B., and D. Branzei.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/emboj.2013.6 7 Tercero, J.A., and J.F.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/3508760 7 Toledo, L.I., M. Murga, R. Zur, R. Soria, A. Rodriguez, S. Martinez, J.  Oyarzabal, J. Pastor, J.R. Bischoff, and O. Fernandez-Capetillo.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/nsmb.207 6 Torres-Rosell, J., F. Machín, A. Jarmuz, and L. Aragón.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi   .org/10.4161/cc.3.4.80 2 Viggiani, C.J., and O.M.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1002/yea.140 6 Vinciguerra, P., S.A. Godinho, K. Parmar, D. Pellman, and A.D. D’Andrea.",Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1172/JCI4339 1 Wang, L.H., B. Mayer, O. Stemmann, and E.A.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1242/jcs.05825 5 Wellinger, R.E., P. Schär, and J.M.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1128/   MCB.23.18.6363-6372.200 3 Wu, L., and I.D.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10.1038/nature0225 3 Wyatt, H.D., S. Sarbajna, J. Matos, and S.C. West.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
"http://dx.doi.org/10   .1016/j.molcel.2013.08.03 5 Yamane, K., M. Kawabata, and T. Tsuruo.",OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
http://dx.doi   .org/10.1038/ncb277 3,Non-OADS,/arxiv_data1/oa_pdf/97/af/JCB_201305157.PMC3882784.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/nn100 7 Alvarez, V.A., and B.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/   10.1146/annurev.neuro.30.051606.09422 2 Bednarek, E., and P. Caroni.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.neuron   .2011.02.03 4 Berger, J., K.A.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1016/S0301-0082(99)00026- X Brachet, A., C. Leterrier, M. Irondelle, M.-P. Fache, V. Racine, J.-B.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1083/jcb.20100304 2 Bréchet, A., M.-P. Fache, A. Brachet, G. Ferracci, A. Baude, M. Irondelle, S.  Pereira, C. Leterrier, and B. Dargent.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1083/jcb.20080516 9 Buchou, T., M. Vernet, O.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1128/MCB.23.3.908-915.200 3 Budnik, V., Y.H.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1038/nrn325 8 Charriaut-Marlangue, C., S. Otani, C. Creuzet, Y. Ben-Ari, and J. Loeb.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/   10.1073/pnas.88.22.1023 2 Cheusova, T., M.A.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1101/gad.37520 6 Chung, H.J., Y.H.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"24:10248– 10259. http://dx.doi.org/10.1523/JNEUROSCI.0546-04.200 4 Cuesto, G., L. Enriquez-Barreto, C. Caramés, M. Cantarero, X. Gasull, C.  Sandi, A. Ferrús, A. Acebes, and M. Morales.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4477-10.201 1 Dietzl, G., D. Chen, F. Schnorrer, K.C.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/nature0595 4 Di Paolo, G., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
http://dx.doi.org/10.1038/   nature0518 5Embryos were collected for 2 h and aged for an additional 3 h at 25°C.,OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
Online supplemental material is   available at http://www.jcb.org/cgi/content/full/jcb.201305134/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/nature0123 5 Litchfield, D.W. 2003.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1042/BJ2002146 9 Lou, D.Y., I. Dominguez, P. Toselli, E. Landesman-Bollag, C. O’Brien, and  D.C. Seldin.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1128/MCB.01119-0 7 Martín-Peña, A., A. Acebes, J.-R. Rodríguez, A. Sorribes, G.G.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1096/   fj.02-0473re v Murray, L.M., K. Talbot, and T.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1007/s00018-009-9149- 8 Penner, C.G., Z. Wang, and D.W. Litchfield.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1016/j.cub.2005.04.03 0 Pielage, J., L. Cheng, R.D.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.02.01 7 Pielage, J., V. Bulat, J.B. Zuchero, R.D.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"69:1114– 1131. http://dx.doi.org/10.1016/j.neuron.2011.02.00 7 Raaf, J., N. Bischoff, K. Klopffleisch, E. Brunstein, B.B.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"50:512– 522. http://dx.doi.org/10.1021/bi101356 3 Roos, J., T. Hummel, N. Ng, C. Klämbt, and G.W.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/S0896-   6273(00)81170- 8 Salvi, M., S. Sarno, O. Marin, F. Meggio, E. Itarte, and L.A. Pinna.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1016/j.febslet.2006.06.03 1 Sanz-Clemente, A., J.A.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.neuron   .2010.08.01 1 Sarno, S., H. Reddy, F. Meggio, M. Ruzzene, S.P.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1016/S0014-5793(01)02404- 8 Saxena, S., and P. Caroni.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1016/j.pneurobio.2007.07.00 7 Saxena, A., R. Padmanabha, and C.V. Glover.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.11.00 1 Schuster, C.M., G.W.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"17:641– 654. http://dx.doi.org/10.1016/S0896-6273(00)80197- X Seldin, D.C., D.Y.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1007/s11010-008-9811- 8Eaton, B.A., and G.W.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/   S0896-6273(02)00721- 3 Enneking, E.-M., S.R.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1371/journal   .pbio.100153 7 Frere, S.G., B. Chang-Ileto, and G. Di Paolo.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1007/978-94-007-3015-1_ 5 Fu, M., X. Yu, J. Lu, and Y. Zuo.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/nature1084 4 Grillo, F.W., S. Song, L.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1073/pnas.121873111 0 Hafezparast, M., R. Klocke, C. Ruhrberg, A. Marquardt, A. Ahmad-Annuar, S.  Bowen, G. Lalli, A.S. Witherden, H. Hummerich, S. Nicholson, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1126/science.108312 9 Hannus, M., F. Feiguin, C.P.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1126/science.276.5314.95 2 Holtmaat, A., and K. Svoboda.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/nrn269 9 Hortsch, M., A.J.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/0896-6273(90)90196- M Huang, H.-D., T.-Y.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1093/nar/gki47 1 Huillard, E., L. Ziercher, O.",Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1128/MCB.01566-0 9 Ikeda, Y., K.A.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1038/ng172 8 Jauch, E., J. Melzig, M. Brkulj, and T. Raabe.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/S0378-1119(02)00921- 6 Jenkins, S.M., and V. Bennett.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1083/jcb.20010902 6 Khuong, T.M., R.L.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi   .org/10.1073/pnas.100179410 7 Klagges, B.R., G. Heimbeck, T.A.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.03.01 9 Lee, T., and L. Luo.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"22:451– 461. http://dx.doi.org/10.1016/S0896-6273(00)80701- 1 Lin, D.M., and C.S.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
13:507– 523. http://dx.doi.org/10.1016/0896-6273(94)90022- 1,Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.5584-08.200 9 Wagh, D.A., T.M.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.02.00 8 Wodarz, A., U. Hinz, M. Engelbert, and E. Knust.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1016/0092-8674(95)90053- 5 Wong, E.V., A.W.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
http://dx.doi.org/10.1046/j.1471-4159.1996.66020779.,Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"http://dx.doi.org/10   .1038/nature0838 9 Yang, G., F. Pan, and W.-B.",OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
http://dx.doi   .org/10.1038/nature0857 7,Non-OADS,/arxiv_data1/oa_pdf/e4/71/JCB_201305134.PMC3882785.pdf
"The clathrin-associated  adaptor protein 1 (AP-1) complex plays a preeminent role  in this process, although other adaptors and coat proteins,  such as AP-4, ARH, Numb, exomer, and retromer, have  also been implicated.Adaptor proteins involved in polarized sorting Juan S. Bonifacino Cell Biology and Metabolism Program, Eunice Kennedy Shriver  National Institute of Child Health and Human Development, National Institutes of Health,   Bethesda, MD 20892 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1083/jcb.20090712 2 Dell’Angelica, E.C., C. Mullins, and J.S.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1074/jbc.274.11.727 8 Diaz, F., D. Gravotta, A. Deora, R. Schreiner, J. Schoggins, E. Falck-Pedersen,  and E. Rodriguez-Boulan.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1091/mbc   .E08-08-080 5 Dotti, C.G., and K. Simons.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90240- F Duffield, A., M.J. Caplan, and T.R.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1016/S1937-6448(08)01404- 4 Dwyer, N.D., C.E.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1093/embo-reports/   kvf09 2 Farfán, P., J. Lee, J. Larios, P. Sotelo, G. Bu, and M.P.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1111/tra.1207 6 Farías, G.G., L. Cuitino, X. Guo, X. Ren, M. Jarnik, R. Mattera, and J.S.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.07.00 7 Fields, I.C., E. Shteyn, M. Pypaert, V. Proux-Gillardeaux, R.S.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20061004 7 Fields, I.C., S.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1091/mbc.E09-01-003 6 Fölsch, H., H. Ohno, J.S.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81650- 5 Fölsch, H., M. Pypaert, P. Schu, and I. Mellman.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.152.3.59 5 Fölsch, H., M. Pypaert, S. Maday, L. Pelletier, and I. Mellman.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1083/jcb.20030902 0 Futter, C.E., A. Gibson, E.H. Allchin, S. Maxwell, L.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1083/jcb.141.3.61 1 Gan, Y ., T.E.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1093/emboj/20.21.595 0 Gonzalez, A., and E. Rodriguez-Boulan.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.febslet.2009.10.05 0 Gravotta, D., J.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.10.00 6References Abou Jamra, R., O. Philippe, A. Raas-Rothschild, S.H.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/   j.ajhg.2011.04.01 9 Anderson, E., S. Maday, J. Sfakianos, M. Hull, B. Winckler, D. Sheff, H. Fölsch,  and I. Mellman.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20050605 1 Ang, A.L., T. Taguchi, S. Francis, H. Fölsch, L.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20040816 5 Apodaca, G., L.I.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1038/ncb263 5 Arimura, N., and K. Kaibuchi.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"123:1149– 1160. http://dx.doi.org/10.1083/jcb.123.5.114 9 Bae, Y.K., H. Qin, K.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1242/dev.0255 5 Barfield, R.M., J.C. Fromme, and R. Schekman.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1091/mbc.E09-04-032 4 Benhra, N., S. Lallet, M. Cotton, S. Le Bras, A. Dussert, and R. Le Borgne.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/   10.1016/j.cub.2010.12.01 0 Berdnik, D., T. Török, M. González-Gaitán, and J.A.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/   10.1016/S1534-5807(02)00215- 0 Bryant, D.M., and K.E.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1038/nrm252 3 Cao, X., M.A.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1038/cr.2012   .64 Carvajal-Gonzalez, J.M., D. Gravotta, R. Mattera, F. Diaz, A. Perez Bay, A.C.  Roman, R.P.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/0092-   8674(91)90139- P Clemens Grisham, R., K. Kindt, K. Finger-Baier, B. Schmid, and T. Nicolson.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1371/journal.pone.006086 6 Cohen, C.J., J. Gaetz, T. Ohman, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1074/jbc.M00953120 0 Cotton, M., N. Benhra, and R. Le Borgne.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.cub.2013.02.02 0 Couturier, L., K. Mazouni, and F. Schweisguth.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1016/j.cub.2013.03.00 2 Deborde, S., E. Perret, D. Gravotta, A. Deora, S. Salvarezza, R. Schreiner, and E.  Rodriguez-Boulan.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1038/nature0682 8 Delevoye, C., I. Hurbain, D. Tenza, J.B. Sibarita, S. Uzan-Gafsou, H. Ohno,  W.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1002/ijc.2613 1 Montpetit, A., S. Côté, E. Brustein, C.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1371/journal.pgen.100029 6 Moreno-De-Luca, A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1136/jmg.2010.08226 3 Nakagawa, T., M. Setou, D. Seog, K. Ogasawara, N. Dohmae, K. Takio,   and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)   00161- 6 Nilsson, L., B. Conradt, A.F.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1534/genetics.108.08724 7 Odorizzi, G., and I.S.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.137.6.125 5 Ohno, H., T. Tomemori, F. Nakatsu, Y. Okazaki, R.C.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S0014-5793(99)00432- 9 Pathak, R.K., M. Yokode, R.E.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.111.2.34 7 Pocha, S.M., T. Wassmer, C. Niehage, B. Hoflack, and E. Knust.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/   j.cub.2011.05.00 7 Polishchuk, R.S., E. San Pietro, A.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
http://dx.doi.org/10.1111/j.1600-0854.2006.00453.,Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1371/journal.pone.002118 1 Ren, X., G.G.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/   10.1016/j.cell.2012.12.04 2 Robinson, M.S.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.tcb.2004.02.00 2 Roush, D.L., C.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1074/   jbc.273.41.2686 2 Sampo, B., S. Kaech, S. Kunz, and G. Banker.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00058- 8 Schmidt, M.R., T. Maritzen, V. Kukhtina, V.A.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/   10.1073/pnas.090426810 6 Schreiner, R., G. Frindt, F. Diaz, J.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1038/ki.2010.16 6 Seaman, M.N., J.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.142.3.66 5 Shafaq-Zadah, M., L. Brocard, F. Solari, and G. Michaux.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1242/dev.07671 1Guo, Y., G. Zanetti, and R. Schekman.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.7554/eLife.0016 0 Hase, K., F. Nakatsu, M. Ohmae, K. Sugihara, N. Shioda, D. Takahashi, Y.  Obata, Y. Furusawa, Y. Fujimura, T. Yamashita, et al.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1053/j.gastro.2013.05.01 3 Hirst, J., N.A.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1091/mbc.10.8.278 7 Hirst, J., G.H.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"22:1711– 1716. http://dx.doi.org/10.1016/j.cub.2012.07.01 2 Hirst, J., C. Irving, and G.H.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1111/tra.1202 8 Jareb, M., and G. Banker.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80468- 7 Kang, R.S., and H. Fölsch.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.121.5.99 7 Klumperman, J., R. Kuliawat, J.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.141.2.35 9 Koivisto, U.M., A.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/   S0092-8674(01)00371- 3 Lasiecka, Z.M., C.C.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1016/S1937-6448(08)01607- 9 Lee, I., B. Doray, J. Govero, and S. Kornfeld.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20070903 7 Lui-Roberts, W.W., L.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20050305 4 Margeta, M.A., G.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1073/pnas.081207810 6 Matsuda, S., and M. Yuzaki.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.02.01 2 Matter, K., W. Hunziker, and I. Mellman.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1016/0092-8674(92)90551- M Mattera, R., M. Boehm, R. Chaudhuri, Y. Prabhu, and J.S.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1074/jbc.M109.01484 5 Mellman, I., and W.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1093/emboj/19.10.219 3 Mimura, M., A. Masuda, S. Nishiumi, K. Kawakami, Y. Fujishima, T. Yoshie,  S. Mizuno, I. Miki, H. Ohno, K. Hase, et al.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1083/jcb.20110601 0 Simmen, T., S. Höning, A. Icking, R. Tikkanen, and W. Hunziker.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1038/ncb74 5 Starr, T.L., S. Pagant, C.W.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1371/journal.pone.004638 6 Takahashi, D., K. Hase, S. Kimura, F. Nakatsu, M. Ohmae, Y .",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1053/j.gastro.2011.04.05 6 Tarpey, P.S., C. Stevens, J. Teague, S. Edkins, S. O’Meara, T. Avis, S. Barthorpe,  G. Buck, A. Butler, J. Cole, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1086/51013 7 Teh, O.K., Y. Shimono, M. Shirakawa, Y. Fukao, K. Tamura, T. Shimada, and  I. Hara-Nishimura.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1093/pcp/pct04 8 Tong, X., D. Zitserman, I. Serebriiskii, M. Andrake, R. Dunbrack, and F. Roegiers.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1091/mbc.E09-09-083 1 Traub, L.M., and J.S.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1101/cshperspect.a01679 0 Valdivia, R.H., D. Baggott, J.S.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1038/ncb115 3 Verkerk, A.J., R. Schot, B. Dumee, K. Schellekens, S. Swagemakers, A.M.  Bertoli-Avella, M.H.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi   .org/10.1016/j.ajhg.2009.06.00 4 Wang, C.W., S. Hamamoto, L. Orci, and R. Schekman.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20060510 6 Weisz, O.A., and E. Rodriguez-Boulan.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"125:5937– 5943. http://dx.doi.org/10.1242/jcs.10942 1 Yamamoto, H., C. Awada, H. Hanaki, H. Sakane, I. Tsujimoto, Y .",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1242/jcs.12605 2 Yap, C.C., M. Murate, S. Kishigami, Y .",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1016/S1044-7431(03)00164- 7 Yap, C.C., D. Wisco, P. Kujala, Z.M.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1083/jcb.20070714 3 Yin, X., S.J.",OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10   .1091/mbc.E13-02-009 3 Zhang, H., A. Kim, N. Abraham, L.A. Khan, D.H. Hall, J.T.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
"http://dx.doi.org/10.1242/dev.07734 7 Zizioli, D., C. Meyer, G. Guhde, P. Saftig, K. von Figura, and P. Schu.",Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
http://dx.doi.org/10.1074/jbc.274.9.538 5,Non-OADS,/arxiv_data1/oa_pdf/0b/45/JCB_201310021.PMC3882786.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1038/375034a 0 Li, T., J.F.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1128/MCB.00204-0 8 Mancini-DiNardo, D., S.J.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.12.01 3 Mohammad, F., R.R.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1128/MCB.02263-0 7 Murakami, K., M. Oshimura, and H. Kugoh.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1007/s10038-007-0196- 4 Murrell, A., S. Heeson, and W. Reik.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi   .org/10.1038/ng140 2 Nagano, T., and P. Fraser.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.01 4 Pandey, R.R., T. Mondal, F. Mohammad, S. Enroth, L. Redrup, J. Komorowski,  T. Nagano, D. Mancini-Dinardo, and C. Kanduri.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi   .org/10.1016/j.molcel.2008.08.02 2 Paulsen, M., T. Khare, C. Burgard, S. Tierling, and J. Walter.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1101/gr.268980 5 Phillips, J.E., and V.G.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.00 1 Prasanth, K.V., and D.L.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1210/me.2007-047 4 Redrup, L., M.R.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/   10.1242/dev.03132 8 Rinn, J.L., M. Kertesz, J.K. Wang, S.L.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.05.02 2 Smilinich, N.J., C.D.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.4161/epi.6.5.1522 1 Terranova, R., S. Yokobayashi, M.B.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.08.01 5 Thakur, N., V.K.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
http://dx.doi.org/   10.1128/MCB.24.18.7855-7862.200 4Table S4 shows primers used for the ChIP assay.,OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201304152/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1038/sj.mt.630038 3 Chen, H.L., T. Li, X.W.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1038/sj.emboj.760139 9 De Marzo, A.M., V.L.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1038/   nmeth82 3 Dekker, J., K. Rippe, M. Dekker, and N. Kleckner.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1126/   science.106779 9 Fitzpatrick, G.V., P.D.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1038/ng98 8 Fitzpatrick, G.V., E.M. Pugacheva, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1128/MCB.02036-0 6 Golding, M.C., L.S.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1242/dev.05777 8 Hu, J.F., and A.R.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/   10.1210/me.9.5.62 8 Hu, J.F., T.H.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/   10.1074/jbc.271.30.1825 3 Hu, J.F., T.H.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10   .1074/jbc.272.33.2071 5 Kanduri, C. 2011.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1016/j.semcdb.2011.02.02 0 Lee, J.T.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10.1126/science.123177 6 Lee, M.P., M.R.",OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/   10.1101/gad.12.23.369 3 Wutz, A., O.W.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
"http://dx.doi.org/10   .1038/3963 1 Yao, X., J.F.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
http://dx.doi.org/10.1083/jcb.20110102 1,Non-OADS,/arxiv_data1/oa_pdf/8b/1f/JCB_201304152.PMC3882787.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
Online sup - plemental material is available at http://www.jcb.org/cgi/content/full/   jcb.201306071/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/   10.1006/cbir.1994.102 5 Condeelis, J., and R.H. Singer.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1042/BC2004006 3 Couttas, T.A., M.J. Raftery, M.P.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1002/pmic.20110057 0 De Calisto, J., C. Araya, L. Marchant, C.F.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1242/dev.0185 7 Dever, T.E., C.E.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1002/cm.97020040 4 Dricu, E. 2012 Methylation: From DNA, RNA and Histones to Diseases and  Treatment.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1074/jbc.270.25.1522 2 Etchevers, H. 2011.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1038/nprot.2011.39 8 Fabianowska-Majewska, K., J.A.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/0006-2952(94)90360- 3 Gammill, L.S., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1242/dev.0017 5 Gammill, L.S., and C.E.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1007/978-1-61779-210-6_ 5 Gao, D., Z. Li, T. Murphy, and W. Sauerbier.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1016/S0167-4781(96)00179- 0 Guendel, I., L. Carpio, C. Pedati, A. Schwartz, C. Teal, F. Kashanchi, and K.  Kehn-Hall.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1371/journal.pone.001137 9 Guerrier, S., J. Coutinho-Budd, T. Sassa, A. Gresset, N.V .",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.04 7 Guo, S., and S. Bao.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1074/jbc.M110.15342 9 Hamburger, V ., and H.L.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1002/aja.100195040 4 Heaslip, A.T., M. Nishi, B. Stein, and K. Hu.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1371/journal.ppat   .100220 1 Hershfield, M.S., and N.M. Krodich.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1126/science.71543 9 Hiatt, W.R., R. Garcia, W.C. Merrick, and P.S.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1101/gad.198747.11 2 Huang, J., and S.L.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1021/pr800569 cadvice and performing mass spectrometry, and T. Markowski for mass spec - trometry sample preparation.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1002/dvdy.2151 3 Ammer, A.G., and S.A. Weed.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"463:958– 962. http://dx.doi.org/10.1038/nature0873 3 Barth, T.K., and A. Imhof.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1016/j.tibs.2010.05.00 6 Basch, M.L., M. Bronner-Fraser, and M.I.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1038/nature0468 4 Beckmann, J.F., T.W.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1016/j.ibmb.2012.12.00 7 Berndt, J.D., M.R.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2008.09.01 3 Boulter, E., S. Estrach, R. Garcia-Mata, and C.C.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1096/fj.11-19225 2 Bronner-Fraser, M., and M. García-Castro.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.10.01 2 Cavallius, J., W. Zoll, K. Chakraburtty, and W.C. Merrick.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/   10.1016/0167-4838(93)90281- U Cavallius, J., A.P.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/S0167-4781(96)00181- 9 Cheng, Y ., M. Cheung, M.M.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"121:233– 241. http://dx.doi.org/10.1016/S0165-3806(00)00049- 3 Chiang, P.K., R.K. Gordon, J. Tal, G.C.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"3:1072. http://dx.doi.org/10.1038/ncomms207 4 Chuikov, S., J.K. Kurash, J.R. Wilson, B. Xiao, N. Justin, G.S.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
21:17– 22. http://dx.doi.org/10.1016/j.conb.2010.09.01 3,OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/S0167-4889(02)00205- 7 Rappsilber, J., Y .",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1021/ac026117 i Riis, B., S.I.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1016/0968-0004(90)90279- K Roffers-Agarwal, J., K.J.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.ydbio.2012.08.00 7 Rottner, K., and T.E.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.ceb   .2011.07.00 3 Schaefer, A., M. Nethe, and P.L.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/   10.1038/nmeth.208 9 Sherman, M., and P.S.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/0003-9861(89)90384- 6 Shevchenko, A., M. Wilm, O. V orm, and M. Mann.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1021/ac950914 h Shu, S., D.C. Mahadeo, X. Liu, W. Liu, C.A.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1073/pnas.060938510 3 Sinha, R., E. Allemand, Z. Zhang, R. Karni, M.P.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"30:2762– 2774. http://dx.doi.org/10.1128/MCB.01270-0 9 Slobin, L.I.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
http://dx.doi.org/10.1111/j.1432-1033.1980.tb04898.,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.08.00 9 Su, I.H., M.W.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.cell.2005.02.02 9 Swartz, M., J. Eberhart, G.S.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1006/dbio.2001.018 1 Teddy, J.M., and P.M. Kulesa.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"131:6141– 6151. http://dx.doi.org/10.1242/dev.0153 4 Theveneau, E., and R. Mayor.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.4161/sgtp.1.2.1367 3 Theveneau, E., and R. Mayor.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.ydbio.2011.12.04 1 Ueland, P.M., and S. Helland.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1002/pmic.20050004 2 Kernstock, S., E. Davydova, M. Jakobsson, A. Moen, S. Pettersen, G.M.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"3:1038. http://dx.doi.org/10.1038/ncomms204 1 Kislauskis, E.H., X. Zhu, and R.H. Singer.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1083/jcb.127.2.44 1 Kislauskis, E.H., X. Zhu, and R.H. Singer.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1083/jcb.136.6.126 3 Kozlowska, M., R.T. Smolenski, W. Makarewicz, C. Hoffmann, B. Jastorff, and  J. Swierczynski.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/S0378-4274(98)00369- 5 Kulesa, P.M., and S.E.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.ydbio.2010.05.00 5 Lee, S., A.C. Doxey, B.J.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi   .org/10.1093/mp/ssr08 3 Lee, V .M., and P.Y .",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/S0091   -679X(08)00206- 9 Levy, D., C.L.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"4:19. http://dx.doi   .org/10.1186/1756-8935-4-1 9 Lin-Moshier, Y ., P.J.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1074/jbc.M112.40576 1 Lipson, R.S., K.J.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1016/j.abb.2010.05.02 3 Liu, G., W.M.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1091/mbc.01-03-014 0 Magrane, M., and U.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1242/dev.01735 0 Moore, K.E., S.M.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.03.00 5 Murray, J.W., B.T.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1083/jcb.135.5.130 9 Ong, S.E., G. Mittler, and M. Mann.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1038/nmeth71 5 Pang, C.N., E. Gasteiger, and M.R.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"11:92. http://dx.doi.org/10   .1186/1471-2164-11-9 2 Polevoda, B., and F. Sherman.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10.1111/j.1365- 2958.2007.05831. x Prasad, M.S., T. Sauka-Spengler, and C. LaBonne.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
Retrieved from http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10 .1021/   pr900699 a Young, N.L., P.A.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1007/s00018-010-0475- 7 Zhang, X., H. Wen, and X. Shi.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
"http://dx.doi.org/10   .1093/abbs/gmr10 0 Zhang, Y ., T.H.",OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
http://dx.doi.org/10.1101/gad.179283.11 1,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JCB_201306071.PMC3882789.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1242/jcs.0340 8 D’Avino, P.P., M.S.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1242/jcs.0233 5 Dong, L., C. Chapline, B. Mousseau, L. Fowler, K. Ramsay, J.L.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1074/jbc.270.43.2553 4 Field, C.M., M. Wühr, G.A.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/   10.1242/jcs.08226 3 Gardner, K., and V. Bennett.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1038/328359a 0 Gazda, L., W. Pokrzywa, D. Hellerschmied, T. Löwe, I. Forné, F. Mueller­ Planitz, T. Hoppe, and T. Clausen.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1126/science.108493 8 Huang, J., A.J.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1016/j.cell.2012.07.02 2 Hughes, C.A., and V. Bennett.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1074/jbc.270.32.1899 0 Joshi, R., and V. Bennett.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1083/jcb.115.3.66 5 Kerber, M.L., and R.E.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1242/   jcs.02354 9 Kuhlman, P.A., C.A.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1074/jbc.273   .30.1932 9 Liao, W., K. Elfrink, and M. Bähler.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1074/jbc.M110.10110 5 Matsuoka, Y., C.A.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1083/jcb.142.2.48 5 McKenney, R.J., M. Vershinin, A. Kunwar, R.B.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.03 5 Mische, S.M., M.S.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1083/jcb   .105.6.283 7 Mitsushima, M., K. Aoki, M. Ebisuya, S. Matsumura, T. Yamamoto, M.  Matsuda, F. Toyoshima, and E. Nishida.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"191:453– 462. http://dx.doi.org/10.1083/jcb.20100713 6 Naydenov, N.G., and A.I.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
http://dx.doi   .org/10.1016/S0092­8674(04)00341­ 1condensation) to anaphase onset was measured for ≥25 cells from three  independent experiments.,OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201306083/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
Additional data are available  in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201306083.dv.,OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1091/mbc.E07 ­08­0818 Bennett, V., K. Gardner, and J.P. Steiner.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
http://dx.doi.org/10.1038/onc.2009.36 3,Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.12.02 0 Toyoshima, F., and E. Nishida.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1038/sj.emboj   .760159 9 Umeki, N., H.S.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1038/nsmb.206 5 Velarde, N., K.C.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"7:142. http://dx.doi.org/10   .1186/1471­213X­7­14 2 Weber, K.L., A.M. Sokac, J.S.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1038/nature0283 4 Woolner, S., and N. Papalopulu.",Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
"http://dx.doi.org/10.1016/j.devcel.2012   .01.00 2 Woolner, S., L.L.",OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
http://dx.doi.org/10.1083/jcb.20080406 2,Non-OADS,/arxiv_data1/oa_pdf/b4/3b/JCB_201306083.PMC3882790.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/   nrm328 8 Alabert, C., J.-C. Bukowski-Wills, S.-B.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi   .org/10.1016/S0092-8674(03)00569- 5 Annunziato, A.T. 2012.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.bbagrm   .2011.07.00 5 Annunziato, A.T., and R.L.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1038/emboj.2012.5 5 Barcaroli, D., L. Bongiorno-Borbone, A. Terrinoni, T.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1073/   pnas.060422710 3 Bester, A.C., M. Roniger, Y.S.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.04 4 Bianco, J.N., J. Poli, J. Saksouk, J. Bacal, M.J. Silva, K. Yoshida, Y.L.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.ymeth.2012.04.00 7 Bonner, W.M., R.S.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1021/bi00417a05 2 Branzei, D., and M. Foiani.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/   nrm285 2 Chabes, A., and L. Thelander.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1074/jbc   .M00079920 0 Cimprich, K.A., and D. Cortez.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/   nrm245 0 Cook, A.J., Z.A.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi   .org/10.1016/j.molcel.2011.11.02 1 Courbet, S., S. Gay, N. Arnoult, G. Wronka, M. Anglana, O. Brison, and M.  Debatisse.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi   .org/10.1038/nature0723 3 Duch, A., I. Felipe-Abrio, S. Barroso, G. Yaakov, M. García-Rubio, A. Aguilera,  E. de Nadal, and F. Posas.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
493:116– 119. http://dx.doi.org/10.1038/nature1167 5used as a negative control.,Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201305017/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201305017.dv.,OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"20:1206– 1218. http://dx.doi.org/10.1128/MCB.20.4.1206-1218.200 0 Murzina, N., A. Verreault, E. Laue, and B. Stillman.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/   S1097-2765(00)80204- X Nabatiyan, A., and T. Krude.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1128/MCB.24.7.2853-2862.200 4 Neelsen, K.J., A.R.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"1094:177– 208. http://dx.doi.org/10.1007/978-1-62703-706-8_1 5 Nelson, D.M., X. Ye, C. Hall, H. Santos, T. Ma, G.D. Kao, T.J.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1128/MCB.22.21.7459-7472.200 2 O’Sullivan, R.J., S. Kubicek, S.L.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1038/nsmb.189 7 Pacek, M., and J.C. Walter.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/sj.emboj.760036 9 Petermann, E., M. Woodcock, and T. Helleday.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10   .1073/pnas.100503110 7 Prado, F., and A. Aguilera.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1128/MCB.25.4.1526-1536.200 5 Quivy, J.P., D. Roche, D. Kirschner, H. Tagami, Y. Nakatani, and G.  Almouzni.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/sj   .emboj.760036 2 Quivy, J.P., A. Gérard, A.J.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/nsmb.147 0 Ray-Gallet, D., A. Woolfe, I. Vassias, C. Pellentz, N. Lacoste, A. Puri, D.C.  Schultz, N.A.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.12.00 6 Sarraf, S.A., and I. Stancheva.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi   .org/10.1016/j.molcel.2004.06.04 3 Schlacher, K., N. Christ, N. Siaud, A. Egashira, H. Wu, and M. Jasin.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.04 1 Schöpf, B., S. Bregenhorn, J.P. Quivy, F.A.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10   .1073/pnas.110669610 9 Seale, R.L., and R.T. Simpson.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/   0022-2836(75)90216- 8 Shibahara, K., and B. Stillman.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80661- 3 Sirbu, B.M., F.B.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1101/gad.205321 1 Smith, D.J., and I. Whitehouse.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1038/nature1089 5 Sobel, R.E., R.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.10.02 3 Feser, J., D. Truong, C. Das, J.J. Carson, J. Kieft, T. Harkness, and J.K. Tyler.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.08.01 5 Fugger, K., M. Mistrik, J.R. Danielsen, C. Dinant, J. Falck, J. Bartek, J. Lukas,  and N. Mailand.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"186:655– 663. http://dx.doi.org/10.1083/jcb.20081213 8 Ge, X.Q., D.A.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1101/gad.45780 7 Görisch, S.M., A. Sporbert, J.H.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.4161/cc.7.13.609 4 Groth, A., D. Ray-Gallet, J.P. Quivy, J. Lukas, J. Bartek, and G. Almouzni.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/j   .molcel.2004.12.01 8 Groth, A., A. Corpet, A.J.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1126/science.114899 2 Gunjan, A., and A. Verreault.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00896- 1 Haring, S.J., A.C. Mason, S.K.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1074/jbc   .M80088120 0 Hoek, M., and B. Stillman.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/nsmb97 2 Kerzendorfer, C., F. Hannes, R. Colnaghi, I. Abramowicz, G. Carpenter, J.R.  Vermeesch, and M. O’Driscoll.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1093/hmg/dds03 3 Kim, U.J., M. Han, P. Kayne, and M. Grunstein.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/nmeth108 9 Lee, K.Y., H. Fu, M.I.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1083/   jcb.20120608 4 Lopes, M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1007/978-1-60327-815-7_3 4 Loyola, A., H. Tagami, T. Bonaldi, D. Roche, J.P. Quivy, A. Imhof, Y. Nakatani,  S.Y.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10   .1038/embor.2009.9 0 Marzluff, W.F., E.J.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/nrg243 8 Maya-Mendoza, A., E. Petermann, D.A.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/   10.1038/sj.emboj.760171 4 Mello, J.A., J.G.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1126/science.107402 3 Sporbert, A., A. Gahl, R. Ankerhold, H. Leonhardt, and M.C.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/S1097-2765(02)00729- 3 Su, C., G. Gao, S. Schneider, C. Helt, C. Weiss, M.A.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/sj.emboj.760012 0 Takami, Y., T. Ono, T. Fukagawa, K. Shibahara, and T. Nakayama.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1091/mbc.E06-05-042 6 Tang, Y., M.V.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi   .org/10.1038/nsmb114 7 Townley-Tilson, W.H., S.A. Pendergrass, W.F.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1261/   rna.7600 6 Van, C., S. Yan, W.M.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1083/jcb   .20090910 5 Weintraub, H. 1972.",Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1038/240449a 0  Worcel, A., S. Han, and M.L.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"http://dx.doi.org/10.1016/0092-8674(78)90280- 5 Yang, X.C., B.D.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"36:267– 278. http://dx.doi.org/10.1016/j.molcel.2009.08.01 6 Ye, X., A.A. Franco, H. Santos, D.M.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
"11:341– 351. http://dx.doi.org/10.1016/S1097-2765(03)00037- 6 Zhang, Z., K. Shibahara, and B. Stillman.",OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
http://dx.doi.org/10.1242/jcs.0152 3,Non-OADS,/arxiv_data1/oa_pdf/d3/12/JCB_201305017.PMC3882791.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"160:729– 740. http://dx.doi.org/10.1083/jcb.20021104 7 Berryman, M., Z. Franck, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1083/jcb.147.7.153 3 Bryant, D.M., and K.E.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/nrm252 3 Bryant, D.M., A. Datta, A.E.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/ncb210 6 Buchan, D.W., S.M.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1074/jbc.M41194120 0 Casaletto, J.B., I. Saotome, M. Curto, and A.I.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/   10.1083/jcb.20120209 4 Eswar, N., B. Webb, M.A.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/nrm286 6 Goldstein, B., and I.G.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1016/j.devcel.2007.10.00 7 Hall, A.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1042/BST2005089 1 Hart, M.J., A. Eva, T. Evans, S.A. Aaronson, and R.A. Cerione.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/354311a 0 Hauri, H.-P., E.E.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1083/jcb.20080712 1 Kamynina, E., K. Kauppinen, F. Duan, N. Muakkassa, and D. Manor.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/   10.1128/MCB.01051-0 6 Komai, K., R. Okayama, M. Kitagawa, H. Yagi, K. Chihara, and S. Shiozawa.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi   .org/10.1016/S0006-291X(02)02645- 1 Komai, K., N. Mukae-Sakairi, M. Kitagawa, and S. Shiozawa.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1016/j.bbrc.2003.08.08 8 Kreis, T.E.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1091/mbc.E03-04-023 5 Linstedt, A.D., and H.P.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
http://dx.doi.org/10.1091/mbc.4.7.67 9standard Western blotting techniques.,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/   full/jcb.201304064/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1083/jcb.134.4.103 1 Batchelor, C.L., J.R. Higginson, Y .J.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
6:353– 363. http://dx.doi.org/10.4161/cc.6.3.381 9,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.07.00 5 Steed, E., N.T.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"10:95. http://dx.doi.org/10.1186/1471-   2121-10-9 5 Suzuki, A., and S. Ohno.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1242/jcs.0289 8 ten Klooster, J.P., M. Jansen, J. Yuan, V. Oorschot, H. Begthel, V. Di Giacomo,  F. Colland, J. de Koning, M.M.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.01.01 6 Tepass, U.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1146/annurev-cellbio-092910-15403 3 Terry, S.J., C. Zihni, A. Elbediwy, E. Vitiello, I.V.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1038/ncb215 6 Vanni, C., A. Parodi, P. Mancini, V. Visco, C. Ottaviano, M.R.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/sj.onc.120750 9 Viswanatha, R., P.Y.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/   10.1083/jcb.20120704 7 Walther, R.F., and F. Pichaud.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/j.cub.2010.04.04 9 Wells, C.D., J.P. Fawcett, A. Traweger, Y. Yamanaka, M. Goudreault, K. Elder,  S. Kulkarni, G. Gish, C. Virag, C. Lim, et al.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/j.cell.2006.02.04 5 Xu, X., T. Omelchenko, and A.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"11:77. http://dx.doi.org/   10.1186/1471-2121-11-7 7 Yamanaka, T., and S. Ohno.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.2741/318 2 Yano, T., Y. Yamazaki, M. Adachi, K. Okawa, P. Fort, M. Uji, S. Tsukita, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1083/jcb.20100910 0 Yoshizaki, H., Y. Ohba, K. Kurokawa, R.E.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1083/jcb.20021204 9Liu, X.F., H. Ishida, R. Raziuddin, and T. Miki.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1128/MCB.24.15.6665-6675.200 4 Makarova, O., M.H.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/   10.1016/S037811190201084 3 Massey-Harroche, D., M.H.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1093/hmg/ddl48 5 Matter, K., and M.S.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/S1046-2023(03)00029- X Matter, K., W. McDowell, R.T. Schwartz, and H.P.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.04 0 Nagai-Tamai, Y., K. Mizuno, T. Hirose, A. Suzuki, and S. Ohno.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
http://dx.doi.org/10.1046/j.1365-2443.2002.00590.,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1074/jbc   .M111.27078 5 Otani, T., T. Ichii, S. Aono, and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1083/jcb.20060501 2 Panagabko, C., S. Morley, M. Hernandez, P. Cassolato, H. Gordon, R. Parsons,  D. Manor, and J. Atkinson.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10   .1021/bi034086 v Pettersen, E.F., T.D.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1002/jcc.2008 4 Pieczynski, J., and B. Margolis.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1091/mbc.E06-11-103 1 Qin, Y., W.H.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1083/jcb.20100209 7 Ratheesh, A., G.A.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/ncb253 2 Saotome, I., M. Curto, and A.I.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1016/j.devcel.2004.05.00 7 Snyder, J.T., D.K.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
"http://dx.doi.org/10.1038/nsb79 6 Speck, O., S.C. Hughes, N.K.",OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
http://dx.doi.org/10.1038/nature0129 5,Non-OADS,/arxiv_data1/oa_pdf/b7/41/JCB_201304064.PMC3882792.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201305084/DC1.,Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"49:872– 883. http://dx.doi.org/10.1016/j.molcel.2013.01.00 1 Fu, X., S. Wan, Y.L.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1371/journal.pone.000200 9 García-Silva, S., and A. Aranda.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1128/MCB.24.17.7514-7523.200 4 García-Silva, S., O. Martínez-Iglesias, L. Ruiz-Llorente, and A. Aranda.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1038/onc.2010.46 4 Garinis, G.A., L.M.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/ncb186 6 Gesing, A., A. Lewi ński, and M. Karbownik-Lewi ńska.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"5:16. http://dx.doi   .org/10.1186/1756-6614-5-1 6 Gugneja, S., and R.C.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1074/jbc.272.30.1873 2 Habershon, S.O.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/   S0140-6736(02)45227- 0 Harper, J.W., and S.J.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.11.01 5 Harvey, M., A.T. Sands, R.S.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/0014-4827(65)90211- 9 Hütter, E., H. Unterluggauer, A. Garedew, P. Jansen-Dürr, and E. Gnaiger.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.exger.2005.09.01 1 Kim, W.G., and S.Y.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.bbagen   .2012.04.00 2 Larsson, N.G., J. Wang, H. Wilhelmsson, A. Oldfors, P. Rustin, M. Lewandoski,  G.S.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/ng0398-23 1 Lee, J.H., and T.T.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1210/jc.2011-207 7 López, M., L. Varela, M.J. Vázquez, S. Rodríguez-Cuenca, C.R.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1038/nm.220 7 Magnus-Levy, A.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1093/qjmed/95.9.55 9 Mookerjee, S.A., A.S. Divakaruni, M. Jastroch, and M.D.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"131:463– 472. http://dx.doi.org/10.1016/j.mad.2010.03.01 0 Mukhopadhyay, P., M. Rajesh, K. Yoshihiro, G. Haskó, and P. Pacher.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2007.04.10 6 Niedernhofer, L.J., G.A.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nature0545 6 Okuno, Y., A. Nakamura-Ishizu, K. Otsu, T. Suda, and Y. Kubota.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nm.284 6Submitted: 16 May 2013 Accepted: 25 November 2013 References Abraham, R.T. 2002.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/ncb1202-e27 7 Alexander, A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.tem.2009.03.01 1 Atzmon, G., N. Barzilai, J.G.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1210/jc.2008-232 5 Baker, D.J., T. Wijshake, T. Tchkonia, N.K.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nature1060 0 Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva,  L.V .",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1038/nature0526 8 Baxter, J.D., P. Webb, G. Grover, and T.S.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"15:154– 157. http://dx.doi.org/10.1016/j.tem.2004.03.00 8 Bergeron, R., J.M.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/   10.1016/j.mce.2008.04.02 1 Callén, E., M. Jankovic, N. Wong, S. Zha, H.T.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.04.02 5 Callén, E., M. Di Virgilio, M.J. Kruhlak, M. Nieto-Soler, N. Wong, H.T.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/   j.cell.2013.05.02 3 Campisi, J., and F. d’Adda di Fagagna.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1038/nrc188 4 Collado, M., and M. Serrano.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10   .1038/nrc277 2 d’Adda di Fagagna, F., P.M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, T.  Von Zglinicki, G. Saretzki, N.P.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nature0211 8 Di Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C.  Schurra, M. Garre’, P.G.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nature0532 7 Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1073/pnas.92.20.936 3 Escribano-Díaz, C., A. Orthwein, A. Fradet-Turcotte, M. Xing, J.T.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1210/   en.2004-139 2 Zimmermann, M., F. Lottersberger, S.B.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1126/science.123157 3Ooka, H., and T. Shinkai.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/   10.1016/0047-6374(86)90052- 7 Oppenheimer, J.H., H.L.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1210/edrv-8-3-28 8 Pascual, A., and A. Aranda.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1016/j.bbagen.2012.03.01 2 Rodier, F., J.P. Coppé, C.K.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/ncb190 9 Rogakou, E.P., C. Boon, C. Redon, and W.M.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1083/jcb.146.5.90 5 Rozing, M.P., J.J. Houwing-Duistermaat, P.E.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1210/jc.2010-087 5 Scarpulla, R.C.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1016/S0167-4781(02)00343- 3 Schultz, L.B., N.H. Chehab, A. Malikzay, and T.D.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi   .org/10.1083/jcb.151.7.138 1 Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81079- X Serrano, M., A.W.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)81902- 9 Sun, Y., K.E.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1007/s11010-007-9575- 6 Suzuki, A., G. Kusakai, A. Kishimoto, Y. Shimojo, T. Ogura, M.F.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1016/j.bbrc.2004.09.14 5 Tata, J.R., L. Ernster, and O. Lindberg.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1083/jcb.17.2.29 9 Upadhyay, G., R. Singh, A. Kumar, S. Kumar, A. Kapoor, and M.M.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1002/hep.2008 5 van der Pluijm, I., G.A.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1371/journal.pbio.005000 2 Videla, L.A. 2010.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1038/nature0721 6 Virbasius, J.V., and R.C.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/   10.1074/jbc.C30011720 0 Wyman, C., and R. Kanaar.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"http://dx.doi.org/10.1146/   annurev.genet.40.110405.09045 1 Yamauchi, M., F. Kambe, X. Cao, X. Lu, Y. Kozaki, Y. Oiso, and H. Seo.",OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
http://dx.doi.org/10.1210/me.2007-024 9,Non-OADS,/arxiv_data1/oa_pdf/1b/a0/JCB_201305084.PMC3882795.pdf
"An upper bound on acetyl-CoA demand for fatty acid biosynthesis (F14) was calculated based on the cell line-speciﬁc growth rate (NCI’s DTP database http://dtp.nci.nih.gov/docs/ misc/common_ﬁles/cell_list.html), assuming that fatty acids com- prise less than 20% of cellular dry weight of 200 mg per 10 6cells.",OADS,/arxiv_data1/oa_pdf/78/be/msb201365.PMC3882799.pdf
"cThe decay rate sof the luciferase was set to 0.14/h, (https://tinyurl.com/promegaBatesLuciferase).",Non-OADS,/arxiv_data1/oa_pdf/57/97/msb201368.PMC3882800.pdf
"In the case of our qPCR and luciferase measurements, we set the decay rate sof the luciferase to 0.14/h (see https://tinyurl.com/promegaBatesLuciferase).",Non-OADS,/arxiv_data1/oa_pdf/57/97/msb201368.PMC3882800.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc-sa/3.0/.Bottlenecks in miRNA-mediated gene regulation J Hausser et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 13,Non-OADS,/arxiv_data1/oa_pdf/57/97/msb201368.PMC3882800.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproductio n in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/44/TOMICROJ-7-152.PMC3882904.pdf
Available from: http://oxforddictionaries.com/defini- tion/consent#m_en_gb0173250.007 2.,Non-OADS,/arxiv_data1/oa_pdf/54/18/or-2013-4-e32.PMC3883073.pdf
Available from: http://www.aicpiemonte.it/uploads/media/2 81_file.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/f0/pr-2013-4-e19.PMC3883085.pdf
"Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/10426/2004-123-40_200412340.pdf, accessed 31 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
"[Riks-Stroke, the Swedish Stroke Register: One yearafter Stroke, 1-year follow-up 2010 –lifesituation, fulﬁlled needs and results of health care services interventions] Available at: http://www.riks-stroke.org/content/analyser/1-arsrapport-09.pdf], accessed 31 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
"Guidelines for Stroke Care].Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/17790/2009-11-4.pdf, accessed 31 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
"Available at: http://www.sweden.gov.se/sb/d/3873/a/ 23125, accessed 31 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
"Good care –on management systems for quality and patient security in the health services] Available at: http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/9406/2006-101-2_20061012.pdf, accessed 31 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
"[Riks-Stroke, the Swedish Stroke Register: Annual report 2011] 2012.Available at: http://www.riks-stroke.org/content/ analyser/RS_arsrapport_2011.pdf, accessed 9 June 2013. ª2013 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/51/69/HEX-16-e24.PMC3883089.pdf
DNA sequences that resulted in low discrimination b e- tween species were further analysed using the Ribosomal  Database Project ( http://rdp.cme.msu.edu ) using default  setting except for inc luding cultured strains only and  EzBioCLoud ( www.ezbiocloud.net ).,OADS,/arxiv_data1/oa_pdf/da/01/TOMICROJ-7-146.PMC3883160.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/  by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/01/TOMICROJ-7-146.PMC3883160.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/85/rmhp-7-019.PMC3883161.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 19–24Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  19ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S5575 2Over-the-counter medication patterns   in households in sharjah, United arab emirates ashraf ahmad Zaghloull Moetaz elsergany2 nagwa abou el-enein1 Hamda alsuwaidi3 Mohamed ayoub3 1Health administration and Behavioral  sciences Department, High institute  of Public Health, University of  alexandria, alexandria, egypt;  2e-school Health and environmental  studies, Hamdan Bin Mohamed  eUniversity, Dubai, United arab  emirates; 3college of Health sciences,   University of sharjah, United arab  emirates.",Non-OADS,/arxiv_data1/oa_pdf/68/85/rmhp-7-019.PMC3883161.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/68/85/rmhp-7-019.PMC3883161.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/85/rmhp-7-019.PMC3883161.pdf
"Available from: http://apps.who.int/medicinedocs/pdf/ whozip32e/whozip32e.pd f. Accessed on July 25, 2013.",OADS,/arxiv_data1/oa_pdf/68/85/rmhp-7-019.PMC3883161.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/20/jit470.PMC3883172.pdf
"Geneva: World Health Organization, 2012 .http://www.who.int/hiv/ pub/guidelines/9789241501972/en/ .",Non-OADS,/arxiv_data1/oa_pdf/60/20/jit470.PMC3883172.pdf
"Geneva: World Health Organization, 2006 .http://www.who.int/hiv/pub/guidelines/ artadultguidelines.pdf .",Non-OADS,/arxiv_data1/oa_pdf/60/20/jit470.PMC3883172.pdf
"Geneva: World Health Organization, 2010 .http://www.who.int/hiv/pub/arv/ adult2010/en/index.html .",Non-OADS,/arxiv_data1/oa_pdf/60/20/jit470.PMC3883172.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/87/27/JCN-2-166.PMC3883210.pdf
Available from: http://www.newbornwhocc.org/pdf/ nnpdreport2002-03.PDF [Last accessed on 2013 May 10].,Non-OADS,/arxiv_data1/oa_pdf/9b/e8/JCN-2-169.PMC3883211.pdf
Available from: http://pediatrics.aappublications.org/content/129/5/1006.full.html [Last accessed on 2013 May 10].,Non-OADS,/arxiv_data1/oa_pdf/9b/e8/JCN-2-169.PMC3883211.pdf
Available from: http://ispub.com/IJPN/12/1/4803 [Last accessed on 2013 May 10].,Non-OADS,/arxiv_data1/oa_pdf/9b/e8/JCN-2-169.PMC3883211.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/cc/f5/JCN-2-173.PMC3883212.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3y sr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/cc/f5/JCN-2-173.PMC3883212.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/54/9e/JCN-2-183.PMC3883214.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/86/91/NMJ-54-289.PMC3883225.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/86/91/NMJ-54-289.PMC3883225.pdf
Available  from: http://www.who.int/healthinfo/survey/ageingdefnolder/ en/index.html [Last accessed on 2012 Dec 28].,OADS,/arxiv_data1/oa_pdf/1b/ba/NMJ-54-295.PMC3883226.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/1b/ba/NMJ-54-295.PMC3883226.pdf
Available from: http://unilorin.edu.ng/ journals/education/ije/feb1983/THE%20APPLICATION%20 OF%20CONTINUOUS%20ASSESSMENT%20MODEL%20 IN%20NIGERIAN%20SCHOOLS.pdf [Last accessed date on  2012 July 4th].,Non-OADS,/arxiv_data1/oa_pdf/73/d9/NMJ-54-302.PMC3883227.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/8b/41/NMJ-54-306.PMC3883228.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/78/e1/NMJ-54-329.PMC3883234.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/21/47/NMJ-54-351.PMC3883239.pdf
UK: Springer; 2012. p.477-516.Access this article online Quick Response Code: Website: www.nigeriamedj.com DOI: 10.4103/0300-1652.122379 Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/cd/7a/NMJ-54-362.PMC3883243.pdf
"Vinca rosea) an evergreen shrub, it grows to  a height of 1 m with a spread of 1 m. The stem is short, erect and branching; the leaves are glossy green, oval, 5 cm long and  opposite acuminate; the flowers are soft pink, tinged with red, 5 petal, open, tubular and 4 cm across, appearing in spring and  autumn (three colors: pink, purple and white) (http://my.opera.com/Thachthaotim84/albums/showpic.dml)",Non-OADS,/arxiv_data1/oa_pdf/b0/2b/IJPVM-4-1231.PMC3883245.pdf
Available from: http://www.Vinca alkaloids\Alkaloids  Cancer Treatment Livestrong_com.mh.,Non-OADS,/arxiv_data1/oa_pdf/b0/2b/IJPVM-4-1231.PMC3883245.pdf
"Geneva, Switzerland; Available from:  http://www.who.int/ageing/publications/Global_age_ friendly_cities_Guide_English.pdf.",Non-OADS,/arxiv_data1/oa_pdf/00/86/IJPVM-4-1282.PMC3883253.pdf
"Geneva, Switzerland: World Health Organization  2006; Available from: http://www.who.int/ageing/en.",Non-OADS,/arxiv_data1/oa_pdf/00/86/IJPVM-4-1282.PMC3883253.pdf
Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/00/86/IJPVM-4-1282.PMC3883253.pdf
Available from:  http://www.haad.ae/Haad/.,Non-OADS,/arxiv_data1/oa_pdf/4f/3f/IJPVM-4-1290.PMC3883254.pdf
Available from: http://www.uaestatistics.,Non-OADS,/arxiv_data1/oa_pdf/4f/3f/IJPVM-4-1290.PMC3883254.pdf
Available from: http://www.midwakh.com/index.,Non-OADS,/arxiv_data1/oa_pdf/4f/3f/IJPVM-4-1290.PMC3883254.pdf
Available from http://ejustice.gov.ae/portal/ page/portal/eJustice%20MOJ%20Portal/About%20Us/ Law%20of%20Personal%20Affairs.,Non-OADS,/arxiv_data1/oa_pdf/4f/3f/IJPVM-4-1290.PMC3883254.pdf
Available from: http://www.arableagueonline.org/.,Non-OADS,/arxiv_data1/oa_pdf/4f/3f/IJPVM-4-1290.PMC3883254.pdf
Available from:  http://www.who int/tobacco/mpower/2008/en/index  html.,Non-OADS,/arxiv_data1/oa_pdf/bf/55/IJPVM-4-1312.PMC3883257.pdf
Available from: http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/40/9c/IJPVM-4-1323.PMC3883260.pdf
Available from: http://www.zdravlje.hzjz.hr/clanak.,Non-OADS,/arxiv_data1/oa_pdf/40/9c/IJPVM-4-1323.PMC3883260.pdf
Available from: http://www.centar ‑ zdravlja.net/zanimljivosti/1878/rani‑stres‑uzrokuje‑ kardiovaskularne‑bolesti/.,Non-OADS,/arxiv_data1/oa_pdf/40/9c/IJPVM-4-1323.PMC3883260.pdf
Integrating prevention  into health care Available from: http://www.who.int/ mediacentre/factsheets/fs172/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/7b/88/IJPVM-4-1331.PMC3883261.pdf
(abstract available at  Available from: http://www.landesbioscience.com/ journals/vaccines/article/14621) [Last accessed on 2011  May].,Non-OADS,/arxiv_data1/oa_pdf/7b/88/IJPVM-4-1331.PMC3883261.pdf
Available from: http://www.femwiki.com/fem/w/wiki/ measures‑of‑disease‑impact.aspx.,Non-OADS,/arxiv_data1/oa_pdf/7b/88/IJPVM-4-1331.PMC3883261.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs318/en/.,Non-OADS,/arxiv_data1/oa_pdf/48/e4/IJPVM-4-1342.PMC3883263.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Beneficial actions of the anti‑inflammatory dimethyl fumarate in  glioblastomas Ali J. Ghods1, Roberta Glick1,2, David Braun3, Douglas Feinstein3 1Departments of Neurosurgery, Rush University Medical Center, 2Anatomy and Cell Biology, University of Illinois at Chicago, 3Anesthesiology, University of Illinois  Chicago, Chicago, IL, USA E‑mail: *Ali J. Ghods ‑ alijghods@hotmail.com; Roberta Glick ‑ rpglick@hotmail.com; David Braun ‑ dbraun@hotmail.com; Douglas Feinstein ‑dlfeins@uic.edu   *Corresponding author: Received: 27 September 13  Accepted: 19 November 13  Published: 24 December 13 Abstract Background:  Dimethylfumarate (DMF), a drug used in the treatment of psoriasis  and multiple sclerosis, has been shown to limit the growth of melanoma cells .",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/160/123656 Copyright: © 2013 Ghods AJ.,Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
"Surgical Neurology International 2013, 4:160  http://www.surgicalneurologyint.com/content/4/1/160INTRODUCTION Dimethylfumarate (DMF), a fumaric acid ester and  antiinflammatory medication, has been safely used since  1959 in the treatment of psoriasis, a T‑cell mediated  dermatological disease resulting from dysfunction of the  immune system.",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
"Surgical Neurology International 2013, 4:160  http://www.surgicalneurologyint.com/content/4/1/160antirabbit IgG antibodies (1:200; Jackson  Immunoresearch Labo‑ratories, West Grove,  PA).",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
"Surgical Neurology International 2013, 4:160  http://www.surgicalneurologyint.com/content/4/1/160cell marker CD133 in this model.",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
"Surgical Neurology International 2013, 4:160  http://www.surgicalneurologyint.com/content/4/1/160that by inhibiting the nuclear translocation of NF‑ κΒ,  you can decrease proliferation, increase susceptibility to  chemotherapy, decrease expression of adhesion molecules,  prevent metastasis, and induce apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
"Surgical Neurology International 2013, 4:160  http://www.surgicalneurologyint.com/content/4/1/160against androgen- independent prostate cancer cells via inhibition of  NF-kappaB and AP-1 pathway in vitro .",Non-OADS,/arxiv_data1/oa_pdf/67/57/SNI-4-160.PMC3883267.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/51/122319Video available on www.clinicalimagingscience.org,Non-OADS,/arxiv_data1/oa_pdf/f0/ad/JCIS-3-51.PMC3883268.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Long segment spinal epidural extramedullary hematopoiesis Kanwaljeet Garg, Pankaj Kumar Singh, Manmohan Singh, P .",Non-OADS,/arxiv_data1/oa_pdf/92/af/SNI-4-161.PMC3883269.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/161/123657 Copyright: © 2013 Garg K.This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/92/af/SNI-4-161.PMC3883269.pdf
"Surgical Neurology International 2013, 4:161  http://www.surgicalneurologyint.com/content/4/1/161revealed palpable splenomegaly, while the neurological  assessment demonstrated localized tenderness over the D5 level, with attendant 4/5 weakness in both lower extremities, hyperactive bilateral Patellar and Achilles reflexes with bilateral Babinski responses, and a graded  sensory loss to pin appreciation below D5.",Non-OADS,/arxiv_data1/oa_pdf/92/af/SNI-4-161.PMC3883269.pdf
"Surgical Neurology International 2013, 4:161  http://www.surgicalneurologyint.com/content/4/1/161due to EMH.",Non-OADS,/arxiv_data1/oa_pdf/92/af/SNI-4-161.PMC3883269.pdf
"Surgical Neurology International 2013, 4:161  http://www.surgicalneurologyint.com/content/4/1/161hematopoiesis in homozygous thalassemia.",Non-OADS,/arxiv_data1/oa_pdf/92/af/SNI-4-161.PMC3883269.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/50/122317,Non-OADS,/arxiv_data1/oa_pdf/13/31/JCIS-3-50.PMC3883270.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/54/122324CASE REPORT Address for correspondence: Dr. Erkan Gokce,   Department of Radiology, Faculty of Medicine, Gaziosmanpaşa University, Tokat ‑ 60200, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/4b/b3/JCIS-3-54.PMC3883271.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/55/122325 Received : 20‑05‑2013 Accepted : 19‑09‑2013 Published : 28‑11‑2013,Non-OADS,/arxiv_data1/oa_pdf/f2/ac/JCIS-3-55.PMC3883272.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/53/122323prominent in FA maps than in MD maps.,Non-OADS,/arxiv_data1/oa_pdf/03/fb/JCIS-3-53.PMC3883273.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Microsurgical anatomy of the transsylvian translimen  insula approach to the mediobasal temporal lobe: Technical  considerations and case illustration David Straus, Richard W .",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/159/123285 Copyright: © 2013 Straus D.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/159temporal lobe posterior to the quadrigeminal plate.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/159nerve was identified in all cases [ Figure  3d].",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/159of Rosenthal.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/159this approach in the case of a mesial temporal lobe AVM  (presented earlier) to provide generous access to the  cisternal arterial feeders from the Circle of Willis, enable  proximal vascular control, minimize stress on draining  veins and have ample working space in the event of  intraoperative hemorrhage or swelling.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/159developed to achieve such adequate and safe exposure  of this region for the treatment of a variety of vascular,  neoplastic, and epileptogenic lesions.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Surgical Neurology International 2013, 4:159  http://www.surgicalneurologyint.com/content/4/1/15931.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/SNI-4-159.PMC3883274.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/56/122326 Journal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor‑in‑Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of  Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format",Non-OADS,/arxiv_data1/oa_pdf/3c/7b/JCIS-3-56.PMC3883275.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/b4/jpr-7-025.PMC3883276.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 25–35Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  25ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5219 5a comparison of Digigait™ and Treadscan™  imaging systems: assessment of pain using gait  analysis in murine monoarthritis christopher W Dorman1 hollis e Krug1–3 sandra P Frizelle1 sonia Funkenbusch1 Maren l Mahowald1–3 1Department of Research,   2Department of Medicine, Minneapolis  Veterans affairs health care system,   Minneapolis, M n, Usa; 3Department  of Medicine, University of Minnesota  Medical school, Minneapolis, M n, Usa correspondence: hollis e Krug   1 Veterans Drive, Rheumatology (111R),  Minneapolis, Mn 55417 Usa   Tel +1 612 467 4190   Fax +1 612 467 2267   email h ollis.krug@va.go vPurpose:  Carrageenan-induced arthritis is a painful acute arthritis model that is simple to  induce, with peak pain and inflammation occurring at about 3 hours.",Non-OADS,/arxiv_data1/oa_pdf/5e/b4/jpr-7-025.PMC3883276.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/5e/b4/jpr-7-025.PMC3883276.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/b4/jpr-7-025.PMC3883276.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/52/122322RADIOLOGIC‑PATHOLOGIC CORRELATION,Non-OADS,/arxiv_data1/oa_pdf/f0/32/JCIS-3-52.PMC3883277.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/c0/39/CCD-4-419.PMC3883316.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementProf.,Non-OADS,/arxiv_data1/oa_pdf/c0/39/CCD-4-419.PMC3883316.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d9/4f/CCD-4-427.PMC3883318.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d9/4f/CCD-4-427.PMC3883318.pdf
Available at http://www.worldbank.org/en/news/ feature/2012/07/10/hiv -aids -india.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/CCD-4-467.PMC3883325.pdf
Statistical Analysis Used: A two‑way  contingency table  analysis software ( JAVASTAT:  http://statpages.org/ctab2 × 2.html) using 95% confidence interval was used to  study the distribution of genotypes among the populations.,OADS,/arxiv_data1/oa_pdf/c2/d4/CCD-4-476.PMC3883327.pdf
Statistical analysis A two-way contingency table  analysis software  (JAVASTAT:   http://statpages.org/ctab2X 2.html) using 95% confidence  interval was used to study the distribution of genotypes  among the populations.,OADS,/arxiv_data1/oa_pdf/c2/d4/CCD-4-476.PMC3883327.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/46/52/CCD-4-488.PMC3883329.pdf
"Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Scien ces(http://ijp.tums.ac.ir )In Memoriam Professor Mohsen Ziai; A Pediatrician with Many Gifts (July 29, 1927 -March 27, 2013) Elaheh Malakan Rad, MD; Ali Rabbani, MD Department of Pediatrics, Tehran university of Medical Sciences, Tehran, Iran Iranian Journal of Pedi atricslost a famous Editorial Board member and the Iranian medical community lost a leader on 27th March 2013, with the death of Prof. Mohsen Ziai, at age 86.",Non-OADS,/arxiv_data1/oa_pdf/b7/83/IJPD-23-373.PMC3883365.pdf
"374 Editorial Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Scien ces(http://ijp.tums.ac.ir )Nahid, 4 daughters, 10 grandchildren, and 2 sisters .",Non-OADS,/arxiv_data1/oa_pdf/b7/83/IJPD-23-373.PMC3883365.pdf
Prof.Ziai is receiving the Samuel Asper Award at Hopkins References 1.The life of Dr. Moshesn Ziai narrated by his grandson 2.http://www.inova.org/Events/EventDetails.aspx?EventID=449 &sid=1 3.http://artic les.washingtonpost.com/2013 -04-18/local/ 38643800_1_pediatrics -great-falls-georgetown -university 4.http://www.hopkinschildrens.org/tpl_news.aspx?id=12220,Non-OADS,/arxiv_data1/oa_pdf/b7/83/IJPD-23-373.PMC3883365.pdf
"Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Scien ces(http://ijp.tums.ac.ir )An Overview ofMutation Detection Methods inGenetic Disorders NejatMahdieh1, PhD;Bahareh Rabbani *2,3, PhD 1.Medical Genetic Group, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran 2.Medical Genetic Group, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran 3.Growth and Development Research Center, Tehran University of Medical Sciences, Tehran,Iran Received:  Jul 04, 2012; Accepted:  Apr 06, 2013; First Online Available:  Apr 28, 2013 Abstract Genetic disorders ar e traditionally categorized into three main groups: single -gene, chromosomal, and multifactorial disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"376 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)Fig 1:A) Nucleus, chromosomes, gene, exon, intron and base pairs.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"377 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Modes of inheritance and their properties Inheritance pattern Description Examples Autosomal DominantOne mutated allele cause sthe disease Each affected person usually has one affected parent Appears in every generation of an affected family (Vertical)Marfan syndrome ; Achondroplasia ; Huntington disease ; Myotonic dystrophy Autosoma l RecessiveTwo mutated alleles need edto cause the disease Parents are usually unaffected heterozygotes Not typically seen in every generation (Horizontal).Beta thalassemia ;Cystic fibrosis;Homocystinuria X-linked DominantFemales are more frequently affected than males no male-to-male transmissionRett syndrome ; Hypophosphatemia X-linked RecessiveMales are more frequently affected than females Both parents of an affected daughter must be carriers Fathers cannot pass X -linked traits to their sonsHemophilia ;Duchenne Muscular Dystrophy MitochondrialOnly females can pass on mitochondrial conditions to their children (maternal inheritance) Both males and females can be affected Can appear in every generation of a familyLHON: Leber's hereditary optic neuropathy syndrome (due to mutation in FBN1) have only mild symptoms (such as being tall and thin with long, slender fingers), while others have life - threatening complications involving the heart and blood vessels as well[6].Furthermore, some individuals exhibit signs and symptoms of a given disorder while others do not, even though they have the disease -causingmutation (i.e.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"378 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)Table 2: Examples of numerical aberrations (aneuploidies) Aneuploidy Karyotype Incidence Main features Down syn.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"379 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )sequencing, DNA hybridization and/or restriction enzyme digestion methods.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"380 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)Table 4: Gene-based Mutations in human disorders Mutation DefinitionExample (Gene)Disease/ conditionRef Point MutationA single base pair alteration; it includes transition: purine (A,G) to purine (G,A) or p yrimidine (C,T) to pyrimidine (T,C), and transversion: purine (A,G) to pyrimidine (T,C) or pyrimidine (T,C) to purine (A,G)A>G, A>T [2,45] a. Missense (Nonsynonymous)A single nucleotide resulting in a codonthat codes for a different amino acidA82P (HSD3B2)3βHSD deﬁciency[46] b.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"381 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"382 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)Table 5: Cytogenetics and molecular methods for mutation detection Method Application Advantage/disadvantageKnown mutationUnknown mutation Cytogenetics KaryotypeDetecting numerical and gross structural aberrationsLow resolution Time consuming and labor requirements+ + FISHDetecting trisomies, monosomies and microdeletionsDetects mosaicism + - CGHDetects copy number variations of genetic materialUsed only for losses and gains+ + Molecular RFLPRestriction fragments are separated by electrophoresisRequires mutation in restriction site+ - ARMS PCRAllele-specific amplification of mutant and normal allele, determination of the genotype of an individualHighly sensitive Possible to detect any know n mutation May increase time and costs+ - Multiplex PCRAmplification of more than one target simultaneouslyReduces time and labor requirements Lower sensitivity and specificity+ - Nested PCRAmplification using external and internal primer setsMore sensitive Decreases nonspecific amplification+ - RT-PCR Amplification of RNAAmplification of all RNA types May increase time and costs+ + Real-time PCRAmplification, detection, and quantification of targetIncreased specificity Usually eliminates postamplification analyses More expensive+ - MLPA Deletions and duplicationsA multiplex technique Identifies very small single gene aberrations (50 -70 nt)+ + DGGEBased on migration within gradient gel electrophoresisDetects close to 100% of pointmutaions- + SSCPBased on migration within gel electrophoresisDetects about 80 –90% of point mutations- + Hetero- duplex analysisBased on homoduplices and heteroduplices motilities in gel electrophoresisDetects nearly 80% of mutations- + CCMDNA: DNA or DNA:RNA heteroduplices are cleaved by piperidineAll possible mutations are detectable Uses toxic substances+ + PTTIt is based on a combination of PCR, transcription, and translationDetects translation - terminating mutations Missense mutations are not detected.- + OLAIt is based on ligation of two flanked primers annealed with target sequencesDetects all base exchanges + + FISH: Fluorescence in situ hybridization; CGH: Comparative genomic hybridization; RELP: Restriction fragment length p olymorphism ; ARMS; Amplification refractory mutation system; PCR: Polymerase chain reaction; RT: Reverse transcriptase; MLPA; Multiplex ligation-dependent probe amplification; DGGE: Denaturing Gradient Gel Electrophoresis; SSCP: Single Strand Conformationa l Polymorphism; CCM: Chemical cleavage of mismatch; PTT: Protein truncation test; OLA: Oligonucleotide ligation assay",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"383 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )A)KnownMutations Many different approaches have been used for identifying known mutations.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"384 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)Fig.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"385 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.4:A) Multiplex ligation -dependent probe amplification (MLPA).",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"386 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)B)Unknown Mutations Single Strand Conformational Polymorphism (SSCP):SSCP is one of the simplest screening techniques for detecting unknown mutations (microlesions) such as unknown single -base substitutions, small deletions, small insertions, or microinversions.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"387 Mahdieh N, Rabbani B Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )of inherited diseases on the DNA level.",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"388 Mutation Detection Methods Iran J Pediatr ;Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums .ac.ir)23.Levsky JM, Singer RH .Fluorescence in situ hybridization :Past, present and future.",OADS,/arxiv_data1/oa_pdf/c6/ca/IJPD-23-375.PMC3883366.pdf
"Iran J Pediatr; Vol 23 (No 4); Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Familial History and Recurrence of Febrile Seizures ;aSystematic Review and Meta-Analysis YousefVeisani1,2, MSc;AliDelpisheh2, PhD;Kourosh Sayehmiri *3,PhD 1.Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran 2.Department of Cl inical Epidemiology, Ilam University of Medical Sciences, Ilam, Iran 3.Psychological Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran Received: Jul02, 2012; Accepted: Apr07, 2013;FirstOnlineAvailable :Apr11,2013 Abstract Objective:Febrile seizure (FS) as the most common form of seizures in childhood, affects 2 -5% of all children across the world.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"390 Familial History and Recurrence of Febrile Seizures Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )(70%-75%)of FSs areofsimple type[6,7].",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"391 Veisani Y ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )considered representing low, medium and high heterogeneity respectively)[17].",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"392 Familial History and Recurrence of Febrile Seizures Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Feature of childhood febrile seizure at different regions of Iran Study location (city)Firstauthor(year)Study periodNo.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"393 Veisani Y ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )N O T E : W e ig h ts a re fro m  ra n d o m  e ffects a n a ly sisO v e ra ll  (I-sq u a re d  =  9 3 .2 % , p  =  0 .0 0 0 )S a n a id a sh ti (2 0 0 6 )Fa lla h  (2 0 0 8 ) H o sse in i n a sa b  (2 0 0 6 )S tu d y K h a z a i (2 0 0 7 )K a ze m i (2 0 0 1 )ID G h o tb i (2 0 0 2 ) M o a y e d i (2 0 0 1 )K h o d a p a n a h h  (2 0 0 1 ) G o le sta n i (2 0 0 8 ) 0 .2 9  (0 .1 9 , 0 .3 8 )0 .5 9  (0 .4 9 , 0 .6 9 )0 .2 9  (0 .2 1 , 0 .3 7 ) 0 .5 0  (0 .4 1 , 0 .6 0 )0 .2 0  (0 .1 4 , 0 .2 6 )0 .1 8  (0 .0 7 , 0 .2 9 )E S  (9 5 %  C I) 0 .2 2  (0 .1 5 , 0 .2 9 ) 0 .3 3  (0 .2 6 , 0 .4 0 )0 .1 0  (0 .0 4 , 0 .1 6 ) 0 .2 0  (0 .1 2 , 0 .2 8 ) 0 .2 9  (0 .1 9 , 0 .3 8 )0 .5 9  (0 .4 9 , 0 .6 9 )0 .2 9  (0 .2 1 , 0 .3 7 ) 0 .5 0  (0 .4 1 , 0 .6 0 )0 .2 0  (0 .1 4 , 0 .2 6 )0 .1 8  (0 .0 7 , 0 .2 9 )E S  (9 5 %  C I) 0 .2 2  (0 .1 5 , 0 .2 9 ) 0 .3 3  (0 .2 6 , 0 .4 0 )0 .1 0  (0 .0 4 , 0 .1 6 ) 0 .2 0  (0 .1 2 , 0 .2 8 ) 0 -.6 8 5 0 .6 8 5 N O TE: W eigh ts are from  ran dom  effects an alysisO verall  (I-squ ared =  9 1.5 % , p =  0 .00 0)K azem i (2 00 1) G olestan i (2 00 8) N am akin (2 01 1)A shrafzadeh  (2 00 2) H ossein i nasab (2 00 6)G hotbi (2 00 2) B arzegar (2 00 6)IDS tu dy 0 .21  (0 .12 , 0 .29 )0 .06  (-0 .01 , 0 .13 ) 0 .25  (0 .17 , 0 .33 ) 0 .25  (0 .18 , 0 .33 )0 .14  (0 .04 , 0 .24 ) 0 .21  (0 .13 , 0 .28 )0 .18  (0 .12 , 0 .25 ) 0 .35  (0 .32 , 0 .39 )E S  (9 5%  C I) 0 .21  (0 .12 , 0 .29 )0 .06  (-0 .01 , 0 .13 ) 0 .25  (0 .17 , 0 .33 ) 0 .25  (0 .18 , 0 .33 )0 .14  (0 .04 , 0 .24 ) 0 .21  (0 .13 , 0 .28 )0 .18  (0 .12 , 0 .25 ) 0 .35  (0 .32 , 0 .39 )E S  (9 5%  C I) 0 -.3 94 0 .3 94 Fig.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"394 Familial History and Recurrence of Febrile Seizures Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Begg's funnel plot with pseudo 95% confidence limits FC s.e.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"395 Veisani Y ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )9.Fukuyama Y, Seki T, Ohtsuka C, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/IJPD-23-389.PMC3883367.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Investigation of the Relationship Between Retinol Binding Protein 4, Metabolic Syndrome  and Insulin Resistance in Iranian Obese 5-17 Year Old Children     Forough Saki 1,2 , MD; Soheil Ashkani-Esfahani 1 , MD; Zohreh Karamizadeh 2* , MD    1.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"     397  Saki F , et al   Iran J  Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  					IR	also	plays	a	crucial	role	in	pathogenesis	and	 is	known	as	a	hallmark	of	Metabolic	syndrome;	a	 syndrome	 which	 may	 include	 a	 number	 of	 metabolic	 abnormalities,	 including	 dyslipidemia	 (decreased	 HDL	 level	 and	 increased	 serum	 triglycerides	 concentration),	 hypertension,	 and	 hyperglycemia [2,3] .",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"    398   Association of RBP4 with Insulin resistance and Metab olic Syndrome    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  radioimmunology	assay	(Linco	Research	inc.,	St.	 Charles,	 MO),	 which	 had	 less	 than	 0.2%	 cross- reaction	with	proinsulin,	with	an	assay	sensitivity	 of	2.3	rU/ml,	and	intra-	and	inter-assay	coefficient	 of	variation	of	7%	and	9%,	respectively.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"     399  Saki F , et al   Iran J  Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: Partial	Spearman	correlation	coefficient	among	Retinol-binding	protein	4	values,	metabolic	syndrome	 components,	and	other	metabolic	parameters 	   RBP4  BMI  WC  SBP   DBP  TG  FPG  HDL  LDL  Chol  HbA1c  Fasting  Insulin  BMI   0.28 	 	 	 	 	 	 	 	 	 	 	 	 WC   0.42 	a 	 0.81 a 	 	 	 	 	 	 	 	 	 	 	 SBP   0.35 	b 	 0.52 	a 	 0.46 	a 	 	 	 	 	 	 	 	 	 	 DBP   0.02 	 - 0.01 	 0.09 	 0.25 	 	 	 	 	 	 	 	 	 TG   0.22 	 - 0 .07 	 0.20 	 0.08 	 0.12 	 	 	 	 	 	 	 	 FPG   0.31 	b 	 0.21 	 0.36 	b 	 0.01 	 - 0.07 	 0.05 	 	 	 	 	 	 	 HDL   - 0.15 	 - .02 	 - 0.10 	 - 0.19 	 - 0.17 	 - 0.62 	a 	 - 0.01 	 	 	 	 	 	 LDL   0.11 	 0.02 	 - 0.19 	 0.16 	 0.19 	 - 0.01 	 - 0.17 	 0.32 	b 	 	 	 	 	 Chol   0.18 	 - .01 	 0.13 	 0.15 	 0.19 	 0.04 	 - 0.07 	 0.38 	a 	 0.96 	a 	 	 	 	 HbA1c   0.31 	b 	 - 0.1 1 	 0.02 	 - 0.18 	 0.17 	 0.21 	 0.39 	a 	 - 0.01 	 0.15 	 0.19 	 	 	 Fasting insulin   0.34 	b 	 0.33 	b 	 0.35 	b 	 0.16 	 - 0.07 	 0.24 	 0.47 	a 	 - 0.03 	 0.03 	 0.06 	 0.12 	 	 HOMA - IR index   0.35 	b 	 0.25 	 0.32 	b 	 0.16 	 0.08 	 0.36 	b 	 0.45 	a 	 - 0.18 	 0.01 	 0.06 	 0.17 	 0.99 	a 	 RBP4:	Retinol	binding	protein	4;	BMI:	Body	mass	index;	WC:	Waist	circumference;	SBP:	Systolic	blood	pressure;	DBP:	Diastolic	 blood	pressure;	TG:,	triglycerides;	FPG,	fasting	plasma	glucose;	HDL:	High	density	lipoproteins;	LDL:	Low	density	lipoproteins;	Chol:	 Total	cholesterol;	HOMA-IR:		Homeostasis	model	assessment	of	IR;		HbA1c;	Glycated	hemoglobin	(HbA1c		 a P ≤0.005					 b P ≤0.05	 The relationship between RBP4 and Insulin  resistance 	 As	 it	 is	 exhibited	 in	 Table	 2	 there	 are	 positive	 correlations	between	RBP4	and	HbA1c	( P=0.03),	 fasting	 insulin	 ( P=0.03),	 FPG	 ( P=0.04),	 and	 expectedly	 the	 HOMA-IR	 index	 ( P=0.02),	 which	 indicated	the	relationship	between	RBP4	plasma	 level	 and	 IR.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"    400   Association of RBP4 with Insulin resistance and Metab olic Syndrome    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"     401  Saki F , et al   Iran J  Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  strong	family	history	of	type	2	diabetes.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"    402   Association of RBP4 with Insulin resistance and Metab olic Syndrome    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  obesity	 and	 type	 2	 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/IJPD-23-396.PMC3883368.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1  (IGF-1) and  insulin-like growth factor binding protein 3 (IGFBP3) Levels Can  Prevent Risk of Retinopathy of Prematurity  Emrah Can, MD; Ali Bülbül; Sinan Uslu, MD; Fatih Bolat, MD; Serdar Cömert, MD; Asiye Nuhoğlu, MD   Department of Pediatrics, Division of Neonatology, Sisli Children's Hospital, Istanbul, Turkey     Received: Jul 06, 2012 ; Accepted: Mar 16, 2013; First Online Available: May 14, 2013   Abstract   Objective:  To evaluate early aggressive vs. conservative nutrition and its effect on Retinopathy of Prematurity  (ROP) in <32 weeks of gestation neonates.",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"    404   Aggressive Pa renteral Nutrition’s Effect on ROP    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  bioavailability of IGF-1 is regulated by insulin  growth factor binding protein (IGFBP).",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"     405  Can E , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  dictated by the experimental protocol.",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"    406   Aggressive Pa renteral Nutrition’s Effect on ROP    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"     407  Can E , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: Nutritional characteristics of the groups  Parameter  APN   (n = 40)  CPN   (n = 35)  P. Value  Duration of parenteral nutrition   (days)    13.1 (3.5)   13.5 (3.0)   0.6   Full enteral feeding time (days)   15.1 (5.8)   14.8 (5.5)   0.8   Energy intake (kcal/kg/day)   121,5(35.5)   115,5(28.5)   0.4   Protein intake (g/kg)   3.52 (0.7)   3.2 (0.5)   0.02   Lipid intake   (g/kg)   6.6 (1.5)   6.1 (0.6)   0.03   Weight gain (g)   115(75)   100(80)   0.4   * Student’s t-test,   mean (SD); APN: Aggressive parenteral nutrition; CPN: Conventional parenteral nutrition  (r²:-0.65), IGFBP3 (r²:-0.51)].",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"    408   Aggressive Pa renteral Nutrition’s Effect on ROP    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 3: Comparison of Insulin-like growth factor-1   (ng/mL) levels in the study groups  Time  APN and ROP  (n=2)  APN and no ROP  (n=38)  P. value*  CPN and ROP  (n=11)  CPN and no ROP  (n=24)  P. value*   First day   18.2  ( 1.1 )   19.1  ( 1.4 )   0.4   17.6  ( 1.6 )   18.0  ( 1.8 )   0.5   1 st  week   20.3  ( 1.2 )   21.5  ( 1.1 )   0.1   14.5  ( 2.1 )   15.6  ( 1.5 )   0.08   2 nd week   24.1  ( 1.7 )   25.4  ( 1.3 )   0.",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"     409  Can E , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    refeeding, particularly when high protein nutrition  was used [22] .",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"    410   Aggressive Pa renteral Nutrition’s Effect on ROP    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  9.",Non-OADS,/arxiv_data1/oa_pdf/25/5d/IJPD-23-403.PMC3883369.pdf
"Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tu ms.ac.ir)Long-Term Results ofTranscatheter Closure ofPatent Ductus Arteriosus in Infants Using Amplatzer Duct Occluder Mostafa Behjati-Ardakani *1,MD;Mohammad -AminBehjati-Ardakani2;Seyed-Habibolla Hosseini3, MD; Noormohammad Noori4, MD 1.Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical sciences, Yazd, Iran 2.Baqiyatallah University of Medical Sciences, Tehran, Iran 3.Department of Anesthesiology, Shahid Sadoughi University of Medical Sciences, Yazd,Iran 4.Department ofPediatrics, Zahedan University of MedicalSciences, Zahedan, Iran Received: Nov12, 2012; Accepted: Apr09, 2013;FirstOnlineAvailable :May27,2013 Abstract Objective :Patent ductus arteriosus (PDA) is one of the most frequently seen congenital heart diseases.",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"412 Long-Term Results of Transcatheter Closure of PDA in Infants Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Since the first description of transcatheter closure of  PDA with an Ivalon plug by Porstmann et al[4]several other devices such as Duct -occluder device (coil)[5]and Amplatzer duct occluder (ADO)[6]have been developed.",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"413 Behjati-Ardakani M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.2:Descending aortogram in lateral view beforerelease of theamplatzer duct occlude showing no residual shunt and appropriate deployment of device maintained on delivery cable.",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"414 Long-Term Results of Transcatheter Closure of PDA in Infants Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Demograp hic and catheterization data of patients und ergoing closure of PDA with amplatzer duct occlude Parameter Mean(Standard Deviation )Median Range Age (month) 9.1(3.2) 9.6 4-12 Weight (kg) 6.73(1.16) 7 4.5-10.1 Mean PAP (mmHg) 31.96(14.15) 29 10-70 QP/Qs 2.75(0.85) 2.8 1.4-4.6 PDA size (mm) 5.7(1.62) 5 3-9 Amplatzer duct occlude (mm) 5.29(1.55) 4 4-10.1 Fluoroscopy Time (min) 6.23(2.9) 6 2.7-17 Procedure Time (min) 48.68(9.6) 49 28-67 Follow-up(mo) 37.9(23.36) 33.4 13.7-89.8 PDA: Patent du ctus arteriosus ;PAP:Pulmonary Artery Pressure QP/QS: Pulmonary Blood Flow / Systemic Blood Flow small and two patients moderate shunt.",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"415 Behjati-Ardakani M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )the mesh to induce thrombosis; it received FDA approvalin May 2003[12].",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"416 Long-Term Results of Transcatheter Closure of PDA in Infants Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )3.Mavroudis C, Backer CL, Gevitz M .Forty-six years of patent ductus arteriosus division at Chi ldren's Memorial Hospital of Chicago.",Non-OADS,/arxiv_data1/oa_pdf/cc/02/IJPD-23-411.PMC3883370.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Evaluation	of	Serum	Lead	Levels	in	Children	with	Constipation	and	Normal	 Controls	in	Northern	Iran 	 Shohreh	Maleknejad* 1 ,	MD;	Abtin	Heidarzadeh 2 ,  MD; 	Morteza	Rahbar 1 ,	MD;	Afshin	Safaei 1 ,	MD;																																								 Babak	Ghomashpasand 5 ,	MD 		 1.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"    418		 Evaluation	of	Serum	Lead	Levels	in	Children	with	Constipation	    Iran J Pediatr; Vol   23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  from constipation.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"     419	 Maleknejad S ,	et	al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table	1:	 Comparison of the demographic data in children with constipation and controls on the basis of  low and high serum lead levels  Variable	 Group	 Lead	serum	level	(%)	 Total	 P value	 <10	µg/dL	 ≥10	µg/dL	 Age	 <7	 Case  49(59.8)  33(40.2)  82(100)  0.001  Control  63(90)  7(10)  70(100)  ≥7	 Case  7(87.5)  1(12.5)  8(100)  0.5  Control  19(95)  1(5)  20(100)  Sex	 Boy	 Case  26(59.1)  18(40.9)  44(100)  0.0002  Control  49(90.7)  5(9.3)  54(100)  Girl	 Case  30(65.2)  16(34.8)  46(100)  0.005  Control  33(91.7)  3(8.3)  36(100)  Age	of	residential	 building	 New	 Case  23(71.9)  9(28.1)  32(100)  0.01  Control  54(91.5)  5(8.5)  59(100)  Old	 Case  33(56.9)  35(43.1)  58(100)  0.001  Control  28(90.3)  3(9.7)  31(100)  Traffic	of	 residential	area	 High	traffic	 Case  15(44.1)  19(55.9)  34(100)  0.08  Control  10(71.4)  4(28.6)  14(100)  Low	traffic	 Case  41(73.2)  15(26.8)  56(100)  0.001  Control  72(94.7)  4(5.3)  76(100)  Parents’	Job	 Low	risk	 Control  24(66.7)  12(33.3)  36(100)  0.006  Case  57(89.1)  7(10.9)  64(100)  High	risk	 Control  32(59.3)  22(40.7)  54(100)  0.001  Case  25(96.2)  1(3.8)  26(100)  Area	of	residence	 Urban		 Control  47(59.5)  32(40.5)  79(100)  0.007         Data were analyzed using SPSS software,  version 18.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"    420		 Evaluation	of	Serum	Lead	Levels	in	Children	with	Constipation	    Iran J Pediatr; Vol   23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table	2:	 Comparison of the confidence interval and odds ratio in children with constipation and their  controls on the basis of  lead level and demographic data (Mantel Haenszel test)  Variable	 	 Confidence	Interval	 Odds	ratio	 Age	<7	 2.472-14.863 6.061  ≥7	 0.149-49.533 2.714  Sex	 Boy	  2.261-20.362  6.785  Girl	 1.554-22.150  5.867  Age	of	residential	 building	New	 1.267-13.992 4.226  Old	 1.929-25.922 7.071  Traffic	of	 residential	area	 High	traffic	 0.827-12.126  3.164  Low	traffic	 2.049-21.169  6.585  Parents’	Job	Low	risk	 1.429-11.601 4.071  High	risk	 2.166-136.368 17.188  Area	of	residence		 Urban  2.530-15.316  6.225  Rural  0.319-50.229  4.0    new ones which shows higher levels in old houses  (OR: 5.55-6.22).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"     421	 Maleknejad S ,	et	al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )       Considering the significant difference between  the children living in old and new houses in our  study, the age of the building was a confounding  factor.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"    422		 Evaluation	of	Serum	Lead	Levels	in	Children	with	Constipation	    Iran J Pediatr; Vol   23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Acknowledgment  Authors would like to thank Dr. Hamid Reza Irevani for  his assistance in performing the tests in his laboratory.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/IJPD-23-417.PMC3883371.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Fatness and Fat Patterning as Independent Anatomical Characteristics of Body  Composition: A Study of Urban South African Children  Daniel Ter Goon, D.Tech    Centre	for	Biokinetics,	Recreation	and	Sport	Science,	University	of	Venda,	Thohoyandou,	South	Africa	 	 Received:	 Agu 24, 2012 ;	Accepted:	 May 12, 2013; First	Online	Available:	 Jul 08, 2013   Abstract   Objective: 	The	purpose	of	this	study	was	to	examine	the	relationship	between	fat	patterning,	age	and	body	 composition,	among	urban	South	African	children	in	Pretoria,	Central.",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"    424   Fatness and Fat Patterning  As Independent Anatomical Characteristics of Body Composition    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  components	analysis	(PCA).",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"     425  Goon DT   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  the	 intraclass	 correlation	 coefficients	 on	 anthropometric	 measures	 between	 observers	 were:	stature	0.98,	body	mass	0.97,	triceps	0.95	 and	subscapular	0.94.",OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"    426   Fatness and Fat Patterning  As Independent Anatomical Characteristics of Body Composition    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1:	Mean	and	standard	deviation	(SD)	for	anthropometric	and	body	composition	measurements	of	South	 African	children	 Variables    Boys   (n= 548)  Girls   (n=588)  Combined    (n= 1136)  95% CI  P. value  Mean (SD)   Mean (SD)   Mean (SD)   Body mass (kg)  41.9	(12.0)	 42.3	(12.1)	 42.1	(12.0)	 41.4-42.8	 0.001	 Stature (cm)  146.8	(11.1)	 144.0	(10.6)	 145.4	(11)	 144.7-146.0	 0.001	 Triceps (mm)  11.2	(5.9)	 15.1	(5.7)	 13.2	(6.1)	 12.8-13.5	 0.001	 Subscapular  (mm)  8.2	(5.0)	 13.2	(7.4)	 10.8	(6.8)	 10.4-11.2	 0.001	 BMI (kg.m -2 )  19.1	(3.5)	 20.2	(4.2)	 19.7	(3.9)	 19.4-19.9	 0.001	 Body fat (%)  16.1(7.7)	 22.7	(5.7)	 19.6	(7.5)	 19.1-20.0	 0.001	 Fat mass (kg)  7.3	(5.6)	 10.1(4.8)	 8.7	(5.4)	 8.4-9.0	 0.001	 Fat-free mass (kg)  34.6	(8.2)	 32.3	(7.9)	 33.4	(8.1)	 33.0-33.9	 0.001	 					CI:	Confidence	Interval;	SD:	Standard	Deviation;	BMI=Body	Mass	Index	 components	 represent	 the	 pattern	 of	 fat	 distribution	independent	of	size	and	fatness.",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"     427  Goon DT   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 3:	Pearson’s	correlation	coefficients	and	associated	probabilities	for	the	principal	components	of	eight	 skinfolds	(factor	scores)	with	age	and	selected	anthropometric	body	composition	of	South	African	children	 Variable  Pearson’s correlation coefficient  ( r )   Age   BMI   FM   FFM   %BF   PC I ‘fatness’ (size)   −0.062* 	 0.745  	 0.672  	 0.583  	 0.701  	 PC2 ‘fat patterning’ (shape) central - peripheral    −0.043 	 −0.059 	 −0.029 	 −0.037 	 −0.502 	 PC3 ‘fat patterning’ (shape) lower trunk - upper  extremity  −0.032	 −0.041	 −0.022	 −0.041	 −0.039	 *Correlations	statistically	significant	at	the	0.05	level	(two-tailed).",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"    428   Fatness and Fat Patterning  As Independent Anatomical Characteristics of Body Composition    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  patterning	in	children	and	adolescence,	correction	 for	levels	of	maturation	between	children	might	 improve	 the	 understanding	 of	 fat	 patterning.",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"     429  Goon DT   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  12.",Non-OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
Available	 at:	 http://www.cdc.gov/nchs/data/	 series/sr_11/sr11_123acc.pdf	 20.,OADS,/arxiv_data1/oa_pdf/a4/04/IJPD-23-423.PMC3883372.pdf
"Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Combination of Probiotics and Antibiotics in the Prevention of Recurrent Urinary Tract Infection in Children Mohammad -JavadMohseni1, MD;ZahraAryan1, MPH;SahraEmamzadeh -Fard1, MD;KooshaPaydary1, MD; VahidMofid2, MSc;HasanJoudaki2, MSc;Abdol-Mohammad Kajbafzadeh*1, MD 1.Pediatric Urology Research Center, Pediatric Center of excellence, Tehran University of Medical Sciences, Tehran, Iran 2.Research and Development Laboratory of Pegah Milk Industry, Iran Dairy Industries Company, Tehran, Iran Received:Feb28, 2013; Accepted: Apr05, 2013;FirstOnlineAvailable :Apr26,2013 Abstract Objective :We examined the preventive effect of probiotic and antibiotics versus antibiotics alone, in children with recurrent urinary tract infections (RUTI) in a pre liminary randomized clinical trial .",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"431 Mohseni M J ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )prescribed at half the therapeutic doses[3,4].",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"432 Combination of Probiotics and Antibiotics in the Prevention of Recurrent UTI Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.1:Flow diagram of thestudy were randomly assigned to each one of the probiotic plus antibiotic and antibiotic groups.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"433 Mohseni M J ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )underwent three episodes comprising 45 days of probiotic -received with 15 days pr obiotic-free intervals.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"434 Combination of Probiotics and Antibiotics in the Prevention of Recurrent UTI Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table1:Grading of v esicoureteral refl uxin probiotic+ antibiotic and antibiotic group (P>0.05) VUR Grade Probiotic+Antibiotic group Antibiotic group Variable Before treatment After treatment Before treatment After treatment Normal 0.0 20(48.9) 0.0 21(47.7) GradeI 11 (26.8) 6 (14.6) 13(29.5) 8 (18.2) GradeII 13 (31.7) 6 (14.6) 15(34.1) 7 (15.9) GradeIII 11 (26.8) 6 (14.6) 10(22.8) 5 (11.4) GradeIV 4 (9.8) 2 (4.9) 4 (9.1) 2 (4.5) GradeV 2 (4.9) 1 (2.4) 2 (4.5) 1 (2.3) VUR:Vesicoureteral reflux intervention and contro l groupswere 8.3 (3.1) and 8.0 (3.0), respectively.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"435 Mohseni M J ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.2:Recurrent Urinary tract infection sand responsible pathogens in two groups of study ( P=0.3) prophylaxis in the prevention of febrile UTIs after three years consumption of probiotic yoghurt.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"436 Combination of Probiotics and Antibiotics in the Prevention of Recurrent UTI Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )suggested that cranberry juice has an effective role in UTI prophylaxis through the modulation of the microbial flora of the intestinal and urogenital environment[22,24].",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"437 Mohseni M J ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )prevention of febrile UTI in comparison with antibiotic therapy alone.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"438 Combination of Probiotics and Antibiotics in the Prevention of Recurrent UTI Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )23.Salo J, Uhari M, Helminen M, et al.Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo - controlled trial .Clin Infect Dis 2011;54(3):340-6.",Non-OADS,/arxiv_data1/oa_pdf/46/e7/IJPD-23-430.PMC3883373.pdf
"Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Outcome of Vesicoureteral Reflux in Infants: Impact of Prenatal Diagnosis Hamid Mohammadjafari *1, MD;Alireza Alam2, MD;SaeedMohammadi3, MD;Seyed-AbdollahMousavi2, MD; Ahmadshahab Kosaryan4, MD;Mohammad Khademloo3, MD;Mohammad Abedi3, MD 1.Molecular andCell Biology Center ,Mazandaran University of Medical Sciences , Sari, Iran 2.Department of Pediatric Surgery ,Mazandaran University of Medical Sciences , Sari, Iran 3.Faculty of Medicine,Mazandaran University of Medical Sciences , Sari, Iran 4.Department of Radiology, Mazandaran University of Medical Sciences, Sari, Iran Received: Dec21, 2012; Accepted: Apr07, 2013;FirstOnlineAvailable :Jul13,2013 Abstract Objective :Vesicoureteral reflux (VUR) is an important disorder that could be diagnosed in ant enatal or postnatal period.",Non-OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"440 Outcome of Vesicoureteral Reflux In Infants: Impact of Prenatal Diagnosis Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Controversy exists regarding the natural history and treatment of VUR diagnosed antenatal lyand those detected later in life, usually after urinary tract infections.",Non-OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"441 Mohammadjafari H,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Demographic and basic clinical features of patients Prenatal groupPostnatal groupP-value Number of patients 67 85 NA Number of renal units 98 138 NA SexMale (%) 45 (67.2) 25(70.6)<0.001Female (%) 22 (32.8) 60(29.4) Length of follow up (months )[Mean(SD)]29.17(19.04) 36.03(18.34) 0.7 NA: not applicable ; SD: Standard deviation Statistical analysis of the differences between groups was determined by χ2and Fisher exact test andWilcox on signed -rank test.",OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"442 Outcome of Vesicoureteral Reflux In Infants: Impact of Prenatal Diagnosis Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 3:UTI development, scar severity and reflux resolution in two sex groups FactorMale Number (% )Female Number (% )P-value Recurrent UTI 4 (5.7) 12 (14.6) 0.07 Scar severityGrade0 81(75) 109(85) 0.1Grade1 10 (9) 8(6) Grade2 3 (3) 5 (4) Grade3 8 (7) 2(2) Grade4 6(6) 4(3) Reflux resolutionUn-changed 11(14) 14(11) 0.9<50% improvement 8(10) 11(9) >50% improvement 10(13) 17(14) Cure 51(64) 81(66) UTI: Urinary tract infection after 12-24months therapy in 2 (18.2%) other cases.",Non-OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"443 Mohammadjafari H,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 5:Patterns of reflux resolution in two prenatal and postnatal groups Resolution pattern Prenatal group Postnatal group P.value No change (%) 7(11) 18(13) <0.001Less than 50% resolution (%) 11(17) 8(6) More than 50% resolution (%) 16(24) 11(8) Full improvement (cure) (%) 32(49) 100(73) has direct influence on persistence of VUR.",Non-OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"444 Outcome of Vesicoureteral Reflux In Infants: Impact of Prenatal Diagnosis Iran J Pediatr; Vol 23 (No 4), Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )References 1.Vachvanichsanong P, Dissaneewate P, Lim A .",Non-OADS,/arxiv_data1/oa_pdf/21/aa/IJPD-23-439.PMC3883374.pdf
"Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Efficiency ,Sensitivity andSpecificity ofAutomated Auscultation Diagnosis Device for Detection and Discrimination of Cardiac Murmurs in Children Armen Kocharian1,2, MD,Amir-AhmadSepehri3, PhD,AzinJanani4, MSE, Elahe hMalakan -Rad*1,2, MD, FACC 1.Department of Pediatrics, Tehran University of Medical Sciences , Tehran, Iran 2.Children’s Medical Center, Pediatrics center of Excellence , Tehran, Iran 3.CAPIS Biomedical Research Department, Mons, Belgium 4.Amirkabir University of Technology, Tehran , Iran Received:Oct20, 2012; Accepted: Apr29, 2013;FirstOnlineAvailable :Jul14,2013 Abstract Objective :Intelligent electronic stethoscopes and computer -aided auscultation systems have highlighted a new era in cardiac auscultation in children.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"446 Automated Auscultation Diagnosis Device for Detection of Cardiac Murmurs Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical S ciences(http://ijp.tums.ac.ir )Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"447 Kocharian A ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"448 Automated Auscultation Diagnosis Device for Detection of Cardiac Murmurs Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical S ciences(http://ijp.tums.ac.ir )Table 1: Characteristic of recorded cardiac auscultation of 563 children aged 2 to 12 years Mean age (years) Patients Cases Final Diagnosis Decision 8.3 71 No murmur –normal heart 7.65 213 Innocent murmur 5.72 94 Ventricular septal defect 5.64 43 Mitral regurgitation 7.12 37 Atrial septal defect 8.5 28 Bicuspid aortic valve 9.21 27 Aortic stenosis 6.34 19 Tetralogy of Fallot 7.54 17 Patent ductus arteriosus 8.1 14 Aortic regurgitation Committee.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"449 Kocharian A ,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 2: Correctness of diagnoses made by the medical device versus average diagnoses made by 4 pediatricians Correctdiagnosis Wrong diagnosis Total number Pediatricians 40 10 50 Medical Device 50 0 50 Discussion Several recent studies have reported the efficacy of computer -assisted cardiac auscultation[8,9], however, as to the best of our knowledge few studies study have been performed to report the efficiency of such systems to detect cardiac murmurs in children[10-15].",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"450 Automated Auscultation Diagnosis Device for Detection of Cardiac Murmurs Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical S ciences(http://ijp.tums.ac.ir )7.Zühlke L, Myer L, Mayosi BM.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/IJPD-23-445.PMC3883375.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Expression of Activation-Induced Cytidine Deaminase Gene in B Lymphocytes of  Patients with Common Variable Immunodeficiency   Hassan Abolhassani 1 , MD, MPH; Amir Salek Farrokhi 2 , PhD; Shabnam Pourhamdi 1 , MD; Payam Mohammadinejad 1 ,  MD; Bamdad Sadeghi 1 , MD; Seyed-Mohammad Moazzeni 2 , PhD; Asghar Aghamohammadi* 1 , MD, PhD;    1.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"    452   Expression of Activation - Induced Cytidine Deaminase Gene in B Lym phocytes of Patients with CVID    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  dendritic cells, the exact pathogenesis of this  disease is yet unknown [5-8] .",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"     453  Abolhassani H , et al   Iran J Pediatr ; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1:  Primer sequences for β–actin  and AID genes   Gene   Primer sequence   Actin  Forward: 5` - TACCACTGGCATCGTGATGGACT - 3`   Reverse : 5`-TCCTTCTGCATCCTGTCGGCAAT-3`  AID  Forward: 5` - GAGGCAAGAAGACACTCTGG - 3`   Reverse : 5`-GTGACATTCCTGGAAGTTGC-3`                            Aid: Activation-induced cytidine deaminase;  Statistical analysis  We classified patients based on the cut-off point of  AID mRNA count calculating two standard  deviations (2SD) below and over the mean of  healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"    454   Expression of Activation - Induced Cytidine Deaminase Gene in B Lym phocytes of Patients with CVID    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"     455  Abolhassani H , et al   Iran J Pediatr ; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: Demographic and immunologic data comparing between three groups of Common variable  immunodeficiency cases classified based on activation-induced cytidine deaminase mRNA expression  Parameters  Reduced AID   mRNA  G1 (N=4)  Mean (SD)  Normal AID   mRNA  (N=20)  Mean (SD)  Increased AID   mRNA  G2 (N=5)  Mean (SD)  P-value *  total  G1 and  G2   G1 and  Normal  group  G2 and  Normal  group   Age at onset, year   3.0 (2.82)  3.38 (0.44)  2.7 (0.41)  0.3  1  0.9  0.9  Age at Diagnosis ,  year  6.25 (3.0)  9.26 (1.1)  6.6 (0.92)  0.7  1  0.6  0.8  Diagnostic delay,  year  3.2 (2.6)  5.8 (0.7)  3.8 (0.53)  0.5  1  0.5  0.7  Current age, year  11.0 (3.16)  19.6 (10.3)  16.4 (9.09)  0.2  0.8  0.1  0.7  WBC, cell/ml  9900.0 (1979.8)  7526.6 (4534.4)  5152.0 (4195.7)  0.3  0.4  0.3  0.4  Lymphocyte , cell/ml   4550.9 (1202.1)  2920.45 (1507.9)  2268.8 (1385.0)  0.6  1  1  0.7  CD3+ lymphocyte,  cell/ml   3731.5 (2372.8)  1927.07 (1233.4)  1270.8 (476.1)  0.1  0.06  0.1  0.5  CD4+ T cells, cell/ml   2053.9 (1480.0)  1139.2 (452.7)  680.4 (557.2)  1  0.2  0.3  0.5  CD8+ T cells, cell/ml   1417.2 (899.2)  751.5 (372.1)  577.0 (238.5)  0.9  0.4  0.7  0.8  CD19+ lymphocyte,  cell/ml   396.8 (98.1)  403.2 (146.7)  520.7 (144.2)  0.4  0.02  0.5  0.07  CD 19+ CD27+ B  cells, cell/ml   7.6 (3.0)  13.5 (4.9)  10.9 (2.4)  0.6  0.6  0.3  0.7  CD19+CD21+  memory Bcell,  cell/ml   14.2 (10.4)  11.4 (9.1)  5.9 (1.8)  0.3  0.4  0.8  0.2  IgG, mg/dl   189.3 (38.6)  321.5 (256.6)  245.7 (200.9)  0.5  0.9  0.4  0.8  IgA, mg/dl   8.5 (6.3)  9.0 (4.2)  19.42 (3.1)  0.5  0.01  0.5  0.04  IgM, mg/dl   23.0 (12.7)  41.3 (22.2)  43.2 (14.9)  0.5  0.6  0.3  1  IgE, IU/ml   1.09 (0.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"    456   Expression of Activation - Induced Cytidine Deaminase Gene in B Lym phocytes of Patients with CVID    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  differentiation of CVID patients which lead to  decreased negative feedback for suppression of  AID expression in most of cases.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"     457  Abolhassani H , et al   Iran J Pediatr ; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  12.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/IJPD-23-451.PMC3883376.pdf
"Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran Univ ersity of Medical Sciences (http://ijp.tums.ac.ir )Apparent Life -Threatening Events in Neonatal Period: Clinical Manifestations and Diagnostic Challenges inaPediatric Referral Center Maliheh Kadivar1,2, MD;Bahareh Yaghmaie1,2, MD;Bahar Allahverdi1,2, MD;Leila Shahbaznejad *2, MD; Nosrat Razi1,2, MD;Ziba Mosayebi1,2, MD 1.Department of Pediatrics, Tehran University of Medical Sciences , Tehran, Iran 2.Children’s Medical Center ,Pediatrics Center of Excellence, Tehran, Iran Received: Aug12, 2012; Accepted: Mar13, 2013;FirstOnlineAvailable :Mar21,2013 Abstract Objective :Apparent Life -Threatening Events (ALTEs)is an episode that is frightening to the observer and is characterized by some combination of apnea, color change, altered muscle tone, choking, and gagging.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"459 Kadivar M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )published reports about prevalence of ALTE are ranging from 0.5% to 0.6% ofattending sto the medical cent ers[2,3]or 2.4 in 1000 live births[4].",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"460 Apparent Life -Threatening Events in Neonatal Period Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Characteristics of neonates who presented with ALTE (n=18) Characteristics Frequency (%) Gender Boy Girl15(83) 3(17) Gestational age ≤37 weeks > 38 weeks8(44) 10(56) Route of delivery Cesarean section Vaginal delivery11(61) 7(39) Perinatal asphyxia 2(11) Birth weight Lessthan 2500 gr 2501-4000 gr7(39) 11(61) Second hand smoker 5(28) Rank in family First child Second child Third child7(39) 10(56) 1(5) Feeding Exclusive Breast milk Formula plus breast milk14(78) 4(22) Parent’s consanguinity 3(17) Recent usage of prescribed or OTC drug 10(56) OTC: Over the counter ; ALTE:Apparent life -threatening events history of hypothyroidism, whoseneonate had alsoabnormal thyroid function test compatible with transient hypo thyroididsm.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"461 Kadivar M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )In 5(28%)neonates ,attacks subsided spon - taneously, in 10 (56%) neonates caregivers provided gentle stimulation to the neonate like bellowing to infant’s face, but 3 (17%) had experienced more severe stimulation i.e.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"462 Apparent Life -Threatening Events in Neonatal Period Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 4:Final diagnosis of neonates who presented with ALTE (n=18) DiagnosisFrequency (%)Notes Sepsis 4(22)Negative blood culture ,but laboratory investigations were consistent with diagnosis of sepsis ,i.e.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"463 Kadivar M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )There are some reports of ALTE in thefirst hours after birth due to breast feeding or a potentially asphyxiating position especially in primiparous mothers[13-15].",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"464 Apparent Life -Threatening Events in Neonatal Period Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )epileptic drugs after a seizure episode may be discontinued and patient followed.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"465 Kadivar M,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.1:Algorithm for evaluat ion and management of neonates who presented with Apparent Life Threatening Event Acknowledgment The authors would like to thank all infants’ families who participated in this study, the personnel of the ED and NICU of CMC for their great help, and Dr Yun es Mohammadi for his great help in the statistical analysis.The proposal of this research project was approved by the Research Deputy’s Ethics Committee of Tehran University of Medical Sciences, No 989, 6thJune 2010.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"466 Apparent Life -Threatening Events in Neonatal Period Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )References 1.McGovern MC, Smith MB.",Non-OADS,/arxiv_data1/oa_pdf/13/20/IJPD-23-458.PMC3883377.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Au g   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Effectiveness of Cognitive-Behavioral Therapy in Decreasing Suicidal Ideation   and Hopelessness of the Adolescents with Previous Suicidal Attempts   Ali Alavi*, MD; Bahare Sharifi; Ahmad Ghanizadeh, MD; Gholamreza Dehbozorgi    Department of Psychiatry, Research Center for Psychiatry and Behavioral Sciences, Hafez Hospital, Shiraz  University of Medical Sciences, Shiraz, Iran   Received: Agu 13, 2012 ; Accepted: Jun 21, 2013; First Online Available: Jul 23, 2013   Abstract   Objective:  To evaluate the effectiveness of a Cognitive-Behavioral therapy (CBT) for suicide prevention in  decreasing suicidal ideation and hopelessness in a sample of depressed 12 to 18 year-old adolescents who  had at least one previous suicidal attempt.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"    468   Effectiveness of  Cognitive - Behavioral Therapy   in Suicidal Attempts    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  States [4] .",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"     469  Alavi A , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  inventory mean higher probability of  hopelessness [11] .",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"    470   Effectiveness of  Cognitive - Behavioral Therapy   in Suicidal Attempts    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )      Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"     471  Alavi A , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"    472   Effectiveness of  Cognitive - Behavioral Therapy   in Suicidal Attempts    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Sciences.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/IJPD-23-467.PMC3883378.pdf
"Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Colonization with Clostridium difficilein Children with Cancer Shahnaz Armin*1,MD;ShahinShamsian2,MD;Hojatollah Drakhshanfar2,MD 1.Pediatric Infections Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2.Department of Pedi atrics,Mofid Children Hospital ,Shahid Beheshti University of Medical Sciences, Tehran, Iran Received: Jul29, 2012; Accepted: Feb25, 2013;FirstOnlineAvailable :Mar07,2013 Abstract Objective :Clostridium difficile is agram-positive, anaerobic , spore-forming bacillus .Usually it does not cause disease unless a patient who is colonized with toxin -producing strains has been treated with antibiotics, particularly those that change the anaerobic flora of the large intestine.",Non-OADS,/arxiv_data1/oa_pdf/ea/10/IJPD-23-473.PMC3883379.pdf
"474 Clostridium difficile in Children with Cancer Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Subjects and Methods During 19 months ( March2008 to September 2009), 152 children with various types of malignancy admitted to hematologic ward at Mofid Children’s Hospital were evaluated .Patients with documented malignancy admitted for starting chemotherapy and also thoseadmitted because of complications of chemotherapy such as fever and neutropenia areincluded in this study.",Non-OADS,/arxiv_data1/oa_pdf/ea/10/IJPD-23-473.PMC3883379.pdf
"475 ArminSh,et al Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.1:Thekind and percentage of antibiotics usage Although study on this type of patients for detection of C. difficile colonization rate waslimited ,studies on normal population showed varyingcolonization rate sin different area s. In immuno competent population host factors likeage, diet, andimmune response play an important role in determining whether the C. difficile causesasymptomatic carrier status or active disease .",Non-OADS,/arxiv_data1/oa_pdf/ea/10/IJPD-23-473.PMC3883379.pdf
"476 Clostridium difficile in Children with Cancer Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )colonization and previous antibiotic usage.",Non-OADS,/arxiv_data1/oa_pdf/ea/10/IJPD-23-473.PMC3883379.pdf
"Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  The Effects of Surfactant on Oxygenation in Term Infants with Respiratory Failure  Serdar Beken*, MD; Canan Turkyılmaz, MD; Esin Koc, MD; Ibrahim M. Hirfanoglu, MD;   Nilgun Altuntas, MD   Department of Pediatrics, Division of Neonatology, Gazi University, Faculty of Medicine, Ankara, Turkey     Received: Agu 16, 2012 ; Accepted: May 31, 2013; First Online Available: Jul 23, 2013   Abstract   Objective:  The objective of the study was to evaluate the effects of exogenous surfactant on respiratory  indices  in term infants with respiratory failure.",Non-OADS,/arxiv_data1/oa_pdf/ad/2e/IJPD-23-477.PMC3883380.pdf
"    478   Surfactant  T reatment in  I nfants    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  had received a single dose of exogenous bovine  surfactant (Survanta®) between January 2008  and December 2010, with a gestational age above  37 weeks were retrospectively studied.",Non-OADS,/arxiv_data1/oa_pdf/ad/2e/IJPD-23-477.PMC3883380.pdf
"     479  Beken S , et al   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: Respiratory indices of patients before and after surfactant treatment 1   Parameter  Before surfactant  treatment  After surfactant  treatment  P. value   Oxygenation index  15.3 (10.0-52.8)  3.4 (1.5-35.0)  <0.001  Mean alveolar pressure  8.5 (7.0-15.0)  8.0 (6.0-14.0)  0.002  Fraction of inspired oxygen (FiO 2 )  80.0 (50.0-100.0)  40.0 (21.0-100.0)  0.001  Arterial oxygen partial pressure (PaO 2 )  45.4 (21.5-56.9)  83.5 (39.0-118.0)  <0.001  Arterial oxygen saturation SaO 2   83.5 (42.0-97.0)  97.0 (50.0-99.5)  <0.001  PaO 2 /FiO 2   60.3 (21.5-99.2)  234.0 (39.0-422.0)  <0.001  1 Median (minimum-maximum)   99.5); 234.0 (39.0-422.0) respectively.",Non-OADS,/arxiv_data1/oa_pdf/ad/2e/IJPD-23-477.PMC3883380.pdf
"    480   Surfactant  T reatment in  I nfants    Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  and early neonatal sepsis benefit from surfactant  administration in the early hours of treatment.",Non-OADS,/arxiv_data1/oa_pdf/ad/2e/IJPD-23-477.PMC3883380.pdf
"Iran J Pediatr; Vol 23 (No 4),Aug 2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Alexander Disease: Reportof Two Unrelated Infantile Form Cases, Identified by GFAPMutation Analysis and Review of Literature ;TheFirst Report fromIran Mahmoud -Reza Ashrafi1,2,3, MD;AlirezaTavasoli2,3*, MD; Omid Aryani4, MD; Ho omanAlizadeh3,5, MD; Massoud Houshmand4,6, PhD 1.Department of Pediatric s,Tehran University of Medical Science s,Tehran, Iran 2.Growth and Development Research Center, Tehran University of Medical Science s,Tehran, Iran 3.Children’s Medical Center ,Pediatric Center of Excellence, Tehran, Iran 4.Department of Medical Genetics, Special Medical Center, Tehran, Iran 5.Department of Radiology, Tehran University of Medical Science s,Tehran, Iran 6.Genetic Department, National Institute for Genetic Engineering and Biotechnology, Tehran,Iran Received: May 13, 2012 ; Accepted: Jan 19, 2013 ;First Online Available: Jul18, 2013 Abstract Background :Alexander disease (AD)is a sporadic leukodystrophy that predominantly affects infants and children and usually results in de ath within ten years after onset.",Non-OADS,/arxiv_data1/oa_pdf/d0/4a/IJPD-23-481.PMC3883381.pdf
"Alexander Disea se; Report of Two Cases 482 Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.",Non-OADS,/arxiv_data1/oa_pdf/d0/4a/IJPD-23-481.PMC3883381.pdf
"Ashrafi MR, et al 483 Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.2:Axial T1 and T2 -weighted MRI images of case -two, showing a periventricular rim (hyper intense in T1 and hypo intense in T2) and predominant frontal white matter involvement pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/d0/4a/IJPD-23-481.PMC3883381.pdf
"Alexander Disea se; Report of Two Cases 484 Iran J Pediatr; Vol 23 (No 4),Aug2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.",Non-OADS,/arxiv_data1/oa_pdf/d0/4a/IJPD-23-481.PMC3883381.pdf
"       Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )            Hashimoto’s Thyroiditis in a Child with  Familial Mediterranean Fever: a Case Report  Ayse Betul Ergul* 1 , MD; Ismail Dursun 2 , MD;                             Yasemin Altuner Torun 3 , MD   1.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/IJPD-23-489.PMC3883383.pdf
"    490 Letters to Editor   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    amyloidosis secondary to FMF.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/IJPD-23-489.PMC3883383.pdf
"     491 Letter to Editor    * Corresponding Author; Address: Department Of Pediatrics,  Jssmedical College, Jss University, Mysore, Karnataka, India    E-mail: jagdishmandya@gmail.com   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    Autoimmune Hemolytic Anemia due to  Varicella Infection  Kalenahalli Jagadish Kumar* 1 , MD; Halasahalli  C.  Krishna Kumar 1 , MD; Vaddambal G.  Manjunath 1 ,  DCH, DNB; Venkatesh Arun 2 , MD.,DM   1.",Non-OADS,/arxiv_data1/oa_pdf/3c/2f/IJPD-23-491.PMC3883384.pdf
"    492 Letters to Editor   Iran J Pediatr; Vol 23 (No  4 ),  Aug   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    of prednisolone therapy Hb reached 14.1g/dL.",Non-OADS,/arxiv_data1/oa_pdf/3c/2f/IJPD-23-491.PMC3883384.pdf
Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr010.pdf.,OADS,/arxiv_data1/oa_pdf/64/34/IJA-57-569.PMC3883391.pdf
Available from: http://www.vasgbi.com/riskscores.php.,Non-OADS,/arxiv_data1/oa_pdf/3b/a1/IJA-57-587.PMC3883394.pdf
http://www.fda.gov/ForConsumers/Consumer Updates/ucm048919.htm.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/IJA-57-627.PMC3883408.pdf
http://www.fda.gov/ForConsumers/Consumer Updates/ucm048919.htm.,Non-OADS,/arxiv_data1/oa_pdf/7a/fb/IJA-57-628.PMC3883409.pdf
Available at: http://dx.doi.org/10.7243/2049-9752-2-15.,Non-OADS,/arxiv_data1/oa_pdf/d6/2c/IJA-57-637.PMC3883417.pdf
Available at: http://dx.doi.org/10.7243/2049-9752-2-15.,Non-OADS,/arxiv_data1/oa_pdf/6d/73/IJA-57-638.PMC3883418.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/e3/ott-6-1605.PMC3883419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1605–1612OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1605Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5250 1combination of neutrophil lymphocyte ratio   and platelet lymphocyte ratio is a useful   predictor of postoperative survival in patients  with esophageal squamous cell carcinoma Ji-Feng Feng1 Ying huang2 Jin-shi liu1 1Department of Thoracic surgery,   2Department of Operating Theatre,   Zhejiang cancer hospital, hangzhou,   People’s republic of china correspondence: Jin-shi liu   Department of Thoracic surgery,  Zhejiang cancer hospital, no 38   guangji road, Banshan Bridge, hangzhou  310022, People’s republic of china   Tel +86 0571 8812 2032   email c dbzjzl@163.co mBackground:  Recent studies have shown that the presence of systemic inflammation correlates  with poor survival in various types of cancers.",Non-OADS,/arxiv_data1/oa_pdf/ad/e3/ott-6-1605.PMC3883419.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/e3/ott-6-1605.PMC3883419.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/e3/ott-6-1605.PMC3883419.pdf
"Each junction type has unique cellular Epithelial adhesive junctions Christopher T. Capaldo, Attila E. Farkas and Asma Nusrat* Address: Epithelial Pathobiology Research Unit, Department of Pathology, Emory University, 615 Michael Street, Atlanta, GA 30322, USA * Corresponding author: Asma Nusrat (anusrat@emory.edu) F1000Prime Reports 2014, 6:1 (doi:10.12703/P6-1) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/b2/biolrep-06-01.PMC3883420.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/1 Abstract Epithelial adhesive cell-to-cell contacts contain large, plasma membrane-spanning multiprotein aggregates that perform vital structural and signaling functions.",Non-OADS,/arxiv_data1/oa_pdf/98/b2/biolrep-06-01.PMC3883420.pdf
"Page 2 of 4 (page number not for citation purposes) F1000Prime Reports 2014, 6:1 http://f1000.com/prime/reports/b/6/1 therefore, a physical link between the  adherens junction (AJ) and actin network is believed to require additional interactions [12,13].",Non-OADS,/arxiv_data1/oa_pdf/98/b2/biolrep-06-01.PMC3883420.pdf
"Kim N, Koh E, Chen X, Gumbiner BM: E-cadherin mediates contact inhibition of pro liferation through Hippo Page 3 of 4 (page number not for citation purposes) F1000Prime Reports 2014, 6:1 http://f1000.com/prime/reports/b/6/1",Non-OADS,/arxiv_data1/oa_pdf/98/b2/biolrep-06-01.PMC3883420.pdf
"Page 4 of 4 (page number not for citation purposes) F1000Prime Reports 2014, 6:1 http://f1000.com/prime/reports/b/6/1",Non-OADS,/arxiv_data1/oa_pdf/98/b2/biolrep-06-01.PMC3883420.pdf
"25, 72076 Tübingen, Germany * Corresponding author: Kamran Ghoreschi (kamran.ghoreschi@med.uni-tuebingen.de) F1000Prime Reports 2014, 6:4 (doi:10.12703/P6-4) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/4 Abstract Psoriasis is a T helper (Th)17/Th1-mediated autoim mune disease affecting the skin and joints.,Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Anti-psoriatic oral compounds and biologics Category Therapeutic Target, mode of action Traditional oral compounds Methotrexate Cyclosporine RetinoidsFumaric acid estersFolic acid antagonist; inhibits T cell activation Inhibits T cell activation and cytokine secretion Vitamin A analogs inhibiting epidermal proliferation and differentitationGSH conjugation, changes in cytokine production Established biologics Infliximab EtanerceptAdalimumabUstekinumabAntibody neutralizing TNF TNFR fusion proteinAntibody neutralizing TNFAntibody neutralizing IL-12/IL-23p40 Modern oral compounds (phase 3 development)Dimethyl fumarate ApremilastTofacitinibGSH conjugation, Nrf2 activation, inhibition of IL-12 and IL-23, induction of IL-10 and Th2PDE4 inhibitor, increase of cAMP, inhibition of IL-12, IL-23, TNF and IFN- g, inhibition of IL-10JAK inhibitor silencing cytokine receptor signaling, inhibiting Th1 and Th17 responses New biologics (phase 3 development)Brodalumab Ixekizumab SecukinumabMK-3222Antibody binding IL-17 receptor A(IL-17RA) Antibody neutralizing IL-17A Antibody neutralizing IL-17AAntibody neutralizing IL-23p19 Approved or in phase 3 development according to http://clinicaltrials.gov/ GSH, glutathione; PDE4, phosphodiesterase type 4; TNF, tumor necrosis factor.",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"TheuseofDMF Page 4of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron J, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R: Development, cytokine profile and function of human Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:4 http://f1000.com/prime/reports/m/6/4",Non-OADS,/arxiv_data1/oa_pdf/50/0e/medrep-06-04.PMC3883421.pdf
"Wheels within wheels: new transcriptional feedback loops in the Arabidopsis circadian clock C. Robertson McClung Address: Department of Biological Sciences, Dartmouth College, Class of 1978 Life Sciences Center, 78 College Street, Hanover, NH 03755-3563, USA Email: c.robertson.mcclung@dartmouth.edu F1000Prime Reports 2014, 6:2 (doi:10.12703/P6-2) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/2 Abstract The circadian clock allows organisms to temporally coordinate their biology with the diurnal oscillation of the environment, which enhances plant performance.",OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Similarly, among EC components, ELF3 and ELF4 Page 2 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:2 http://f1000.com/prime/reports/b/6/2",OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Future directions Although Somers ‘s“dearth of activators ”has been at least partially redressed by the identification of LWDs as Page 3 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:2 http://f1000.com/prime/reports/b/6/2",Non-OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Hicks KA, Millar AJ, Carré IA, Somers DE, Straume M, Meeks- Wagner DR, Kay SA: Conditional circadian dysfunction of the Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:2 http://f1000.com/prime/reports/b/6/2",Non-OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Sanchez SE, Petrillo E, Beckwith EJ, Zhang X, Rugnone ML, Hernando CE, Cuevas JC, Godoy Herz MA, Depetris-Chauvin A, S i m p s o nC G ,B r o w nJ W S ,C e r d á nP D ,B o r e v i t zJ O ,M a sP , Ceriani MF, Kornblihtt AR, Yanovsky MJ: A methyl transferase Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:2 http://f1000.com/prime/reports/b/6/2",Non-OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:2 http://f1000.com/prime/reports/b/6/2",Non-OADS,/arxiv_data1/oa_pdf/7c/9e/biolrep-06-02.PMC3883422.pdf
"Perinatal neuroprotection Kirsten E. Salmeen1*, Angie C. Jelin2and Mari-Paule Thiet3 Addresses:1513 Parnassus Avenue, Room HSE-1634, Box 0556, San Francisco, CA 94143-0556, USA;2106 Irving Street, NW, Room POB 108, Washington, DC 20010, USA;3505 Parnassus Avenue, Moffitt 1478, Box 0132, San Francisco, CA 94143-0132, USA * Corresponding author: Kirsten E. Salmeen (salmeenk@obgyn.ucsf.edu) F1000Prime Reports 2014, 6:6 (doi:10.12703/P6-6) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/6 Abstract Fetal or neonatal brain injury can result in lifelong neurologic disability.,Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"A broad community awareness of the symptoms of HIE and the importance of prompt Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"In 2000, Wu and Colfordperformed a meta-analysis of 26 studies and demon- strated that clinical chorioamnionitis was associated Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Xia and colleagues performed Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
[http://www.fda.gov/ Drugs/DrugSafety/ucm353333.htm].,Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, Thoresen M, Whitelaw A, Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Romero R, Savasan ZA, Chaiworapongsa T, Berry SM, Kusanovic JP, Hassan SS, Yoon BH, Edwin S, Mazor M: Hematologic profile of Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
[http://clinicaltrials.gov/ct2/results?term= umbilical+cord+blood+an d+neonatal+brain+injury&Search=Search].,OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:6 http://f1000.com/prime/reports/m/6/6",Non-OADS,/arxiv_data1/oa_pdf/1f/b4/medrep-06-06.PMC3883423.pdf
"Advances in understanding pituitary tumors Anna Kopczak*, Ulrich Renner and Günter Karl Stalla Address: Max Planck Institute of Psychiatry, Clinical Neurendocrinology Group, Kraepelinstraße 2-10, 80804 Munich, Germany * Corresponding author: Anna Kopczak (anna_kopczak@mpipsykl.mpg.de) F1000Prime Reports 2014, 6:5 (doi:10.12703/P6-5) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/5 Abstract Pituitary tumors are common in the general population.,Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
"Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:5 http://f1000.com/prime/reports/m/6/5",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
"Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:5 http://f1000.com/prime/reports/m/6/5",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH: Diagnosis and treatment of Page 4 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:5 http://f1000.com/prime/reports/m/6/5",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:5 http://f1000.com/prime/reports/m/6/5",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:5 http://f1000.com/prime/reports/m/6/5",Non-OADS,/arxiv_data1/oa_pdf/60/c8/medrep-06-05.PMC3883424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/3c/ijn-8-4379.PMC3883425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4379–4389International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4379OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S53221Improved antibacterial activity   and biocompatibility on vancomycin-loaded   TiO2 nanotubes: in vivo and in vitro studies hangzhou Zhang1 Yu sun1 ang Tian2 Xiang Xin Xue2 lin Wang1 ali alquhali1 Xizhuang Bai1 1Department of sports Medicine  and Joint surgery, First affiliated  hospital of china Medical University,   2school of Materials and Metallurgy,   Northeastern University, shenyang,   People’s republic of china correspondence: Xizhuang Bai   Department of sports Medicine and   Joint Surgery, First Affiliated Hospital   of china Medical University, 155 Nanjing   North street, shenyang, liaoning 110001,   People’s republic of china   T el +86 135 0490 0218/   +86 186 0245 3666   Fax +86 24 8328 2772   email zpmhh@sina.co mAbstract:  The goal for current orthopedic implant research is to design implants that have  not only good biocompatibility but also antibacterial properties.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/ijn-8-4379.PMC3883425.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/ijn-8-4379.PMC3883425.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/3c/ijn-8-4379.PMC3883425.pdf
"A CRISPR method for genome engineering Royce Wilkinson and Blake Wiedenheft* Address: Department of Immunology and Infectious Diseases, Montana State University, Bozeman, MT 59717, USA * Corresponding author: Blake Wiedenheft (bwiedenheft@gmail.com) F1000Prime Reports 2014, 6:3 (doi:10.12703/P6-3) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/3 Abstract Clustered regularly interspaced short palindromic repeat (CRISPR) RNA-guided adaptive immune systems that protect bacteria and archaea from infection by viruses are now being routinely repurposed for genome engineering in a wide variety of cell types and multicellular organisms.,Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 2 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 3 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 4 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3 simplify these two RNA systems, Jinek",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"These Page 5 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA: Programmable repression and activation of bacterial gene Page 6 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 7 of 10 (page number not for citation purposes) F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Horvath P, Romero DA, Coûté-Monvoisin A, Richards M, Deveau H, Moineau S, Boyaval P, Fremaux C, Barrangou R: Diversity, activity, Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:3 http://f1000.com/prime/reports/b/6/3",Non-OADS,/arxiv_data1/oa_pdf/f5/7f/biolrep-06-03.PMC3883426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 1–19Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5330 4Overview of diagnostic/targeted treatment  combinations in personalized medicine   for breast cancer patients Anna T essari1 Dario Palmieri2 Serena Di Cosimo1 1Division of Medical Oncology 1,   Fondazione iRCCS istituto Nazionale  dei T umori, Milan, italy; 2Molecular  Biology and Cancer Genetics,   Comprehensive Cancer Center, The  Ohio State University College of  Medicine, Columbus, OH, USA Correspondence: Anna Tessari   Division of Medical Oncology 1,  Fondazione iRCCS istituto Nazionale   dei Tumori, via G venezian 1,   20123 Milan, italy   Tel +39 02 239 025 20   Fax +39 02 239 020 55   email anna.tessari@istitutotumori.mi.i tAbstract:  Breast cancer includes a body of molecularly distinct subgroups, characterized by  different presentation, prognosis, and sensitivity to treatments.",Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm312965.htm.,Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/ medicines/human/medicines/001038/human_med_000633.,Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
Available from http://clinicaltrials.gov/show/NCT01633060.,Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7f/04/pgpm-7-001.PMC3883531.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/20/opth-8-165.PMC3883548.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 165–168Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  165Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5632 7Correlations between choroidal   abnormalities, Lisch nodules, and age   in patients with neurofibromatosis type 1 shinji Makino Hironobu Tampo Yusuke arai Hiroto Obata Department of Ophthalmology,    Jichi Medical University, shimotsuke,   T ochigi, Japan Correspondence: shinji Makino   Department of Ophthalmology, Jichi   Medical University, shimotsuke, 3311-1   Yakushiji, Tochigi, 329-0498, Japan   Tel +812 8558 7382   Fax +812 8544 8365   email makichan@jichi.ac.j pAbstract:  To evaluate correlations between choroidal abnormalities, Lisch nodules, and age  in patients with neurofibromatosis type 1 (NF1), we examined ten cases with NF1 using near- infrared reflectance imaging.",Non-OADS,/arxiv_data1/oa_pdf/78/20/opth-8-165.PMC3883548.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/78/20/opth-8-165.PMC3883548.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/20/opth-8-165.PMC3883548.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/43/ijwh-6-041.PMC3883549.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 41–46International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  41OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S3986 3Autopsy-certified maternal mortality   at Ile-Ife, nigeria amatare Dinyain1 g Olutoyin Omoniyi-esan2 Olaejirinde O Olaofe3 Donatus sabageh3 akinwumi O Komolafe2 Olusegun s Ojo2 1Department of anatomic Pathology,   niger Delta University Teaching  Hospital, Okolobiri, Bayelsa state,   nigeria; 2Department of Morbid  anatomy and Forensic Medicine,   Obafemi awolowo University, Ile-Ife,   Osun state, nigeria; 3Department of  Morbid anatomy and Histopathology,   ladoke akintola University of  T echnology, Ogbomoso, Oyo state,   nigeria correspondence: Olutoyin Omoniyi-esan   Department of Morbid anatomy and  Forensic Medicine, Obafemi awolowo  University, Ile-Ife, Osun state, nigeria   Tel +234 803 353 6852   email goesan@oauife.edu.n g, gomoniyi_ esan@yahoo.co mAim:  Maternal mortality is a major health problem, especially in Nigeria, where accurate  autopsy-based data on the prevalent causes are not readily available.",Non-OADS,/arxiv_data1/oa_pdf/22/43/ijwh-6-041.PMC3883549.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/22/43/ijwh-6-041.PMC3883549.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/43/ijwh-6-041.PMC3883549.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/3b/cia-9-085.PMC3883550.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 85–93Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  85OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5515 7Incidence and risk of developing contrast-induced  acute kidney injury following intravascular  contrast administration in elderly patients Wei song T uo Zhang Jun Pu linghong shen Ben he Department of Cardiology,    ren Ji hospital, school of Medicine,   shanghai Jiao T ong University,   shanghai, People’s republic of China Correspondence: Ben he   Department of Cardiology,   ren Ji hospital, school of Medicine,  shanghai Jiao Tong University,   1630 Dong Fang road,   shanghai 200127, People’s   republic of China   Tel +86 21 5875 2345   Fax +86 21 6838 3069   email profheben@126.co mBackground:  The purpose of this meta-analysis was to evaluate the epidemiology of   contrast-induced acute kidney injury (CI-AKI) in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/bb/3b/cia-9-085.PMC3883550.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/bb/3b/cia-9-085.PMC3883550.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/3b/cia-9-085.PMC3883550.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/ijn-9-265.PMC3883551.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 265–271International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  265OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5490 6cytotoxicity and apoptosis induced   by nanobacteria in human breast cancer cells Ming-jun Zhang1 sheng-nan liu1 ge Xu2 Ya-nan guo1 Jian-nan Fu3 De-chun Zhang1 1Molecular Medicine and T umor  research center, chongqing Medical  University, 2electron Microscopy  group, Department of life science,   chongqing Medical University,   chongqing, People’s republic of  china; 3First People’s hospital of  Jiulongpo District, chongqing, People’s  republic of china correspondence: De-chun Zhang,   Molecular Medicine and Tumor   research center, chongqing Medical   University,1 Medical college road,   Yuzhong District, chongqing 400016,   People’s republic of china   Tel +86 023 6848 6133   Fax +86 023 6848 6133   email zhangdechun46@163.co mBackground:  The existing evidence that nanobacteria (NB) are closely associated with human  disease is overwhelming.",Non-OADS,/arxiv_data1/oa_pdf/e1/0a/ijn-9-265.PMC3883551.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e1/0a/ijn-9-265.PMC3883551.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/ijn-9-265.PMC3883551.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/c3/ijn-9-243.PMC3883552.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 243–255International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  243OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5405 0Improving aqueous solubility and antitumor  effects by nanosized gambogic acid-mPeg2000  micelles lulu cai1,* Neng Qiu2,* Mingli Xiang3,* rongsheng T ong1 Junfeng Yan1 lin he1 Jianyou shi1 Tao chen4 Jiaolin Wen3 Wenwen Wang3 lijuan chen3 1Department of Pharmacy, sichuan  academy of Medical science and  sichuan Provincial People’s hospital,   2college of Materials and chemistry  and chemical engineering, chengdu  University of T echnology, 3state  Key laboratory of Biotherapy, West  china hospital, West china Medical  school, sichuan University, chengdu,   People’s republic of china; 4Faculty  of  Pharmacy, University of Montreal,   Montreal, Qc , canada *These authors contributed equally to  this paper correspondence: lijuan chen   state Key laboratory of Biotherapy,  West china hospital, sichuan University,  4 Keyuan road, 1 gaopeng street,  chengdu 610041, sichuan, People’s  republic of china   T el +86 28 8516 4103   Fax +86 28 8516 4060   email lijuan501@hotmail.co m lulu cai  Department of Pharmacy, sichuan  academy of Medical science and  sichuan Provincial People’s hospital,   chengdu 610071, sichuan, People’s  republic of china   T el +86 28 8739 3316   Fax +86 28 8516 4060   email lzxlulu@126.co mAbstract:  The clinical application of gambogic acid, a natural component with promising   antitumor activity, is limited due to its extremely poor aqueous solubility, short half-life in blood,  and severe systemic toxicity.",Non-OADS,/arxiv_data1/oa_pdf/47/c3/ijn-9-243.PMC3883552.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical ﬁeld.",Non-OADS,/arxiv_data1/oa_pdf/47/c3/ijn-9-243.PMC3883552.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/c3/ijn-9-243.PMC3883552.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/da/ndt-10-055.PMC3883553.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 55–62Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  55OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5595 6relationship between alexithymia and coping  strategies in patients with somatoform disorder T oshiyuki T ominaga1,4 hyungin choi2 Yasuhide Nagoshi3 Y oshihisa Wada4 Kenji Fukui4 1health Management Doctor’s Office  (Mental health), salary, Personnel  health, and Welfare Division, Kyoto  Prefecture, Japan; 2Department of  Psychiatry, iwakura hospital, Kyoto,   Japan; 3Department of Psychiatry  (Psychosomatic Medicine), Kyoto First  red cross hospital, Kyoto, Japan;   4Department of Psychiatry, graduate  school of Medical science, Kyoto  Prefectural University of Medicine,   Kyoto, Japan correspondence: Toshiyuki Tominaga   Health Management Doctor’s Office  (Mental health), salary, Personnel health,  and Welfare Division, Yabunouti-cho,  Nishiiru, shinmachi, simodatiuri-dori,  Kamigyo-ku, Kyoto 602-8570, Japan   Tel +81 75 451 8111   Fax +81 75 451 8112   email totomi@koto.kpu-m.ac.j pPurpose:  A multidimensional intervention integrating alexithymia, negative affect, and type  of coping strategy is needed for the effective treatment of somatoform disorder; however, few  studies have applied this approach to the three different dimensions of alexithymia in patients  with somatoform disorder.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/ndt-10-055.PMC3883553.pdf
Available from: http://www.who.int/  classifications/icd/en/GRNBOOK.pdf .,OADS,/arxiv_data1/oa_pdf/fc/da/ndt-10-055.PMC3883553.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/ndt-10-055.PMC3883553.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/da/ndt-10-055.PMC3883553.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/5b/jmdh-7-011.PMC3883554.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 11–24Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  11CoMMentaryopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JMDH.S5287 0Skin, fascias, and scars: symptoms   and systemic connections Bruno Bordoni1 emiliano Zanier2 1rehabilitation Cardiology Institute   of Hospitalization and Care   with Scientific address, S Maria   nascente Don Carlo Gnocchi   Foundation.",Non-OADS,/arxiv_data1/oa_pdf/39/5b/jmdh-7-011.PMC3883554.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/39/5b/jmdh-7-011.PMC3883554.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/5b/jmdh-7-011.PMC3883554.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/27/ott-7-079.PMC3883580.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 79–86OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  79Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5470 2high expression of sonic hedgehog signaling  pathway genes indicates a risk of recurrence   of breast carcinoma Kuo-shyang Jeng1 i-shyan sheen2 Wen-Juei Jeng2 Ming-che Yu3 hsin-i hsiau3 Fang-Yu chang3 1Department of surgery, Far  eastern Memorial hospital, Taipei,   2Department of internal Medicine,   chang-gung Memorial hospital,   linkou Medical center, chang-gung  University, Tao-Yuan, 3Department  of Medical research, Far eastern  Memorial hospital, Taipei, Taiwan correspondence: Kuo-shyang Jeng   Department of surgery, Far eastern   Memorial hospital, no 21, sec 2,   nanya s rd, Banqiao Dist,   new Taipei city 220, Taiwan   Tel +88 62 8966 7000 ext 1611   Fax +88 62 8966 8505   email kevin.ksjeng@gmail.co mBackground:  Abnormal activation of the Sonic Hedgehog ( SHH ) signaling pathway   contributing to carcinogenesis of some organs has been reported in the literature.",Non-OADS,/arxiv_data1/oa_pdf/2d/27/ott-7-079.PMC3883580.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2d/27/ott-7-079.PMC3883580.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/27/ott-7-079.PMC3883580.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/1a/opth-8-149.PMC3883581.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 149–156Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  149Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5545 6Phase III safety and efficacy study   of long-term brinzolamide/timolol fixed  combination in Japanese patients with open-angle  glaucoma or ocular hypertension Masayuki nakajima1 naoki iwasaki2 Masaki adachi3 1nakajima eye Clinic, Kyoto, 2iwasaki  eye Clinic, 3adachi eye Clinic, Osaka,   Japan Correspondence: Masayuki nakajima   nakajima eye Clinic   51 Kawashimahigashidaicho Kyoto  nishikyo-ku, Kyoto, Japan   Tel +81 075 381 0122   Fax +81 075 392 3086   email eye-masa@amber.plala.or.j pBackground:  The purpose of this study was to evaluate the safety and efficacy of a long-term,  twice-daily brinzolamide 1%/timolol 0.5% fixed combination ophthalmic suspension (BRINZ/ TIM-FC) in Japanese patients with open-angle glaucoma (primary open-angle, normal-tension,  exfoliation, or pigmentary) or ocular hypertension.",Non-OADS,/arxiv_data1/oa_pdf/0e/1a/opth-8-149.PMC3883581.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0e/1a/opth-8-149.PMC3883581.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/1a/opth-8-149.PMC3883581.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/a7/dddt-8-067.PMC3883582.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 67–78Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  67Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5279 1Development and characterization of a  gastroretentive dosage form composed   of chitosan and hydroxyethyl cellulose   for alendronate Ying-chen chen1,* hsiu-O ho1,* chiao-chi chiu1 Ming-Thau sheu1,2 1school of Pharmacy, college of  Pharmacy, Taipei Medical University,  2clinical research center and  Traditional herbal Medicine research  center, Taipei Medical University  hospital, Taipei, Taiwan *These authors contributed equally   to this work correspondence: Ming-Thau sheu   Taipei Medical University,   250 Wu-hsing street, Taipei 110,   Taipei, Taiwan   Tel +886 2 2736 1661 ext 6112   Fax +886 2 2377 1942   email mingsheu@tmu.edu.t wAbstract:  In this study, alendronate, the most commonly used biphosphonate for treating  osteoporosis, was formulated as gastroretentive dosage form (GRDF) table ts to enhance its oral  bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/26/a7/dddt-8-067.PMC3883582.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/26/a7/dddt-8-067.PMC3883582.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/a7/dddt-8-067.PMC3883582.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/b3/opth-8-119.PMC3883583.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 119–126Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  119ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5308 8Anterior-segment morphology and   corneal biomechanical characteristics   in pigmentary glaucoma Annemarie Klingenstein Marcus Kernt Florian Seidensticker Anselm Kampik Christoph Hirneiss Department of Ophthalmology,   University of Munich Hospital,    Ludwig-Maximilians University,    Munich, Germany Correspondence: A Klingenstein   Ludwig-Maximilians University,   Department of Ophthalmology,   Klinikum der Universität München,   Campus Innenstadt, Mathildenstraße 8,   D-80336 Munich, Germany   Tel +49 89 5160 3811   Fax +49 89 5160 5160   Email annemarie.",Non-OADS,/arxiv_data1/oa_pdf/ef/b3/opth-8-119.PMC3883583.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ef/b3/opth-8-119.PMC3883583.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b3/opth-8-119.PMC3883583.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/40/ott-7-087.PMC3883584.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 87–90OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  87Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5484 3The long-term survival of a thymic carcinoma  patient treated with s-1: a case report   and literature review Hisashi Tanaka1 Takeshi Morimoto1 Kageaki Taima1 Y oshihito Tanaka1 Kunihiko Nakamura1 akihito Hayashi3 akira Kurose2 Ken Okumura1 shingo Takanashi4 1Department of Cardiology,   respiratory Medicine and Nephrology,   Hirosaki University Graduate school  of Medicine, Zaifu-cho, Hirosaki, Japan;   2Department of anatomic pathology,   Hirosaki University Graduate school  of Medicine, Zaifu-cho, Hirosaki, Japan;   3respiratory Medicine, Hachinohe  City Hospital, Tamukaibishamontai,   Hachinohe, Japan; 4Hirosaki University,   Health administration Center, Bunkyo,   Hirosaki, Japan Correspondence: Hisashi Tanaka   Department of Cardiology, respiratory  Medicine and Nephrology, Hirosaki  University Graduate school of Medicine,  5 Zaifu-cho, Hirosaki, 036-8562 Japan   Tel +81 17 239 5330   Fax +81 17 239 5329   email h-tanaka@cc.hirosaki- u.ac.jpBackground:  Thymic carcinoma is a rare neoplasm of the thymus.",Non-OADS,/arxiv_data1/oa_pdf/cf/40/ott-7-087.PMC3883584.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/40/ott-7-087.PMC3883584.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/40/ott-7-087.PMC3883584.pdf
"Available from: http://www.nccn.org/professionals/ physician_ gls/pdf/thymic.pd f. Accessed November 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/cf/40/ott-7-087.PMC3883584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/10/ijn-9-301.PMC3883587.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 301–310International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  301OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5241 4Anti-obesity efficacy of nanoemulsion oleoresin  capsicum in obese rats fed a high-fat diet Joo-Yeon Kim1,* Mak-soon lee1,* sunyoon Jung1 hyunjin Joo1 chong-Tai Kim2 In-hwan Kim3 sangjin seo1 soojung Oh1 Yangha Kim1 1Department of Nutritional science  and Food Management, ewha Womans  University, seoul, republic of Korea;   2Functional Materials research group,   Korea Food research Institute,   seongnam, gyeonggi, republic of  Korea; 3Department of Food and  Nutrition, Korea University, seoul,   republic of Korea *These authors contributed equally to  this work correspondence: Yangha Kim   Department of Nutritional science  and Food Management, ewha Womans  University, 52 ewhayeodae-gil,  seodaemun-gu, seoul 120-750,   republic of Korea   Tel +82 2 3277 4425   Fax +82 2 3277 4425   email yhmoon@ewha.ac.k rPurpose:  This study determined the effects of oleoresin capsicum (OC) and nanoemulsion OC  (NOC) on obesity in obese rats fed a high-fat diet.",Non-OADS,/arxiv_data1/oa_pdf/06/10/ijn-9-301.PMC3883587.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/06/10/ijn-9-301.PMC3883587.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/10/ijn-9-301.PMC3883587.pdf
"Further analysis indicated that the nob ERG  phenotype reflected a large insertion in the Gpr179  locus, the Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > Received 17 July 2013 | Accepted 27 December 2013 | Published 31 December 2013© 2013 Molecular Vision 2615Presence of the Gpr179nob5 allele in a C3H-derived transgenic  mouse Jasmin Balmer,1,2 Rui Ji,3 Thomas A. Ray,3 Fabia Selber,1 Max Gassmann,4 Neal S. Peachey,5,6,7 Ronald G.  Gregg,3 Volker Enzmann1 1Department of Ophthalmology, Inselspital, University of Bern, Switzerland; 2Graduate School for Cellular and Biomedical  Sciences, University of Bern, Switzerland; 3Department of Biochemistry and Molecular Biology, University of Louisville, KY;  4Institute of Veterinary Physiology, University of Zürich, Switzerland; 5Department of Ophthalmic Research, Cole Eye Institute,  Cleveland Clinic, Cleveland OH; 6Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland OH; 7Department of  Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland OH Purpose:  To identify the mutation responsible for an abnormal electroretinogram (ERG) in a transgenic mouse line  (tg21) overexpressing erythropoietin (Epo).",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
"Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2616same mutation recently reported in Gpr179nob5 mice [ 7], and  that this mutation is present in additional C3H-derived mouse  lines.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2617Histology and immunohistochemistry:  Mouse eyecups  were freshly prepared by removing the cornea and the lens.,Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
"Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2618in Figure 2B, there was no significant difference between the  retinal morphology of the WT and tg21 nob mice, including  the inner nuclear layer (INL), where DBC cell bodies are  located.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2619primers developed to genotype the Gpr179nob5 allele (Figure  8).,Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
"Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2620Pde6b+ mice, we observed that C3H.Pde6b+ mice carry the  Gpr179nob5 allele (Figure 10).",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
"Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2621nob mouse, the “sighted” C3H.Pde6b+ mouse.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2622and was recently identified in several inbred lines [ 26].,Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2623 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
"Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  2624a mouse line, it would be efficient to evaluate whether the  Gpr179nob5 allele may be responsible.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
Molecular Vision  2013; 19:2615-2625 <http://www.molvis.org/molvis/v 19/2615 > © 2013 Molecular Vision  262519.,Non-OADS,/arxiv_data1/oa_pdf/0b/32/mv-v19-2615.PMC3883591.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/c8/ijn-9-231.PMC3883593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 231–242International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  231OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5554 1An efficient Trojan delivery of tetrandrine   by poly(N-vinylpyrrolidone)-block-   poly(ε-caprolactone) (PVP-b-PCL) nanoparticles  shows enhanced apoptotic induction of lung cancer  cells and inhibition of its migration and invasion huae Xu1,2 Zhibo hou3 hao Zhang4 hui Kong2 Xiaolin li4 hong Wang2 Weiping Xie2 1Department of Pharmacy,  2Department of Respiratory Medicine,  The First Affiliated Hospital of Nanjing  Medical University, Nanjing, People’s  republic of china; 3First Department  of Respiratory Medicine, Nanjing  Chest Hospital, Nanjing, People’s  republic of china; 4Department of  Geriatric Gastroenterology, The First  Affiliated Hospital of Nanjing Medical  University, Nanjing, People’s Republic  of china correspondence: hong Wang;   Weiping Xie   Department of Respiratory Medicine,   The First Affiliated Hospital of Nanjing   Medical University, 300# Guangzhou  Road, Nanjing 210029,   People’s Republic of China   Tel +86 25 68 136 580; +86 25 68 136 379   email hongwang@njmu.edu.c n;   wpxie@njmu.edu.c nAbstract:  Earlier studies have demonstrated the promising antitumor effect of tetrandrine (Tet)  against a series of cancers.",Non-OADS,/arxiv_data1/oa_pdf/e8/c8/ijn-9-231.PMC3883593.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e8/c8/ijn-9-231.PMC3883593.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/c8/ijn-9-231.PMC3883593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/17/ijn-9-289.PMC3883594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 289–299International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  289OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5452 9Nanostructured lipid carrier-loaded hyaluronic  acid microneedles for controlled dermal   delivery of a lipophilic molecule sang gon lee1,* Jae han Jeong1,* Kyung Min lee1 Kyu ho Jeong1 huisuk Yang2 Miroo Kim2 hyungil Jung2 sangkil lee3 Y oung Wook choi1 1college of Pharmacy, chung- ang  University, seoul, south Korea;   2Department of Biotechnology,   Y onsei University, seoul, south Korea;   3college of Pharmacy, Keimyung  University, Daegu, south Korea *These authors contributed equally to  this work correspondence: Young Wook choi   college of Pharmacy, chung-ang  University, 221 heuksuk-dong,  Dongjak-gu, seoul 156-756,   south Korea   Tel +82 2 820 5609   Fax +82 2 826 3781   email ywchoi@cau.ac.k rAbstract:  Nanostructured lipid carriers (NLCs) were employed to formulate a lipophilic  drug into hydrophilic polymeric microneedles (MNs).",Non-OADS,/arxiv_data1/oa_pdf/0b/17/ijn-9-289.PMC3883594.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0b/17/ijn-9-289.PMC3883594.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/17/ijn-9-289.PMC3883594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/e4/cia-9-079.PMC3883595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 79–84Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  79OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5605 4homocysteine is associated with plasma   high-sensitivity cardiac troponin T levels   in a community-dwelling population ruihua Cao* Y ongyi Bai* ruyi Xu Ping Ye Department of geriatric Cardiology,   Chinese P lA general hospital,   Beijing, People’s republic of China *These authors contributed equally to  this work Correspondence: Ping Ye   Department of geriatric Cardiology,   Chinese PlA general hospital,   no 28, Fuxing road, Beijing 100853,   People’s republic of China   T el +86 10 6687 6369   Fax +86 10 6687 6349   email yeping301@sina.co mObjectives:  Homocysteine (HCY) is associated with an increased risk for cardiovascular  disease, possibly leading to myocardial damage.",Non-OADS,/arxiv_data1/oa_pdf/56/e4/cia-9-079.PMC3883595.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/56/e4/cia-9-079.PMC3883595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/e4/cia-9-079.PMC3883595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/3d/ijn-9-257.PMC3883596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 257–263International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  257OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5489 7Greater fibroblast proliferation on an ultrasonicated   ZnO/PVc nanocomposite material Paul M Maschhoff1 Benjamin M geilich2 Thomas J Webster1,3 1Department of chemical engineering,   2Program in Bioengineering, college  of engineering, Northeastern   University, Boston, M a, Usa; 3center  of excellence for advanced Materials  Research, King Abdulaziz University,   Jeddah, Saudi Arabia Correspondence: Thomas J Webster   chemical engineering, Northeastern  University, Boston, 360 huntington  avenue, Ma 02115, Usa   Tel +1 617 373 8565   email th.webster@neu.ed uAbstract:  There has been a significant and growing concern over nosocomial medical device  infections.",Non-OADS,/arxiv_data1/oa_pdf/ba/3d/ijn-9-257.PMC3883596.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs194/en /.,Non-OADS,/arxiv_data1/oa_pdf/ba/3d/ijn-9-257.PMC3883596.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ba/3d/ijn-9-257.PMC3883596.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/3d/ijn-9-257.PMC3883596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/28/imcrj-7-007.PMC3883597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 7–10International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  7Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S4967 4sudden and rapid progression of lung affectation  but stability in kidney function: a case report   of anti-neutrophil cytoplasmic antibody-   associated vasculitis Cheng Chen* Ye-Han Zhu* Hong-Ying Qian* Ling-Yi Yang Jian-an Huang Respiratory Division, the First  affiliated Hospital of soochow  University, suzhou, people’s   Republic of China *these authors contributed equally to  this article Correspondence: Jian-an Huang   Respiratory Division, The First Affiliated  Hospital of soochow University,   188 shizi street, suzhou, 215006,   people’s Republic of China   tel +86 512 6778 0356   email huang_jian_an@163.co mAbstract:  We report the case of a patient with anti-neutrophil cytoplasmic antibody   (ANCA)-associated vasculitis (AA V) who exhibited sudden progression of lung infiltration  while maintaining s table  kidney function.",Non-OADS,/arxiv_data1/oa_pdf/ad/28/imcrj-7-007.PMC3883597.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/ad/28/imcrj-7-007.PMC3883597.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/28/imcrj-7-007.PMC3883597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/14/dddt-8-087.PMC3883598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 87–100Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  87Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4164 5Rituximab for the treatment of rheumatoid  arthritis: an update Chi Chiu Mok Department of Medicine, T uen  Mun Hospital, Hong Kong, Special  Administrative Region of the People’s  Republic of China Correspondence: Chi Chiu Mok   Department of Medicine, Tuen Mun   Hospital, New Territories, Hong Kong,   Special Administrative Region of the   People’s Republic of China   Tel +852 2468 5389   Fax +852 2456 9100   email ccmok2005@yahoo.co mAbstract:  Rituximab is a chimeric monoclonal antibody that targets the CD20 molecule  expressed on the surface of B cells.",Non-OADS,/arxiv_data1/oa_pdf/05/14/dddt-8-087.PMC3883598.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/05/14/dddt-8-087.PMC3883598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/14/dddt-8-087.PMC3883598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/60/ijgm-7-043.PMC3883615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 43–47International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  43RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S5695 7Antibiotics for the treatment   of rheumatoid arthritis Mesut Ogrendik Division Physical Therapy and  Rheumatology, Nazilli State Hospital,   Nazilli, T urkey Correspondence: Mesut Ogrendik   Nazilli State Hospital, Division of  Physical Therapy and Rheumatology,  Nazilli-Aydin, Turkey   Tel 90 256 312 0000   email neml82@hotmail.co mAbstract:  Antibiotic treatment for rheumatoid arthritis (RA) commenced in the 1930s with  the use of sulfasalazine.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/ijgm-7-043.PMC3883615.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/e5/60/ijgm-7-043.PMC3883615.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/60/ijgm-7-043.PMC3883615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/07/opth-8-143.PMC3883616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 143–148Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  143Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5648 3retinal angiomatous proliferation associated   with risk alleles of ARMS2 /HTRA1  gene   polymorphisms in Japanese patients Yasuhiro Ohkuma1 Takaaki hayashi1 Tsutomu sakai1 akira Watanabe1 hisashi Yamada2 Masakazu akahori3 Takeshi itabashi3 Takeshi iwata3 T oru noda4 hiroshi Tsuneoka1 1Department of Ophthalmology,   2Department of Molecular genetics,   institute of D na Medicine, The  Jikei University school of Medicine,   3Division of Molecular and Cellular  Biology, national institute of sensory  Organs, 4Division of Ophthalmology,   national hospital Organization Tokyo  Medical Center, T okyo, Japan Correspondence: Takaaki hayashi   Department of Ophthalmology,   The Jikei University school of   Medicine, 3-25-8 nishi-shimbashi,  Minato-ku, Tokyo 105-8461, Japan   Tel +81 3 3433 1111 ext 3581   Fax +81 3 3433 1936   email taka@jikei.ac.j pBackground:  The purpose of this study was to investigate the association between ARMS2/ HTRA1 , CFH , and C3 gene polymorphisms and retinal angiomatous proliferation (RAP), an  infrequent and severe form of exudative age-related macular degeneration, which is character - ized by intraretinal neovascularization.",Non-OADS,/arxiv_data1/oa_pdf/99/07/opth-8-143.PMC3883616.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/99/07/opth-8-143.PMC3883616.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/07/opth-8-143.PMC3883616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/fb/opth-8-157.PMC3883617.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 157–164Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  157Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5382 2evaluation of clinical outcomes in patients  with dry eye disease using lubricant eye drops  containing polyethylene glycol   or carboxymethylcellulose stephen Cohen1 anna Martin2 Kenneth sall3 1Cohen Optometry, scottsdale, aZ,   Usa; 2alcon laboratories inc, Fort  Worth, TX, Usa; 3sall research  Medical Center inc, artesia, C a, Usa Correspondence: stephen Cohen   Cohen Optometry, 10900 n scottsdale  rd suite #301, scottsdale, arizona  85254, Usa   Tel +1 480 513 3937   Fax +1 480 367 6711   email stephen.cohen@doctormyeyes.ne tBackground:  The purpose of this study was to compare changes in corneal staining in patients  with dry eye after 6 weeks of treatment with Systane® Gel Drops or Refresh Liquigel® lubricant  eye drops.",Non-OADS,/arxiv_data1/oa_pdf/b9/fb/opth-8-157.PMC3883617.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b9/fb/opth-8-157.PMC3883617.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/fb/opth-8-157.PMC3883617.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/76/ijn-9-223.PMC3883618.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 223–229International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  223OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5597 4Interaction between nanoparticles generated   by zinc chloride treatment and oxidative  responses in rat liver Inès azzouz hamdi Trabelsi amel hanini soumaya Ferchichi Olfa T ebourbi Mohsen sakly hafedh abdelmelek laboratory of Integrative Physiology,   Faculty of sciences of Bizerte,   carthage University, T unisia correspondence: Inès azzouz   laboratoire de Physiologie Intégrée,  Faculté des sciences de Bizerte,   7021 Jarzouna, Tunisia   Tel +216 22 874 731   Fax +216 72 590 566   email inessazzouz@hotmail.f rAbstract:  The aim of the present study was to investigate the interaction of zinc chloride  (3 mg/kg, intraperitoneally [ip]) in rat liver in terms of the biosynthesis of nanoparticles.",Non-OADS,/arxiv_data1/oa_pdf/b7/76/ijn-9-223.PMC3883618.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b7/76/ijn-9-223.PMC3883618.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/76/ijn-9-223.PMC3883618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/1b/ceg-7-007.PMC3883619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 7–12Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  7OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S5417 0High degree of duodenal inflammation   in nigerians with functional dyspepsia sylvester Chuks  nwokediuko1 Uchenna n ijoma1 Olive Obienu1 Gideon E anigbo1 Okechukwu Okafor2 1Department of Medicine,   2Department of Morbid anatomy,   University of nigeria Teaching  hospital, ituku/Ozalla Enugu, nigeria Correspondence: sylvester Chuks  nwokediuko   Gastroenterology Unit, Department   of Medicine, University of nigeria   Teaching hospital ituku/Ozalla,   PMB 01129 Enugu, nigeria   Tel +234 803 321 8181   Email scnwokediuko@yahoo.co mBackground:  Functional dyspepsia (FD) is a heterogeneous disorder associated with diverse  pathophysiological mechanisms, including immune activation and low-grade mucosal  inflammation.",Non-OADS,/arxiv_data1/oa_pdf/44/1b/ceg-7-007.PMC3883619.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/44/1b/ceg-7-007.PMC3883619.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/1b/ceg-7-007.PMC3883619.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 79–86Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  79Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3861 7Overview of clinical use and side effect profile   of valsartan in Chinese hypertensive patients Qi-Fang Huang Yan Li Ji-Guang wang Centre for epidemiological Studies   and Clinical Trials, The Shanghai   institute of Hypertension, Ruijin   Hospital, Shanghai Jiaotong   University School of Medicine,    Shanghai, People’s Republic of China Correspondence: Ji-Guang wang   The Shanghai institute of Hypertension,   Ruijin 2nd Road 197, Shanghai 200025,   People’s Republic of China   Tel +86 21 6437 0045 ext 610911   Fax +86 21 6466 2193   email jiguangwang@aim.co mAbstract:  We reviewed the Chinese and English literature for the efficacy and safety data of  valsartan monotherapy or combination therapy in Chinese hypertensive patients.",Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
Selection of studies We searched randomized controlled trials and side effect case  reports involving valsartan via PubMed ( http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
"nlm.nih.gov/pubmed /) and VIP ( http://www.cqvip.com /) for  the English- and Chinese-language literature, respectively.",Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/15/dddt-8-079.PMC3883632.pdf
"T o submit a comment, go to: http://ep.physoc.org/ letters/submit/expphysiol;99/1/55.",Non-OADS,/arxiv_data1/oa_pdf/a4/b4/eph0099-0055.PMC3883647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/af/cia-9-073.PMC3883731.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 73–78Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  73OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5141 0Application of rapid artificial cardiac   pacing in thoracic endovascular aortic   repair in aged patients Jun Chen1,* Wenhui huang2,* songyuan luo2,* Dahao Yang1 Zhengrong Xu1 Jianfang luo2 1Department of Angiocardiopathy,  Affiliated Baoan Hospital of Southern  Medical University, shenzhen City,   People’s republic of China; 2Department  of Cardiology, guangdong Cardiovascular  Institute, guangdong general hospital,  guangdong Academy of Medical sciences,  guangzhou, People’s republic of China *These authors contributed equally to  this work Correspondence: Zhengrong Xu   Department of Angiocardiopathy,   Affiliated Baoan Hospital of Southern  Medical University, shenzhen City, guangdong   518101, People’s republic of China   email xuzhengrong_smu@163.co m     Jianfang luo   Department of Cardiology, guangdong  Cardiovascular Institute, guangdong  general hospital, guangdong Academy of  Medical sciences, guangzhou, guangdong  510080, People’s republic of China   email henryjfl@tom.co mObjective:  To compare the safety, efficacy, and impact on stent graft positioning between  rapid artificial cardiac pacing (RACP), induced hypotension and sodium nitroprusside (SNP)  induced hypotension during thoracic endovascular aortic repair (TEV AR) for Stanford B aortic  dissection.",Non-OADS,/arxiv_data1/oa_pdf/22/af/cia-9-073.PMC3883731.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/22/af/cia-9-073.PMC3883731.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/af/cia-9-073.PMC3883731.pdf
"reported that PFD inhibited the fibroblast-like Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > Received 17 June 2013 | Accepted 27 December 2013 | Published 31 December 2013© 2013 Molecular Vision 2626Pirfenidone inhibits migration, differentiation, and proliferation  of human retinal pigment epithelial cells in vitro Jing Wang, Yangfan Yang, Jiangang Xu, Xianchai Lin, Kaili Wu, Minbin Yu State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China Purpose:  To investigate the effects of pirfenidone (PFD) on the migration, differentiation, and proliferation of retinal  pigment epithelial (RPE) cells and demonstrate whether the drug induces cytotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
"Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2627phenotype of retinal pigment epithelial (RPE) cells induced  by transforming growth factor beta 1 (TGFβ1), and the  possible mechanism involved blocking TGFβ signaling path - ways [ 17].",Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
"Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2628were analyzed with a Gel Genius Bioimaging System (Vilber  Lourmat Co, Paris, France), and the densitometry values  were read by Quantity One software (Bio-Rad Laborato - ries).",OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
"Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2629of PFD on FN was shown with densitometry analysis of three  independent experiments; at PFD levels of 0.3 mg/ml and  0.5 mg/ml, the protein levels were significantly inhibited  (p<0.01; Figure 3C,D).",Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2630Annexin V (+) PI (+; shown in the Q2 area).,Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2631 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2632A Trypan Blue assay was also used to detect RPE cell  viability.,OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
"Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  2633factor (PDGF)-induced activation of the Na+/K+ exchanger  and protein kinase C, but the inhibition is irrelevant with  PDGF-receptor autophosphorylation.",Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  26343.,Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Molecular Vision  2013; 19:2626-2635 <http://www.molvis.org/molvis/v 19/2626 > © 2013 Molecular Vision  263530.,Non-OADS,/arxiv_data1/oa_pdf/af/19/mv-v19-2626.PMC3883732.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 08/18/13; Accepted: 08/18/13http://dx.doi.org/10.4161/epi.26238findings suggest that the transient reduc - tion of 5mC and 5hmC in dedifferentiated  cells is associated with active demethyl - ation during regeneration of zebrafish fin.,OADS,/arxiv_data1/oa_pdf/fc/5f/epi-8-885.PMC3883764.pdf
"www.landesbioscience.com Epigenetics 953Epigenetics 8:9, 953–961; September 2013; © 2013 Landes Bioscience RESEaR ch PaPER RESEaR ch PaPER *Correspondence to: Chris Boshoff; Email: c.boshoff@ucl.ac.uk; Stephan Beck; Email: s.beck@ucl.ac.uk Submitted: 05/31/13; Revised: 06/26/13; Accepted: 07/02/13http://dx.doi.org/10.4161/epi.25614Introduction One in six cancers worldwide is believed to be caused by infection,  with human papillomavirus (HPV) being one of the leading cul - prits.1 HPV is known to represent a major independent risk fac - tor for Head and Neck Squamous Cell Carcinoma (HNSCC).2,3  It is particularly associated with oropharyngeal carcinoma, of which 20–50% test positive for the HPV-16 subtype, showing expression of the E6 and E7 viral oncogenes.",Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
"Reads that failed  to align to the human genome were mapped, using BWA,31 to  1776 viral genomes, including 29 human papillomaviruses ( Table  S2), obtained from NCBI Genomes (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
"Quality control was  performed using FastQC (v0.9.4, http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) and MEDIPS (v1.0.0).",OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Clin Sci (Lond)  2006; 110:525-41; PMID:16597322; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Cancer Res 2009; 69:3828-32;  PMID:19401452; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3099 29.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Clin Cancer Res 2011; 17:6262-71; PMID:21969383; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0388 30.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Methods 2010; 52:223-31; PMID:20385236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Bioinformatics 2009; 25:1754-60; PMID:19451168; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Bioinformatics 2009; 25:2078- 9; PMID:19505943; http://dx.doi.org/10.1093/bioin- formatics/btp352 33.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Genome Res 2010; 20:1441- 50; PMID:20802089; http://dx.doi.org/10.1101/ gr.110114.110 34.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
BMC Bioinformatics 2008; 9:523;  PMID:19061503; http://dx.doi.org/10.1186/1471-2105-9-523 35.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Genome Biol 2010; 11:R106;  PMID:20979621; http://dx.doi.org/10.1186/gb-2010-11-10-r106 36.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Bioinformatics  2010; 26:841-2; PMID:20110278; http://dx.doi.org/10.1093/bioinformatics/btq033 37.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Methods 2010;  52:248-54; PMID:20434562; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
BMC Cancer 2011; 11:66; PMID:21314941;  http://dx.doi.org/10.1186/1471-2407-11-66 39.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Genome Res 2009;  19:1639-45; PMID:19541911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Cancer Prev Res (Phila)  2011; 4:207-17; PMID:21292634; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Gigascience 2012; 1:3; PMID:23587164;  http://dx.doi.org/10.1186/2047-217X-1-3 15.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Genome  Med 2013; 5:15; PMID:23419152; http://dx.doi.org/10.1186/gm419 16.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nucleic  Acids Res 2012; 40(Database issue):D84-90; PMID:22086963; http://dx.doi.org/10.1093/nar/ gkr991 17.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nat Methods 2012; 9:215-6; PMID:22373907; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nature 2009; 459:108-12; PMID:19295514;  http://dx.doi.org/10.1038/nature07829 20.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Cell 2013; 153:320- 34; PMID:23582323; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nat Protoc  2011; 6:1860-9; PMID:22051799; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nucleic Acids Res 2013; 41(Database  issue):D377-86; PMID:23193289; http://dx.doi.org/10.1093/nar/gks1118 24.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Nat Rev Mol Cell Biol 2002; 3:11-20;  PMID:11823794; http://dx.doi.org/10.1038/nrm714 25.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
"Cancer Epidemiol Biomarkers Prev 2005; 14:467-75; PMID:15734974; http://dx.doi.org/10.1158/1055- 9965.EPI-04-0551References 1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F ,  Forman D, et al.",Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Lancet Oncol 2012; 13:607-15; PMID:22575588;  http://dx.doi.org/10.1016/S1470-2045(12)70137-7 2.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
N Engl J Med  2007; 356:1944-56; PMID:17494927; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Head  Neck 2007; 29:64-70; PMID:16823878; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Am J Clin Oncol  2009; 32:535-9; PMID:19652580; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
J  Natl Cancer Inst 2008; 100:261-9; PMID:18270337;  http://dx.doi.org/10.1093/jnci/djn011 6.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Oncogene 2010; 29:1405- 20; PMID:20101211; http://dx.doi.org/10.1038/ onc.2009.517 7.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Genome Res 2008; 19:438- 51; PMID:19208682; http://dx.doi.org/10.1101/ gr.083550.108 8.,OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Virology 2009; 389:100- 7; PMID:19443004; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Int J Cancer 2008; 123:1832- 40; PMID:18688866; http://dx.doi.org/10.1002/ ijc.23707 10.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Virology 2006; 349:175-83; PMID:16472835; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
Virology 2007; 361:185-93; PMID:17175003; http://dx.doi.org/10.1016/j.virol.2006.11.010 12.,Non-OADS,/arxiv_data1/oa_pdf/21/f5/epi-8-953.PMC3883772.pdf
"www.landesbioscience.com Epigenetics 979Epigenetics 8:9, 979–989; September 2013; © 2013 Landes Bioscience RESEaR ch papER RESEaR ch papER *Correspondence to: Aniruddha Chatterjee; Email: aniruddha.chatterjee@otago.ac.nz Submitted: 05/06/13; Revised: 07/01/13; Accepted: 07/18/13http://dx.doi.org/10.4161/epi.25797Introduction DNA methylation provides a stable mechanism of epigenetic  regulation of gene expression that is prevalent in all vertebrates.1,2  DNA methylation has a crucial role in gene silencing, tissue dif - ferentiation, genomic imprinting, X chromosome inactivation, phenotypic plasticity, and disease susceptibility.",Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nature 2005; 434:400-4; PMID:15772666;  http://dx.doi.org/10.1038/nature03479 4.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome Res 2006; 16:157- 63; PMID:16365381; http://dx.doi.org/10.1101/gr.43620065.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Rev Genet  2008; 9:465-76; PMID:18463664; http://dx.doi.org/10.1038/nrg2341 6.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Biochem Biophys Res Commun 2008; 376:658- 64; PMID:18805397; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Bioinformation 2011;  7:369-70; PMID:22355239; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Cancer Cell  2002; 1:299-305; PMID:12086841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Biotechniques 2005;  39:227-37; PMID:16116796; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nature 2013; 496:494- 7; PMID:23594742; http://dx.doi.org/10.1038/ nature11992 45.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Mol Biol 1987; 196:261-82;  PMID:3656447; http://dx.doi.org/10.1016/0022- 2836(87)90689-9 49.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Genet 2009; 41:1350-3;  PMID:19881528; http://dx.doi.org/10.1038/ng.471 51.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome Res 2010; 20:320- 31; PMID:20133333; http://dx.doi.org/10.1101/ gr.101907.109 52.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
PLoS One 2011; 6:e18844; PMID:21526191;  http://dx.doi.org/10.1371/journal.pone.0018844 54.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Hum Mol Genet  2011; 20:670-80; PMID:21112978; http://dx.doi.org/10.1093/hmg/ddq513 55.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nature 2009; 462:315-22; PMID:19829295;  http://dx.doi.org/10.1038/nature08514 56.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Cell Sci Suppl 1995; 19:37-9; PMID:8655645; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome Res 2012; 22:2043- 53; PMID:22593555; http://dx.doi.org/10.1101/ gr.134833.11129.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Clin Invest 2011; 121:1748- 52; PMID:21490393; http://dx.doi.org/10.1172/ JCI43169 30.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome Res  2011; 21:688-96; PMID:21467265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Neurosci 2008; 28:10576- 86; PMID:18923034; http://dx.doi.org/10.1523/JNEUROSCI.1786-08.2008 32.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Neurosci 2010; 13:1338-44; PMID:20975758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Mutat Res 2009; 667:82-97;  PMID:19026668; http://dx.doi.org/10.1016/j.mrfm- mm.2008.10.011 34.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Neurosci 2011; 31:7951-9;  PMID:21632916; http://dx.doi.org/10.1523/ JNEUROSCI.0169-11.2011 35.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Am J Hum Genet 2008; 82:696-711;  PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nucleic Acids Res 2012;  40:e79; PMID:22344695; http://dx.doi.org/10.1093/ nar/gks150 38.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Epigenetics 2012; 7:421-8; PMID:22415013;  http://dx.doi.org/10.4161/epi.19565 39.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Dev Dyn  2005; 233:1509-16; PMID:15937923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genetics 2009; 182:747-55;  PMID:19433629; http://dx.doi.org/10.1534/genet- ics.109.102079 41.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Cell 2012; 148:816-31; PMID:22341451;  http://dx.doi.org/10.1016/j.cell.2011.12.035 43.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
BMC Genomics 2013; 14:11; PMID:23324053; http://dx.doi.org/10.1186/1471-2164-14-1113.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Cell Cycle  2006; 5:573-7; PMID:16582610; http://dx.doi.org/10.4161/cc.5.6.2550 15.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Biotechnol 2006; 24:73-5;  PMID:16327811; http://dx.doi.org/10.1038/nbt1169 16.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Rev Genet 2007; 8:353-67; PMID:17440532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Methods Cell Biol 2011; 104:327-39;  PMID:21924171; http://dx.doi.org/10.1016/B978-0- 12-374814-0.00018-5 18.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Prog Mol Biol T ransl Sci 2011; 101:193-218;  PMID:21507352; http://dx.doi.org/10.1016/B978-0- 12-387685-0.00005-6 19.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Cell 2013; 153:773- 84; PMID:23663777; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Dev Genes Evol 2004; 214:412-7;  PMID:15309635; http://dx.doi.org/10.1007/s00427- 004-0418-0 22.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Genet 1999; 23:139-40;  PMID:10508504; http://dx.doi.org/10.1038/13767 23.,Non-OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome  Biol 2012; 13:R65; PMID:22830626; http://dx.doi.org/10.1186/gb-2012-13-7-r65 25.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nat Rev Genet  2010; 11:191-203; PMID:20125086; http://dx.doi.org/10.1038/nrg2732 26.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
PLoS Genet  2011; 7:e1002228; PMID:21852959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Cell 2011; 144:439- 52; PMID:21295703; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Nucleic Acids Res  2012; 40(Database issue):D1245-9; PMID:22140101;  http://dx.doi.org/10.1093/nar/gkr1193 65.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Methods 2009; 48:226-32; PMID:19442738;  http://dx.doi.org/10.1016/j.ymeth.2009.05.00362.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Bioinformatics 2011; 27:1571-2; PMID:21493656;  http://dx.doi.org/10.1093/bioinformatics/btr167 63.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Genome Biol 2012;  13:R87; PMID:23034086; http://dx.doi.org/10.1186/ gb-2012-13-10-r8759.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Biochim Biophys Acta 2012; 1819:1217- 27; PMID:23124110; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
Chem Soc Rev 2012; 41:6916- 30; PMID:22842880; http://dx.doi.org/10.1039/ c2cs35104h 61.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
J Biomed Biotechnol 2012;  2012:741542; PMID:23193365; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/5a/epi-8-979.PMC3883775.pdf
"In this issue of Epigenetics Barbara P r attner Landes Bioscience; s an d iego, CA U sA Correspondence to: Barbara P Rattner; Email: barbara@landesbioscience.com Submitted: 07/23/13; Accepted: 07/23/13http://dx.doi.org/10.4161/epi.25863Central to these pathways are epigenetic  enzymes, which have recently emerged as possible new drug targets for multiple cancers.",Non-OADS,/arxiv_data1/oa_pdf/e2/e0/epi-8-773.PMC3883778.pdf
"Epigenetics 8:8, 778–784; August 2013; © 2013 Landes Bioscience Point-of-Vi Ew 778 Epigenetics  V olume 8 i ssue 8Keywords:  muscle enhancers, transcrip - tional enhancers, ChIP-seq, skeletal  muscle, differentiation, transcription, MyoD1, myogenesis Submitted: 05/15/13Revised: 06/10/13Accepted: 06/18/13http://dx.doi.org/10.4161/epi.25441 *Correspondence to: Roy Blum;   Email: Roy.Blum@nyumc.orgMyoD1 is a key regulator that  orchestrates skeletal muscle dif - ferentiation through the regulation of gene expression.",Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 2013; 152:895-908; PMID:23375746; http://dx.doi.org/10.1016/j.cell.2012.12.041 23.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Immunity 2010; 32:317-28; PMID:20206554; http://dx.doi.org/10.1016/j.immuni.2010.02.008 24.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Genet 2012; 44:89-93; PMID:22138689; http://dx.doi.org/10.1038/ng.1006 25.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genome Res 2010; 20:381-92; PMID:20075146; http://dx.doi.org/10.1101/gr.098657.109 26.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 2010; 143:156-69; PMID:20887899; http://dx.doi.org/10.1016/j.cell.2010.09.006 27.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2009; 23:2824-38; PMID:20008934; http://dx.doi.org/10.1101/gad.1861209 28.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 2012; 151:981-93; PMID:23178119; http://dx.doi.org/10.1016/j.cell.2012.09.044 29.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 2013; 152:157-71; PMID:23332752; http://dx.doi.org/10.1016/j.cell.2012.12.018 30.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2011; 470:279-83; PMID:21160473; http://dx.doi.org/10.1038/nature09692 31.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genome Res 2012; 22:2043-53; PMID:22593555; http://dx.doi.org/10.1101/gr.134833.111 32.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2011; 25:2227-41; PMID:22056668; http://dx.doi.org/10.1101/gad.176826.111 34.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2011; 25:2453-64; PMID:22085726; http://dx.doi.org/10.1101/gad.176008.111 35.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Development 2005; 132:2685-95; PMID:15930108; http://dx.doi.org/10.1242/dev.018747.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell Stem Cell 2009; 4:80-93; PMID:19128795; http://dx.doi.org/10.1016/j.stem.2008.11.011 8.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Science 1998; 281:60-3; PMID:9679020; http://dx.doi.org/10.1126/science.281.5373.60 10.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell Res 2012; 22:490-503; PMID:22270183; http://dx.doi.org/10.1038/cr.2012.15 11.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Science 2012; 336:736-9; PMID:22499810; http://dx.doi.org/10.1126/sci - ence.1217277 12.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2005; 434:857-63; PMID:15829955; http://dx.doi.org/10.1038/nature03467 13.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Am J Hum Genet 2005; 76:8-32; PMID:15549674; http://dx.doi.org/10.1086/426833 14.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2009; 461:199-205; PMID:19741700; http://dx.doi.org/10.1038/nature08451 15.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
"Annu Rev Genomics Hum Genet 2010; 11:1-23; PMID:20438361; http://dx.doi.org/10.1146/annurev-genom-082509-141651 16.  v an den Boogaard M, Wong LY, Tessadori F, Bakker  ML, Dreizehnter LK, Wakker V, et al.",OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Clin Invest 2012; 122:2519-30; PMID:22706305; http://dx.doi.org/10.1172/JCI62613 17.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genome Res 2012; 22:446-55; PMID:22234890; http://dx.doi.org/10.1101/gr.128652.111 18.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Genet 2007; 39:311-8; PMID:17277777; http://dx.doi.org/10.1038/ng1966 19.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genome Res 2011; 21:1273-83; PMID:21632746; http://dx.doi.org/10.1101/gr.122382.111 20.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2010; 465:182-7; PMID:20393465; http://dx.doi.org/10.1038/nature09033 21.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
"PLoS Biol 2010; 8:e1000384; PMID:20485488; http://dx.doi.org/10.1371/journal.pbio.1000384augment expression of genes essential for  specifying the muscle lineage, a key role for this factor appears to be its ability to bind to enhancers.",Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Rev Genet 2011; 12:283-93; PMID:21358745; http://dx.doi.org/10.1038/nrg2957 2.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 2011; 144:327-39; PMID:21295696; http://dx.doi.org/10.1016/j.cell.2011.01.024 3.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Rev Genet 2012; 13:613-26; PMID:22868264; http://dx.doi.org/10.1038/nrg3207 4.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 2013; 49:825-37; PMID:23473601; http://dx.doi.org/10.1016/j.molcel.2013.01.038 5.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2009; 459:108-12; PMID:19295514; http://dx.doi.org/10.1038/nature07829 6.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nature 2009; 457:854-8; PMID:19212405; http://dx.doi.org/10.1038/nature07730 ©2013 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Biol Chem 2002; 277:40043-54; PMID:12171923; http://dx.doi.org/10.1074/jbc.M205494200 66.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nucleic Acids Res 1999; 27:3752-61; PMID:10471746; http://dx.doi.org/10.1093/nar/27.18.3752 67.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 1992; 68:507-19; PMID:1310896; http://dx.doi.org/10.1016/0092-8674(92)90187-H 68.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2005; 19:1715-22; PMID:16024660; http://dx.doi.org/10.1101/gad.1318305 69.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 1997; 1:35-45; PMID:9659901; http://dx.doi.org/10.1016/S1097-2765(00)80005-2 70.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Struct Mol Biol 2007; 14:1150-6; PMID:18026121; http://dx.doi.org/10.1038/nsmb1316 71.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Genet 2004; 36:738-43; PMID:15208625; http://dx.doi.org/10.1038/ng1378 72.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
EMBO J 2006; 25:502-11; PMID:16437161; http://dx.doi.org/10.1038/sj.emboj.7600958 73.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Biol Chem 1996; 271:9009-13; PMID:8621548; http://dx.doi.org/10.1074/jbc.271.15.9009 74.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 1999; 4:725-34; PMID:10619020; http://dx.doi.org/10.1016/S1097-2765(00)80383-4 75.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Cell Biol 2011; 194:551-65; PMID:21859860; http://dx.doi.org/10.1083/jcb.201010090 76.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Biol Chem 2000; 275:18418-23; PMID:10748198; http://dx.doi.org/10.1074/jbc.M910211199 78.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 2007; 28:291-303; PMID:17964267; http://dx.doi.org/10.1016/j.mol - cel.2007.10.00250.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 1988; 2(12B):1779-90; PMID:3240859; http://dx.doi.org/10.1101/gad.2.12b.1779 52.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nucleic Acids Res 1990; 18:6239-46; PMID:2243772; http://dx.doi.org/10.1093/nar/18.21.6239 53.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2008; 22:265-76; PMID:18198342; http://dx.doi.org/10.1101/gad.442408 57.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Dev Biol 2004; 269:595-608; PMID:15110722; http://dx.doi.org/10.1016/j.ydbio.2004.02.013 58.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Eur J Biochem 2001; 268:948-57; PMID:11179961; http://dx.doi.org/10.1046/j.1432-1327.2001.01954.x 59.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
PLoS One 2008; 3:e2184; PMID:18478108; http://dx.doi.org/10.1371/journal.pone.0002184 61.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2012; 26:2763-79; PMID:23249738; http://dx.doi.org/10.1101/gad.200113.112 62.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Rev Genet 2008; 9:689-98; PMID:18663365; http://dx.doi.org/10.1038/nrg2413 63.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genome Res 2006; 16:855-63; PMID:16769978; http://dx.doi.org/10.1101/gr.4717506 64.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Biotechnol 2010; 28:511-5; PMID:20436464; http://dx.doi.org/10.1038/nbt.162136.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 1993; 75:1351-9; PMID:8269513; http://dx.doi.org/10.1016/0092-8674(93)90621-V 37.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 1987; 51:987-1000; PMID:3690668; http://dx.doi.org/10.1016/0092-8674(87)90585-X 38.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 1991; 66:305-15; PMID:1649701; http://dx.doi.org/10.1016/0092-8674(91)90620-E 40.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 2002; 9:587-600; PMID:11931766; http://dx.doi.org/10.1016/S1097-2765(02)00481-1 41.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Cell 1989; 58:537-44; PMID:2503252; http://dx.doi.org/10.1016/0092-8674(89)90434-0 42.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Science 1990; 250:1104-10; PMID:2174572; http://dx.doi.org/10.1126/science.2174572 43.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 2005; 19:553-69; PMID:15706034; http://dx.doi.org/10.1101/gad.1281105 44.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Dev Cell 2010; 18:662-74; PMID:20412780; http://dx.doi.org/10.1016/j.dev - cel.2010.02.014 45.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Science 1992; 256:1027-30; PMID:1317057; http://dx.doi.org/10.1126/sci - ence.1317057 46.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Genes Dev 1993; 7(7A):1277-89; PMID:8391506; http://dx.doi.org/10.1101/gad.7.7a.1277 49.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Science 1993; 261:215-8; PMID:8392225; http://dx.doi.org/10.1126/science.8392225 ©2013 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nat Genet 2001; 27:195-200; PMID:11175789; http://dx.doi.org/10.1038/84839 89.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Cell Biol 2002; 157:137-48; PMID:11927606; http://dx.doi.org/10.1083/jcb.200108071 90.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell 2007; 28:200-13; PMID:17964260; http://dx.doi.org/10.1016/j.mol - cel.2007.08.02184.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Annu Rev Cell Dev Biol 1998; 14:167-96; PMID:9891782; http://dx.doi.org/10.1146/annurev.cellbio.14.1.167 85.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
J Cell Biol 2009; 187:991-1005; PMID:20026657; http://dx.doi.org/10.1083/jcb.200907037 86.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell Biol 2000; 20:3951-64; PMID:10805738; http://dx.doi.org/10.1128/MCB.20.11.3951-3964.2000 87.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Mol Cell Biol 2000; 20:8983-95; PMID:11073997; http://dx.doi.org/10.1128/MCB.20.23.8983-8995.200079.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Physiol Rev 2004; 84:209-38; PMID:14715915; http://dx.doi.org/10.1152/physrev.00019.2003 80.,Non-OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
EMBO J 2005; 24:974-84; PMID:15719023; http://dx.doi.org/10.1038/sj.emboj.7600528 81.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
Nucleic Acids Res 1999; 27:2646-54; PMID:10373581; http://dx.doi.org/10.1093/nar/27.13.2646 82.,OADS,/arxiv_data1/oa_pdf/de/f2/epi-8-778.PMC3883780.pdf
"However, some tumor cells are able to  *Correspondence to: Nagi G Ayad; Email: nayad@med.miami.edu Submitted: 05/08/13; Revised: 06/13/13; Accepted: 06/18/13http://dx.doi.org/10.4161/epi.25440Glioblastoma multiforme (GBM) is the most common malignant  adult brain tumor.",Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
23-26 miR10b controls GBM cell and stem cell cycle traverse  and is correlated with poor prognosis (http://tcga-data.nci.nih.gov/tcga).,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Neurosurg  2001; 95:190-8; PMID:11780887; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2011; 146:209-21; PMID:21737130; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Proc Natl Acad Sci U S A 2012; 109:E2998- 3007; PMID:23045694; http://dx.doi.org/10.1073/ pnas.12158991095.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Science 2012; 338:1080-4; PMID:23087000;  http://dx.doi.org/10.1126/science.1226929 6.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
PLoS One  2011; 6:e24454; PMID:21931722; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nature  2012; 488:522-6; PMID:22854781; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
PLoS One 2013; 8:e53823;  PMID:23405074; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Biol Chem 2012; 287:27396-406;  PMID:22736761; http://dx.doi.org/10.1074/jbc.M112.359109 42.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer  Res 2009; 69:9211-8; PMID:19934320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Neuropathol Appl Neurobiol 2011; 37:381-94;  PMID:20946108; http://dx.doi.org/10.1111/j.1365- 2990.2010.01132.x 45.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nat Rev Cancer 2012; 12:599-612;  PMID:22898539; http://dx.doi.org/10.1038/nrc3343 46.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Mol Cell 2012; 48:572-86; PMID:23063525;  http://dx.doi.org/10.1016/j.molcel.2012.09.004 47.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Science  2010; 329:689-93; PMID:20616235; http://dx.doi.org/10.1126/science.1192002 48.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Genes Dev 2010; 24:2615- 20; PMID:21123648; http://dx.doi.org/10.1101/ gad.1983810 49.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Res 2011; 71:6320-6; PMID:21862635;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1021 50.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Hepatology  2011; 54:1679-89; PMID:21769904; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nature 2012; 492:108-12; PMID:23051747; http://dx.doi.org/10.1038/ nature11606 52.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Biochem Biophys  Res Commun 2005; 334:1351-8; PMID:16039986;  http://dx.doi.org/10.1016/j.bbrc.2005.07.030 25.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Res 2011; 71:3563-72;  PMID:21471404; http://dx.doi.org/10.1158/0008- 5472.CAN-10-3568 26.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Neurooncol  2013; 112:153-63; PMID:23307328; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell  2011; 147:344-57; PMID:22000013; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2011; 147:370-81; PMID:22000015; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2011; 147:382- 95; PMID:22000016; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
FASEB J 2013; 27:907-19; PMID:23180826;  http://dx.doi.org/10.1096/fj.12-220905 31.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Bioinformation 2012;  8:731-3; PMID:23055620; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2010; 142:409- 19; PMID:20673990; http://dx.doi.org/10.1016/j.cell.2010.06.040 33.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nat Biotechnol 2011; 29:742-9;  PMID:21804560; http://dx.doi.org/10.1038/nbt.1914 35.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nat Rev Genet  2009; 10:155-9; PMID:19188922; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Cell Biochem 2012; 113:1868- 74; PMID:22234798; http://dx.doi.org/10.1002/jcb.240558.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nature 2012; 488:527-30; PMID:22854777;  http://dx.doi.org/10.1038/nature11344 9.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nature  2008; 455:1061-8; PMID:18772890; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Science  2012; 337:1231-5; PMID:22837387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Science 2008;  321:1807-12; PMID:18772396; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
N Engl J Med 2009; 360:765-73; PMID:19228619;  http://dx.doi.org/10.1056/NEJMoa0808710 13.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2011; 144:864- 73; PMID:21414479; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Adv Genet 2010; 70:277-308; PMID:20920752;  http://dx.doi.org/10.1016/B978-0-12-380866- 0.60010-1 15.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nature 2012; 482:226-31; PMID:22286061; http://dx.doi.org/10.1038/nature10833 16.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2011; 144:646-74;  PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 17.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Cell 2010; 17:98-110; PMID:20129251;  http://dx.doi.org/10.1016/j.ccr.2009.12.020 18.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nat Rev Neurol  2011; 7:439-50; PMID:21727940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Sci  2010; 101:1331-6; PMID:20384628; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Lett 2012; In press; PMID:22531315;  http://dx.doi.org/10.1016/j.canlet.2012.04.008 21.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cell 2012; 150:12- 27; PMID:22770212; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Cell  2012; 22:425-37; PMID:23079654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Cancer Res 2005; 65:6029-33; PMID:16024602;  http://dx.doi.org/10.1158/0008-5472.CAN-05-0137,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Multivariate Anal 2004; 90:196-212; http://dx.doi.org/10.1016/j.jmva.2004.02.009 68.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Bioinformatics  2008; 24:1063-9; PMID:18310054; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Mol Cell 2013; 49:202-12; PMID:23352241;  http://dx.doi.org/10.1016/j.molcel.2012.12.020 72.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
PLoS Med 2005; 2:e124; PMID:16060722;  http://dx.doi.org/10.1371/journal.pmed.0020124 73.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Nat Genet 2009; 41:149- 55; PMID:19174838; http://dx.doi.org/10.1038/ ng.29559.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Neurotoxicology 2013; 35:1-14; PMID:23261424;  http://dx.doi.org/10.1016/j.neuro.2012.11.001 60.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Front  Neurosci 2012; 6:59; PMID:22586361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Bioinformatics 2005;  21(Suppl 1):i159-68; PMID:15961453; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Comput Methods Programs Biomed  2011; 104:e112-21; PMID:21708413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Comput  Biol 2000; 7:601-20; PMID:11108481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Science 2008; 322:1695-9; PMID:19008416;  http://dx.doi.org/10.1126/science.1165395 54.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Mol Aspects Med 2013; 34:849-62; PMID:22771539;  http://dx.doi.org/10.1016/j.mam.2012.06.007 56.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
Eur Neuropsychopharmacol 2008; 18:157-69;  PMID:17683917; http://dx.doi.org/10.1016/j.euro- neuro.2007.06.003 57.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
J Clin Bioinforma 2012; 2:2;  PMID:22297051; http://dx.doi.org/10.1186/2043-9113-2-2.,OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
PLoS One 2011; 6:e14681; PMID:21358821; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/b1/epi-8-785.PMC3883781.pdf
"Epigenetics 8:8, 864–872; August 2013; © 2013 Landes Bioscience REsEAR ch p ApER 864 Epigenetics Volume 8 Issue 8*Correspondence to: Norberto D Iusem; Email: norbius@fbmc.fcen.uba.ar Submitted: 02/08/13; Revised: 06/20/13; Accepted: 06/24/13http://dx.doi.org/10.4161/epi.25524Introduction Epigenetic research has generated a fair amount of information  on certain plant models, such as Arabidopsis ,1,2 rice,3 and maize.4  Eukaryotic DNA methylation is one of the most studied epi - genetic processes as it results in a direct and heritable covalent modification triggered by external stimuli.",Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
This computational tool is known as a “moving average” (http://lorien.ncl.ac.uk/ming/filter/filmav.htm).,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
"14 Our studies  centered on the tomato plant ( Solanum lycopersicum ), an edible  plant crop (http://mips.helmholtz-muenchen.de/plant/tomato/index.jsp) of great economic importance with a genome 15 that  is almost 10 times larger than that of Arabidopsis and with very few epigenetics surveys.",Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
The moving average  statistical tool (http://lorien.ncl.ac.uk/ming/filter/filmav.htm) was employed.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
"To analyze the methylation data,  we used the Kismeth software 63 (http://katahdin.mssm.edu/kis - meth/revpage.pl), which allows visualization of the proportion of clones (epialleles) showing methylation at every particular site.",OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
"2 ), we employed the moving  average statistical tool (http://lorien.ncl.ac.uk/ming/filter/fil - mav.htm), which calculates the mean in a recursive fashion, that is, depending on a previously calculated value.",OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
"The primers were designed using the Beacons Designer software (http://www.premierbiosoft.com/molecular_beacons/index.html) to have the highest possible con - tent of T residues, especially at the 3' ends, to favor the selective amplification of bisulfite-converted molecules.",Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Epigenetics 2009; 4:557-63; PMID:19934651;  http://dx.doi.org/10.4161/epi.4.8.10347 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
J Genet Genomics 2010; 37:1-12; PMID:20171573; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Ann Bot 2007; 100:205-17; PMID:17576658;  http://dx.doi.org/10.1093/aob/mcm110 4.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Cell  2009; 21:1053-69; PMID:19376930; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Dev Growth Differ 2010; 52:555-66;  PMID:20646028; http://dx.doi.org/10.1111/j.1440- 169X.2010.01192.x 6.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
FEBS Lett 2011; 585:2008-15; PMID:20727353;  http://dx.doi.org/10.1016/j.febslet.2010.08.017 7.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Proc Natl Acad Sci U S  A 1996; 93:8449-54; PMID:8710891; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Cell 2012; 151:167- 80; PMID:23021223; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Nature 2002; 416:556- 60; PMID:11898023; http://dx.doi.org/10.1038/ nature73110.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Curr Biol 2002; 12:1138-44;  PMID:12121623; http://dx.doi.org/10.1016/S0960- 9822(02)00925-9 11.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Science 2008; 320:489-92; PMID:18436779; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Science 2010; 330:622-7; PMID:21030646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
EMBO J 2009; 28:1078- 86; PMID:19262562; http://dx.doi.org/10.1038/emboj.2009.59 14.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
T rends Plant Sci  1999; 4:26-30; PMID:10234267; http://dx.doi.org/10.1016/S1360-1385(98)01361-2 15.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Nature 2012; 485:635-41; PMID:22660326; http://dx.doi.org/10.1038/nature11119 16.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
BMC Plant  Biol 2011; 11:94; PMID:21599976; http://dx.doi.org/10.1186/1471-2229-11-9418.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Nat Biotechnol  2013; 31:154-9; PMID:23354102; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Physiol 2008; 148:6- 24; PMID:18772351; http://dx.doi.org/10.1104/ pp.108.120725 20.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Gene  2006; 378:74-83; PMID:16822623; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Sci 2001; 161:739- 46; http://dx.doi.org/10.1016/S0168-9452(01)00464- 2 22.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Planta  2008; 227:1213-9; PMID:18270732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Biochem Biophys Res Commun 2007; 352:831- 5; PMID:17157822; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
PLoS  One 2012; 7:e41008; PMID:22899993; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
BMC Genomics 2012; 13:300;  PMID:22747568; http://dx.doi.org/10.1186/1471- 2164-13-300 55.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
J Exp Bot 2011; 62:1951- 60; PMID:21193578; http://dx.doi.org/10.1093/jxb/ erq391 56.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Cell 2013; 152:352-64; PMID:23313553; http://dx.doi.org/10.1016/j.cell.2012.10.054 57.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Nature 2007; 447:418-24; PMID:17522675;  http://dx.doi.org/10.1038/nature05917 58.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Biochim Biophys Acta 2007;  1769:276-86; PMID:17341434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Curr Biol  2012; 22:R54-6; PMID:22280908; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Mol Plant 2010; 3:594-602; PMID:20410255; http://dx.doi.org/10.1093/mp/ ssq014 61.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Am J Bot 2001; 88:1888-902;  PMID:21669622; http://dx.doi.org/10.2307/3558365 62.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
BMC Res Notes 2008; 1:54;  PMID:18710507; http://dx.doi.org/10.1186/1756- 0500-1-54 63.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Methods 2010; 6:11;  PMID:20380723; http://dx.doi.org/10.1186/1746- 4811-6-11 65.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Environ Exp Bot  2004; 51:281-8; http://dx.doi.org/10.1016/j.envexp- bot.2003.11.00741.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Cell 2006; 126:1189-201;  PMID:16949657; http://dx.doi.org/10.1016/j.cell.2006.08.003 42.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Mol Gen Genet  1997; 253:581-8; PMID:9065691; http://dx.doi.org/10.1007/s004380050360 45.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Epigenetics 2011; 6:344-54; PMID:21150311; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
BMC Plant Biol 2012; 12:51;  PMID:22512782; http://dx.doi.org/10.1186/1471-2229-12-51 47.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Curr Biol  2007; 17:379-84; PMID:17239600; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Genes Dev  2007; 21:267-77; PMID:17242155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Science 2001; 292:2077-80; PMID:11349138; http://dx.doi.org/10.1126/sci- ence.1059745 51.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Cell Physiol 2012; 53:766-84;  PMID:22302712; http://dx.doi.org/10.1093/pcp/ pcs008 52.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Plant Cell Physiol 2011; 52:149-61; PMID:21097475;  http://dx.doi.org/10.1093/pcp/pcq182 53.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Physiol Plant  2006; 127:111-8; http://dx.doi.org/10.1111/j.1399- 3054.2006.00664.x 26.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Genetica  2009; 136:13-25; PMID:18636230; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Mol Gen Genet 1998;  258:1-8; PMID:9613566; http://dx.doi.org/10.1007/s004380050700 28.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Ann Bot 2012; 110:205-12; PMID:22730024;  http://dx.doi.org/10.1093/aob/mcs136 29.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Curr Opin Plant Biol 2002; 5:101-6;  PMID:11856603; http://dx.doi.org/10.1016/S1369- 5266(02)00233-9 30.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Environ Mol Mutagen 2008; 49:61- 72; PMID:17948278; http://dx.doi.org/10.1002/ em.20347 31.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Curr Opin Plant Biol  2009; 12:133-9; PMID:19179104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
PLoS One 2010; 5:e9514; PMID:20209086; http://dx.doi.org/10.1371/ journal.pone.0009514 34.,Non-OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Cell 2007; 128:693-705; PMID:17320507; http://dx.doi.org/10.1016/j.cell.2007.02.005 35.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Nat Protoc 2006; 1:2353-64; PMID:17406479; http://dx.doi.org/10.1038/ nprot.2006.324 36.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Bioinformatics 2012; 28:i163-71;  PMID:22689757; http://dx.doi.org/10.1093/bioinfor- matics/bts231 38.,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
Proc Natl Acad Sci U S A 2009; 106:1660- 5; PMID:19164525; http://dx.doi.org/10.1073/ pnas.0809294106,OADS,/arxiv_data1/oa_pdf/bb/ca/epi-8-864.PMC3883789.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003311 .,Non-OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
34:426 – 444. http://dx.doi.org/10.1111/ j.1574-6976.2009.00204.x .,Non-OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
Com-mun 4:1809. http://dx.doi.org/10.1038/ncomms2789 .,OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
http://dx.doi.org/10.1038/nm.3145 .,OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
http://dx.doi.org/10.1126/ecosal.17 .,Non-OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
2:0008. http://dx.doi.org/10.1038/msb41000500008 .,Non-OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
http://dx.doi.org/10.1093/nar/28.1.97 .,Non-OADS,/arxiv_data1/oa_pdf/19/ff/mBio.00944-13.PMC3884056.pdf
http://dx.doi.org/10.1101/cshperspect.a006833 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/journal.pone.0036620 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1074/jbc.M113.497131 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/journal.pone.0035383 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
"http://dx.doi.org/10.1371/journal.ppat.1002370 .24.Langevin C, Andreoletti O, Le Dur A, Laude H, Beringue V. 2011.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/journal.ppat.1000859 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/ journal.pone.0001419 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/journal.pone.0041210 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002835 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
3:741. http://dx.doi.org/10.1038/ncomms1730 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000421 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/ journal.pone.0013152 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/journal.pone.0069632 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
http://dx.doi.org/10.1371/ journal.ppat.1001217 .,Non-OADS,/arxiv_data1/oa_pdf/19/c1/mBio.00829-13.PMC3884057.pdf
"In recent years, submission of scientiﬁc information for publica- tion when the information results from “dual use research of concern” (DURC) has led to a vexing problem for journal editors.DURC was deﬁned by the National Science Advisory Board onBiosecurity (NSABB) as “research that, based on current under-standing, can be reasonably anticipated to provide knowledge,products, or technologies that could be directly misapplied byothers to pose a threat to public health and safety, agriculturalcrops and other plants, animals, the environment, or materiel”( http://oba.od.nih.gov/biosecurity ).",Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
"Redaction refers to the results of an action, “to select or adapt (asby obscuring or removing sensitive information) for publicationor release” ( http://www.merriam-webster.com/dictionary ).",Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
207: 207. http://dx.doi.org/10.1093/infdis/jis528 .,Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
http://dx.doi.org/10.1093/infdis/jit449 .,Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
http://dx.doi.org/10.1093/infdis/jit450 .,Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
http://dx.doi.org/ 10.1093/infdis/jit529 .,Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
Science 342: 178. http://dx.doi.org/10.1126/ science.342.6155.178 .,Non-OADS,/arxiv_data1/oa_pdf/36/f6/mBio.00991-13.PMC3884058.pdf
13:148. http://dx.doi.org/10.1186/gb4005 .,Non-OADS,/arxiv_data1/oa_pdf/48/5c/mBio.00846-13.PMC3884059.pdf
http://dx.doi.org/10.1128/ mBio.00240-10 .,Non-OADS,/arxiv_data1/oa_pdf/48/5c/mBio.00846-13.PMC3884059.pdf
Strain to phylummapping was performed according to the NCBI hierarchy (a sum-mary sheet for this hierarchy can be found on the NCBI taxonomysite ftp://ftp.ncbi.nlm.nih.gov/pub/taxonomy/) .,OADS,/arxiv_data1/oa_pdf/4e/65/mBio.00744-13.PMC3884060.pdf
"All Gene Ontology(GO) terms accompanying each of the (full-length) proteins inUniProt were collected, then we removed GO terms associatedwith any non-DUF domains according to the (largely manuallycurated) Pfam2GO mapping on the Gene Ontology Consortiumwebsite ( http://www.geneontology.org/external2go/pfam2go ) (28).",OADS,/arxiv_data1/oa_pdf/4e/65/mBio.00744-13.PMC3884060.pdf
BMCGenomics 11:470. http://dx.doi.org/10.1186/1471-2164-11-470 .,OADS,/arxiv_data1/oa_pdf/4e/65/mBio.00744-13.PMC3884060.pdf
2:2006.0008. http://dx.doi.org/10.1038/msb4100050 .,Non-OADS,/arxiv_data1/oa_pdf/4e/65/mBio.00744-13.PMC3884060.pdf
http://dx.doi.org/10.1093/infdis/jit435 .,Non-OADS,/arxiv_data1/oa_pdf/64/14/mBio.00986-13.PMC3884061.pdf
http://dx.doi.org/10.1128/mBio.00379-13 .,Non-OADS,/arxiv_data1/oa_pdf/23/22/mBio.00769-13.PMC3884062.pdf
http://dx.doi.org/10.1128/mBio.00217-13 .,Non-OADS,/arxiv_data1/oa_pdf/23/22/mBio.00769-13.PMC3884062.pdf
12:210. http://dx.doi.org/ 10.1186/1471-2180-12-210 .,Non-OADS,/arxiv_data1/oa_pdf/23/22/mBio.00769-13.PMC3884062.pdf
BMC Bioinformatics 13:134. http://dx.doi.org/ 10.1186/1471-2105-13-134 .,OADS,/arxiv_data1/oa_pdf/23/22/mBio.00769-13.PMC3884062.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/28/b6/cjc-33-02-068.PMC3884064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 877–895International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  877RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S5166 5Pathogenesis and management of postprandial  hyperglycemia: role of incretin-based therapies John Gerich Department of Medicine, endocrine/ Metabolism Division, University  of Rochester School of Medicine,   Rochester, NY, USA Correspondence: John Gerich   403 woodcrest Road, wayne,   PA 19087, USA   Tel +1 585 752 2860   Fax +1 610 293 9588   email johngerich@compuserve.co mAbstract:  Postprandial plasma glucose concentrations are an important contributor to  glycemic control.",Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
"Available from: http://www.idf.org/webdata/docs/ Guideline_PMG_final.pd f. Accessed October 26, 2012.",Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
Available from: http://www.uptodate.com/ contents/ management-of-persistent-hyperglycemia-in-type-2-diabetes- mellitus?sourc e=search_result&search =management +of+persistent +hy perglycemia +in+type+2+diabetes&selectedTitle =1%7E150.,Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
"Aailable  from: http://www.fda.gov/downloads/Drugs/ GuidanceCompliance RegulatoryInformation /%20Guidances/UCM071627.pd f. Accessed  October 26, 2012.",Non-OADS,/arxiv_data1/oa_pdf/17/69/ijgm-6-877.PMC3884108.pdf
"Recently, genetic alterations in squamous cell lung cancer  (SQCLC) have been studied extensively2 and are attracting  attention because mutations, which have a critical role in the  development of SQCLC and are frequently found in patients,  can become targets of anti-cancer chemotherapy.REVIEWhttp://dx.doi.org/10.4046/trd.2013.75.6.231 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:231-235 231Address for correspondence: Cheol Hyeon Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/99/8d/trd-75-231.PMC3884109.pdf
"29, 2013 Revised:  Aug. 6, 2013 Accepted:  Aug. 12, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/99/8d/trd-75-231.PMC3884109.pdf
Druggable targets of squamous cell lung cancer http://dx.doi.org/10.4046/trd.2013.75.6.231  233 www.e-trd.orgsubunit (p110 a).,Non-OADS,/arxiv_data1/oa_pdf/99/8d/trd-75-231.PMC3884109.pdf
Druggable targets of squamous cell lung cancer http://dx.doi.org/10.4046/trd.2013.75.6.231  235 www.e-trd.orgNCT00775307).,Non-OADS,/arxiv_data1/oa_pdf/99/8d/trd-75-231.PMC3884109.pdf
"Although the preva - lence of ALK-positive lung cancer varies between 2% and  13% according to several previous studies, this is attributable  to the pre-selections of clinical and demographic character -REVIEW http://dx.doi.org/10.4046/trd.2013.75.6.236 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:236-237 236Address for correspondence: Chang Min Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6d/d0/trd-75-236.PMC3884110.pdf
"3, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/6d/d0/trd-75-236.PMC3884110.pdf
ALK and ROS1  rearranged lung cancer http://dx.doi.org/10.4046/trd.2013.75.6.236  237 www.e-trd.org6 and 42 weeks.,Non-OADS,/arxiv_data1/oa_pdf/6d/d0/trd-75-236.PMC3884110.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.6.238 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:238-243 238Address for correspondence: Tae Sun Shim, M.D., Ph.D. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, Korea Phone:  82-2-3010-3892, Fax: 82-2-3010-6968 E-mail: shimts@amc.seoul.kr Received:  Aug. 16, 2013 Revised:  Sep. 23, 2013 Accepted:  Oct. 17, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/trd-75-238.PMC3884111.pdf
"Changed diagnosis of notified as tuberculosis cases http://dx.doi.org/10.4046/trd.2013.75.6.238  239 www.e-trd.orgIntroduction Tuberculosis (TB) is caused by the Mycobacterium tuber - culosis  complex, which was first discovered in 1882 by Robert  Koch1.",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/trd-75-238.PMC3884111.pdf
Changed diagnosis of notified as tuberculosis cases http://dx.doi.org/10.4046/trd.2013.75.6.238  241 www.e-trd.orgresult of our study is that more than 10% of patients notified  as TB cases did not in fact have TB.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/trd-75-238.PMC3884111.pdf
Changed diagnosis of notified as tuberculosis cases http://dx.doi.org/10.4046/trd.2013.75.6.238  243 www.e-trd.orgmore difficult in instances of extrapulmonary TB than in pul - monary TB.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/trd-75-238.PMC3884111.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.6.244 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:244-249 244Address for correspondence: Seung Joon Kim, M.D., Ph.D. Division of Pulmonology, Department of Internal Medicine, Seoul St.  Mary’s Hospital, The Catholic University of Korea College of Medicine,  222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Phone:  82-2-2258-6063, Fax: 82-2-599-3589 E-mail: cmcksj@catholic.ac.kr *Chang Dong Yeo and Jin Woo Kim contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/37/d3/trd-75-244.PMC3884112.pdf
"29, 2013 Accepted:  Oct. 17, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/37/d3/trd-75-244.PMC3884112.pdf
Pentraxin-3 in pleural effusions http://dx.doi.org/10.4046/trd.2013.75.6.244  245 www.e-trd.orgPentraxin-3 (PTX3) is one of the long members of the  pentraxin superfamily.,Non-OADS,/arxiv_data1/oa_pdf/37/d3/trd-75-244.PMC3884112.pdf
Pentraxin-3 in pleural effusions http://dx.doi.org/10.4046/trd.2013.75.6.244  247 www.e-trd.org2.,Non-OADS,/arxiv_data1/oa_pdf/37/d3/trd-75-244.PMC3884112.pdf
Pentraxin-3 in pleural effusions http://dx.doi.org/10.4046/trd.2013.75.6.244  249 www.e-trd.org19.,Non-OADS,/arxiv_data1/oa_pdf/37/d3/trd-75-244.PMC3884112.pdf
"Giudice et al.2 reported a patient  with bronchial metastasis of uterine leiomyosarcoma who  developed progressive hemoptysis and died without proper CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.6.250 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:250-255 250Address for correspondence: Young Sik Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/58/56/trd-75-250.PMC3884113.pdf
"Division of Pulmonary and Critical Care Medicine, Department of  Internal Medicine, Seoul National University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 110-744, Korea Phone:  82-2-2072-7214, Fax: 82-2-762-9662 E-mail: mdyspark@gmail.com Received:  Aug. 2, 2013 Revised:  Aug. 23, 2013 Accepted:  Sep. 2, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/58/56/trd-75-250.PMC3884113.pdf
Interventional bronchoscopy as adjuvant treatment http://dx.doi.org/10.4046/trd.2013.75.6.250  251 www.e-trd.orgCase Report 1.,Non-OADS,/arxiv_data1/oa_pdf/58/56/trd-75-250.PMC3884113.pdf
Interventional bronchoscopy as adjuvant treatment http://dx.doi.org/10.4046/trd.2013.75.6.250  253 www.e-trd.orging cryoextraction.,Non-OADS,/arxiv_data1/oa_pdf/58/56/trd-75-250.PMC3884113.pdf
"Interventional bronchoscopy as adjuvant treatment http://dx.doi.org/10.4046/trd.2013.75.6.250  255 www.e-trd.orgTherefore, endoscopic management for endobronchial tu - mors should be considered in the treatment of endobronchial  metastasis, even in patients with advanced malignancies.",Non-OADS,/arxiv_data1/oa_pdf/58/56/trd-75-250.PMC3884113.pdf
"It is also used in CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.6.256 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:256-259 256Address for correspondence: Ji Young Kang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ff/91/trd-75-256.PMC3884114.pdf
"24, 2013 Accepted:  Sep. 16, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ff/91/trd-75-256.PMC3884114.pdf
Successful rechallenge with imatinib induced pneumonitis in CML http://dx.doi.org/10.4046/trd.2013.75.6.256  257 www.e-trd.orgCase Report A 43-year-old man was admitted to the hospital for 2 weeks  of dyspnea.,Non-OADS,/arxiv_data1/oa_pdf/ff/91/trd-75-256.PMC3884114.pdf
Successful rechallenge with imatinib induced pneumonitis in CML http://dx.doi.org/10.4046/trd.2013.75.6.256  259 www.e-trd.orgby exclusion of other infectious causes via microbiologic  and clinical studies.,Non-OADS,/arxiv_data1/oa_pdf/ff/91/trd-75-256.PMC3884114.pdf
"All rights reserved.Introduction Invasive aspergillosis is known to have an important cause CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.6.260 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:260-263 260Address for correspondence: So Young Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/96/61/trd-75-260.PMC3884115.pdf
"30, 2013 Revised:  Aug. 27, 2013 Accepted:  Sep. 10, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/96/61/trd-75-260.PMC3884115.pdf
"Pulmonary aspergillosis in an immunocompetent patient http://dx.doi.org/10.4046/trd.2013.75.6.260  261 www.e-trd.orgCase Report A 60-year-old man was admitted chiefly with shortness of  breath, pleural chest pain.",Non-OADS,/arxiv_data1/oa_pdf/96/61/trd-75-260.PMC3884115.pdf
"Pulmonary aspergillosis in an immunocompetent patient http://dx.doi.org/10.4046/trd.2013.75.6.260  263 www.e-trd.orgDiscussion Aspergillus  is widely distributed in the soil, and people  normally inhale hundreds of spores daily, although healthy in - dividuals are able to filter airborne fungi through the epithelial  mucociliary defense mechanism and resident phagocyte ac - tions3.",Non-OADS,/arxiv_data1/oa_pdf/96/61/trd-75-260.PMC3884115.pdf
"All rights reserved.Introduction There are about >5,000 species of mushrooms in the world; CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.6.264 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:264-268 264Address for correspondence: Cheol-Hong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ff/06/trd-75-264.PMC3884116.pdf
"12, 2013 Revised:  Aug. 14, 2013 Accepted:  Sep. 13, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ff/06/trd-75-264.PMC3884116.pdf
"Fatal respiratory failure by Podostroma cornu-damae  poisoning http://dx.doi.org/10.4046/trd.2013.75.6.264  265 www.e-trd.orgrhea, dry mouth, and hot flushes 3 hours after eating boiled  wild mushrooms.",Non-OADS,/arxiv_data1/oa_pdf/ff/06/trd-75-264.PMC3884116.pdf
"Fatal respiratory failure by Podostroma cornu-damae  poisoning http://dx.doi.org/10.4046/trd.2013.75.6.264  267 www.e-trd.orgmore aggravated as follows: WBC count, 120/ mL (ANC, 80/ mL); platelet count, 32,000/ mL; PT INR, 1.50; aPTT, 41.7 sec - onds; fibrin degradation product>20 mg/mL (reference, 0.0−5.0  mg/mL); plasma D-dimer, 4.95 mg/mL (reference, 0.0−0.5 mg/ mL); CRP , 250 mg/L; AST, 122 IU/L; AL T, 54 IU/L; total bili - rubin, 5.0 mg/dL; serum creatinine, 2.0 mg/dL; LDH, 500 IU/ L; CK, 4,997 IU/L; and serum myoglobin>1,000 ng/mL (refer - ence, 10−92 ng/mL).",Non-OADS,/arxiv_data1/oa_pdf/ff/06/trd-75-264.PMC3884116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Impaired fasting glucose in obese children E Hagman et al 45 &2014 Macmillan Publishers Limited International Journal of Obesity (2014) 40 – 45",Non-OADS,/arxiv_data1/oa_pdf/9d/a4/ijo2013124a.PMC3884136.pdf
311 2011; http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/dc/34/ijo2013187a.PMC3884137.pdf
"2010; http://www.health.gov.au/ internet/abhi/publishing.nsf/Content/Weight, þwaistþcircumference þandþ BMI-lp#overweight.",Non-OADS,/arxiv_data1/oa_pdf/dc/34/ijo2013187a.PMC3884137.pdf
Pediatr Rheumatol 2011; http://www.ped-rheum.com/content/9/1/3.,Non-OADS,/arxiv_data1/oa_pdf/dc/34/ijo2013187a.PMC3884137.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Musculoskeletal pain in children SM Smith et al 15 &2014 Macmillan Publishers Limited International Journal of Obesity (2014) 11 – 15",Non-OADS,/arxiv_data1/oa_pdf/dc/34/ijo2013187a.PMC3884137.pdf
"2007; Available from: http://www.nice.org.uk/CG48  [129] Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association.",Non-OADS,/arxiv_data1/oa_pdf/62/cc/CPEMH-9-255.PMC3884151.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/cc/CPEMH-9-255.PMC3884151.pdf
Available from: https://web.emmes.com/study/ped/annlrept/2010_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"1993;122(3):397-402, http://dx.doi.org/10.1016/S0022-3476(05)83423-7.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2001;72(1):13-21, http://dx.doi.org/10.1097/00007890- 200107150-00006.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"1998; 79(6):481-7, http://dx.doi.org/10.1136/adc.79.6.481.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2002; 62(2):688-96, http://dx.doi.org/10.1046/j.1523-1755.2002.00489.x 10.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"1998;12(6):437- 46, http://dx.doi.org/10.1007/s004670050483.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2011;26(6):961-6, http://dx.doi.org/10.1007/s00467-011- 1811-3.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2000;70(3):405-10, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"1995;60(12):1443-50, http://dx.doi.org/ 10.1097/00007890-199560120-00013.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2005;79(9):1241-6, http://dx.doi.org/ 10.1097/01.TP.0000161668.09170.F4.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2008;12(4):436-41, http://dx.doi.org/10.1111/j.1399-3046.2007.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2010;14(7):879-86, http://dx.doi.org/10.1111/j.1399-3046.2010.01361.x.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2006;25(7):772-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2004;23(2 Suppl):S127, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2010;19(1):68- 77, http://dx.doi.org/10.1053/j.sempedsurg.2009.11.009.CLINICS 2014;69(S1):3-7 Growth following solid organ transplantation Fine RN 7",Non-OADS,/arxiv_data1/oa_pdf/8a/53/cln-69-s1-003.PMC3884153.pdf
"2014;69(S1):3-7, http://dx.doi.org/10.6061/clinics/2014(Sup01) 02.Copyright /C2232014 CLINICS – This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):8-16, http://dx.doi.org/10.6061/clinics/ 2014(Sup01)03.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):17-21, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014; 69(S1):22-27, http://dx.doi.org/10.6061/clinics/2014(Sup01)05.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):28-38, http://dx.doi.org/10.6061/ clinics/2014(Sup01)06.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):39-41, http://dx.doi.org/10.6061/ clinics/2014(Sup01)07.7.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):42-46, http://dx.doi.org/10.6061/clinics/2014 (Sup01)08.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014; 69(S1):47-50, http://dx.doi.org/10.6061/clinics/2014(Sup01)09.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):51-54, http://dx.doi.org/10.6061/clinics/2014(Sup01)10.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):55-72, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"2014;69(S1):73-75, http://dx.doi.org/10.6061/ clinics/2014(Sup01)12.Challenge topics in pediatric transplantation Azeka E et al.CLINICS 2014;69(S1):1-2 2",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/cln-69-s1-001.PMC3884154.pdf
"Am J Cardiol, 1968;22(6):782-90, http://dx.doi.org/10.1016/0002-9149(68)90173-2.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2000; 232(3):302-11, http://dx.doi.org/10.1097/00000658-200009000-00002.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2004;23(2):S114, http://dx.doi.org/10.1016/j.healun.2003.11.217.",OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2003;7(3)217- 22, http://dx.doi.org/10.1034/j.1399-3046.2003.00079.x.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"1999;3(1):27-32, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2013;17(2):93-4, http://dx.doi.org/10.1111/petr.12053.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"Transplantation.2005;80(4):457- 65, http://dx.doi.org/10.1097/01.tp.0000165847.05787.08.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2013;8(1):e53252, http://dx.doi.org/10.1371/journal.pone.0053252.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2013;17(3):205-15, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2012;18(9):1009- 28, http://dx.doi.org/10.1002/lt.23478.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2010;95(3):281-2, http://dx.doi.org/ 10.1590/S0066-782X2010001300001.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"2011;66(6):931-2, http://dx.doi.org/10.1590/ S1807-59322011000600001.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
Available from: http://www.ctotc.org/index.html.CLINICS 2014;69(S1):73-75 Pediatric research transplantation Azeka E et al.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/cln-69-s1-073.PMC3884155.pdf
"1963;186(12):1065- 74, http://dx.doi.org/10.1001/jama.1963.63710120001010.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2002;6(4):270-9, http://dx.doi.org/10.1034/j.1399-3046.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"Elsevier; 2013;32(10):989-97, http://dx.doi.org/10.1016/j.healun.2013.08.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2013;32(10): 965-78, http://dx.doi.org/10.1016/j.healun.2013.08.007.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2011;13(1):68-78, http://dx.doi.org/10.1007/s11936- 010-0105-6.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2013;32(1):44-9, http://dx.doi.org/ 10.1016/j.healun.2012.09.027.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2006;25(7):745-55, http://dx.doi.org/10.1016/j.healun.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2010;57(2):375-91, http://dx.doi.org/10.1016/ j.pcl.2010.01.017.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"1996;110(2):559-62, http://dx.doi.org/10.1378/ chest.110.2.559.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2005;24(10):1454-9, http://dx.doi.org/10.1016/j.healun.2004.11.049.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2013;187(5):527-34, http://dx.doi.org/ 10.1164/rccm.201210-1865OC.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2007;26(12):1229-42, http://dx.doi.org/10.1016/j.healun.2007.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2007;26(5):423- 30, http://dx.doi.org/10.1016/j.healun.2007.01.040.",OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2007;189(4):904-12, http://dx.doi.org/10.2214/AJR.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2011;140(2):502-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/82/71/cln-69-s1-051.PMC3884157.pdf
"2012;31(2):173-9, http://dx.doi.org/10.1016/j.healun.2011.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;94(4):362-8, http://dx.doi.org/ 10.1097/TP.0b013e31825b7608.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;44(1):214- 6, http://dx.doi.org/10.1016/j.transproceed.2011.12.017.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;6(1):e16521, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;21 Suppl 2:124-32, http://dx.doi.org/10.1017/S1047951111001703.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;30(11):1221-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2007;26(11):1163-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;29(10):1129- 41, http://dx.doi.org/10.1016/j.healun.2010.08.008.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;30(10):1095-103, http://dx.doi.org/ 10.1016/j.healun.2011.08.005.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;160(5):820-6 e3, http://dx.doi.org/10.1016/j.jpeds.2011.10.038.16.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2013;56(1):84-92, http://dx.doi.org/10.1093/cid/cis823.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;29(6):625-32, http://dx.doi.org/10.1016/j.healun.2009.12.009.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012; 8(6):348-57, http://dx.doi.org/10.1038/nrneph.2012.81.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;31(1):46-51, http://dx.doi.org/10.1016/j.healun.2011.10.009.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;72(1):5-10, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;74(5):664-73, http://dx.doi.org/10.1038/ki.2008.249.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;90(8):875-81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;86(9):1214-21, http://dx.doi.org/10.1097/TP.0b013e3181880b35.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;27(6):1011-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;92(1):41-7, http://dx.doi.org/10.1097/TP.0b013e 31821cdf0d.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;16(1):12-7, http://dx.doi.org/10.1111/j.1399-3046.2011.01599.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;31(7):686-93, http://dx.doi.org/10.1016/j.healun.2012.03.009.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;26(1):62-9, http://dx.doi.org/10.1016/j.trim.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;307(3):283-93, http://dx.doi.org/10.1001/ jama.2011.2014.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;120(6):1836-47, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;120(6):1848-61, http://dx.doi.org/10.1172/JCI39922.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011; 15(1):25-31, http://dx.doi.org/10.1111/j.1399-3046.2010.01439.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2006;10(7):811-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;26(3):449-57, http://dx.doi.org/10.1007/ s00467-010-1724-6.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;16(2):160-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2006;10(5):558-64, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;14(1):52-60, http://dx.doi.org/10.1111/j.1399-3046.2009.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010(118):S8-14, http://dx.doi.org/ 10.1038/ki.2010.210.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;88(3):367-73, http://dx.doi.org/10.1097/TP.0b013e3181ae67f0.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;23(3):415-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;13(5):599-605, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2005;9(4):498-503, http://dx.doi.org/10.1111/j.1399-3046.2005.00334.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2002;17(1):1-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010; 25(10):2129-39, http://dx.doi.org/10.1007/s00467-010-1572-4.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;16(1):41-9, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;28(12):1273-8, http://dx.doi.org/10.1016/j.healun.2009.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;86(8):1028-34, http://dx.doi.org/ 10.1097/TP.0b013e318187748f.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011; 15(7):699-705, http://dx.doi.org/10.1111/j.1399-3046.2011.01564.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;87(5):726-33, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;93(9):887-94, http://dx.doi.org/10.1097/TP.0b013e31824ad60a.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;13(4):475-81, http://dx.doi.org/10.1111/j.1399-3046.2008.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;12(5):541-9, http://dx.doi.org/10.1111/j.1399-3046.2007.00847.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2005;16(8):2509-16, http://dx.doi.org/10.1681/ASN.2005030312.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011; 25(2):78-89, http://dx.doi.org/10.1016/j.trre.2011.01.001.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;15(4):437-41, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2004;77(7):1033-7, http://dx.doi.org/10.1097/01.TP.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;25(3):276-82, http://dx.doi.org/10.1111/j.1432-2277.2011.01400.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;26(12):2235-44, http://dx.doi.org/ 10.1007/s00467-011-1934-6.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2003;75(10):1664-70, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2007;105(2):c68-76, http://dx.doi.org/10.1159/000097601.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;26(12):2227-33, http://dx.doi.org/10.1007/s00467-011- 1920-z.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;92(4):404-9, http://dx.doi.org/ 10.1097/TP.0b013e3182247bd5.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;14(4):469-77, http://dx.doi.org/10.1002/ lt.21397.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;12(4):436-41, http://dx.doi.org/10.1111/j.1399- 3046.2007.00826.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;12(5):557-62, http://dx.doi.org/10.1111/j.1399-3046.2007.00859.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2003;76(8):1195-200, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;14(2):249-56, http://dx.doi.org/10.1111/j.1399-3046.2009.01214.x.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2007; 39(4):1074-8, http://dx.doi.org/10.1016/j.transproceed.2007.04.002.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;13(6):701-10, http://dx.doi.org/10.1111/j.1399-3046.2008.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2010;156(2):270-6 e1, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008 Apr; 14(4):460-8, http://dx.doi.org/10.1002/lt.21352.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"1997;130(6):862-71, http://dx.doi.org/10.1016/S0022- 3476(97)70270-1.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"J Heart Lung Transplant.2006;25(3):261-70, http://dx.doi.org/10.1016/ j.healun.2005.09.011.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2006;25(3):345-52, http://dx.doi.org/10.1016/j.healun.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2005;9(2):170-7, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2000;118(1):115-22, http://dx.doi.org/ 10.1378/chest.118.1.115.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"1995;108(6):1587-93, http://dx.doi.org/10.1378/chest.108.6.1587.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2005;24(4):474-80, http://dx.doi.org/10.1016/ j.healun.2003.12.013.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2011;15(8):849-54, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;256(3):494-508, http://dx.doi.org/10.1097/SLA.0b013e318265f310.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2003;111(6 Pt 1):e725-31, http://dx.doi.org/10.1542/peds.111.6.e725"",-1,""xxx/6.e725.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2007;26(2):120-6, http://dx.doi.org/10.1016/j.healun.2006.1 1.013.",OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2002;6(1):53-62, http://dx.doi.org/10.1034/j.1399-3046.2002.1o040.x.127.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2009;51(1):71-4, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2005;79(9):1252-6, http://dx.doi.org/10.1097/01.TP.0000161251.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2008;27(10):1079-84, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2012;344:e3718, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/cln-69-s1-028.PMC3884158.pdf
"2006;36(1-3):255-64, http://dx.doi.org/10.1385/IR:36:1: 255.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2009;23(2):80-93, http://dx.doi.org/10.1016/j.trre.2009.01.001.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2003;14(5):1336-48, http://dx.doi.org/10.1097/01.ASN.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2011;139(1-2):1-6, http://dx.doi.org/10.1016/j.imlet.2011.04.014.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2005;9(2):208-14, http://dx.doi.org/10.1111/j.1399-3046.2005.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2009;28(2):123-9, http://dx.doi.org/10.1016/j.healun.2008.11.908.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2010;29(1):109-16, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2007;26(6):565-71, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2011;30(11):1221-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2004; 29(1-3):41-54, http://dx.doi.org/10.1385/IR:29:1-3:041.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2000;69(7):1370-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2004;23(10):1135-41, http://dx.doi.org/10.1016/j.healun.2003.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2008;40(3):718-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2005;15(1):63-8, http://dx.doi.org/ 10.1016/j.trim.2005.05.001.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"1997;64(12):1744-7, http://dx.doi.org/10.1097/00007890- 199712270-00021.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2000; 4(1):6-11, http://dx.doi.org/10.1034/j.1399-3046.2000.00075.x.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2005;66(5):513-8, http://dx.doi.org/ 10.1016/j.humimm.2004.12.008.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2004;13(1):63-71, http://dx.doi.org/10.1016/j.trim.2004.01.005.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"1993;1(1):60-5, http://dx.doi.org/10.1016/0966-3274(93)90060-L. 30.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2012;31(10):1065-72, http://dx.doi.org/ 10.1016/j.healun.2012.08.001.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2004;78(5):1703-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2007;26(11):1163-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2011;32(5):615-20, http://dx.doi.org/10.1007/s00246-011-9928-5.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2010;139 (6):1402-8, http://dx.doi.org/10.1016/j.jtcvs.2009.12.034.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2006; 19(3):239-44, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2006; 13(2):101-4, http://dx.doi.org/10.1111/j.1399-3089.2006.00276.x.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2005;79(6):696-701, http://dx.doi.org/10.1097/ 01.TP.0000148732.26761.FA.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2008;26:513-33, http://dx.doi.org/ 10.1146/annurev.immunol.26.021607.090232.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2009;158 Suppl 1:2-13, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"1996;62(5):691-3, http://dx.doi.org/10.1097/00007890-199609150-00027.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2004;15(12):3256-62, http://dx.doi.org/10.1097/01.ASN.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2011;25(1):E61-7, http://dx.doi.org/10.1111/j.1399-0012.2010.01334.x.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2007;26(9):876-82, http://dx.doi.org/10.1016/j.healun.2007.",OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
ClinicalTrials.gov Identifier: NCT01005316 [cited 2012 Nov 12]; Avail- able from: http://www.clinicaltrials.gov/ct2/show/NCT01005316?term = ctotc-04&rank = 1.,OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2011;30(2):158-63, http://dx.doi.org/ 10.1016/j.healun.2010.08.020.CLINICS 2014;69(S1):17-21 Sensitization and Pediatric Heart Transplant Conway J and Dipchand AI 21",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/cln-69-s1-017.PMC3884159.pdf
"2009;24(8):1553-60, http://dx.doi.org/10.1007/s00467-009-1174-1.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2013;17(5):498, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2010;22(2):189-96, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2001;33(5):2821-4, http://dx.doi.org/10.1016/S0041-1345(01)02204-7.",OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2010;54(3):211-8, http://dx.doi.org/10.1111/j.1754-9485.2010.02161.x.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2013;95(6):878-82, http://dx.doi.org/10.1097/TP.0b013e318281b953.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2002;6(4):313-8, http://dx.doi.org/10.1034/j.1399-3046.2002.02019.x.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2013;18(5):537-42, http://dx.doi.org/10.1097/MOT.0b013e3283 651b35.CLINICS 2014;69(S1):39-41 Postoperative care in pediatric kidney transplantation Torricelli FC et al.",Non-OADS,/arxiv_data1/oa_pdf/42/b5/cln-69-s1-039.PMC3884160.pdf
"2012;44(1):214- 6, http://dx.doi.org/10.1016/j.transproceed.2011.12.017.",OADS,/arxiv_data1/oa_pdf/04/9a/cln-69-s1-022.PMC3884161.pdf
"2013;27(1):1-8, http://dx.doi.org/10.1016/j.trre.",OADS,/arxiv_data1/oa_pdf/04/9a/cln-69-s1-022.PMC3884161.pdf
Available from: https://web.emmes.com/study/ped/annlrept/2010_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/9a/cln-69-s1-022.PMC3884161.pdf
"2011;15(5):502-4, http://dx.doi.org/ 10.1111/j.1399-3046.2011.01480.x.",Non-OADS,/arxiv_data1/oa_pdf/04/9a/cln-69-s1-022.PMC3884161.pdf
"2008;86(3):384-90, http://dx.doi.org/10.1097/TP.0b01 3e31817c90f5.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1997;63(7):977-83, http://dx.doi.org/10.1097/000078 90-199704150-00013.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;8(6):348-57, http://dx.doi.org/10.1038/nrneph.2012.81.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1990;49(1):85-91, http://dx.doi.org/10.1097/00007890-199001000-00019.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1992; 53(3):550-5, http://dx.doi.org/10.1097/00007890-199203000-00011.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2002;11(6)609-18, http://dx.doi.org/10.1097/00041552-2002 11000-00007.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;6(4):922-36, http://dx.doi.org/ 10.2215/CJN.08140910.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;85(8):1086-90, http://dx.doi.org/10.1097/TP.0b013e31816b3ed1.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;86(6):820-5, http://dx.doi.org/10.1097/TP.0b01 3e3181856f98.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;90(2):160-7, http://dx.doi.org/10.1097/TP.0b013e3 181e36e08.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;25(6):623-32, http://dx.doi.org/10.1111/j.1432-2277.2012.01453.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;25(11):1165-73, http://dx.doi.org/10.1111/ j.1432-2277.2012.01544.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2009;24(3):475-84, http://dx.doi.org/10.1007/s00467- 007-0559-2.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;18(4):1046-56, http://dx.doi.org/ 10.1681/ASN.2007010073.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;369(1-2):1-21, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2009;87(4):557-62, http://dx.doi.org/10.1097/TP.0b01 3e3181943c76.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007; 11(1):77-81, http://dx.doi.org/10.1111/j.1399-3046.2006.00617.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;16(1):12-7, http://dx.doi.org/10.1111/j.1399-3046.2011.01599.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;86(8): 1019-25, http://dx.doi.org/10.1097/TP.0b013e3181889748.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;1(3):415-20, http://dx.doi.org/10.2215/CJN.01881105.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1996;61(11):1586-92, http://dx.doi.org/10.1097/00007 890-199606150-00007.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2002;13(3):2417-9, http://dx.doi.org/10.1097/01.ASN.0000030140.74450.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2003;76(1):102-8, http://dx.doi.org/10.1097/ 01.TP.0000069040.16457.06.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2002;13(9):2371-80, http://dx.doi.org/10.1097/01.ASN.0000025780.03790.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;68(8):645-51, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;25(4):154-66, http://dx.doi.org/10.1016/j.trre.2011.04.001.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;102(7):777-85, http://dx.doi.org/10.1161/CIRCRESAHA.107.170332.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1997;64(11):1531-6, http://dx.doi.org/10.1097/00007890-199712150-00005.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
Available from: https://web.emmes.com/study/ped/annlrept/2010_ Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2013;28(2):327-32, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2001;72(6):1037-42, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2000;70(6):887-95, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2000;70(10):1531- 6, http://dx.doi.org/10.1097/00007890-200011270-00023.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2005; 9(2):155-61, http://dx.doi.org/10.1111/j.1399-3046.2005.00256.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;27(2-3):107-13, http://dx.doi.org/10.1016/j.trim.2012.08.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;16(2):E49-52, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;93(3):319- 24, http://dx.doi.org/10.1097/TP.0b013e31823f7eea.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;8(11):670-8, http://dx.doi.org/10.1038/nrneph.2012.212.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;78(2):152-9, http://dx.doi.org/10.1038/ki.2010.75.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;24(3):142-8, http://dx.doi.org/10.1016/j.trim.2010.11.006.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;6(12):2894-900, http://dx.doi.org/10.2215/CJN.03710411.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;24 Suppl 1:S7-S27, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;117(4 Suppl):S525-53, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;26(7):1149-56, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;86(4):502-10, http://dx.doi.org/10.1097/TP.0b013e318 1812f85.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;22:1213-20, http://dx.doi.org/ 10.1681/ASN.2010101022.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;22(7):496-502, http://dx.doi.org/10.1007/s00467-006-03 61-6.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
Available from: https://web.emmes.com/study/ped/annlrept/2010_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1972;2(7773):343-8, http://dx.doi.org/10.1016/S0140-6736(72)91 734-5.89.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2001;59(1):328-33, http://dx.doi.org/10.1046/j.1523-1755.2001.00494.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;5(12):2363-72, http://dx.doi.org/10.2215/CJN.06720810.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2005;20(2):210-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;15(5):495-501, http://dx.doi.org/10.1111/j.1399-3046.2011.01478.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2001;71(5):628-33, http://dx.doi.org/10.1097/000078 90-200103150-00008.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;5(11):2115-21, http://dx.doi.org/10.2215/ CJN.03800609.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;14(3):314-25, http://dx.doi.org/10.1111/j.1399-3046.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2004;17(3):151-7, http://dx.doi.org/10.1111/j.1432-2277.2004.tb00420.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2002;73(3):366-72, http://dx.doi.org/10.1097/000078 90-200202150-00009.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;93(12):1238-44, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;14(1):55-63, http://dx.doi.org/10.1038/nm1696.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;17(8):952-60, http://dx.doi.org/10.1038/ nm.2411.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2000;58(5):1973-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;77(7):571-80, http://dx.doi.org/10.1038/ki.2009.424.Pediatric solid-organ transplantation Lipshultz SE et al.CLINICS 2014;69(S1):55-72 70",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;14(9):931-8, http://dx.doi.org/10.1038/nm.1857.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;90(12):1407- 20, http://dx.doi.org/10.1007/s00109-012-0960-6.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;82(4):492, http://dx.doi.org/10.1038/ki.2012.230.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;21(4):428-32, http://dx.doi.org/10.1097/MNH.0b013e328354a681.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;30(2):111-25, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
Available from: http://www.fonttrial.org/.,Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1996; 77(15):1339-44, http://dx.doi.org/10.1016/S0002-9149(96)00202-0.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1991;23(4):300-1, http://dx.doi.org/10.1002/ ccd.1810230415.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;85(7):969-74, http://dx.doi.org/ 10.1097/TP.0b013e318168d571.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1999;18(3):194-201, http://dx.doi.org/10.1016/S1053-2498(98)00031-X.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1999;138(4 Pt 1):721-30, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1996; 132(4):820-6, http://dx.doi.org/10.1016/S0002-8703(96)90317-8.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2001;7(12):1347-52, http://dx.doi.org/10.1038/ nm1201-1347.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;17(1):26-32, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;22(2):66-71, http://dx.doi.org/10.1097/HCO.0b013e328028fd68.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1956;51(4):533-41, http://dx.doi.org/10.1016/0002-8703(56)90099-0.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2001;103(13):1813-8, http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2005;14(1):33-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2009;23(5):672-80, http://dx.doi.org/10.1111/j.1399-0012.2009.01074.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;27(6):649-54, http://dx.doi.org/10.1016/j.healun.2008.03.008.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;117(16):2131-41, http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.711911.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;27(9):970-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;60(4):324-31, http://dx.doi.org/10.1016/j.jacc.2012.02.065.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;13(4):438- 44, http://dx.doi.org/10.1097/MOT.0b013e328309ee31.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;6(10):606-13, http://dx.doi.org/10.1038/nrneph.2010.112.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;29(6):256-62, http://dx.doi.org/10.1016/ j.it.2008.03.002.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;9:174, http://dx.doi.org/10.1186/1479-5876-9-174.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2009;14(1):34-9, http://dx.doi.org/10.1097/ MOT.0b013e32831e13d0.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;25(12):1389-95, http://dx.doi.org/10.1016/j.healun.2006.10.002.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;27(3):297-301, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;26(12):1255-63, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;27(8):932-4, http://dx.doi.org/10.1016/j.healun.2008.05.001.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;3(6):37, http://dx.doi.org/10.1186/gm253.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2003;17(2):77-88, http://dx.doi.org/10.1034/j.1399-0012.2003.00013.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;82(5):663-8, http://dx.doi.org/10.1097/01.tp.0000234837.02126.70.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;29(5):504-8, http://dx.doi.org/10.1016/j.healun.2009.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2008;27(8):817-22, http://dx.doi.org/10.1016/j.healun.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2005;19(6):834-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;10(5):613-6, http://dx.doi.org/10.1111/j.1399-3046.20 06.00510.x.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2009;28(1):26-31, http://dx.doi.org/10.1016/j.healun.2008.10.001.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2004;3(4):367-78, http://dx.doi.org/10.1074/mcp.R4 00007-MCP200.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;6(3):1001-10, http://dx.doi.org/10.1002/pmic.200500105.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2003;75(1):43- 9, http://dx.doi.org/10.1097/00007890-200301150-00008.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011; 187(2):1023-30, http://dx.doi.org/10.4049/jimmunol.1004195.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;32(5):25-34, http://dx.doi.org/10.1016/j.ppedcard.2011.06.006.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;32(1):11-4, http://dx.doi.org/10.1016/j.ppedcard.2011.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;31(1):53-7, http://dx.doi.org/10.1016/j.ppedcard.2010.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1997;96(1):227-31, http://dx.doi.org/10.1161/01.CIR.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2006;296(15):1867-76, http://dx.doi.org/10.1001/jama.296.15.18 67.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;124(7):814-23, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2010;3(6):689-97, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.109.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2007;115(6):773-81, http://dx.doi.org/10.1161/ CIRCULATIONAHA.106.621185.",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;164(3):442-8, http://dx.doi.org/10.1016/j.ahj.2012.04.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2011;30(7):755-60, http://dx.doi.org/10.1016/j.healun.2011.",OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"2012;126(9):1079-86, http://dx.doi.org/10.1161/CIRCULATIONAHA.110.011999.Pediatric solid-organ transplantation Lipshultz SE et al.CLINICS 2014;69(S1):55-72 72",Non-OADS,/arxiv_data1/oa_pdf/54/ba/cln-69-s1-055.PMC3884162.pdf
"1998;351(9117):1701-2, http://dx.doi.org/10.1016/S0140-6736(05)77739-4.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;88(6):799-802, http://dx.doi.org/10.1097/TP.0b01 3e3181b4aaf5.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2008;86(12):1725-31, http://dx.doi.org/10.1097/TP.0b0 13e3181903da7.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2005;80(4):457- 65, http://dx.doi.org/10.1097/01.tp.0000165847.05787.08.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2001;71(9):1282-7, http://dx.doi.org/ 10.1097/00007890-200105150-00017.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;87(2):233- 42, http://dx.doi.org/10.1097/TP.0b013e3181927a41.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;16(2):106-22, http://dx.doi.org/10.1111/j.1399-3046.2012.01644.x.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2006;24(8):1663-70, http://dx.doi.org/10.1097/01.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;41(6 Suppl):S3-5, http://dx.doi.org/ 10.1016/j.transproceed.2009.06.091.",OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;298(1):F142-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;15(7):746-9, http://dx.doi.org/10.1111/j.1399-3046.2011.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;42(10):4441-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;14(5):566-70, http://dx.doi.org/ 10.1097/MOT.0b013e32832e6f7b.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;15(4):437-41, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;17(5):515-9, http://dx.doi.org/ 10.1097/MOT.0b013e328356b080.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2008;12(4):456-63, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011; 92(6):658-62, http://dx.doi.org/10.1097/TP.0b013e3182295bed.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;15(8):784-9, http://dx.doi.org/10.1111/j.1399-3046.2011.01550.x.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;12(7):965-79, http://dx.doi.org/ 10.1517/14712598.2012.683522.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
Retrieved from http://packageinserts.bms.com/pi/pi_nulojix.pdf (2013).,OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2008;372(9636): 383-91, http://dx.doi.org/10.1016/S0140-6736(08)60998-8.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
Available from: http://www.fda.gov/downloads/Advi soryCommittees/CommitteesMeeting Materials/PediatricAdvisoryCommittee/ucm193143.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;6(10):584-93, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2007;581(19):3652-7, http://dx.doi.org/10.1016/j.febslet.2007.",OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2003;18(2):243-53, http://dx.doi.org/10.1016/S1074-7613(03)00024-4.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2008;86(12):1754-61, http://dx.doi.org/ 10.1097/TP.0b013e318190af83.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;93(3):319-24, http://dx.doi.org/10.1097/TP.0b013e31823f7eea.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;26(8):1325-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;5(10):556-7, http://dx.doi.org/ 10.1038/nrneph.2009.148.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;10(9):2142-7, http://dx.doi.org/10.1111/j.1600- 6143.2010.03228.x.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;36(6):653-9, http://dx.doi.org/10.1055/s-0030-1262887.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;26(4):613- 9, http://dx.doi.org/10.1007/s00467-010-1708-6.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;6(5):297-306, http://dx.doi.org/10.1038/nrneph.2010.34.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;13:68, http://dx.doi.org/10.1186/1471-2369-13-68.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;39(1):86-92, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2005;37(1):126- 9, http://dx.doi.org/10.1016/j.transproceed.2005.02.016.",OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2003; 75(11):1881-7, http://dx.doi.org/10.1097/01.TP.0000064710.78335.D3.CLINICS 2014;69(S1):8-16 Immunosuppression in transplantation Nguyen C and Shapiro R 15",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;51(1):15-28, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2011;26(11):3802-5, http://dx.doi.org/10.1093/ndt/gfr503.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2009;15(7):746-9, http://dx.doi.org/10.1038/nm.1993.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2012;56(5):2726- 34, http://dx.doi.org/10.1128/AAC.05983-11.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;2(12):2740-2762, http://dx.doi.org/10.3390/v2122740.",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2010;54(11):4714-22, http://dx.doi.org/ 10.1128/AAC.00974-10.Immunosuppression in transplantation Nguyen C and Shapiro RCLINICS 2014;69(S1):8-16 16",Non-OADS,/arxiv_data1/oa_pdf/da/ad/cln-69-s1-008.PMC3884163.pdf
"2002;21(8):827-40, http://dx.doi.org/10.1016/S1053-2498 (02)00496-5.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"2002;6(3):208-13, http://dx.doi.org/10.1034/j.1399-3046.2002.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"1993;22(1):41-54, http://dx.doi.org/10.1016/ 0735-1097(93)90814-H. 16.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"1995;92(9 Suppl):II206-9, http://dx.doi.org/10.1161/01.CIR.92.9.206.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"1994;58(4):972-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"2012;44(8):2483-5, http://dx.doi.org/10.1016/j.transproceed.2012.",OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"2005;24(11):1710-20, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"2011;30(10):1095-103, http://dx.doi.org/ 10.1016/j.healun.2011.08.005.",OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"2009;64(2):127-34, http://dx.doi.org/10.1590/S1807- 59322009000200010.Clinical recommendations for heart transplantation Azeka E et al.CLINICS 2014;69(S1):47-50 50",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cln-69-s1-047.PMC3884164.pdf
"http://www.unicef.org/publications/index_4424.html  (access ed August 19, 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/12/78/cop-0004-0184.PMC3884172.pdf
"http://www.sante.public.lu/publications/ rester-bonne-sante/alimentation/plan-national-alimentation-sain e-activite-physique/plan-national- alimentation-saine-activite-physique.pdf, Luxembourg, 2007.",Non-OADS,/arxiv_data1/oa_pdf/04/28/cee-0003-0121.PMC3884179.pdf
"J Oncol ,  http://dx.doi.org/10.1155/2012/723541 .",Non-OADS,/arxiv_data1/oa_pdf/dd/c9/cde-0005-0272.PMC3884180.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1e/db/srep03598.PMC3884221.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3598 | DOI: 10.1038/srep03598 9",Non-OADS,/arxiv_data1/oa_pdf/1e/db/srep03598.PMC3884221.pdf
"International Symposium on Environmental Monitoring and Dose Estimation of Residents after Accident of TEPCO’s Fukushima Daiichi NuclearPower Station, Kyoto University Research Reactor Institute, Kyoto, 25–32 (2012).,http://www.rri.kyoto-u.ac.jp/anzen_ kiban/outcome/Proceedings_for_Web/ Topics_1-07.pdf .",Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
",http://www.tepco.co.jp/en/press/corp-com/ release/betu12_e/images/120524e0201.pdf .",Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
",https://wiki.ceh.ac.uk/ download/attachments/115802176/fasset_d1.pdf .",Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
",http://www.mext.go.jp/component/ english/__icsFiles/afieldfile/2011/05/10/1304797_0506.pdf .",Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3599 | DOI: 10.1038/srep03599 5",Non-OADS,/arxiv_data1/oa_pdf/46/42/srep03599.PMC3884222.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3606 | DOI: 10.1038/srep03606 6",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/srep03606.PMC3884223.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cb/a4/srep03605.PMC3884224.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3605 | DOI: 10.1038/srep03605 6",Non-OADS,/arxiv_data1/oa_pdf/cb/a4/srep03605.PMC3884224.pdf
"Reuters, China, a Rare Earths Giant, Set to Start Importing the Elements (08/2012) New York Times http://www.nytimes.com/2012/07/12/business/global/china-a- rare-earths-giant-set-to-start-importing-the-elements.html?ref 5rareearths&_ r51&.",Non-OADS,/arxiv_data1/oa_pdf/08/b6/srep03603.PMC3884225.pdf
"Ching, N. Rare Earths in New York Times (06/2012) http://topics.nytimes.com/ top/reference/timestopics/subjects/r/rare_earths/index.html.",Non-OADS,/arxiv_data1/oa_pdf/08/b6/srep03603.PMC3884225.pdf
Characteristics and Properties (01/1998-2001) http://www.ioffe.rssi.ru/SVA/NSM/Semicond/Si/ bandstr.html.,OADS,/arxiv_data1/oa_pdf/08/b6/srep03603.PMC3884225.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/08/b6/srep03603.PMC3884225.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3603 | DOI: 10.1038/srep03603 7",Non-OADS,/arxiv_data1/oa_pdf/08/b6/srep03603.PMC3884225.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3602 | DOI: 10.1038/srep03602 5",Non-OADS,/arxiv_data1/oa_pdf/64/fc/srep03602.PMC3884227.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d7/96/srep03594.PMC3884228.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3594 | DOI: 10.1038/srep03594 7",Non-OADS,/arxiv_data1/oa_pdf/d7/96/srep03594.PMC3884228.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/5b/srep03597.PMC3884229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3597 | DOI: 10.1038/srep03597 5",Non-OADS,/arxiv_data1/oa_pdf/c7/5b/srep03597.PMC3884229.pdf
"Expression of ST6GALNAC5 in human derived heart cells which was previously evidenced in microarray based tissue transcriptome studies (accession numbers in EMBI- EBI (http://www.ebi.ac.uk/expressionprofiler/): E-GEOD-2240, E-GEOD-40231, E-GEOD-3526) was here confirmed by cDNA syn- thesis17.",Non-OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
jcvi.org) and PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) bioinformatics tools predicted that two of the 12 variations would be damaging to protein function.,OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"The DiANNA software (http://clavius.bc.edu/ ,clotelab/DiANNA/) that predicts disulfide bond formation within proteins based on a neural network approach was used to predict whether the mutated C-terminus would changedisulfide bond patterns within ST6GALNAC5 24.",OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"Expression ofST6GALNAC5 in murine (accession numbers in EMBI-EBI (http://www.ebi.ac.uk/expressionprofiler/): E-GEOD-775, E-GEOD-1479, and E-GEOD-24940) and human (E-GEOD-2240, E-GEOD-40231) heart cells, including human coronary artery cells(E-GEOD-3526), has been shown in several microarray experi-ments 17.",Non-OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"In addition to CASAVA, variants were analyzed using Enlis Genomics (http://www.enlis.com) and NextBio (http://www.nextbio.com/b/ nextbio.nb) analysis softwares, again with reference to human genome referencesequence NCBI37/hg19.",OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: J.B.F., C.T., S.A., F.S., K.G.",Non-OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3595 | DOI: 10.1038/srep03595 8",Non-OADS,/arxiv_data1/oa_pdf/15/60/srep03595.PMC3884232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3600 | DOI: 10.1038/srep03600 6",Non-OADS,/arxiv_data1/oa_pdf/3c/13/srep03600.PMC3884233.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3583 | DOI: 10.1038/srep03583 7",Non-OADS,/arxiv_data1/oa_pdf/61/92/srep03583.PMC3884522.pdf
"Prolongation of the QT interval may be seen withmanydrugs,including:amiodarone,amitriptyline, astemizole, azithromycin, citalopram, clarithromycin, erythromycin, fingolimod, haloperidol, imipramine, mirtazapine, moxifloxacin, olanzapine, risperidone, sertraline, sotalol, terfenadine, venlafaxine, many tyrosinekinaseinhibitors(seehttp://www.azcert.org).",Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
"28.WestphalN,PlichtB,NaberC.Infectiveendocarditis--prophylaxis, diagnosticcriteria,andtreatment.DtschArzteblInt.2009 Jul;106(28-29):481-9;quiz490.DOI: 10.3238/arztebl.2009.0481 29.Bundesärztekammer(BÄK),KassenärztlicheBundesvereinigung (KBV),ArbeitsgemeinschaftderWissenschaftlichen MedizinischenFachgesellschaften(AWMF).Nationale VersorgungsLeitlinieAsthma–Langfassung.2.ed.,Version1.3; 2011.Availablefrom:http://www.versorgungsleitlinien.de/ themen/asthma 30.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
GOLD–GlobalInitiativeforObstructiveLungDisease.Update 2013.Availablefrom:http://www.goldcopd.org 33.,Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
Availablefrom:http://www.adka.de/solva_docs/1415_sa-la- zusammenfassung-xls.pdf 79.,Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
"HoltS,SchmiedlS,ThürmannPA.PRISCUS-Listepotenziell inadäquaterMedikationfürältereMenschen.Availablefrom: http://www.priscus.net 81.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
"DOI:10.3205/cto000094,URN:urn:nbn:de:0183-cto0000941Thisarticleisfreelyavailablefrom http://www.egms.de/en/journals/cto/2013-12/cto000094.shtml Published: 2013-12-13 Copyright ©2013Waldfahrer.ThisisanOpenAccessarticledistributedunder thetermsoftheCreativeCommonsAttributionLicense (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en).You arefree:toShare—tocopy,distributeandtransmitthework,provided theoriginalauthorandsourcearecredited.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/CTO-12-02.PMC3884537.pdf
"Although the international countofconsultationsinthisregardiscurrentlydeclining alittle[5] ,thenumberofsurgeriesisincreasing.Regard- ing in-patient treatments in the Federal Republic of Ger- many in 2010, the diagnosis “chronic sinusitis” was en- coded approximately 58,600 times (Federal Health Monitoringhttp://gbe-bund.de).Anothersourcementions 45,000in-patientcasesperyear(0.05%ofallin-patient cases) with 38 000 patients treated via surgery [6] .",Non-OADS,/arxiv_data1/oa_pdf/ce/1a/CTO-12-06.PMC3884541.pdf
In order to overcome deficiencies in communica- tion adequate guidelines on a secure legal basis are availabletothephysicianandthegeneralpublic(alliance forpatientsecurity:“AktionsbündnisPatientensicherheit” http://www.aktionsbuendnis-patientensicherheit.de/ apsside/Reden_ist_Gold_final.pdf).Mostofthetimelittle attentionispaidtothefactthatconfrontingthesurgeon withapossibleerrorintreatmentleadstorelevantemo- tionalstressproportionalto theobservedresultsforthe physician as a person (“the second victim”).,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/CTO-12-06.PMC3884541.pdf
"DOI: 10.3205/cto000098,URN:urn:nbn:de:0183-cto0000981 Thisarticleisfreelyavailablefrom http://www.egms.de/en/journals/cto/2013-12/cto000098.shtml Published: 2013-12-13 Copyright ©2013 Hosemannetal .",Non-OADS,/arxiv_data1/oa_pdf/ce/1a/CTO-12-06.PMC3884541.pdf
"This is anOpenAccess articledistributed underthetermsoftheCreative CommonsAttributionLicense (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en).You arefree:toShare—tocopy,distributeandtransmitthework,provided theoriginalauthorandsourcearecredited.",Non-OADS,/arxiv_data1/oa_pdf/ce/1a/CTO-12-06.PMC3884541.pdf
"DOI: 10.3205/cto000099,URN:urn:nbn:de:0183-cto0000998Thisarticleisfreelyavailablefrom http://www.egms.de/en/journals/cto/2013-12/cto000099.shtml Published: 2013-12-13 Copyright ©2013Gubischetal .ThisisanOpenAccessarticledistributedunder thetermsoftheCreative CommonsAttributionLicense (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en).You arefree:toShare—tocopy,distributeandtransmitthework,provided theoriginalauthorandsourcearecredited.",Non-OADS,/arxiv_data1/oa_pdf/40/09/CTO-12-07.PMC3884542.pdf
"153.StuckBA.Gemeinsame Stellungnahme zurNotwendigkeit präoperativ erGerinnungsdiagnostik vorTonsillekotmieund AdenotomiebeiKindern.2005.Availablefrom:http://hno.org/ kollegen/StellungnahmeGerinnungsdiagnostikv orAT-TE.pdf 154.SarnyS,OssimitzG,Habermann W,Stammberger H.Preoperativ e coagulation screeningpriortotonsillectomyinadults:current practiceandrecommendations.",Non-OADS,/arxiv_data1/oa_pdf/0a/24/CTO-12-08.PMC3884543.pdf
"Figure1:Numbersofprocedures withmedianvolumes(ml)grafted Figure2:Medianoperation time(min)perprocedure(P1–P10) Results Inclusioncriteriaofthisstudywerefulfilledin28reg- isteredpostmastectomycases(WHOdatabase ID: DRKS0000423 4http://apps.who.int/trialsear ch/ Trial.aspx?T rialID=DRKS00004234 ).Fivecaseswerebi- lateral,amounting to33reconstruct edbreastsbyalto- gether135largevolumefatgraftingprocedures.Sixteen patients(58%)hadpreviouslyreceivedpost-mastectomy radiotherapy(PMRT)and20patients(71%)chemother- apy.Twenty-threepatientshadturneddowntraditional breastreconstruction methodssuchasautologousflap reconstruction orimplantsorthepatientswerenotsuit- ableforthem(poortissue,cardiacissues).Fivepatients withcomplicationsafterimmediatebreastreconstruction withimplants(capsularcontraction, hardness,infection, rupture)receivedacompletereconstruction bylipotrans- fer.Infivepatientswithextremelytightskin,temporary expanderswereinsertedatP1andgraduallydeflatedin thefollowingprocedures.",Non-OADS,/arxiv_data1/oa_pdf/0f/06/GMS-11-17.PMC3884560.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003684).,Non-OADS,/arxiv_data1/oa_pdf/55/e2/bmjopen-2013-003684.PMC3884585.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003558).,Non-OADS,/arxiv_data1/oa_pdf/9b/e1/bmjopen-2013-003558.PMC3884589.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/e1/bmjopen-2013-003558.PMC3884589.pdf
"They also thank the Russia Longitudinal Monitoring Survey Phase 2, funded by the USAID and NIH (R01-HD38700), Higher School ofEconomics and Pension Fund of Russia, and the University of North Carolina Population Center (5 R24 HD050924) (Source: ‘Russia Longitudinal Monitoring survey, RLMS-HSE ’, conducted by HSE and ZAO ‘Demoscope ’ together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS (RLMS-HSE sites: http://www.cpc.unc.edu/projects/rlms, http://www.hse.ru/org/hse/rlms)) for sharing the data with them.",Non-OADS,/arxiv_data1/oa_pdf/f5/56/bmjopen-2013-003733.PMC3884590.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/56/bmjopen-2013-003733.PMC3884590.pdf
http://www.ncdalliance.org/node/3517 (accessed 22 Feb 2013).10.,OADS,/arxiv_data1/oa_pdf/f5/56/bmjopen-2013-003733.PMC3884590.pdf
http://www.food.gov.uk/multimedia/pdfs/saltreductioninitiatives.pdf (accessed 13 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/56/bmjopen-2013-003733.PMC3884590.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004146).,Non-OADS,/arxiv_data1/oa_pdf/7a/d8/bmjopen-2013-004146.PMC3884592.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/d8/bmjopen-2013-004146.PMC3884592.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003971).,Non-OADS,/arxiv_data1/oa_pdf/41/1b/bmjopen-2013-003971.PMC3884594.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/41/1b/bmjopen-2013-003971.PMC3884594.pdf
http://www.stat.go.jp/english/data/jinsui/tsuki/index.htm (accessed 12 Oct 2013).,OADS,/arxiv_data1/oa_pdf/41/1b/bmjopen-2013-003971.PMC3884594.pdf
2011. http://api-net.jfap.or.jp/status/2011/ 11nenpo/hyo_01.pdf (accessed 12 Oct 2013).,OADS,/arxiv_data1/oa_pdf/41/1b/bmjopen-2013-003971.PMC3884594.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003906).,Non-OADS,/arxiv_data1/oa_pdf/dd/57/bmjopen-2013-003906.PMC3884595.pdf
"Each capsule will consist of the herbal granule extracts of seven plant herbal substances (Fang Feng 75 mg, Chao Bai Zhu 75 mg, Ku Shen 75 mg, Sheng DiHuang 100 mg, Bai Shao 50 mg, Gan Cao 50 mg and Bai Xian Pi 75 mg), all of which are listed as approved Figure 2 Capsule swallowing training guidelines —modified from the ‘Teach children how to swallow tablets and capsules ’ guidelines by the Royal Children ’s Hospital (http://www.rch.org.au/pharmacy/clinical_services/Teach_children_how_to_swallow_ tablets_and_capsules).",Non-OADS,/arxiv_data1/oa_pdf/dd/57/bmjopen-2013-003906.PMC3884595.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003666).,Non-OADS,/arxiv_data1/oa_pdf/ad/45/bmjopen-2013-003666.PMC3884598.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004065).,Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
"Bacteria were identified by the Molecular Microbiology Laboratory at the University of WashingtonMedical Center http://depts.washington.edu/molmicdx Ethics approval Institutional Review Board, University of South Florida College of Medicine, Tampa, Florida.",Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.23k48.,OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
http://www.medcalc.org/calc/odds_ratio.php (accessed 29 Oct 2013).12.,Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
2013. http://www.genealogybank.com/ gbnk/ssdi/?kbid=9064&m=9 (accessed 7 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
http://clinicaltrials.gov/show/NCT01245036 (accessed29 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/b3/5d/bmjopen-2013-004065.PMC3884606.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004023).,Non-OADS,/arxiv_data1/oa_pdf/9c/7d/bmjopen-2013-004023.PMC3884610.pdf
13. http://www.nhsemployers.org/Aboutus/Publications/Documents/ qof-2013-14.pdf 14. http://www.dementiapartnerships.org.uk/diagnosis/dementia- prevalence-calculator/ 15.,Non-OADS,/arxiv_data1/oa_pdf/9c/7d/bmjopen-2013-004023.PMC3884610.pdf
"London: Alzheimer ’s Society, 2012. http://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=1348 16.",Non-OADS,/arxiv_data1/oa_pdf/9c/7d/bmjopen-2013-004023.PMC3884610.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003387).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.screening.nhs.uk/cervicalcancer (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.isdscotland.org/ Health-Topics/Cancer/Cervical-Screening/ (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.nhs.uk/Conditions/Blood-pressure-%28high%29/Pages/ Diagnosis.aspx (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.nhs.uk/ Conditions/Cholesterol/Pages/Diagnosis.aspx (accessed3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.lifelinescreening.co.uk/health-screening-services/heart-disease/high-cholesterol.aspx (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.nhs.uk/Livewell/ dentalhealth/Pages/Dentalcheckups.aspx (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
https://cfs.scot.nhs.,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.nhsdirect.wales.nhs.uk/localservices/dentistfaq/ (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
http://www.nhs.uk/ NHSEngland/Healthcosts/Pages/Eyecarecosts.aspx (accessed3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
https://cfs.scot.nhs.uk/ sight.php (accessed 3 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/c7/bmjopen-2013-003387.PMC3884617.pdf
doi:10.1136/bmjopen-2013- 003607 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003607).,Non-OADS,/arxiv_data1/oa_pdf/05/b5/bmjopen-2013-003607.PMC3884618.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003453).,Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
Quality assessment was guided by the ‘Assessment Tool for Quantitative Studies ’(http://www.city.hamilton.on.,Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
"nhsbt.nhs.ukDepartment of Health (UK) —http://www.dh.gov.uk Kidney Research (UK) —http://www.kidneyresearch.org.uk US Department of Transplant (funded studies) http://www.organdonor.gov/dtcp/behavior.html 2.Inclusion critera : Country: UK, USADate of publication: 1980 –2012 Ethnicity: Visible ethnic minorityDesign: Intervention study, evaluation studyOutcomes: Verified registration, willingness/intent to register,change in registration ratesParticipants: Adults and school age childrenSetting: CommunityFull search terms are available in the online supplementarymaterial.",Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
2013. http://www.ons.gov.uk/.../census/...census/...england-and-wales/rft-ct0010.xls (accessed 10 May 2013).,OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
2012. http://www.organdonation.nhs.uk/statistics/transplant_activity_report/current_activity_reports/ukt/ activity_report_2011_12.pdf (accessed 10 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
2008. http://www.dh.gov.uk (Search for: 9291).,Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
37. http://www.kcl.ac.uk/medicine/research/divisions/hscr/research/ groups/Long-Term-Conditions/current/donate/programme.aspx 38.,Non-OADS,/arxiv_data1/oa_pdf/92/27/bmjopen-2013-003453.PMC3884619.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"Paris: INSERM, 2013. http://www.europeristat.com/images/European%20Perinatal%20Health%20Report_2010.pdf (accessed31 Aug 2013) 2.",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
http://www.dh.gov.uk/prod_consum_dh/groups/dh_ digitalassets/documents/digitalasset/dh_131723.pdf (accessed 31 Aug 2013).,OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"The Times , 2012. http://www.thetimes.co.uk/tto/health/news/article3612548.ece(accessed 31 Aug 2013) 4.",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
http://www.pi.nhs.uk/pnm/CESDI %20SB%20commentary.pdf (accessed 31 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
Confidential enquiry into stillbirths with intrauterine growth restriction — West Midlands Perinatal Institute 2007. http://www.pi.nhs.uk/rpnm/CE_SB_Final.pdf (accessed 31 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"West Midlands Perinatal Institute, 2007 http://www.pi.nhs.uk/ultrasound/Birmingham_FGR_Audit_-_Summary.pdf (accessed 31 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
2012. http://www.gestation.net/GROW_documentation.pdf (accessed 31 Aug 2013).,OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"2002, 2013. http://www.rcog.org.uk/womens-health/investigation-and-management-small-gestational-age-fetus-green-top-31 (accessed Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"Health Statistics Quarterly, ONS, 2008. http://www.ons.gov.uk/ons/rel/hsq/health-statistics-quarterly/no--39--autumn-2008/health-statistics-quarterly.pdf (accessed31 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
Key Performance Indicator report —Q2 2010/11; West Midlands Perinatal Institute 2011. http://www.pi.nhs.uk/pnm/maternitydata/Q2_2010-11_Perinatal_KPI_report.pdf (accessed 31 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
http://www.pi.nhs.uk/pnm/maternitydata/IfH2c_WM_Q4_Report.pdf(accessed 31 Aug 2013) 34.,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
West Midlands Perinatal Institute 2012. http://www.pi.nhs.uk/pnm/clusterreports/2011/WM_2011_Stillbirth_Update_Sept_2012.pdf (accessed 31 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"Gestation Related Average Weight (GRAW) v1, 2010. http://www.gestation.net/fetal_growth/graw/ (accessed 31 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
"National Institute for Health and Care Excellence, 2010. http://www.nice.org.uk/newsroom/ features/measuringeffectivenessandcosteffectivenesstheqaly.jsp 10 Gardosi J, Giddings S, Clifford S, et al.BMJ Open 2013; 3:e003942.",Non-OADS,/arxiv_data1/oa_pdf/97/2b/bmjopen-2013-003942.PMC3884620.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004064).,Non-OADS,/arxiv_data1/oa_pdf/86/13/bmjopen-2013-004064.PMC3884621.pdf
KDOQI Clinical Practice Guidelines for bone metabolism and disease in children with chronic kidney disease.Secondary KDOQI Clinical Practice Guidelines for bone metabolismand disease in children with chronic kidney disease 2005. http://www.kidney.org/professionals/kdoqi/guidelines_pedbone/guide14.htm 17.,Non-OADS,/arxiv_data1/oa_pdf/34/24/bmjopen-2013-004265.PMC3884624.pdf
Secondary CG73 Chronic kidney disease: full guideline 2008.http://guidance.nice.org.uk/CG73/Guidance/pdf/English 20.,Non-OADS,/arxiv_data1/oa_pdf/34/24/bmjopen-2013-004265.PMC3884624.pdf
Secondary BHS & NICE Hypertension Guideline 2011. http://guidance.nice.org.uk/CG12727.,Non-OADS,/arxiv_data1/oa_pdf/34/24/bmjopen-2013-004265.PMC3884624.pdf
Secondary CG66 type 2 diabetes: full guideline 2008. http://guidance.nice.org.uk/CG66/Guidance/pdf/English 28.,Non-OADS,/arxiv_data1/oa_pdf/34/24/bmjopen-2013-004265.PMC3884624.pdf
"2011. http://www.nicedsu.org.uk/Other-TSDs(2391674).htm 8 Hill NR, Lasserson D, Fatoba S, et al.BMJ Open 2013; 3:e004265.",OADS,/arxiv_data1/oa_pdf/34/24/bmjopen-2013-004265.PMC3884624.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/2d/bmjopen-2013-003961.PMC3884632.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004348).,Non-OADS,/arxiv_data1/oa_pdf/3a/94/bmjopen-2013-004348.PMC3884636.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/94/bmjopen-2013-004348.PMC3884636.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039388.113.,OADS,/arxiv_data1/oa_pdf/a9/bc/1659.PMC3884647.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported),as described at http://creativecommons.org/licenses/by-nc/3.0/.REPORT RNA 19:1659 –1668; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1659",Non-OADS,/arxiv_data1/oa_pdf/a9/bc/1659.PMC3884647.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040675.113.,OADS,/arxiv_data1/oa_pdf/48/0a/1617.PMC3884648.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.BIOINFORMATICS RNA 19:1617 –1631; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1617",Non-OADS,/arxiv_data1/oa_pdf/48/0a/1617.PMC3884648.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040931.113.© 2013 Aktar et al.,OADS,/arxiv_data1/oa_pdf/5f/dd/1648.PMC3884649.pdf
"After 12 months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.REPORT 1648 RNA 19:1648 –1658; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/5f/dd/1648.PMC3884649.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040543.113.© 2013 Kalweit and Hammann This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b4/3a/1595.PMC3884650.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.LETTER TO THE EDITOR RNA 19:1595 –1604; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1595",Non-OADS,/arxiv_data1/oa_pdf/b4/3a/1595.PMC3884650.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042143.113.,OADS,/arxiv_data1/oa_pdf/a8/03/1767.PMC3884652.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a8/03/1767.PMC3884652.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.036806.112.© 2013 Ryvkin et al.,OADS,/arxiv_data1/oa_pdf/21/7d/1684.PMC3884653.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/21/7d/1684.PMC3884653.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/21/7d/1684.PMC3884653.pdf
Theweb version of HAMR is available at http://wanglab.pcbi.,OADS,/arxiv_data1/oa_pdf/21/7d/1684.PMC3884653.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041517.113.,OADS,/arxiv_data1/oa_pdf/4b/d0/1703.PMC3884654.pdf
"Freely availableonline through the RNA Open Access option.© 2013 Huang and Lilley This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported),as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/4b/d0/1703.PMC3884654.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039206.113.,OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as de-scribed at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
"We, therefore, did not rely on RNA-editing sites identifiedbased on our RNA-seq data, but instead focused on the set of RNA-editing sites previously identified in the human tran- scriptome from a meticulous analysis of human EST (ex-pressed sequence tags), available from the Database of RNA Editing (DARNED, http://darned.ucc.ie/) (Kiran andBaranov 2010).",OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
"The remainingreads were mapped to the reference genomes of human, chimpan-zee, and rhesus macaque (hg19, panTro2, and rheMac2 genomeassemblies were used for these three species throughout thiswork) using the RNA-seq read mapping software TopHat (v1.0.10,http://tophat.cbcb.umd.edu/) (Trapnell et al.",OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
The numbers of de-novo identified A-to-I RNA-editing sites in each brain region of each of the three speciesare shown in Supplemental Figure S1.DARNED sites and A-to-I editing Genomic locations of annotated human A-to-I RNA-editing sites(genome assembly version: hg19) were downloaded from theDARNED (http://darned.ucc.ie/) (Kiran and Baranov 2010).Among all DARNED sites we selected 8041 sites located in annotat-ed exonic regions and with no single nucleotide polymorphisms aslisted in the NCBI RefSeq database: SNP131 (Sherry et al.,OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
"2001).To determine the orthologous genomic sites in chimpanzee andmacaque for these editing sites, we converted their coordinates be-tween each pair of the three species genomes using the standaloneUCSC tool LiftOver (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
"The sequence alignment ma-nipulation software SAMtools (http://samtools.sourceforge.net/, v.0.1.18) was used to extract base calling information and predict con-sensus genotypes for each genomic site.",OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
SAMtools uses a consensus genotype-calling model implemented in MAQ(http://maq.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
The PCR products of appropriate sizeswere dissected and purified from the electrophoresis gel and se-quenced using the ABI3730XL sequencing platform (http://www.appliedbiosystems.com/).,Non-OADS,/arxiv_data1/oa_pdf/15/05/1693.PMC3884655.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041178.113.© 2013 Liu et al.,OADS,/arxiv_data1/oa_pdf/b8/ec/1848.PMC3884656.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD 1848 RNA 19:1848 –1856; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/1848.PMC3884656.pdf
"The deep sequencing data were mapped to a Homo sa- piens genome provided in a GenBank flat file (retrieved April 1, 2013, ftp://ftp.ncbi.nih.gov/refseq/H_sapiens/mRNA_Prot/human.rna.gbff.gz).",OADS,/arxiv_data1/oa_pdf/b8/ec/1848.PMC3884656.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042317.113.© 2013 Yao et al.,OADS,/arxiv_data1/oa_pdf/a7/3d/1781.PMC3884657.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/1781.PMC3884657.pdf
We aligned the top 20 most enriched motifs in each group and generated se-quence logos using WebLogo 3 (http://weblogo.threeplusone.com/)as previously described (Yao et al.,OADS,/arxiv_data1/oa_pdf/a7/3d/1781.PMC3884657.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040501.113.© 2013 Jung et al.,OADS,/arxiv_data1/oa_pdf/b6/25/1864.PMC3884658.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD 1864 RNA 19:1864 –1873; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/b6/25/1864.PMC3884658.pdf
Melting temperatures were calculated using Primer 3output with Breslauer ’s enthalpy and entropy from the online Oligo Melting Tool (http://bioinformatics.weizmann.ac.il/blocks-bin/oligomelt.pl).,OADS,/arxiv_data1/oa_pdf/b6/25/1864.PMC3884658.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039636.113.© 2013 van der Werf et al.,OADS,/arxiv_data1/oa_pdf/58/5e/1833.PMC3884659.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/58/5e/1833.PMC3884659.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042374.113.© 2013 Turner et al.,OADS,/arxiv_data1/oa_pdf/d7/28/1857.PMC3884660.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d7/28/1857.PMC3884660.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD RNA 19:1857 –1863; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1857",Non-OADS,/arxiv_data1/oa_pdf/d7/28/1857.PMC3884660.pdf
"While use ofNaH in DMF has a long history, it has more recently been recognized as particularly dangerous (http://www.crhf.org.",Non-OADS,/arxiv_data1/oa_pdf/d7/28/1857.PMC3884660.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040204.113.© 2013 Rage et al.,OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
( A) Venn diagram (http://bioinfogp.cnb.csic.es/tools/ venny/) showing overlap between SMN-associated mRNAs and tran- scripts identified in transcriptome studies of axons from dorsal root ganglion neurons (Willis et al.,OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
"Microarrays were analyzedwith the specific R script (http://www.R-project.org/), which in-cludes methods from the Bioconductor (Gentleman et al.",OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
Gene Ontology analyses The WebGestalt program (http://bioinfo.vanderbilt.edu/webgestalt) (Zhang et al.,OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
"Affymetrix microar-rays were processed in the Microarray Core Facility of the Instituteof Research on Biotherapy, CHRU-INSERM-UM1 Montpellier(http://irb.chu-montpellier.fr/).",OADS,/arxiv_data1/oa_pdf/0c/28/1755.PMC3884661.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041731.113.© 2013 Chauleau and Shuman This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d2/bf/1840.PMC3884662.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d2/bf/1840.PMC3884662.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042028.113.© 2013 Deryusheva and Gall This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/0c/69/1802.PMC3884663.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0c/69/1802.PMC3884663.pdf
"Although thereare no FISH data for these vertebrate guide RNAs, they have been annotated as scaRNAs based on the possession of CAB-box motifs (Lestrade and Weber 2006) (http://www-snorna.biotoul.fr/).",Non-OADS,/arxiv_data1/oa_pdf/0c/69/1802.PMC3884663.pdf
RNA sequence analysis An initial prediction of scaRNA folding was carried out using the Mfold web server (http://mfold.rna.albany.edu/).,OADS,/arxiv_data1/oa_pdf/0c/69/1802.PMC3884663.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040030.113.© 2013 Demirci et al.,OADS,/arxiv_data1/oa_pdf/d9/e1/1791.PMC3884664.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/1791.PMC3884664.pdf
"The PyMOL Molecular Graphics System, Version 1.5. http://www.pymol.org/.",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/1791.PMC3884664.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041194.113.© 2013 Dembowski et al.,OADS,/arxiv_data1/oa_pdf/a4/15/1639.PMC3884665.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.REPORT RNA 19:1639 –1647; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1639",Non-OADS,/arxiv_data1/oa_pdf/a4/15/1639.PMC3884665.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038356.113.,OADS,/arxiv_data1/oa_pdf/23/cf/1669.PMC3884666.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/23/cf/1669.PMC3884666.pdf
"The structures were generated with PyMol, by modifying a PyMol Session downloaded from http://www.mol.biol.ethz.ch/groups/ban_group/Ribosome, based on the PDB files 2XZM(40S) and 4A17, 4A19 (60S).",OADS,/arxiv_data1/oa_pdf/23/cf/1669.PMC3884666.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040865.113.© 2013 Cox et al.,OADS,/arxiv_data1/oa_pdf/20/ed/1825.PMC3884667.pdf
"After 12 months, it is availa- ble under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/20/ed/1825.PMC3884667.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040055.113.,OADS,/arxiv_data1/oa_pdf/a2/ec/1632.PMC3884668.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.REPORT 1632 RNA 19:1632 –1638; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/a2/ec/1632.PMC3884668.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040360.113.© 2013 Sabath et al.,OADS,/arxiv_data1/oa_pdf/a2/80/1726.PMC3884669.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a2/80/1726.PMC3884669.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039461.113.© 2013 Moreno-Mateos et al.,OADS,/arxiv_data1/oa_pdf/88/46/1711.PMC3884670.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/88/46/1711.PMC3884670.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/88/46/1711.PMC3884670.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039677.113.© 2013 Jiang et al.,OADS,/arxiv_data1/oa_pdf/26/aa/1745.PMC3884671.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/26/aa/1745.PMC3884671.pdf
http://www.bnf.org/ 9.,Non-OADS,/arxiv_data1/oa_pdf/ec/c3/bmjopen-2013-003815.PMC3884700.pdf
"http://www.dh.gov.uk/publications Thomas CM, Cameron S. BMJ Open 2013; 3:e003815.",Non-OADS,/arxiv_data1/oa_pdf/ec/c3/bmjopen-2013-003815.PMC3884700.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003900).,Non-OADS,/arxiv_data1/oa_pdf/d0/bd/bmjopen-2013-003900.PMC3884701.pdf
2012. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/bd/bmjopen-2013-003900.PMC3884701.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003950).,Non-OADS,/arxiv_data1/oa_pdf/86/a9/bmjopen-2013-003950.PMC3884740.pdf
"Data sharing statement No additional data are available.Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/86/a9/bmjopen-2013-003950.PMC3884740.pdf
Secondary adherence to long-term therapies: evidence for action 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/86/a9/bmjopen-2013-003950.PMC3884740.pdf
Secondary Report on the Global AIDS Epidemic 2010. http://www.unaids.org/globalreport/global_report.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/86/a9/bmjopen-2013-003950.PMC3884740.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003898).,Non-OADS,/arxiv_data1/oa_pdf/34/15/bmjopen-2013-003898.PMC3884742.pdf
http://wok.mimas.ac.uk/ 22.,Non-OADS,/arxiv_data1/oa_pdf/34/15/bmjopen-2013-003898.PMC3884742.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
2012. http://www.apps.who.int/iris/bitstream/10665/75263/1/9789241564458_eng.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"London, 2005. http://www.rcpsych.ac.uk/pdf/ whocareswins.pdf 4.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
2011. http://www.rcpsych.ac.uk/pdf/NATIONAL%20REPORT%20-%20Full%20Report%201201122.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"London: Department of Health, 2009. https://www.gov.uk/government/publications/ living-well-with-dementia-a-national-dementia-strategy 6.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"London: Department of Health, 2010. https://www.gov.uk/government/publications/quality-outcomes-for-people-with-dementia-building-on-the-work-of -the-national-dementia-strategy 7.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"London: Royal College of Nursing, 2010. http://nursingstandard.rcnpublishing.co.uk/shared/cms/file.asp?e=35&i=172190 8.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"2012. http://www.netscc.ac.uk/hsdr/projdetails.php?ref=08-1809-227 Spencer K, Foster P, Whittamore KH, et al.BMJ Open 2013; 3:e004198.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://nottingham.ac.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://www.trialsjournal.com/content/12/1/ 123 16.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://www.joaag.com/uploads/06_Research_Note_ Srivastava_and_Thomson_4_2_.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://journals.cambridge.org/action/ displayAbstract?fromPage=online&aid=230595 21.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://dx.doi.org/10.1016/j.ijnurstu.2013.03.001 23.,OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 12919216 24.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://www.ssiacymru.org.uk/resource/9_n_Beyond_Person_Centred_Care.pdf 32.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
http://onlinelibrary.wiley.com/doi/10.1046/j.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
2011. http://www.sdo.nihr.ac.uk/projdetails.php?ref=08-1819-218 39.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
2011. http://www.cqc.org.uk/sites/ default/files/media/documents/20111007_dignity_and_nutrition_inspection_report_final_update.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
"London: Alzheimer ’s Society, 2012. http://www.alzheimers.org.uk/ dementia2012 8 Spencer K, Foster P, Whittamore KH, et al.BMJ Open 2013; 3:e004198.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/bmjopen-2013-004198.PMC3884743.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004029).,Non-OADS,/arxiv_data1/oa_pdf/76/13/bmjopen-2013-004029.PMC3884754.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/76/13/bmjopen-2013-004029.PMC3884754.pdf
The questionnaire is availableat http://www.genomethics.org; ﬁlm and animation are used toexplain the concepts needed to answer the questions.,OADS,/arxiv_data1/oa_pdf/3b/a5/ajmg0161-2099.PMC3884757.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004085).,Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
2013. http://ash.org.uk/files/documents/ASH_106.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
[Online]http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201304&RIN=0910-AG38 (accessed 20 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
2012. http://ash.org.uk/files/documents/ASH_701.,Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
[Online] http://neighbourhood.statistics.gov.uk/HTMLDocs/nessgeography/superoutputareasexplained/output-areas-explained.htm (accessed21 Aug 2013).,OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
2010. https://www.gov.uk/government/publications/english-indices-of-deprivation-2010 (accessed 9 Aug 2010).,Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
"Reuters, 2013. http://uk.reuters.com/article/2013/06/13/us-ecigarettes-factbox-idUSBRE95C0FG20130613 (accessed 10 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/04/90/bmjopen-2013-004085.PMC3884782.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003729).,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/bmjopen-2013-003729.PMC3884786.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003486).,Non-OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
http://www.diabetes.ca/documents/about diabetes/PrevalanceandCost_09.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
http://www.phac-aspc.gc.ca/publicat/2009/ndssdic-snsddac-09/pdf/report-2009-eng.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
[cited 1 Sep 2012].http://www.diabetes.ca/docments/for-professionals/CJD--March_2010--Beatty.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
http://www.statcan.gc.ca/pub/82-625-x/2012001/article/11656-eng.htm 15.,OADS,/arxiv_data1/oa_pdf/a6/cc/bmjopen-2013-003486.PMC3884805.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003687).,Non-OADS,/arxiv_data1/oa_pdf/9d/7a/bmjopen-2013-003687.PMC3884819.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. van den Broek IVF, Hoebe CJPA, van Bergen JEAM, et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/7a/bmjopen-2013-003687.PMC3884819.pdf
http://www.soaaids-professionals.nl/training_scholing/online_consult (accessed Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/9d/7a/bmjopen-2013-003687.PMC3884819.pdf
Rutgers Nisso Group 2010. http://www.rutgerswpf.nl/article/onderzoekspublicatie-seksuele-gezondheid-nederland-2009 (accessed Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/9d/7a/bmjopen-2013-003687.PMC3884819.pdf
http://www.dndi.org/diseases-projects/diseases/hat/target-product-pro ﬁle.html29 HAT: target and compound selection,Non-OADS,/arxiv_data1/oa_pdf/fc/59/S0031182013001017a.PMC3884840.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004141).,Non-OADS,/arxiv_data1/oa_pdf/a0/56/bmjopen-2013-004141.PMC3884842.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a0/56/bmjopen-2013-004141.PMC3884842.pdf
"U.S. Food and Drug Administration, Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trialsfor Therapeutics in Adult Healthy Volunteers, Pharmacology andToxicology, 2005, http://www.fda.gov/cder/guidance/index.htm 37.",Non-OADS,/arxiv_data1/oa_pdf/a0/56/bmjopen-2013-004141.PMC3884842.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003737).,Non-OADS,/arxiv_data1/oa_pdf/8b/02/bmjopen-2013-003737.PMC3884844.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/02/bmjopen-2013-003737.PMC3884844.pdf
European eHealth Initiative: http://subs.emis.de/LNI/ Proceedings/Proceedings91/GI-Proceedings-91-2.pdf (accessed29 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/8b/02/bmjopen-2013-003737.PMC3884844.pdf
http://www.casp-uk.net/wp- content/uploads/2011/11/CASP-Economic-Evaluations-Checklist-31.05.13.pdf (accessed 29 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/8b/02/bmjopen-2013-003737.PMC3884844.pdf
http://www.crd.york.ac.uk/prospero (assessed 29 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/8b/02/bmjopen-2013-003737.PMC3884844.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004140).,Non-OADS,/arxiv_data1/oa_pdf/ad/c4/bmjopen-2013-004140.PMC3884851.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/jer-9-6-495-1.PMC3884866.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 495The Journal of Exercise Rehabilitation  starts as the  international journal Chang-Ju Kim The Journal of Exercise Rehabilitation  is listed in the PubMed  Central, few months after changing to English journal.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/jer-9-6-495-1.PMC3884866.pdf
"Publisher of the Journal of Exercise Rehabilitation   Department of Physiology, Kyung Hee University College of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea  E-mail: changju@khu.ac.kr http://dx.doi.org/10.12965/jer.130083Editorial Journal of Exercise Rehabilitation 2013;9(6):495",Non-OADS,/arxiv_data1/oa_pdf/dd/13/jer-9-6-495-1.PMC3884866.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 496*Corresponding author:  Sooyeon Kim College of Physical Education, Kookmin University, 77 Jeongneung-ro, Seongbuk- gu, Seoul 136-702, Korea  Tel: +82-2-910-5949, Fax: +82-2-910-4789, E-mail: sueykim@kookmin.ac.kr Received:  November 1, 2013/ Revised:  November 25, 2013/   Accepted:  December 16, 2013Neuro-cognition and social-cognition: application to  exercise rehabilitation Sooyeon Kim* College of Physical Education, Kookmin University, Seoul, Korea The discovery of mirror neurons has been recognized as one of the ma - jor developments in neuroscience, with possible implications for the  explanation of many important cognitive functions, including action and perception understanding, imitation, and empathy.",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
http://dx.doi.org/10.12965/jer.130074Review Article Journal of Exercise Rehabilitation 2013;9(6):496-499,Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
"http://www.e-jer .org     497 http://dx.doi.org/10.12965/jer .130074 Kim S  •  Neuro-cognition and social-cognitionNEURO-COGNITION: MIRROR NEURON  AND MOTOR PERCEPTION When observing other people’s performance, human brains sim - ulate the performance of the observed action.",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
"http://dx.doi.org/10.12965/jer .130074 Kim S  •  Neuro-cognition and social-cognition 498    http://www.e-jer .orgResearchers in the field of body psychotherapy have stressed that  therapeutic interventions based on bodily expression can foster  empathy and, more generally, develop interpersonal coordination  (McGarry and Russo, 2011).",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
"http://www.e-jer .org     499 http://dx.doi.org/10.12965/jer .130074 Kim S  •  Neuro-cognition and social-cognitionDecety J, Jackson PL.",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jer-9-6-496-2.PMC3884867.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 500*Corresponding author:  Hyunna Kim Department of Social Welfare, Cheongam College, 1641 Noksaek-ro, Suncheon  540-743, Korea Tel: +82-10-6254-0901, Fax: +82-61-740-7298, E-mail: hyunna@chol.com Received:  December 1, 2013/ Revised:  December 19, 2013/   Accepted:  December 23, 2013Exercise rehabilitation for smartphone addiction Hyunna Kim* Department of Social Welfare, Cheongam College, Suncheon, Korea Internet addiction after launching smartphone is becoming serious.",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"Among them, 4,585 students  (1.81%) were risky users; they cannot done properly school work, http://dx.doi.org/10.12965/jer.130080Review Article Journal of Exercise Rehabilitation 2013;9(6):500-505",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"http://www.e-jer .org     501 http://dx.doi.org/10.12965/jer .130080 Kim H  •  Exercise rehabilitation for smartphone addictioninterpersonal relationship and feel psychological anxiety and lone - liness without using smartphone (Online news, 2013).",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"http://dx.doi.org/10.12965/jer .130080 Kim H  •  Exercise rehabilitation for smartphone addiction 502    http://www.e-jer .orgsymptoms, dropping out of school, antisocial personality disorder  and alcohol abuse.",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"http://www.e-jer .org     503 http://dx.doi.org/10.12965/jer .130080 Kim H  •  Exercise rehabilitation for smartphone addictionComplementary treatment Previous studies have documented that an adolescent’s family  environment is highly predictive for adolescent internet addiction  (Nam, 2008).",Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
http://dx.doi.org/10.12965/jer .130080 Kim H  •  Exercise rehabilitation for smartphone addiction 504    http://www.e-jer .orgTHE APPLICABILITY OF EXERCISE  REHABILITATION Exercise rehabilitation has the evidence-based exercise science  knowledge to address a wide range of physical and psychological  problems.,Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
http://www.e-jer .org     505 http://dx.doi.org/10.12965/jer .130080 Kim H  •  Exercise rehabilitation for smartphone addictionCONFLICT OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
Available from http://www.hankyung.com/news/ app/newsview.php?aid=2012111339986.,Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
Available from  http://www.kyeonggi.com/news/articleView.html?idxno=675154.,Non-OADS,/arxiv_data1/oa_pdf/eb/de/jer-9-6-500-3.PMC3884868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 506*Corresponding author:  Soon Gi Baek Department of Sports Health, College of Health Care, Jungwon University, 85  Munmu-ro, Goesan-gun, Chungcheongbuk-do 367-700, Korea Tel: +82-43-830-8840, Fax: +82-43-830-8679, E-mail: bsg@jwu.ac.kr Received:  October 23, 2013/ Revised:  November 13, 2013/   Accepted:  December 9, 2013Age-dependent effect of treadmill exercise on  hemorrhage-induced neuronal cell death in rats Jin-Hwan Yoon1, Hee-Hyuk Lee1, Eun-Surk Yi2, Soon Gi Baek3,* 1Department of Sports Science, College of Life Science and Nano Technology, Hannam University, Daejeon, Korea 2Department of Exercise Rehabilitation & Welfare, College of Health Science, Gachon University, Incheon, Korea 3Department of Sports Health Medicine, College of Health Science, Jungwon University, Chungcheongbuk-do, Korea Intracerebral hemorrhage (ICH) is a major cause of death and disability  in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
(2005) showed that treadmill exercise suppressed http://dx.doi.org/10.12965/jer.130070Original Article Journal of Exercise Rehabilitation 2013;9(6):506-510,Non-OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"http://www.e-jer .org     507 http://dx.doi.org/10.12965/jer .130070 Yoon J-H, et al.",OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"http://dx.doi.org/10.12965/jer .130070 Yoon J-H, et al.",OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"http://www.e-jer .org     509 http://dx.doi.org/10.12965/jer .130070 Yoon J-H, et al.",OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"http://dx.doi.org/10.12965/jer .130070 Yoon J-H, et al.",OADS,/arxiv_data1/oa_pdf/25/59/jer-9-6-506-4.PMC3884869.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/62/jer-9-6-511-5.PMC3884870.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 511*Corresponding author:  Soon Gi Baek Department of Sports Health, College of Health Care, Jungwon University, 85  Munmu-ro, Goesan-gun, Chungcheongbuk-do 367-700, Korea Tel: +82-43-830-8840, Fax: +82-43-830-8679, E-mail: bsg@jwu.ac.kr Received:  November 9, 2013/ Revised:  December 9, 2013/   Accepted:  December 19, 2013The effects of different beverage intake on blood  components during exercise under high-temperature  environment Soon Gi Baek* Department of Sports Health Medicine, College of Health Science, Jungwon University, Chungcheongbuk-do, Korea High temperature environment causes detrimental effects on health.",Non-OADS,/arxiv_data1/oa_pdf/4f/62/jer-9-6-511-5.PMC3884870.pdf
Experimental procedure The conditions of exercise chamber were 38-40˚C temperature http://dx.doi.org/10.12965/jer.130078Original Article Journal of Exercise Rehabilitation 2013;9(6):511-513,Non-OADS,/arxiv_data1/oa_pdf/4f/62/jer-9-6-511-5.PMC3884870.pdf
http://dx.doi.org/10.12965/jer .130078 Baek SG  •  Effects of different beverage intake on blood components 512    http://www.e-jer .orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/jer-9-6-511-5.PMC3884870.pdf
"http://www.e-jer .org     513 http://dx.doi.org/10.12965/jer .130078 Baek SG  •  Effects of different beverage intake on blood componentsHigh intensity exercise causes increment of glucose concentra - tion (Geor et al., 2000) and submaximal intensity exercise causes  increment of glucose concentration 30 min after exercise (Flynn et  al, 1990).",Non-OADS,/arxiv_data1/oa_pdf/4f/62/jer-9-6-511-5.PMC3884870.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 514*Corresponding author:  Eun-Ok Lee Department of Physical Rehabilitation, Russian State University of Physical Education,  Sport, Y outh and Tourism, Moscow, Sirenevy Boulevard 4, 105-122, Russia Tel: +7-495-961-3111, Fax: +82-10-9428-0010, E-mail: y21c486@naver.com  Received:  August 27, 2013/ Revised:  October 24, 2013/ Accepted:  December 16, 2013The effect of complex exercise rehabilitation program on  body composition, blood pressure, blood sugar, and vessel  elasticity in elderly women with obesity Eun-Ok Lee1,*, Kwon-Ho Lee2, Olga Kozyreva1 1Department of Physical Rehabilitation, Russian State University of Physical Education, Sport, Youth and Tourism, Moscow, Russia 2Department of Physical Therapy, Joong Bu University, Geumsan, Korea The purpose of this study is to identify what kind of effects complex ex - ercise rehabilitation program has on body composition of female, blood  pressure, blood sugar, blood vessel elasticity and find more effective complex exercise program for elderly females.",Non-OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"Also, during se -http://dx.doi.org/10.12965/jer.130065Original Article Journal of Exercise Rehabilitation 2013;9(6):514-519",Non-OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"http://www.e-jer .org     515 http://dx.doi.org/10.12965/jer .130065 Lee E-O, et al.",OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"http://dx.doi.org/10.12965/jer .130065 Lee E-O, et al.",OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"http://www.e-jer .org     517 http://dx.doi.org/10.12965/jer .130065 Lee E-O, et al.",OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"http://dx.doi.org/10.12965/jer .130065 Lee E-O, et al.",OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"http://www.e-jer .org     519 http://dx.doi.org/10.12965/jer .130065 Lee E-O, et al.",OADS,/arxiv_data1/oa_pdf/11/c4/jer-9-6-514-6.PMC3884871.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 520*Corresponding author:  Sunghee Park  College of Physical Education and Sport Science, Kookmin University, 77  Jeongneung-ro, Seongbuk-gu, Seoul 136-702, Korea  Tel: +82-10-9262-8616, Fax: +82-2-910-4789, E-mail: sungheepark@kookmin.ac.kr Received:  October 31, 2013/ Revised:  December 13, 2013/   Accepted:  December 16, 2013Participation motivation and competition anxiety among  Korean and non-Korean wheelchair tennis players Irully Jeong, Sunghee Park* College of Physical Education and Sport Science, Kookmin University, Seoul, Korea The purpose of this study was to examine differences in participation  motivation and competition anxiety between Korean and non-Korean wheelchair tennis players and to identify relations between participa - tion motivation and competition anxiety in each group.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
Anxiety is one of the most popular topics in the sport psycholo -http://dx.doi.org/10.12965/jer.130072Original Article Journal of Exercise Rehabilitation 2013;9(6):520-525,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"http://www.e-jer .org     521 http://dx.doi.org/10.12965/jer .130072 Jeong I, et al.",OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"http://dx.doi.org/10.12965/jer .130072 Jeong I, et al.",OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"http://www.e-jer .org     523 http://dx.doi.org/10.12965/jer .130072 Jeong I, et al.",OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"http://dx.doi.org/10.12965/jer .130072 Jeong I, et al.",OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"http://www.e-jer .org     525 http://dx.doi.org/10.12965/jer .130072 Jeong I, et al.",OADS,/arxiv_data1/oa_pdf/1f/fe/jer-9-6-520-7.PMC3884872.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 526*Corresponding author:  Seung-Ae Y ang College of Nursing, Sungshin Women’s University, 55 Dobong-ro 76ga-gil,  Gangbuk-gu, Seoul 142-732, Korea Tel: +82-2-920-7728, Fax: +82-2-968-0560, E-mail: ewha63@sungshin.ac.kr Received:  November 29, 2013/ Accepted:  December 16, 2013Association of TLR6 single nucleotide polymorphisms and  clinical features of ischemic stroke in Korean population Seung-Ae Yang* College of Nursing, Sungshin Women’s University, Seoul, Korea Recent studies showed association between diseases and TLR6 poly - morphisms.",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
"Moreover, TNF-alpha me- diated inflammation may contribute to the cerebral aneurysms,  which is another cerebral artery disease and related with severe in - flammatory responses, and TLR-mediated innate immunity was http://dx.doi.org/10.12965/jer.130076Original Article Journal of Exercise Rehabilitation 2013;9(6):526-531",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
"http://www.e-jer .org     527 http://dx.doi.org/10.12965/jer .130076 Yang S-A  •  TLR6 SNPs and ischemic strokerelated with higher TNF-alpha expression (Jayaraman et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
"Statistical analysis SNPStats (http://bioinfo.iconcologia.net/index.php?module =  Snpstats) and SPSS 20.0 (SPSS Inc., Chicago, IL, USA) were used  to obtain odds ratios (ORs), 95% confidence intervals (CIs), and P  values.",OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
http://dx.doi.org/10.12965/jer .130076 Yang S-A  •  TLR6 SNPs and ischemic stroke 528    http://www.e-jer .orgdy-Weinberg equilibrium of each SNP was tested in SNPstats.,OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
http://www.e-jer .org     529 http://dx.doi.org/10.12965/jer .130076 Yang S-A  •  TLR6 SNPs and ischemic strokeTable 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
http://dx.doi.org/10.12965/jer .130076 Yang S-A  •  TLR6 SNPs and ischemic stroke 530    http://www.e-jer .orgTable 5.,Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
http://www.e-jer .org     531 http://dx.doi.org/10.12965/jer .130076 Yang S-A  •  TLR6 SNPs and ischemic strokebility to Crohn’s disease independent of NOD2.,Non-OADS,/arxiv_data1/oa_pdf/ef/a1/jer-9-6-526-8.PMC3884873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 532*Corresponding author:  Byoung-Hee Lee Department of Physical Therapy, Sahmyook University, 815 Hwarang-ro,   Nowon-gu, Seoul 139-742, Korea Tel: +82-2-3399-1634, Fax: +82-2-3399-1639, E-mail: 3679@syu.ac.kr Received:  November 19, 2013/ Accepted:  December 19, 2013A study of the relationship among fear-avoidance beliefs,  pain and disability index in patients with low back pain Eun Jung Chung1, Young-Goo Hur2, Byoung-Hee Lee1,* 1Department of Physical Therapy, Sahmyook University, Seoul, Korea 2Department of Physical Therapy, Cheju Halla University, Cheju, Korea This study was conducted in order to determine the relationship among  fear-avoidance beliefs, pain and disability index in patients with low back pain as well as to identify factors having an influence on fear-avoid - ance beliefs, pain and disability index.",Non-OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"High scores on the Fear-Avoid - ance Beliefs Questionnaire (FABQ) (Waddell et al., 1993), a vali - dated two-part questionnaire, which examines the role of fear in  physical activity and work, have been attributed to the mainte - nance of both chronic pain and pain-related disability (Basler et  al., 2008).http://dx.doi.org/10.12965/jer.130079Original Article Journal of Exercise Rehabilitation 2013;9(6):532-535",Non-OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"http://www.e-jer .org     533 http://dx.doi.org/10.12965/jer .130079 Chung EJ, et al.",OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"http://dx.doi.org/10.12965/jer .130079 Chung EJ, et al.",OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"http://www.e-jer .org     535 http://dx.doi.org/10.12965/jer .130079 Chung EJ, et al.",OADS,/arxiv_data1/oa_pdf/8a/bd/jer-9-6-532-9.PMC3884874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 536*Corresponding author:  Sook-Ja Hong  Department of Social Welfare, Continuing Education Center, Dankook University,  152 Jukjeon-ro, Suji-gu, Y ongin 448-701, Korea  Tel: +82-31-8005-2613, Fax: +82-31-8021-7170, E-mail: soohong2@naver.com Received:  November 15, 2013/ Revised:  December 3, 2013/   Accepted:  December 14, 2013A study on the network of disabled person rehabilitation  using social network analysis: focus on the comparison  between two governments  Jae-Moo Lee, Sook-Ja Hong* Department of Social Welfare, Continuing Education Center, Dankook University, Yongin, Korea  This study compared the network of rehabilitation for the disabled  during the Roh, Moo-hyun administration and the Lee, Myung-bak ad - ministration.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"The special features of  networks are high flexibility and adaptability in various situations  since the connection and route of each agents can be shown in in - tersections, lines and diagrams and expressed in mathematical http://dx.doi.org/10.12965/jer.130081Original Article Journal of Exercise Rehabilitation 2013;9(6):536-543",Non-OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://www.e-jer .org     537 http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://www.e-jer .org     539 http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://www.e-jer .org     541 http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"http://www.e-jer .org     543 http://dx.doi.org/10.12965/jer .130081 Lee J-M, et al.",OADS,/arxiv_data1/oa_pdf/27/b3/jer-9-6-536-10.PMC3884875.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 544*Corresponding author:  Y ang Chool Lee Department of Sports & Leisure Studies, Gachon University,   1342 Seongnam-daero, Sujeong–gu, Seongnam 461-701, Korea Tel: +82-32-820-4354, Fax: +82-32-820-4049, E-mail: yclee@gachon.ac.kr Received:  November 18, 2013/ Accepted:  December 18, 2013The relationship between mental health and health- related physical fitness of university students  Bog Ja Jeoung1, Myoung-Sun Hong2, Yang Chool Lee3,* 1Department of Exercise Rehabilitation &Welfare, Gachon University, Inchon, Korea 2Department of Health Care Management, Gachon University, Seongnam, Korea 3Department of Sports & Leisure Studies, Gachon University, Seongnam, Korea The purpose of this study was to examine the relationship between  mental health and health-related physical fitness of university students.",Non-OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
MATERIALS AND METHODS Participants After explaining the purpose of the research to the university http://dx.doi.org/10.12965/jer.130082Original Article Journal of Exercise Rehabilitation 2013;9(6):544-548,Non-OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"http://www.e-jer .org     545 http://dx.doi.org/10.12965/jer .130082 Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"http://dx.doi.org/10.12965/jer .130082 Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"http://www.e-jer .org     547 http://dx.doi.org/10.12965/jer .130082 Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"http://dx.doi.org/10.12965/jer .130082 Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/a2/jer-9-6-544-11.PMC3884876.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/1b/jer-9-6-549-12.PMC3884877.pdf
"Copyright © 2013 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 549Erratum: Figure Change in Journal of Exercise  Rehabilitation (JER) http://dx.doi.org/10.12965/jer.130002s1Correspondence Journal of Exercise Rehabilitation 2013;9(6):549 Effects of aging and exercise training on apoptosis in the heart Hyo-Bum Kwak Journal of Exercise Rehabilitation 2013;9(2):212-219. doi:10.12965/jer.130002 In the page 213 and 216, there were mistakes in Fig.",Non-OADS,/arxiv_data1/oa_pdf/2b/1b/jer-9-6-549-12.PMC3884877.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/2d/rrt076.PMC3885110.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/1d/rrt082.PMC3885115.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/rrt083.PMC3885116.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/rrt086.PMC3885119.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/ef/rrt087.PMC3885120.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/a5/rrt089.PMC3885122.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/65/rrt100.PMC3885132.pdf
"Corresponding Author :   Fariba Asghari  Address: Medical Ethics and History of Medicine Research Center, #21, Shanzdah Azar St.Tehran, Iran  Email: fasghari@tums.ac.ir    Tel: 98 21 66 41 96 61  Fax: 98 21 66 41 96 61      Received: 23 Jan 2013  Accepted: 22 Jun 2013  Published: 05 Aug 2013      J Med Ethics Hist Med, 2013, 6:7  http://journals.tums.ac.ir/abs/23708     © 2013 Fariba Asghari et al.",Non-OADS,/arxiv_data1/oa_pdf/91/4a/jmehm-6-7.PMC3885212.pdf
HKSPM Newsletter 2007; 3: 30 -36.  http://www.fmshk.org/database/articles/dignityrespectfordignityanddignityconservinginpall.pdf  (accessed in 2013)   19.,Non-OADS,/arxiv_data1/oa_pdf/c0/04/jmehm-6-12.PMC3885223.pdf
"Probe preparation for ﬂuorescence in situ hybridization Bacterial artiﬁcial chromosome (BAC) clones were selected using University of California, Santa Cruz(UCSC) genome browser (http://genome.ucsc.edu; hg19) and obtained from Children’s Hospital Oakland ResearchLOC100507651 LOC286177 LINC00588UBXN2B CYP7A1 SDCBPCA8 RAB2ACLVS1 ASPH FAM110B TOXCHD7 NSMAFLOC100130298MIR4470 NKAIN3UG0898H09 GGH TTPA YTHDF3 LOC286184 LOC100130155MIR124-2 LOC401463 BHLHE22 CYP7B1 LINC00251ARMC1 MTFR1RRS1 MYBL11FLUS 6APC PREX2 TRIM55 COPS5VCPIP1 LOC286189 C8ORF34 LOC10050718 PDE7ASGK3 PTTG3P LOC286186 DNAJC5BCRH CSPP1 ARFGEF1 LOC100505659 LOC100505676ADHFE1 C8orf46C8orf44-SGK3 MCMDC2SNHG6 SNORD87 TCF24 PPP1R428q12.1 8q12.28q12.3 8q13.18q13.2 Monfort 2008 Lehman 2009 Amouroux 2012 current report (mosaic)Vincent 1994 Rickard 2001 (without DRS)Calabrese 2000 Calabrese 1998Pizzuti 2002Current report Luo 2012 (without DRS) Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/66/df/ccr30001-0030.PMC3885256.pdf
"C8ORF34 is a cDNA isolated from a human vestibular library which encodes an uncharacterized protein contain- ing a putative cAMP-dependent protein kinase regulatorysubunit expressed in adult brain, eye, ear, pituitary gland,thymus, kidney, and stomach (UCSC genome browserhttp://genome.ucsc.edu and Stanford SOURCE search genereport, http://source.stanford.edu).",OADS,/arxiv_data1/oa_pdf/66/df/ccr30001-0030.PMC3885256.pdf
Declaration of Helsinki (May 2011)  http://www.wma.net/en/30publications/10policies/b3/index.html  (accessed in 2013)  3.,Non-OADS,/arxiv_data1/oa_pdf/4a/7e/jmehm-6-8.PMC3885271.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/61/sbs136.PMC3885287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/ab/sbs151.PMC3885290.pdf
Office for National  Statistcs ; 2005. http://www.ons.gov.uk/ons/guide-method/ classifications/current-standard-classifications/soc2010/ index.html .,OADS,/arxiv_data1/oa_pdf/64/ab/sbs151.PMC3885290.pdf
London: ODPM; 2004. http://data.gov.uk/dataset/ imd_2004 .,OADS,/arxiv_data1/oa_pdf/64/ab/sbs151.PMC3885290.pdf
nationalarchives.gov.uk/+/http://www.dca.gov.uk/elections/ elect_odpm_turnout.pdf .,Non-OADS,/arxiv_data1/oa_pdf/64/ab/sbs151.PMC3885290.pdf
"Tissue Barriers 2013;1: e25039; http://dx.doi.org/10.4161/tisb.25039Zonula occludens  proteins (Z o-1, Z o-2, Z o-3), which belong to  the family of membrane-associated guanylate kinase (MA gUK)  homologs, serve as molecular hubs for the assembly of multi- protein networks at the cytoplasmic surface of intercellular  contacts in epithelial and endothelial cells.",OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Cold Spring Harb Perspect Biol 2010; 2:a002907; PMID:20182608; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Fluids Barriers CNS 2012; 9:23;  PMID:23140302; http://dx.doi.org/10.1186/2045- 8118-9-23 4.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell Res  2008; 314:3356-68; PMID:18817772; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Epilepsia  2012; 53(Suppl 6):1-6; PMID:23134489; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Ann Neurol 2012; 72:648-72; PMID:23280789;  http://dx.doi.org/10.1002/ana.23648 7.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Neurotoxicology 2012; 33:586-604; PMID:22198708;  http://dx.doi.org/10.1016/j.neuro.2011.12.009 8.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
CNS Neurosci  Ther 2012; 18:609-15; PMID:22686334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Nature 1993; 361:552-5;  PMID:8429911; http://dx.doi.org/10.1038/361552a0 10.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
"Methods 2003; 30:228-34; PMID:12798137;  http://dx.doi.org/10.1016/S1046-2023(03)00029-X 11. van Meer G, Gumbiner B, Simons K. The tight junc-tion does not allow lipid molecules to diffuse from one  epithelial cell to the next.",Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
"Nature 1986; 322:639-41;  PMID:3748143; http://dx.doi.org/10.1038/322639a0 12. van Meer G, Simons K. The function of tight junc-tions in maintaining differences in lipid composition  between the apical and the basolateral cell surface  domains of MDCK cells.",OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Histochem Cell Biol 2008; 130:1-20; PMID:18365233; http://dx.doi.org/10.1007/s00418- 008-0418-7 14.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Neural T ransm 2011;  118:7-21; PMID:20865434; http://dx.doi.org/10.1007/ s00702-010-0484-6 15.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Biochim  Biophys Acta 2009; 1788:820-31; PMID:18706883;  http://dx.doi.org/10.1016/j.bbamem.2008.07.015 16.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Adv Drug Deliv Rev 2005; 57:811- 4; PMID:15820554; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Biochim Biophys Acta 2008; 1778:729-56;  PMID:17950242; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
T rends Cell Biol 2010; 20:142- 9; PMID:20061152; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Kidney Int 2007; 72:1448-58;  PMID:17914350; http://dx.doi.org/10.1038/ sj.ki.5002579 20.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Int Rev Cytol 2006; 248:261- 98; PMID:16487793; http://dx.doi.org/10.1016/ S0074-7696(06)48005-0 21.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Biochim Biophys Acta 2008; 1778:660- 9; PMID:17854762; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Ann N Y Acad Sci 2012; 1258:9-18; PMID:22731710; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Essays Biochem 2012;  53:83-93; PMID:22928510; http://dx.doi.org/10.1042/ bse0530083 27.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Bioessays 1999; 21:912- 21; PMID:10517864; http://dx.doi.org/10.1002/ (SICI)1521-1878(199911)21:11<912::AID- BIES3>3.0.CO;2-Z 28.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Annu Rev Biochem 2005; 74:219-45;  PMID:15952887; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
"Semin Cell Dev Biol 2000; 11:315- 24; PMID:10966866; http://dx.doi.org/10.1006/scdb.2000.0178 30. te Velthuis AJ, Admiraal JF , Bagowski CP .",OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
BMC Evol Biol 2007; 7:129; PMID:17678554; http://dx.doi.org/10.1186/1471-2148-7-129 31.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2003; 278:6873-8; PMID:12482754; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Proc Natl Acad Sci U S A 1991;  88:3460-4; PMID:2014265; http://dx.doi.org/10.1073/ pnas.88.8.3460 33.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 1998; 141:199- 208; PMID:9531559; http://dx.doi.org/10.1083/ jcb.141.1.199 34.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol  1994; 124:949-61; PMID:8132716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Cell Mol Life Sci 2004; 61:1354-65;  PMID:15170513; http://dx.doi.org/10.1007/s00018- 004-4010-6 65.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 1999; 147:1569-82; PMID:10613913; http://dx.doi.org/10.1083/ jcb.147.7.1569 67.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Curr Biol  2004; 14:1436-50; PMID:15324660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Tight-junction pro- tein zonula occludens 2 is a target of phosphorylation  by protein kinase C. Biochem J 2001; 360:295-304;  PMID:11716757; http://dx.doi.org/10.1042/0264- 6021:3600295 69.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Biol Cell 2009; 20:4120-9;  PMID:19625451; http://dx.doi.org/10.1091/mbc.E08-11-1129 70.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2002; 277:24855- 8; PMID:12023272; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Sci 2008; 121:814-24; PMID:18285450; http://dx.doi.org/10.1242/ jcs.014878 74.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell Res 2006; 312:3323- 35; PMID:16920099; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Proc Natl Acad Sci U S  A 1996; 93:10779-84; PMID:8855257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 1994; 127:1617- 26; PMID:7798316; http://dx.doi.org/10.1083/ jcb.127.6.1617 52.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 1999; 147:1351-63; PMID:10601346; http://dx.doi.org/10.1083/ jcb.147.6.1351 53.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
EMBO J 2001; 20:3738- 48; PMID:11447115; http://dx.doi.org/10.1093/ emboj/20.14.3738 55.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 2001; 154:491- 7; PMID:11489913; http://dx.doi.org/10.1083/ jcb.200103047 56.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 2002; 157:161-72; PMID:11927608; http://dx.doi.org/10.1083/jcb.200109010 57.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
FEBS Lett 2005; 579:3725-30; PMID:15975580; http://dx.doi.org/10.1016/j.febs- let.2005.05.062 58.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Am J Pathol 2010; 176:134- 45; PMID:19959811; http://dx.doi.org/10.2353/ ajpath.2010.090220 59.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol 1997; 139:785- 95; PMID:9348294; http://dx.doi.org/10.1083/ jcb.139.3.785 60.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2007; 282:37710- 6; PMID:17928286; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 1999; 274:5981-6; PMID:10026224; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Neurochem Int 2009; 54:393-402; PMID:19418635;  http://dx.doi.org/10.1016/j.neuint.2009.01.003 63.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biol  1986; 103:755-66; PMID:3528172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biomed Biotechnol  2010; 2010:402593; PMID:20224657; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Ann N Y Acad Sci 2009; 1165:113-20;  PMID:19538295; http://dx.doi.org/10.1111/j.1749- 6632.2009.04440.x 38.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2000; 275:30573-85; PMID:10874042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 1999; 274:35179- 85; PMID:10575001; http://dx.doi.org/10.1074/ jbc.274.49.35179 41.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Biol Cell 2007; 18:721-31;  PMID:17182847; http://dx.doi.org/10.1091/mbc.E06- 08-0764 42.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Sci 2003; 116:1279-89;  PMID:12615970; http://dx.doi.org/10.1242/jcs.00302 43.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 1997; 272:31589-97; PMID:9395497; http://dx.doi.org/10.1074/jbc.272.50.31589 44.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Cell Neurosci 1998; 11:149- 60; PMID:9647693; http://dx.doi.org/10.1006/ mcne.1998.0677 45.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Dev Cell  2011; 21:479-91; PMID:21920314; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
PLoS One 2013; 8:e54410; PMID:23349879;  http://dx.doi.org/10.1371/journal.pone.0054410 48.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Biofactors  2012; 38:338-48; PMID:22674855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Biochem 1997;  67:275-86; PMID:9328833; http://dx.doi.org/10.1002/ (SICI)1097-4644(19971101)67:2<275::AID- JCB13>3.0.CO;2-E 106.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Antioxid Redox Signal  2011; 15:1305-23; PMID:21294658; http://dx.doi.org/10.1089/ars.2011.3923 107.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Neurodegener 2012; 7:21;  PMID:22587708; http://dx.doi.org/10.1186/1750- 1326-7-21 108.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Neurochem 2009; 108:811-20;  PMID:19187098; http://dx.doi.org/10.1111/j.1471- 4159.2008.05821.x 109.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Stroke  1998; 29:1020-30; PMID:9596253; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Stroke  1998; 29:2189-95; PMID:9756602; http://dx.doi.org/10.1161/01.STR.29.10.2189 111.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2003; 278:9125- 33; PMID:12511571; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Cancer Ther 2008; 7:1195-206; PMID:18483307;  http://dx.doi.org/10.1158/1535-7163.MCT-07-2199 114.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Microvasc  Res 2009; 77:212-9; PMID:19103208; http://dx.doi.org/10.1016/j.mvr.2008.11.003 115.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Virol  2011; 85:11544-56; PMID:21775458; http://dx.doi.org/10.1128/JVI.05410-11 116.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Cell Sci  2005; 118:4283-93; PMID:16141229; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Antioxid  Redox Signal 2011; 15:1235-53; PMID:21294657;  http://dx.doi.org/10.1089/ars.2011.391391.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
FEBS Lett 2010; 584:4175-80;  PMID:20850437; http://dx.doi.org/10.1016/j.febs- let.2010.09.020 92.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Biol Cell 2004; 15:5503-15; PMID:15456900; http://dx.doi.org/10.1091/mbc.E04- 04-0350 94.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell  Res 2004; 292:51-66; PMID:14720506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Nucleic Acids Res 1996;  24:843-9; PMID:8600450; http://dx.doi.org/10.1093/ nar/24.5.843 96.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
PLoS One 2010; 5:e10248; PMID:20422039;  http://dx.doi.org/10.1371/journal.pone.0010248 97.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Cardiovasc Res 2009; 83:115- 22; PMID:19380416; http://dx.doi.org/10.1093/cvr/cvp117 98.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Am J Physiol Renal Physiol  2013; 304:F77-87; PMID:23034938; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Hear Res 2011; 281:18- 27; PMID:21782914; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Am J Hum Genet 2010; 87:101- 9; PMID:20602916; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Clin Invest 2009; 119:1420-8;  PMID:19487818; http://dx.doi.org/10.1172/JCI3910477.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell Res 2002; 274:138-48;  PMID:11855865; http://dx.doi.org/10.1006/ excr.2001.5457 78.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell Res 2004; 297:247- 58; PMID:15194440; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
J Biol Chem 2003; 278:2692-700; PMID:12403786; http://dx.doi.org/10.1074/jbc.M206821200 80.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Biol Cell  2009; 20:1102-17; PMID:19056685; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Cell Mol Life Sci 2009; 66:3951-66;  PMID:19784548; http://dx.doi.org/10.1007/s00018- 009-0156-6 82.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Proc Natl Acad Sci  U S A 1993; 90:7834-8; PMID:8395056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Cell 1991; 66:451-64;  PMID:1651169; http://dx.doi.org/10.1016/0092-8674(81)90009-X 84.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Exp Cell Res 2007; 313:1533- 47; PMID:17374535; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Cell Biol 2008; 28:1669- 78; PMID:18172007; http://dx.doi.org/10.1128/ MCB.00891-07 86.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Mol Biol Cell 2007; 18:4826-36; PMID:17881732; http://dx.doi.org/10.1091/mbc.E07- 02-0109 88.,Non-OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
Biochem  J 2010; 432:461-72; PMID:20868367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9e/tisb-1-e25039.PMC3885625.pdf
"In summary, the recent studies sug - gest that several interventions that can increase lifespan across species, including MnSOD overexpression, hormesis-type environmental stress, and knockdown of ETC and MRP genes, have in common the activation of the mUPR and may act  *Correspondence to: Jie Shen; Email: shenjie@hdu.edu.cn Submitted: 07/01/2013; Accepted: 07/12/2013http://dx.doi.org/10.4161/cc.26354Comment on: Landis G, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
Cell Death Differ 2012; 19:1308-16;  PMID:22301916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
Genome Biol 2007; 8:R262;  PMID:18067683 ; http://dx.doi.org/10.1186/ gb-2007-8-12-r262 4.,OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
Cell 2011; 144:79-91; PMID:21215371 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
Free Radic Biol Med 2011; 51:1575-82; PMID:21839827 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
Nature 2013; 497:451- 7; PMID:23698443 ; http://dx.doi.org/10.1038/ nature12188Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/09/cc-12-3237.PMC3885629.pdf
"1,8 Cdk7 is a common  *Correspondence to: Robert P Fisher; Email: robert.fisher@mssm.edu Submitted: 07/16/2013; Accepted: 07/19/2013http://dx.doi.org/10.4161/cc.26355Comment on: Schachter MM, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
"Mol Cell 2013; 50:250-60; PMID:23622515; http://dx.doi.org/10.1016/j.molcel.2013.04.003The CDK-activating kinase Cdk7 Taking yes for an answer Miriam Merzel  schachter  and  robert P  Fisher* department of s tructural and Chemical Biology; Graduate s chool of Biomedical s ciences; i cahn s chool of Medicine at Mount s inai; New y ork, N y usa",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
J Cell Sci 2005; 118:5171-80;  PMID:16280550 ; http://dx.doi.org/10.1242/ jcs.02718 2.,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
Mol Cell 2007; 25:839-50;  PMID:17386261 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
Mol Cell 2008; 32:662-72;  PMID:19061641 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
Mol Cell Biol 2009; 29:4188- 200;  PMID:19487459 ; http://dx.doi.org/10.1128/ MCB.01823-08 5.,Non-OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
Mol Cell 2013; 50:250-60; PMID :23622515 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
PLoS Genet 2013; 9:e1003546;  PMID:23737759 ; http://dx.doi.org/10.1371/jour - nal.pgen.1003546 7.,Non-OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
EMBO J 2012; 31:2498-510; PMID:22505032 ; http://dx.doi.org/10.1038/ emboj.2012.94 8.,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
Nat Struct Mol Biol 2012; 19:1108- 15; PMID:23064645 ; http://dx.doi.org/10.1038/ nsmb.2399,OADS,/arxiv_data1/oa_pdf/ca/d1/cc-12-3239.PMC3885630.pdf
"5 Surprisingly, the  *Correspondence to: Peter Lewis; Email: plewis@discovery.wisc.edu Submitted: 07/18/2013; Accepted: 07/21/2013http://dx.doi.org/10.4161/cc.26356Comment on: Lewis PW, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
"Science 2013; 340:857-61; PMID:23539183; http://dx.doi.org/10.1126/science.1232245Poisoning the “histone code” in pediatric  gliomagenesis Peter W  lewis* and  C d avid  allis laboratory of Chromatin Biology & Epigenetics; t he r ockefeller u niversity; New y ork, N y usa",Non-OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Nature 2012; 482:226- 31; PMID:22286061; http://dx.doi.org/10.1038/ nature10833 2.,Non-OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Nat Genet 2012; 44:251-3; PMID:22286216;  http://dx.doi.org/10.1038/ng.1102 3.,OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Acta Neuropathol 2012;  124:439-47; PMID:22661320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Science 2013; 340:857-61; PMID:23539183; http://dx.doi.org/10.1126/ science.1232245 5.,Non-OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Genes Dev 2013; 27:985-90;  PMID:23603901; http://dx.doi.org/10.1101/ gad.217778.113 6.,OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
J Biol Chem 2009; 284:17775-82; PMID:19407342; http://dx.doi.org/10.1074/jbc.M109.003087 8.,OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
Cell 2010; 140:678-91; PMID:20211137; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/57/cc-12-3241.PMC3885631.pdf
"*Correspondence to: Ahmed Mansouri; Email: amansou@gwdg.de; Patrick Collombat; Email: collombat@unice.fr Submitted: 07/23/2013; Accepted: 07/24/2013http://dx.doi.org/10.4161/cc.26357Comment on: Al-Hasani K, et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
"Dev Cell 2013; 26:86-100; PMID:23810513; http://dx.doi.org/10.1016/j.devcel.2013.05.018Induction of multiple cycles of pancreatic   β-cell replacement anja Pfeifer1,2,3,‡, Monica Courtney1,2,3,‡, Nouha Ben- othman1,2,3,‡, Keith a l-Hasani1,2,3,†,‡, Elisabet Gjernes1,2,3,‡, andhira Vieira1,2,3,  Noémie d ruelle1,2,3, Fabio a volio1,2,3, Biljana Faurite1,2,3, ahmed Mansouri4,5,6,*, and Patrick Collombat1,2,3,6,* 1university Nice s ophia a ntipolis; iBV; u Mr 7277; Nice, France; 2inserm; iBV; u 1091; Nice, France; 3CNrs; iBV; u Mr 7277; Nice, France; 4Max-Planck i nstitute for Biophysical  Chemistry; d epartment of Molecular Cell Biology; Göttingen, Germany; 5department of Clinical Neurophysiology; u niversity of Göttingen; Göttingen, Germany;   6Genome and s tem Cell Center; GENK oK; Erciyes u niversity; Kayseri, t urkey †Current affiliation: Epigenetics in Human Health and d isease l aboratory; Baker idi Heart and d iabetes i nstitute;   the a lfred Medical r esearch and Education Precinct; Melbourne, V iC australia ‡these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Mech Dev 2006; 123:501-12;  PMID:16822656 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
J Clin Invest 2007; 117:961-70; PMID:17404619 ; http://dx.doi.org/10.1172/ JCI29115 4.,Non-OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Genes Dev 2003; 17:2591- 603; PMID:14561778 ; http://dx.doi.org/10.1101/ gad.269003 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Cell 2009; 138:449-62;  PMID:19665969 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Dev Cell 2013; 26:86-100; PMID:23810513 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Lancet 1968; 1:670-1; PMID:4170654 ; http://dx.doi.org/10.1016/ S0140-6736(68)92103-X 8.,OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
Development 2013; 140:751-64;  PMID:23325761 ; http://dx.doi.org/10.1242/ dev.090159,Non-OADS,/arxiv_data1/oa_pdf/7a/54/cc-12-3243.PMC3885632.pdf
"This raises the possibility that other agents that act on this crucial activation  *Correspondence to: Dror Meirow; Email: meirow@post.tau.ac.il Submitted: 07/23/2013; Accepted: 07/24/2013http://dx.doi.org/10.4161/cc.26358Comment on: Kalich-Philosoph L, et al.",Non-OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
Sci Transl Med 2013; 5:85ra62; PMID:23677591; http://dx.doi.org/10.1126/scitranslmed.3005402Ovarian follicle burnout A universal phenomenon?,Non-OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
Semin Reprod Med 2011;  29:283-98;  PMID:21972066 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
Sci Transl Med 2013;  5:85ra62;  PMID:23677591 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
N Engl J Med 2005; 353:318- 21; PMID:15983020 ; http://dx.doi.org/10.1056/ NEJMc055237 5.,OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
Hum Reprod Update 2010; 16:395- 414; PMID:20124287 ; http://dx.doi.org/10.1093/ humupd/dmp056 6.,OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
"Fertil Steril 2012; 97:1394-8, e1; PMID:22425199 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
PLoS One 2011; 6:e22024;  PMID:21789206 ; http://dx.doi.org/10.1371/jour - nal.pone.0022024 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/cc-12-3245.PMC3885633.pdf
"Cell Cycle 2013; 12;3336–44;  PMID:24036543; http://dx.doi.org/10.4161/cc.26327 Jie Qiao1 and Mo Li2,*; 1Center of Reproductive Medicine; Department of Obstetrics and Gynecology; Peking University Third Hospital; Beijing, People’s Republic of  China; 2Division of Molecular Medicine & Genetics; Department of Internal Medicine; University of Michigan; Ann Arbor, MI USA;   *Email: limobio@126.com; http://dx.doi.org/10.4161/cc.26636 Cells encounter up to 106 DNA damages  per day, which can be induced by exogenous  physical agents, spontaneous chemical reac - tions, and products of endogenous metabo - lism.1 To cope with these threats, the DNA  damage response (DDR) system is employed to detect and repair these damages.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
Mol Cell 2010; 40:179-204;  PMID:20965415 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
Cancer Cell 2013; 23:693-704;  PMID :23680151 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
Mol Cell 2007; 28:739-45;  PMID:18082599 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
Lieber MR. Annu Rev Biochem 2010; 79:181- 211; PMID:20192759 ; http://dx.doi.org/10.1146/ annurev.biochem.052308.093131 6.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
Hum Reprod Update 2008; 14:345-57; PMID:18535004 ; http://dx.doi.org/10.1093/ humupd/dmn011,OADS,/arxiv_data1/oa_pdf/40/5e/cc-12-3247.PMC3885634.pdf
"As expected, both Keywords:  cell cycle, senescence,  aging, cancer, growth, rapalogs Submitted: 06/20/2013Revised: 08/15/2013Accepted: 08/21/2013http://dx.doi.org/10.4161/cc.26248 *Correspondence to: Olga V Leontieva;   Email: olga.leontieva@roswellpark.org;  Mikhail V Blagosklonny;  Email: Blagosklonny@oncotarget.com; mikhail.blagosklonny@roswellpark.org",Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell 1997; 88:593-602; PMID:9054499 ;  http://dx.doi.org/10.1016/S0092-8674(00)81902-9 3.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Genes Dev 1998; 12:3008-19;  PMID:9765203 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Exp Cell Res 1999; 253:503- 10; PMID:10585273 ; http://dx.doi.org/10.1006/ excr.1999.46985.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Mol Cell Biol 2002; 22:3497-508; PMID:11971980 ; http://dx.doi.org/10.1128/ MCB.22.10.3497-3508.2002 6.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Curr Opin Cell Biol 2001; 13:748- 53; PMID:11698192 ; http://dx.doi.org/10.1016/ S0955-0674(00)00278-7 7.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Eur J Biochem 2001; 268:2784-91;  PMID:11358493 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell 2007; 130:223-33; PMID:17662938 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2012; 11:2231- 2; PMID:22714590 ; http://dx.doi.org/10.4161/ cc.21065 11.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Genes Dev 2013; 27:900-15; PMID:23599344 ;  http://dx.doi.org/10.1101/gad.203984.112 12.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle  2012; 11:2391-401;  PMID:22627671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2012; 11:2402-7; PMID:22672902 ;  http://dx.doi.org/10.4161/cc.20882 15.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2008; 7:3355- 61; PMID:18948731 ; http://dx.doi.org/10.4161/ cc.7.21.6919 16.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2009; 8:1888-95;  PMID:19471117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Proc Natl Acad Sci U S A 2010; 107:9660-4;  PMID:20457898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Proc Natl Acad Sci U S A  2012; 109:13314-8;  PMID:22847439 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2012; 11:3926-31;  PMID:22987149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Death Differ 2013; 20:1241- 9; PMID:23852369 ; http://dx.doi.org/10.1038/ cdd.2013.86 27.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Science  2009; 326:140-4;  PMID:19797661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2010; 9:1859-62;  PMID:20436272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Genes Dev 2006; 20:174-84; PMID:16418483 ;  http://dx.doi.org/10.1101/gad.1381406 31.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Metab 2012; 15:713-24; PMID:22560223 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Rejuvenation Res 2010; 13:246-7; PMID:20017609 ;  http://dx.doi.org/10.1089/rej.2009.0903 33.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Metab 2010; 11:35-46; PMID:20074526 ;  http://dx.doi.org/10.1016/j.cmet.2009.11.010 34.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Exp Gerontol 2011; 46:376- 81; PMID:20849947 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
J Gerontol A Biol Sci Med Sci 2011; 66:191-201;  PMID:20974732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Aging Cell 2012; 11:675-82; PMID:22587563 ;  http://dx.doi.org/10.1111/j.1474-9726.2012.00832.x 41.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle  2011; 10:4230-6;  PMID:22107964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Biochem J 2010; 431:245-55;  PMID:20704563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Oncogene 2003; 22:3937-42; PMID:12813467 ;  http://dx.doi.org/10.1038/sj.onc.1206565 49.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
FASEB J 2004; 18:311-9; PMID:14769825 ;  http://dx.doi.org/10.1096/fj.03-0731com 50.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Cycle 2012; 11:2959-60; PMID:22926561 ;  http://dx.doi.org/10.4161/cc.21558 53.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Cell Stem Cell 2008; 3:442-55;  PMID:18940735 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Oncogene 2008; 27:1106-13; PMID:17724476 ;  http://dx.doi.org/10.1038/sj.onc.1210715 56.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Toxicol Sci 2011; 124:75-87; PMID:21813464 ;  http://dx.doi.org/10.1093/toxsci/kfr203 57.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
Oncogene 2000; 19:2165-70; PMID:10815808 ;  http://dx.doi.org/10.1038/sj.onc.1203573,OADS,/arxiv_data1/oa_pdf/f3/af/cc-12-3249.PMC3885635.pdf
"19 In  addition, the lack of Caf1 sensitizes the yeast cells to UV irradia - tion.17 CAF-1 directly interacts with the PCNA clamp.20,21 PCNA is an essential homotrimeric protein required for  numerous DNA replication and repair transactions.22,23 PCNA  is loaded on the 3 ′ ends of the primer/template junctions by the  *Correspondence to: Farid A Kadyrov ; Email: fkadyrov@siumed.edu Submitted: 08/12/2013; Accepted: 08/28/2013http://dx.doi.org/10.4161/cc.26310Human CAF-1-dependent nucleosome assembly   in a defined system Lyudmila Y Kadyrova, e lena Rodriges Blanko, and Farid A Kadyrov* Department of Biochemistry and Molecular Biology; s outhern Illinois University s chool of Medicine; Carbondale, IL U sA Keywords:  replication, nucleosome assembly, CAF-1, PCNA, RFC, ASF1, DNA polymerase delta, histone chaperone, chromatin Abbreviations : ASF1, anti-silencing function 1; CAF-1, chromatin assembly factor 1; PCNA, proliferat - ing cell nuclear antigen; RFC, replication factor C; NAP1L1, nucleosome assembly protein 1L1; ccDNA, cova - lently closed DNA; scDNA, supercoiled DNA; ssDNA, single-stranded DNA; DTT, dithiothreitol Replication-coupled nucleosome assembly is a critical step in packaging newly synthesized DNA into chromatin.",Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Science 1974; 184:868- 71; PMID:4825889 ; http://dx.doi.org/10.1126/ science.184.4139.868 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature 1997; 389:251-60;  PMID:9305837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2007; 128:721-33; PMID:17320509 ;  http://dx.doi.org/10.1016/j.cell.2007.01.030 4.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2010; 140:183-95;  PMID:20141833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Trends Genet 2004; 20:320-6; PMID :15219397 ;  http://dx.doi.org/10.1016/j.tig.2004.05.004 6.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
FEBS Lett 2008; 582:1938- 49; PMID:18343227 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell 2010; 37:834- 42; PMID:20347425 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
EMBO J 2001;  20:7294-302;  PMID:11743005 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 1989; 58:15-25; PMID:2546672 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Proc Natl Acad Sci U S A  2003; 100:12183-8;  PMID:14519857 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 1995; 81:1105-14; PMID:7600578 ; http://dx.doi.org/10.1016/ S0092-8674(05)80015-714.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 1996; 87:95-104; PMID :8858152 ; http://dx.doi.org/10.1016/ S0092-8674(00)81326-4 15.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Histopathology 2010; 57:716-24;  PMID:21083601 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Genes Dev 1997; 11:345-57;  PMID:9030687 ; http://dx.doi.org/10.1101/ gad.11.3.345 18.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature  2012; 483:434-8;  PMID :22419157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 1999; 96:575- 85; PMID:10052459 ; http://dx.doi.org/10.1016/ S0092-8674(00)80661-3 21.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature 1987; 326:517-20;  PMID:2882424 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2007; 129:665- 79; PMID:17512402 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Proc Natl Acad Sci U S A 2010; 107:16066-71;  PMID:20713735 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature  1977; 266:273-5;  PMID:846573 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2004; 116:51- 61; PMID:14718166 ; http://dx.doi.org/10.1016/ S0092-8674(03)01064-X 32.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature 1999; 402:555-60;  PMID:10591219 ; http://dx.doi.org/10.1038/990147 33.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Curr Biol 2001; 11:1068- 73; PMID:11470414 ; http://dx.doi.org/10.1016/ S0960-9822(01)00298-6 34.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Science 2007; 318:1928-31;  PMID:18096807 ;  http://dx.doi.org/10.1126/science.1148992 35.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature 2007; 446:338-41; PMID:17293877 ;  http://dx.doi.org/10.1038/nature05613,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
EMBO Rep 2002; 3:329-34; PMID:11897662 ; http://dx.doi.org/10.1093/ embo-reports/kvf068 37.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell  2005; 17:301-11;  PMID :15664198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
J Biol Chem 2006;  281:13817-27;  PMID:16537536 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2006; 127:495-508;  PMID:17081973 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
J Mol Biol  2011; 407:647-60;  PMID:21333655 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Biochim Biophys Acta 2008; 1783:1595- 604; PMID:18474252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Biochemistry  2005; 44:13673-82;  PMID:16229457 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Curr Biol 2005; 15:2044-9;  PMID:16303565 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Science 2003; 301:1090-3; PMID:12934006 ;  http://dx.doi.org/10.1126/science.1085703 50.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell Biol  2000; 20:1206-18;  PMID:10648606 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
J Biol Chem 2009; 284:4041- 5; PMID:18835809 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nature 1994; 369:207-12; PMID:7910375 ;  http://dx.doi.org/10.1038/369207a0 56.,Non-OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
J Biol Chem 2002; 277:3894-901;  PMID:11711545 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 1986;  45:555-65;  PMID:3011272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Protein Expr Purif 2010; 72:194-204;  PMID:20347990 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nucleic Acids Res 2012; 40:11229-39;  PMID:23034810 ; http://dx.doi.org/10.1093/nar/ gks906 60.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nucleic Acids Res 2012; 40:10139-49;  PMID:22941638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Proc Natl Acad Sci U S A 1990; 87:1023-7; PMID:1967833 ; http://dx.doi.org/10.1073/ pnas.87.3.102362.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
J Mol Biol 1986;  189:189-204;  PMID:3023620 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Genes Dev 2004; 18:2764-73; PMID :15520275 ;  http://dx.doi.org/10.1101/gad.1252304 64.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell 2008; 30:137- 44; PMID:18439893 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nat Genet 2002; 32:627-32;  PMID :12434153 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nat Struct Mol Biol 2008; 15:477-84; PMID:18408730 ; http://dx.doi.org/10.1038/ nsmb.1419 67.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nat Struct Mol Biol 2009; 16:1167-72;  PMID:19855395 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell 2011; 43:638- 48; PMID:21855802 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Nucleic Acids Res 2008; 36:2208-18;  PMID:18281699 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Proc Natl Acad Sci U S A 2009; 106:8495- 500; PMID:19420220 ; http://dx.doi.org/10.1073/ pnas.0903654106 72.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Cell 2006; 126:297-308;  PMID:16873062 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
Mol Cell 2004; 15:31-41; PMID:15225546 ;  http://dx.doi.org/10.1016/j.molcel.2004.06.016 74.,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
DNA 1985; 4:157-64; PMID:3996184 ; http://dx.doi.org/10.1089/ dna.1985.4.157,OADS,/arxiv_data1/oa_pdf/b5/4f/cc-12-3286.PMC3885639.pdf
"(2013), 14(4),  373-380 http://dx.doi.org/10.4142/jvs.2013.14.4.373 Received: 24 Aug. 2012, Revised: 22 Sep. 2012, Accepted: 23 Oct .",Non-OADS,/arxiv_data1/oa_pdf/f6/7e/jvs-14-373.PMC3885729.pdf
"(2013), 14(4),  381-386 http://dx.doi.org/10.4142/jvs.2013.14.4.381 Received: 25 Sep. 2012, Revised: 9 Dec. 2012, Accepted: 24 Dec.  2012 Original Article *Corresponding author: Tel: +82-2-2650-5710; Fa x: +82-2-2650-5711; E-mail: khhan@ewha.ac.kr ⓒ 2013 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/25/62/jvs-14-381.PMC3885730.pdf
"(2013), 14(4),  387-393 http://dx.doi.org/10.4142/jvs.2013.14.4.387 Received: 7 Feb. 2013, Revised: 15 Apr.",Non-OADS,/arxiv_data1/oa_pdf/bb/b8/jvs-14-387.PMC3885731.pdf
"(2013), 14(4),  395-403 http://dx.doi.org/10.4142/jvs.2013.14.4.395 Received: 23 Oct. 2012, Revised: 21 Mar.",Non-OADS,/arxiv_data1/oa_pdf/8d/07/jvs-14-395.PMC3885732.pdf
"(2013), 14(4),  405-412 http://dx.doi.org/10.4142/jvs.2013.14.4.405 Received: 10 Dec. 2012, Revised: 2 Feb. 2013, Accepted: 16 Feb.  2013 Original Article *Corresponding author: Tel: +86-514-87991448; Fax:  +86-514-87972218; E-mail: liuzongping@yzu.edu.cn †The first two authors contribu ted equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/8b/97/jvs-14-405.PMC3885733.pdf
"(2013), 14(4),  413-419 http://dx.doi.org/10.4142/jvs.2013.14.4.413 Received: 23 Nov. 2012, Revised: 7 Jan. 2013, Accepted: 16 Feb.  2013 Original Article *Corresponding author: Tel: +91-824-2248936; Fax: +91-824-2248366; E-mail: kalkulishankar@gmail.com ⓒ 2013 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/1f/6e/jvs-14-413.PMC3885734.pdf
"(2013), 14(4),  421-424 http://dx.doi.org/10.4142/jvs.2013.14.4.421 Received: 7 Feb. 2013, Revised: 27 Mar.",Non-OADS,/arxiv_data1/oa_pdf/87/3f/jvs-14-421.PMC3885735.pdf
"(2013), 14(4),  425-432 http://dx.doi.org/10.4142/jvs.2013.14.4.425 Received: 8 Jan. 2013, Revised: 7 Jun.",Non-OADS,/arxiv_data1/oa_pdf/53/50/jvs-14-425.PMC3885736.pdf
"(2013), 14(4),  433-440 http://dx.doi.org/10.4142/jvs.2013.14.4.433 Received: 11 May 2012, Revised: 1 Apr.",Non-OADS,/arxiv_data1/oa_pdf/9b/7f/jvs-14-433.PMC3885737.pdf
"(2013), 14(4),  441-447 http://dx.doi.org/10.4142/jvs.2013.14.4.441 Received: 26 Dec. 2012, Revised: 18 Jan. 2013, Accepted: 16 Feb .",Non-OADS,/arxiv_data1/oa_pdf/5d/02/jvs-14-441.PMC3885738.pdf
"The resulting supernatant can be directly used as vaccine antigens without the need for concentration or purification.Materials and Methods Optimization of the capsid gene 　According to the codon usage frequency of Spodoptera  (S.) frugiperda cells, the amino acid sequence of the  RHDV capsid was optimized online (http://www.kazusa.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/jvs-14-441.PMC3885738.pdf
"(2013), 14(4),  449-456 http://dx.doi.org/10.4142/jvs.2013.14.4.449 Received: 26 Dec. 2011, Revised: 6 Mar.",Non-OADS,/arxiv_data1/oa_pdf/25/95/jvs-14-449.PMC3885739.pdf
"(2013), 14(4),  457-465 http://dx.doi.org/10.4142/jvs.2013.14.4.457 Received: 30 Oct. 2012, Revised: 21 Dec. 2012, Accepted: 16 Feb .",Non-OADS,/arxiv_data1/oa_pdf/89/be/jvs-14-457.PMC3885740.pdf
"(2013), 14(4),  467-472 http://dx.doi.org/10.4142/jvs.2013.14.4.467 Received: 7 Dec. 2012, Revised: 16 Feb. 2013, Accepted: 19 Feb.  2013 Original Article *Corresponding author: Tel: +82-2-880-1263; Fa x: +82-2-874-2738; E-mail: yoohs@snu.ac.kr ⓒ 2013 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/67/fe/jvs-14-467.PMC3885741.pdf
"(2013), 14(4),  473-479 http://dx.doi.org/10.4142/jvs.2013.14.4.473 Received: 17 Jul.",Non-OADS,/arxiv_data1/oa_pdf/68/da/jvs-14-473.PMC3885742.pdf
"(2013), 14(4),  481-486 http://dx.doi.org/10.4142/jvs.2013.14.4.481 Received: 18 Jan. 2013, Revised: 4 Apr.",Non-OADS,/arxiv_data1/oa_pdf/ec/17/jvs-14-481.PMC3885743.pdf
"(2013), 14(4),  487-490 http://dx.doi.org/10.4142/jvs.2013.14.4.487 Received: 30 Nov. 2012, Revised: 23 Feb. 2013, Accepted: 11 Apr .",Non-OADS,/arxiv_data1/oa_pdf/d2/ee/jvs-14-487.PMC3885744.pdf
"(2013), 14(4),  491-494 http://dx.doi.org/10.4142/jvs.2013.14.4.491 Received: 7 Feb. 2013, Revised: 4 Apr.",Non-OADS,/arxiv_data1/oa_pdf/b4/31/jvs-14-491.PMC3885745.pdf
"(2013), 14(4),  495-497 http://dx.doi.org/10.4142/jvs.2013.14.4.495 Received: 14 Dec. 2011, Revised: 21 Aug. 2012, Accepted: 30 Aug .",Non-OADS,/arxiv_data1/oa_pdf/7a/9d/jvs-14-495.PMC3885746.pdf
"(2013), 14(4),  499-502 http://dx.doi.org/10.4142/jvs.2013.14.4.499 Received: 24 Sep. 2012, Revised: 20 Dec. 2012, Accepted: 16 Feb .",Non-OADS,/arxiv_data1/oa_pdf/57/82/jvs-14-499.PMC3885747.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.1 www.annlabmed.org  1Ann Lab Med 2014;34:1-6 http://dx.doi.org/10.3343/alm.2014.34.1.1Original Article Clinical Chemistry Assessment of Therapeutic Drug Monitoring of  Vancomycin in Elderly Patients According to New  Guidelines Se Jin Oh, M.D.1, Ki-Sook Hong, M.D.1, Eun Jeong Lee, R.Ph.2, Hee Jung Choi, M.D.3, Kyoung Ae Kong, M.D.4,   Miae Lee, M.D.1, and Wha Soon Chung, M.D.1 Departments of Laboratory Medicine1, Pharmacy2, and Internal Medicine3, Ewha Clinical Trial Center4, Ewha Womans University School of Medicine,   Seoul, Korea Background:  Concerns regarding increasing microbial resistance to vancomycin have re - sulted in recommendations for a higher trough serum vancomycin concentration.",Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
"TDM of vancomycin in new guidelines 2  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.1 With the rapid increase in microbial resistance and concerns  about the clinical consequences of underdosing, the efficient  achievement of target concentrations of vancomycin has be - come increasingly important.",Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
TDM of vancomycin in new guidelines http://dx.doi.org/10.3343/alm.2014.34.1.1 www.annlabmed.org  32.,Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
"TDM of vancomycin in new guidelines 4  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.1kg/day and 32.0±12.8 mg/kg/day in the previous and new  guideline groups, respectively, without significant difference  (P=0.425); however, the dose interval was shorter in the new  guideline group (14.1±4.8 hr vs. 10.4±2.2 hr) ( P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
"TDM of vancomycin in new guidelines http://dx.doi.org/10.3343/alm.2014.34.1.1 www.annlabmed.org  5guideline group and 52.8% in the new guideline group, and the  percentage of patients in whom it was <10 mg/L was 45.4%  and 29.6%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
TDM of vancomycin in new guidelines 6  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.1microb Chemother 2000;45:329-35.,Non-OADS,/arxiv_data1/oa_pdf/ab/f4/alm-34-1.PMC3885766.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.15 www.annlabmed.org  15Ann Lab Med 2014;34:15-19 http://dx.doi.org/10.3343/alm.2014.34.1.15Original Article Clinical Microbiology Comparison of ChromID Agar and Clostridium difficile   Selective Agar for Effective Isolation of C. difficile  from  Stool Specimens Bo-Moon Shin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e7/49/alm-34-15.PMC3885767.pdf
ChromID agar for C. difficile  16  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.15the rapid and specific isolation of C. difficile .,Non-OADS,/arxiv_data1/oa_pdf/e7/49/alm-34-15.PMC3885767.pdf
"ChromID agar for C. difficile  http://dx.doi.org/10.3343/alm.2014.34.1.15 www.annlabmed.org  17(78.9%) were tcdA+tcdB+ strains, 11 (6.1%) were tcdA¯tcdB+  strains, and 27 (15.0%) were tcdA¯tcdB¯ strains; all of them were  tpi positive.",Non-OADS,/arxiv_data1/oa_pdf/e7/49/alm-34-15.PMC3885767.pdf
"ChromID agar for C. difficile  18  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.15detection rates were not significantly different between IDCd  and CDSA on day 3, the positivity rate was significantly higher  on IDCd than on CDSA on day 1 (55.6% vs. 19.4%, P<0.001)  and on day 2 (85.0% vs. 75.6%, P=0.0245).",Non-OADS,/arxiv_data1/oa_pdf/e7/49/alm-34-15.PMC3885767.pdf
ChromID agar for C. difficile  http://dx.doi.org/10.3343/alm.2014.34.1.15 www.annlabmed.org  193.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/alm-34-15.PMC3885767.pdf
"ISSN 2234-3806 • eISSN 2234-3814  20  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.20Ann Lab Med 2014;34:20-25 http://dx.doi.org/10.3343/alm.2014.34.1.20Original Article Clinical Microbiology Rates of Fecal Transmission of Extended-Spectrum  β-Lactamase-Producing and Carbapenem-Resistant  Enterobacteriaceae  Among Patients in Intensive Care  Units in Korea Jayoung Kim, M.D.1, Ji Young Lee, Ph.D.2, Sang Il Kim, M.D.3, Wonkeun Song, M.D.4, Jae-Seok Kim, M.D.4,   Seungwon Jung, M.D.4, Jin Kyung Yu, M.S.5, Kang Gyun Park, M.T.5, and Yeon-Joon Park, M.D.5 Department of Laboratory Medicine1, College of Medicine, The Catholic University of Korea, Daejeon St. Mary’s Hospital, Daejeon; Department of Infection  Control2, Seoul St. Mary’s Hospital, Seoul; Division of Infectious Disease3, Department of Internal Medicine, College of Medicine, The Catholic University of  Korea, Seoul; Department of Laboratory Medicine4, Hallym University College of Medicine, Seoul; Department of Laboratory Medicine5, College of Medicine,  The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea Background:  We investigated the rates of fecal transmission of extended-spectrum  β-lactamase (ESBL)-producing Enterobacteriaceae  (ESBL-E) and carbapenem-resistant  Enterobacteriaceae  (CRE) among patients admitted to intensive care units (ICUs).",Non-OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
Fecal transmission of ESBL-E and CRE http://dx.doi.org/10.3343/alm.2014.34.1.20 www.annlabmed.org  21hospital stays.,Non-OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
Fecal transmission of ESBL-E and CRE 22  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.20efficient greater than 80%.,OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
Fecal transmission of ESBL-E and CRE http://dx.doi.org/10.3343/alm.2014.34.1.20 www.annlabmed.org  2315/24) for K. pneumoniae .,Non-OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
Fecal transmission of ESBL-E and CRE 24  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.20Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
Fecal transmission of ESBL-E and CRE http://dx.doi.org/10.3343/alm.2014.34.1.20 www.annlabmed.org  2527.,Non-OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
http://www.cdc.go.kr/CDC/info/CdcKrInfo0206.jsp?menuIds=   HOME001-NU0004NU0026-MNU0031&fid=73&q_type=&q_value=   &cid=20100&pageNum= (Updated on Jun 2013).,OADS,/arxiv_data1/oa_pdf/6f/4f/alm-34-20.PMC3885768.pdf
"ISSN 2234-3806 • eISSN 2234-3814  26  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.26Ann Lab Med 2014;34:26-30 http://dx.doi.org/10.3343/alm.2014.34.1.26Original Article Clinical Microbiology Early Detection of Mycobacteria Using a Novel  Hydrogel Culture Method Mi Hee Jang, M.S.1,*, Shine Young Kim, M.D.1,*, Chang-Ki Kim, M.D.2, Sang-Hyun Hwang, M.D.3, Byung Kyu Park, M.D.4,  Sung Soo Kim, Ph.D.5, Eun Yup Lee, M.D.1, and Chulhun L. Chang, M.D.1,6 Department of Laboratory Medicine1, Pusan National University School of Medicine, Yangsan; Department of Laboratory Medicine2, Korean Institute of  Tuberculosis, Osong; Department of Laboratory Medicine3, Center for Diagnostic Oncology, National Cancer Center Hospital, Goyang; Department of Physical  Medicine & Rehabilitation4, Korea University College of Medicine, Seoul; Department of Social Studies of Medicine5, Pusan National University School of  Medicine, Yangsan; Research Institute for Convergence of Biomedical Science and Technology6, Pusan National University Yangsan Hospital, Yangsan, Korea Background:  Early laboratory detection of Mycobacterium tuberculosis  is crucial for con - trolling tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
Hydrogel culture of mycobacteria http://dx.doi.org/10.3343/alm.2014.34.1.26 www.annlabmed.org  27mycobacterial culture is different.,Non-OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
Hydrogel culture of mycobacteria 28  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.26used for the comparison of the time to detection of positive cul - ture results.,OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
Hydrogel culture of mycobacteria http://dx.doi.org/10.3343/alm.2014.34.1.26 www.annlabmed.org  29days).,Non-OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
Hydrogel culture of mycobacteria 30  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.26competitive with this culture method in this respect.,Non-OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
http://www.who.int/tb/publications/global_ report/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b3/74/alm-34-26.PMC3885769.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.31 www.annlabmed.org  31Ann Lab Med 2014;34:31-37 http://dx.doi.org/10.3343/alm.2014.34.1.31Original Article Clinical Microbiology The Drug Resistance Profile of Mycobacterium  abscessus  Group Strains from Korea Seung Heon Lee, Ph.D.1, Hee Kyung Yoo, M.S.1, Seol Hee Kim, B.S.1, Won-Jung Koh, M.D.2, Chang Ki Kim, M.D.1,   Young Kil Park, Ph.D.1, and Hee Jin Kim, M.D.1 Korean Institute of Tuberculosis1, Chengwon; Division of Pulmonary and Critical Care Medicine2, Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Bacteria of the Mycobacterium abscessus  group are the second most com - mon pathogens responsible for lung disease caused by nontuberculous mycobacteria in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
"Drug resistance in M. abscessus  clinical strains 32  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.31generation of inducible resistance to clarithromycin and that  gene sequence variations between M. abscessus  and M. mas - siliense  strains are useful for bacterial identification in such  cases [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
"Drug resistance in M. abscessus  clinical strains http://dx.doi.org/10.3343/alm.2014.34.1.31 www.annlabmed.org  33well, incubated at 30°C, and the minimal inhibitory concentra - tion (MIC) was examined.",Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
Drug resistance in M. abscessus  clinical strains 34  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.31mg/L) (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
"Drug resistance in M. abscessus  clinical strains http://dx.doi.org/10.3343/alm.2014.34.1.31 www.annlabmed.org  35gene, alanine at amino acid position 92 ( M. abscessus  number - ing) was converted to valine in 1 strain, and aspartic acid at po - sition 96 was mutated to asparagine in 3 strains.",Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
Drug resistance in M. abscessus  clinical strains 36  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.31ribosomal RNA gene associated with amikacin resistance.,Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
Drug resistance in M. abscessus  clinical strains http://dx.doi.org/10.3343/alm.2014.34.1.31 www.annlabmed.org  37Agents Chemother 2009;53:1367-76.,Non-OADS,/arxiv_data1/oa_pdf/d2/30/alm-34-31.PMC3885770.pdf
"ISSN 2234-3806 • eISSN 2234-3814  38  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.38Ann Lab Med 2014;34:38-42 http://dx.doi.org/10.3343/alm.2014.34.1.38Original Article Diagnostic Immunology Evaluation of a Novel Array-Based Toxoplasma,  Rubella, Cytomegalovirus, and Herpes Simplex Virus  IgG Enzyme Linked Immunosorbent Assay and Its  Comparison with Virion/Serion Enzyme Linked  Immunosorbent Assays Dongsheng Wu, M.D., Yuanjian Wu, M.D., Liuhong Wang, M.D., Weidong Xu, M.D., and Qiao Zhong, M.D.",OADS,/arxiv_data1/oa_pdf/4e/77/alm-34-38.PMC3885771.pdf
"A novel BGI-Array ELISA TORCH IgG assay http://dx.doi.org/10.3343/alm.2014.34.1.38 www.annlabmed.org  39have certain limitations, such as low throughput and significant  hands-on time.",Non-OADS,/arxiv_data1/oa_pdf/4e/77/alm-34-38.PMC3885771.pdf
"A novel BGI-Array ELISA TORCH IgG assay 40  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.38cal package (Stata Corp., College Station, TX, USA).",OADS,/arxiv_data1/oa_pdf/4e/77/alm-34-38.PMC3885771.pdf
A novel BGI-Array ELISA TORCH IgG assay http://dx.doi.org/10.3343/alm.2014.34.1.38 www.annlabmed.org  413.,OADS,/arxiv_data1/oa_pdf/4e/77/alm-34-38.PMC3885771.pdf
"A novel BGI-Array ELISA TORCH IgG assay 42  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.38ELISA, which is sufficient for the clinical application of TORCH  IgG screening.",Non-OADS,/arxiv_data1/oa_pdf/4e/77/alm-34-38.PMC3885771.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.43 www.annlabmed.org  43Ann Lab Med 2014;34:43-50 http://dx.doi.org/10.3343/alm.2014.34.1.43Original Article Transfusion Medicine Effects of Platelet Lysate Preparations on the  Proliferation of HaCaT Cells Sae Yun Baik, M.D.1, Young Ae Lim, M.D.2, Seon Joo Kang, M.D.2, Sun Hyun Ahn, M.D.2, Wee Gyo Lee, M.D.2,   and Chul Ho Kim, M.D.3 Green Cross Laboratories1, Yongin; Departments of Laboratory Medicine2 and Otolaryngology3, School of Medicine, Ajou University, Suwon, Korea Background:  Standard protocols are lacking for the preparation of platelet lysates (PL) as  an alternative to using fetal bovine serum as a cell culture supplement.",Non-OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
"Effects of platelet lysates on cell proliferation 44  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.43growth factors from platelet granules, PRP is activated either by  adding the platelet agonists of thrombin and calcium chloride,  or by repeating the freeze-thaw (FT) process.",Non-OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
Effects of platelet lysates on cell proliferation http://dx.doi.org/10.3343/alm.2014.34.1.43 www.annlabmed.org  45controls.,Non-OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
Effects of platelet lysates on cell proliferation 46  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.43tured in 5% FBS and 5% PL or between cells from different  passages (Fig.,Non-OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
Effects of platelet lysates on cell proliferation http://dx.doi.org/10.3343/alm.2014.34.1.43 www.annlabmed.org  47the 1×1012 cells/L PL group (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
"Effects of platelet lysates on cell proliferation 48  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.43 There were significant correlations among the concentrations  of growth factors: VEGF and PDGF-AB/BB (r=0.582, P=0.011),  VEGF and PDGF-AA (r=0.841, P<0.001), PDGF-AB/BB and  PDGF-AA (r=0.675, P=0.002), PDGF-AA and EGF (r=0.588,  P=0.011), and PDGF-AB/BB and EGF (r=0.778, P<0.001).",OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
"Effects of platelet lysates on cell proliferation http://dx.doi.org/10.3343/alm.2014.34.1.43 www.annlabmed.org  49and 3×109/L [20], were lower than that used in our experiments  (1×1012 cells/L).",OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
"Effects of platelet lysates on cell proliferation 50  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.43meyer E, et al.",OADS,/arxiv_data1/oa_pdf/cb/99/alm-34-43.PMC3885772.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.51 www.annlabmed.org  51Ann Lab Med 2014;34:51-55 http://dx.doi.org/10.3343/alm.2014.34.1.51Brief Communication Clinical Microbiology Assessment of the Quantitative Ability of AdvanSure  TB/NTM Real-Time PCR in Respiratory Specimens by  Comparison with Phenotypic Methods Hyeyoung Lee, M.D.1, Kang Gyun Park, M.T.1, Gundong Lee, M.T.1, Joonhong Park, M.D.1, Yong-Gyu Park, Ph.D.2,   and Yeon-Joon Park, M.D.1 Departments of Laboratory Medicine1, and Biostatistics2, School of Medicine, The Catholic University of Korea, Seoul, Korea Accurate quantification of mycobacterial load is important to evaluate disease severity and  to monitor the course of treatment in tuberculosis (TB).",Non-OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
"Quantitative ability of AdvanSure TB/NTM assay 52  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.51the culture-positive specimens, we compared Ct values and  phenotypical observations.",OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
"Quantitative ability of AdvanSure TB/NTM assay http://dx.doi.org/10.3343/alm.2014.34.1.51 www.annlabmed.org  5333.3], P=0.069).",Non-OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
"Quantitative ability of AdvanSure TB/NTM assay 54  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.51cause of variation in IS6110 copy number as it varies between 9  and 22 even within the Beijing family strains [8], which com - prise about 78.1% of Korean clinical isolates of MTB [9].",Non-OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
Quantitative ability of AdvanSure TB/NTM assay http://dx.doi.org/10.3343/alm.2014.34.1.51 www.annlabmed.org  55MGIT 960 System and TB/NTM real-time PCR for detecting Mycobac - terium  species.,OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
http://wwwn.cdc.gov/dls/ILA/Training   %20Workshops/Kenya1103/Ch3/Module5microstrat.rtf (Updated on  Nov 2003).,Non-OADS,/arxiv_data1/oa_pdf/b1/73/alm-34-51.PMC3885773.pdf
"ISSN 2234-3806 • eISSN 2234-3814  56  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.56Ann Lab Med 2014;34:56-59 http://dx.doi.org/10.3343/alm.2014.34.1.56Brief Communication Clinical Microbiology Recent Trends in Clinically Significant Nontuberculous  Mycobacteria  Isolates at a Korean General Hospital Hyun Soo Kim, M.D.1, Yangsoon Lee, M.D.1,2, Sangsun Lee, M.T.2, Young Ah Kim, M.D.2, and Young-Kyu Sun, M.D.2 Department of Laboratory Medicine1, Yonsei University College of Medicine, Seoul; Department of Laboratory Medicine2, National Health Insurance Service  Ilsan Hospital, Goyang, Korea Lung disease caused by nontuberculous mycobacteria (NTM) represents an increasing  proportion of all mycobacterial diseases.",Non-OADS,/arxiv_data1/oa_pdf/f2/bb/alm-34-56.PMC3885774.pdf
Trends in clinically significant NTM isolates http://dx.doi.org/10.3343/alm.2014.34.1.56 www.annlabmed.org  57lung infections.,Non-OADS,/arxiv_data1/oa_pdf/f2/bb/alm-34-56.PMC3885774.pdf
"Trends in clinically significant NTM isolates 58  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.5610, 11].",OADS,/arxiv_data1/oa_pdf/f2/bb/alm-34-56.PMC3885774.pdf
Trends in clinically significant NTM isolates http://dx.doi.org/10.3343/alm.2014.34.1.56 www.annlabmed.org  59of occurrences prior to this alteration was probably higher than  what was detected.,OADS,/arxiv_data1/oa_pdf/f2/bb/alm-34-56.PMC3885774.pdf
"ISSN 2234-3806 • eISSN 2234-3814  60  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.60Ann Lab Med 2014;34:60-63 http://dx.doi.org/10.3343/alm.2014.34.1.60Letter to the Editor  Diagnostic Hematology Four Cases of Chronic Myelogenous Leukemia in   Mixed Phenotype Blast Phase at Initial Presentation  Mimicking Mixed Phenotype Acute Leukemia with  t(9;22) Woojin Choi, M.D.1, Myungshin Kim, M.D.1, Jihyang Lim, M.D.1, Kyungja Han, M.D.1, Seok Lee, M.D.2, Jae Wook Lee, M.D.3,  Nack Gyun Chung, M.D.3, and Yonggoo Kim, M.D.1 Departments of Laboratory Medicine1, Internal Medicine2, and Pediatrics3, College of Medicine, The Catholic University of Korea, Seoul, Korea The t(9;22)(q34;q11.2) translocation results in a BCR-ABL1  fu- sion gene located on the Philadelphia chromosome (Ph), caus - ing a constitutively active BCR-ABL1 tyrosine kinase.",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/alm-34-60.PMC3885775.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/alm-34-60.PMC3885775.pdf
"CML in mixed phenotype BP  http://dx.doi.org/10.3343/alm.2014.34.1.60 www.annlabmed.org  61 A BM study after the first induction cycle without tyrosine-ki - nase inhibitor (TKI) revealed 50% cellularity with less than 1%  blasts; however, a cytogenetic study revealed 46,XY,t(9;22) (q34;q11.2) in 28 of 30 cells analyzed.",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/alm-34-60.PMC3885775.pdf
"CML in mixed phenotype BP  62  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.60phils, and 3% eosinophils.",OADS,/arxiv_data1/oa_pdf/3f/ea/alm-34-60.PMC3885775.pdf
CML in mixed phenotype BP  http://dx.doi.org/10.3343/alm.2014.34.1.60 www.annlabmed.org  63malignancies to distinguish CML presenting in lymphoblastic BP  from lymphoblast-restricted Ph+ ALL [12].,Non-OADS,/arxiv_data1/oa_pdf/3f/ea/alm-34-60.PMC3885775.pdf
"ISSN 2234-3806 • eISSN 2234-3814  64  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.64Ann Lab Med 2014;34:64-65 http://dx.doi.org/10.3343/alm.2014.34.1.64Letter to the Editor  Diagnostic Hematology Comments on Point of Care D-Dimer Testing in the  Emergency Department: A Bioequivalence Study Suzanne Ekelund, M.S.",Non-OADS,/arxiv_data1/oa_pdf/43/5a/alm-34-64.PMC3885776.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/5a/alm-34-64.PMC3885776.pdf
"Comments on POC D-Dimer bioequivalence study http://dx.doi.org/10.3343/alm.2014.34.1.64 www.annlabmed.org  65cluded 97 study reports on 198 D-dimer assays in 99 different  patient groups, a substantial heterogeneity, particularly with re - gard to specificity.",Non-OADS,/arxiv_data1/oa_pdf/43/5a/alm-34-64.PMC3885776.pdf
"ISSN 2234-3806 • eISSN 2234-3814  66  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.66Ann Lab Med 2014;34:66-67 http://dx.doi.org/10.3343/alm.2014.34.1.66Letter to the Editor  Diagnostic Hematology Response to the Comments on ‘Point of Care D-Dimer  Testing in the Emergency Department–A  Bioequivalence Study’ and Erratum to the Results Shuhana Perveen, MBBS1, Danielle Unwin, FACEM1, Amith L Shetty, FACEM1, and Karen Byth, Ph.D.2 Emergency Department1, Westmead Hospital; Millennium Research Institute2, Sydney, Australia We have read with interest the comments made on our study ti - tled ‘Point of care (POC) D-dimer testing in the Emergency de - partment–a bioequivalence study’ [1].",Non-OADS,/arxiv_data1/oa_pdf/bc/1a/alm-34-66.PMC3885777.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/1a/alm-34-66.PMC3885777.pdf
"POC D-dimer testing– bioequivalence study http://dx.doi.org/10.3343/alm.2014.34.1.66 www.annlabmed.org  67mer results, and these results together with the wide Bland-Alt - man limits of agreement (0.24-2.13) led to a conclusion that the  two assays were not bioequivalent.",OADS,/arxiv_data1/oa_pdf/bc/1a/alm-34-66.PMC3885777.pdf
"ISSN 2234-3806 • eISSN 2234-3814  68  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.68Ann Lab Med 2014;34:68-70 http://dx.doi.org/10.3343/alm.2014.34.1.68Letter to the Editor  Diagnostic Hematology A Case of Therapy-Related Acute Myeloid Leukemia  With a Normal Karyotype After Sustained Molecular  Complete Remission of Acute Promyelocytic Leukemia Sang Hyuk Park, M.D.1, Hyun-Sook Chi, M.D.1, Young-Uk Cho, M.D.1, Seongsoo Jang, M.D.1, Chan-Jeoung Park, M.D.1,   and Je-Hwan Lee, M.D.2 Departments of Laboratory Medicine1 and Hematology2, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Dear editor, Given that the current therapeutic regimen for acute promyelo - cytic leukemia (APL) includes idarubicin (a topoisomerase II in - hibitor) and methotrexate (an alkylating agent), therapy-related  acute myeloid leukemia (t-AML) can develop after APL treat - ment, and several cases have been reported to date [1-13].",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/alm-34-68.PMC3885778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/alm-34-68.PMC3885778.pdf
Normal karyotype t-AML after APL remission http://dx.doi.org/10.3343/alm.2014.34.1.68 www.annlabmed.org  69noted at diagnosis of APL.,Non-OADS,/arxiv_data1/oa_pdf/d2/4b/alm-34-68.PMC3885778.pdf
Normal karyotype t-AML after APL remission 70  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.68elocytic leukemia treated with all-trans-retinoic Acid and anthracycline- based chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/d2/4b/alm-34-68.PMC3885778.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.7 www.annlabmed.org  7Ann Lab Med 2014;34:7-14 http://dx.doi.org/10.3343/alm.2014.34.1.7Original Article Clinical Chemistry Quantification of Human Plasma-Busulfan  Concentration by Liquid Chromatography-Tandem  Mass Spectrometry Soo Young Moon, M.D.1, Min Kyoo Lim, M.T.1, Susie Hong, M.T.1, Yongbum Jeon, M.D.1, Minje Han, M.D.1,   Sang Hoon Song, M.D.1, Kyoung Soo Lim, M.D.2, Kyung-Sang Yu, M.D.2, In-Jin Jang, M.D.2, Ji Won Lee, M.D.3,   Hyoung Jin Kang, M.D.3, and Junghan Song, M.D.4 Departments of Laboratory Medicine1, Pharmacology and Clinical Pharmacology2, and Pediatrics3, Seoul National University Hospital, Seoul; Department of  Laboratory Medicine4, Seoul National University Bundang Hospital, Seongnam, Korea Background:  Busulfan, an alkylating agent administered prior to hematopoietic stem cell  transplantation, has a narrow therapeutic range and wide variability in metabolism.",OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
Quantification of busulfan by LC-MS/MS 8  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.7oral bioavailability and precise administration.,Non-OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
Quantification of busulfan by LC-MS/MS http://dx.doi.org/10.3343/alm.2014.34.1.7 www.annlabmed.org  9321.1 for IS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
Quantification of busulfan by LC-MS/MS 10  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.7lated as the ratio of the concentrations in the stock solutions  and the prepared plasma samples [23].,OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
"Quantification of busulfan by LC-MS/MS http://dx.doi.org/10.3343/alm.2014.34.1.7 www.annlabmed.org  11107.5% in the range of 220-2,887 ng/mL.",OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
"Quantification of busulfan by LC-MS/MS 12  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.7rapid reporting of busulfan concentrations to the clinicians,  which helps them decide whether to adjust next day’s dosage.",Non-OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
Quantification of busulfan by LC-MS/MS http://dx.doi.org/10.3343/alm.2014.34.1.7 www.annlabmed.org  13cause there are not adequate laboratories or accounts on the  measurement of busulfan in plasma in clinical laboratories in  Korea.,OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
Quantification of busulfan by LC-MS/MS 14  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.7blood spot in combination with liquid chromatography/tandem mass  spectrometry.,OADS,/arxiv_data1/oa_pdf/3f/76/alm-34-7.PMC3885779.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.1.71 www.annlabmed.org  71Ann Lab Med 2014;34:71-75 http://dx.doi.org/10.3343/alm.2014.34.1.71Letter to the Editor  Clinical Microbiology Necrotizing Pneumonia and Empyema in an  Immunocompetent Patient Caused by Nocardia  cyriacigeorgica  and Identified by 16S rRNA  and   secA1  Sequencing Changmin Yi, M.D.1, Min-Jung Kwon, M.D.1, Chang-Seok Ki, M.D.2, Nam Yong Lee, M.D.2, Eun-Jeong Joo, M.D.3,   Joon-Sup Yeom, M.D.3, Hee-Yeon Woo, M.D.1, and Hyosoon Park, M.D.1 Department of Laboratory Medicine1, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine; Department of Laboratory Medicine and  Genetics2, Samsung Medical Center, Sungkyunkwan University School of Medicine; Division of Infectious Diseases3, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine, Seoul, Korea Nocardiosis is a rare and potentially life-threatening infection.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
Isolation of Nocardia cyriacigeorgica 72  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.71mothorax and was empirically treated intravenously with a third- generation cephalosporin and aminoglycoside.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
"Isolation of Nocardia cyriacigeorgica http://dx.doi.org/10.3343/alm.2014.34.1.71 www.annlabmed.org  73protein is an essential component of the preprotein translocase  ATPase, which provides the driving force for the export of pro - teins across the bacterial cytoplasmic membrane [5].",Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
Phylogenetic trees were  constructed with the neighbor-joining method using the MEGA 5  software package (http://www.megasoftware.net) and Kimura 2  parameters as the substitution model [8].,OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
"Currently, the Nocardia  genus has approximately 100 re - ported species of different taxonomic statuses (http://www.bacte - rio.cict.fr/n/nocardia.html).",Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
Isolation of Nocardia cyriacigeorgica 74  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.71A BNocardia abscessus IMMIB D-1592 (NR_025059.1)99 40 27 34100 100 10073 96 95 92 60 37 0.005386644 1847 25 4932Nocardia higoensis IFM 10084 (NR_028651.1) Nocardia higoensis IFM 10084 (NR_028651.1) Nocardia farcinica IFM 0221 (AB162791.1) Nocardia brasiliensis DSM 43758 (NR_041860.1) Nocardia thailandica IFM 10145 (NR_040994.1) This case Nocardia cyriacigeorgica GUH-2 (NR_074699.1) Nocardia transvalensis DSM 43405 (NR_041867.1) Nocardia camea DSM 43397 (NR_041859.1) Nocardia_flavorosea_10.268-1_(NR_026525.1) Nocardia_sienata_IFM_10088_(NR_024825.1) Nocardia_testacea_JCM_12235_(NR_041251.1) Nocardia_aobensis_strain_IFM_0372_(NR_040995.1) Nocardia_cerradoensis_Y9_(NR_028704.1) Nocardia_niigatensis_DSM_44670_(NR_043916.1) Nocardia_otitidiscaviarum_DSM_43242_(NR_041874.1) Nocardia_terpenica_IFM_0706_(NR_041289.1) Nocardia_brevicatena_DSM_43024_(NR_041862.1) Nocardia_paucivorans_DSM_44386_(NR_041863.1) Nocardia_araoensis_strain_IFM_0575_(NR_028652.1) Nocardia_pneumoniae_IFM_0784_(NR_028653.1) Nocardia_exalbida_IFM_0803_(NR_041237.1) Nocardia_takedensis_MS1-3_(NR_024832.1) Nocardia concava DSM 44804 (EU178746.1) Nocardia niigatensis DSM 44670 (DQ360278.1) Nocardia otitidiscaviarum DSM 43242 (JNO41986.1) Nocardia terpenica DSM 44935 (GU584194.1) Nocardia transvalensis DSM 46068 (JNO41998.1) Nocardia asteroides ATCC 19247 (DQ360267.1) Nocardia thailandica DSM 44808 (EU178752.1) Nocardia higoensis DSM 44732 (EU178747.1) Nocardia takedensis DSM 44801 (JF803975.1) Nocardia brasiliensis DSM 43758 (JNO42009.1) Nocardia abscessus DSM 44432 (JNO41963.1) Nocardia pneumoniae DSM 44730 (EU178749.1) Nocardia asiatica DSM 44668 (JNO41961.1) Nocardia araoensis DSM 44729 (EU178745.1) Nocardia exalbida DSM 44883 (GU584191.1) This case Nocardia cyriacigeorgica DSM 44484 (JNO42034.1) Nocardia brevicatena ATCC 15333 (DQ360270.1) Nocardia paucivorans DSM 44386 (JNO42061.1) Nocardia aobensis DSM 44805 (JNO42089.1) Nocardia cerradoensis DSM 44546 (JNO42082.1) Nocardia camea DSM 44558 (JNO42072.1) Nocardia flavorosea DSM 44480 (JNO42071.1) Nocardia sienata DSM 44766 (DQ360285.1) Nocardia testacea DSM 44765 (DQ360286.1)85 71 28 12 19 34 27 35 8532 23 40 83 100 100 100 1009999946860 0.005 Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
"Isolation of Nocardia cyriacigeorgica http://dx.doi.org/10.3343/alm.2014.34.1.71 www.annlabmed.org  75cin (4 µg/mL), imipenem (64 µg/mL), cefepime (32 µg/mL), and  amoxicillin/clavulanic acid (64/32 µg/mL).",Non-OADS,/arxiv_data1/oa_pdf/0e/33/alm-34-71.PMC3885780.pdf
"ISSN 2234-3806 • eISSN 2234-3814  76  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.76Ann Lab Med 2014;34:76-79 http://dx.doi.org/10.3343/alm.2014.34.1.76Letter to the Editor  Clinical Microbiology Fatal Pulmonary Mucormycosis Caused by Rhizopus  microsporus  in a Patient with Diabetes Moon Jin Kim, M.D., Pil-Whan Park, M.D., Jeong-Yeal Ahn, M.D., Kyung-Hee Kim, M.D., Ja Young Seo, M.D.,   Ji-Hun Jeong, M.D., Mi-Jung Park, M.D., Jin-Woo Jung, M.D., and Yiel-Hea Seo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0c/16/alm-34-76.PMC3885781.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/16/alm-34-76.PMC3885781.pdf
Pulmonary Rhizopus  infection http://dx.doi.org/10.3343/alm.2014.34.1.76 www.annlabmed.org  77nous amphotericin B.,Non-OADS,/arxiv_data1/oa_pdf/0c/16/alm-34-76.PMC3885781.pdf
Pulmonary Rhizopus  infection 78  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.76as R. microsporus .,Non-OADS,/arxiv_data1/oa_pdf/0c/16/alm-34-76.PMC3885781.pdf
Pulmonary Rhizopus  infection http://dx.doi.org/10.3343/alm.2014.34.1.76 www.annlabmed.org  79pergillus-active antifungal therapy: a case-control observational study of  27 recent cases.,Non-OADS,/arxiv_data1/oa_pdf/0c/16/alm-34-76.PMC3885781.pdf
"ISSN 2234-3806 • eISSN 2234-3814  80  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.80Ann Lab Med 2014;34:80-84 http://dx.doi.org/10.3343/alm.2014.34.1.80Letter to the Editor  Diagnostic Genetics Ataxia-Telangiectasia with Novel Splicing Mutations in  the ATM Gene Heejeong Jeong, M.D.1,*, Hee Jae Huh, M.D.2,*, Jinyoung Youn, M.D.3, Ji Sun Kim, M.D.4, Jin Whan Cho, Ph.D.3,   and Chang-Seok Ki, M.D.2 Department of Neurology1, Gyeongsang National University School of Medicine, Jinju; Department of Laboratory Medicine and Genetics2, Samsung Medical  Center, Sungkyunkwan University School of Medicine, Seoul; Department of Neurology3, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul; Department of Neurology4, Soonchunhyang University Hospital, Soonchunhyang University School of Medicine, Seoul, Korea Ataxia-telangiectasia (A-T) is a hereditary neurodegenerative dis - order that is characterized by progressive cerebellar ataxia, ocu - lar or cutaneous telangiectasia, oculomotor apraxia, choreoathe - tosis, and dysarthria.",Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
"Ataxia-Telangiectasia with ATM gene mutations http://dx.doi.org/10.3343/alm.2014.34.1.80 www.annlabmed.org  81(q32;q11.2)[6]/46,XX,t(7;14)(p15.1;q11.2)[2]/46,XX,inv(7) (p1?q3?)[2]/46,XX[30].",Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
Ataxia-Telangiectasia with ATM gene mutations 82  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.80A B Proband Father Mother c.7090-2A > C c.3154-2A > CFig.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
Ataxia-Telangiectasia with ATM gene mutations http://dx.doi.org/10.3343/alm.2014.34.1.80 www.annlabmed.org  83for possible splicing aberrations.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
Ataxia-Telangiectasia with ATM gene mutations 84  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.1.8010.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/alm-34-80.PMC3885782.pdf
"505 http://dx.doi.org/10.3345/kjp.2013.56.12.505Mechanisms of immune tolerance to allergens  in children Umut C. Kucuksezer, PhD1, Cevdet Ozdemir, MD2, Mübeccel Akdis, MD, PhD3, Cezmi A. Akdis, MD3,4  1Department of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey, 2Department of Pediatric Allergy, Atasehir Hospital,  Memorial Health Group, Istanbul, Turkey, 3Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland, 4Christine Kühne – Center  for Allergy Research and Education, Davos, Switzerland Because the prevalence of allergic diseases has significantly increased in recent years, understanding  the causes and mechanisms of these disorders is of high importance, and intense investigations are  ongoing.",Non-OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"Key words: Allergen specific immunotherapy, Allergy, Regulatory T cells, ToleranceCorresponding author: Cezmi A. Akdis, MD Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Obere Strasse 22, CH-7270 Davos Platz, SwitzerlandTel: +41-81-4100848Fax: +41-81-4100840E-mail: akdisac@siaf.uzh.ch  Received: 31 October 2013 Accepted: 11 November 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(12):505-513 http://dx.doi.org/10.3345/kjp.2013.56.12.505 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Immune tolerance is essential for maintenance of homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.505Kucuksezer UC, et al.",OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
507 http://dx.doi.org/10.3345/kjp.2013.56.12.505Korean J Pediatr 2013;56(12):505-513 Continued exposure to allergen often establishes a state of  chronicity10) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.505Kucuksezer UC, et al.",OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"509 http://dx.doi.org/10.3345/kjp.2013.56.12.505Korean J Pediatr 2013;56(12):505-513 profiles, similar to Th1 and Th2-cells.",OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.505Kucuksezer UC, et al.",OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
511 http://dx.doi.org/10.3345/kjp.2013.56.12.505Korean J Pediatr 2013;56(12):505-513 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.505Kucuksezer UC, et al.",OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
"513 http://dx.doi.org/10.3345/kjp.2013.56.12.505Korean J Pediatr 2013;56(12):505-513 blind, placebo-controlled dose escalation study.",Non-OADS,/arxiv_data1/oa_pdf/67/cf/kjped-56-505.PMC3885784.pdf
514 http://dx.doi.org/10.3345/kjp.2013.56.12.514Food protein-induced proctocolitis: Is this allergic  disorder a reality or a phantom in neonates?,Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
"Key words: Food allergy, Proctocolitis, Dietary protein, Food hypersensitivity, Neonates, Rectal  bleedingCorresponding author: Jin-Bok Hwang, MD, PhD Division of Pediatric Gastroenterology & Nutrition, Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, KoreaTel: +82-53-250-7331Fax: +82-53-250-7783E-mail: pedgi@kmu.ac.kr Received: 29 May 2013 Accepted:  28 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(12):514-518 http://dx.doi.org/10.3345/kjp.2013.56.12.514 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  In sick neonates with small and fresh rectal bleeding, the presence of severe illnesses  such as infections, necrotizing enterocolitis, or some surgical condition should be  determined through extensive investigations.",Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
515 http://dx.doi.org/10.3345/kjp.2013.56.12.514Korean J Pediatr 2013;56(12):514-518 Diagnostic dilemma of FPIPC 1.,Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.514Hwang JB and Hong J  • Food protein-induced proctocolitis in neonates 516stopped without any evidence of infection or any other cause,  we considered the case as idiopathic neonatal transient colitis  (INTC).",Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
"517 http://dx.doi.org/10.3345/kjp.2013.56.12.514Korean J Pediatr 2013;56(12):514-518 of the breast-fed newborn showed a positive response to oral  food ECT with fish and eggs in the maternal diet, and was also  confirmed to have FPIPC.",Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
http://dx.doi.org/10.3345/kjp.2013.56.12.514Hwang JB and Hong J  • Food protein-induced proctocolitis in neonates 518colitis in breast-fed infants.,Non-OADS,/arxiv_data1/oa_pdf/97/42/kjped-56-514.PMC3885785.pdf
519 http://dx.doi.org/10.3345/kjp.2013.56.12.519Inflammation and hyponatremia: an underrecog- nized condition?,Non-OADS,/arxiv_data1/oa_pdf/ac/d9/kjped-56-519.PMC3885786.pdf
"Key words: Hyponatremia, Inappropriate ADH Syndrome, Cytokines, Inflammatory disease, Critical  conditionCorresponding author: Jae Il Shin, MD, PhD Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-2050Fax: +82-2-393-9118E-mail: shinji@yuhs.ac Received: 13 June 2013 Accepted: 12 September 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(12):519-522 http://dx.doi.org/10.3345/kjp.2013.56.12.519 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Hyponatremia, characterized by a serum sodium level that is less than 135 mEq/L, is  one of the most commonly diagnosed electrolyte disorders in clinical medicine1).",Non-OADS,/arxiv_data1/oa_pdf/ac/d9/kjped-56-519.PMC3885786.pdf
http://dx.doi.org/10.3345/kjp.2013.56.12.519Park SJ and Shin JI  • Inflammation and hyponatremia: an underrecognized condition?,Non-OADS,/arxiv_data1/oa_pdf/ac/d9/kjped-56-519.PMC3885786.pdf
"521 http://dx.doi.org/10.3345/kjp.2013.56.12.519Korean J Pediatr 2013;56(12):519-522 dimercaptosuccinic acid scintigraphy, we determined the serum  sodium concentrations.",Non-OADS,/arxiv_data1/oa_pdf/ac/d9/kjped-56-519.PMC3885786.pdf
http://dx.doi.org/10.3345/kjp.2013.56.12.519Park SJ and Shin JI  • Inflammation and hyponatremia: an underrecognized condition?,Non-OADS,/arxiv_data1/oa_pdf/ac/d9/kjped-56-519.PMC3885786.pdf
523 http://dx.doi.org/10.3345/kjp.2013.56.12.523Does hypertension begin in adolescence?,Non-OADS,/arxiv_data1/oa_pdf/b3/61/kjped-56-523.PMC3885787.pdf
"Kyung Lim Yoon, MD, PhD Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea  Corresponding author: Kyung Lim Yoon, MD, PhD Department of pediatrics, Kyung Hee University  Hospital at Gandong, 892 Dongnam-ro, Gandong-gu, Seoul 137-727, KoreaTel: +82-2-440-7000Fax:+82-2-440-7175Email: ykr3215@hanmail.net Received: 10 October, 2013 Accepted: 29 October, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Editorial Korean J Pediatr 2013;56(12):523-525 http://dx.doi.org/10.3345/kjp.2013.56.12.523 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Hypertension is a major public health problem throughout the world as well as a leading  cause of cardiovascular disease, which contributes to premature mortality.",Non-OADS,/arxiv_data1/oa_pdf/b3/61/kjped-56-523.PMC3885787.pdf
http://dx.doi.org/10.3345/kjp.2013.56.12.523Yoon KL  • Does hypertension begin in adolescents?,Non-OADS,/arxiv_data1/oa_pdf/b3/61/kjped-56-523.PMC3885787.pdf
525 http://dx.doi.org/10.3345/kjp.2013.56.12.523Korean J Pediatr 2013;56(12):523-525 hypertension: new insights into mechanisms.,Non-OADS,/arxiv_data1/oa_pdf/b3/61/kjped-56-523.PMC3885787.pdf
http://dx.doi.org/10.1038/hr.2013.109.,Non-OADS,/arxiv_data1/oa_pdf/b3/61/kjped-56-523.PMC3885787.pdf
"526 http://dx.doi.org/10.3345/kjp.2013.56.12.526The relationships of body mass index, waist-to- height ratio, and body fat percentage with blood  pressure and its hemodynamic determinants in  Korean adolescents: a school-based study Na Young Kim, MD1, Young Mi Hong, MD, PhD2, Jo Won Jung, MD, PhD3, Nam Su Kim, MD, PhD4, Chung Il Noh, MD, PhD5, Young- Hwan Song, MD, PhD1 1Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, 2Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, 3Department  of Pediatrics, Yonsei University College of Medicine, Seoul, 4Department of Pediatrics, Hanyang University College of Medicine, Seoul, 5Department of Pediatrics,  Seoul National University College of Medicine, Seoul, Korea Purpose:  Obesity is an important risk factor for hypertension in adolescents.",Non-OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"Key words: Adolescent, Obesity, Blood pressure, Body mass indexCorresponding author: Young Hwan Song, MD,  PhD Department of Pediatrics, Inje University SanggyePaik Hospital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, KoreaTel: +82-2-950-1451Fax:+82-2-951-1246E-mail: yyyyysong@paik.ac.kr  Received: 11 May 2013 Revised: 28 June 2013Accepted: 8 July 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(12):526-533 http://dx.doi.org/10.3345/kjp.2013.56.12.526 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction The increase in the prevalence of cardiovascular disease (CVD) is a global health concern  because CVD has become an important cause of morbidity and mortality worldwide1).",Non-OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"527 http://dx.doi.org/10.3345/kjp.2013.56.12.526Korean J Pediatr 2013;56(12):526-533 as well as in adults4,5).",Non-OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.526Kim NY , et al.",OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
529 http://dx.doi.org/10.3345/kjp.2013.56.12.526Korean J Pediatr 2013;56(12):526-533 3.,Non-OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.526Kim NY , et al.",OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
531 http://dx.doi.org/10.3345/kjp.2013.56.12.526Korean J Pediatr 2013;56(12):526-533 WHR was significantly and positively correlated with SV and  CO in the age- and height-adjusted model (M1).,OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.526Kim NY , et al.",OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
533 http://dx.doi.org/10.3345/kjp.2013.56.12.526Korean J Pediatr 2013;56(12):526-533  9.,Non-OADS,/arxiv_data1/oa_pdf/74/7e/kjped-56-526.PMC3885788.pdf
"534 http://dx.doi.org/10.3345/kjp.2013.56.12.534Early postictal electroencephalography and  correlation with clinical findings in children with febrile seizures Kyung A Jeong, MD, Myung Hee Han, MD, Eun Hye Lee, MD,PhD, Sajun Chung, MD, PhD Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea Purpose: Electroencephalography (EEG) is frequently ordered for patients with febrile seizures despite its  unclear diagnostic value.",Non-OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
"Key words: Febrile seizures, Postictal, Electroencephalography Corresponding author: Sajun Chung, MD Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, KoreaTel: +82-2-958-8295Fax:+82-2-958-8845E-mail: sajchung@khmc.or.kr Received: 29 May 2013 Revised: 25 August 2013Accepted: 7 September 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(12):534-539 http://dx.doi.org/10.3345/kjp.2013.56.12.534 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Febrile seizures (FS) are the most common convulsive events in children less than 5  years old, with an incidence of 2–5%1,2).",Non-OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
"535 http://dx.doi.org/10.3345/kjp.2013.56.12.534Korean J Pediatr 2013;56(12):534-539 may be present in children with FS, their clinical significance is  unclear.",Non-OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.534Jeong KA, et al.",OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
537 http://dx.doi.org/10.3345/kjp.2013.56.12.534Korean J Pediatr 2013;56(12):534-539 patients with two FS recurrences and in one of four with three  recurrences.,Non-OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.534Jeong KA, et al.",OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
539 http://dx.doi.org/10.3345/kjp.2013.56.12.534Korean J Pediatr 2013;56(12):534-539 febrile seizures?,Non-OADS,/arxiv_data1/oa_pdf/12/77/kjped-56-534.PMC3885789.pdf
"540 http://dx.doi.org/10.3345/kjp.2013.56.12.540Asymptomatic moyamoya syndrome,  atlantoaxial subluxation and basal ganglia calcification in a child with Down syndrome Kyung Yeon Lee, MD1, Kun-Soo Lee, MD2, Young Cheol Weon, MD3 1Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, 2Department of Neurosurgery, Inje University Busan Paik  Hospital, Busan, 3Department of Radiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea Down syndrome, the most common chromosomal abnormality, may be associated with various neurologic  complications such as moyamoya syndrome, cervical spinal cord compression due to atlantoaxial  subluxation, and basal ganglia damage, as well as epileptic seizures and stroke.",Non-OADS,/arxiv_data1/oa_pdf/f2/05/kjped-56-540.PMC3885790.pdf
"Key words: Down syndrome, Moyamoya disease, Atlantoaxial instability, Basal ganglia calcificationCorresponding author: Kyung Yeon Lee, MD Department of Pediatrics, Ulsan UniversityHospital, University of Ulsan College of Medicine,877 Bangeojinsunhwan-doro, Dong-gu,Ulsan 682-714, KoreaTel: +82-52-250-8980Fax: +82-52-250-8071E-mail: pdsnoopy@naver.com Received: 23 August 2012 Revised: 29 November 2012Accepted: 9 May 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(12):540-543 http://dx.doi.org/10.3345/kjp.2013.56.12.540 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  The patient with Down syndrome may present with diverse neurologic manifestations,  including moyamoya syndrome, cervical spinal cord compression related to atlantoaxial  subluxation, and basal ganglia damage1-4).",Non-OADS,/arxiv_data1/oa_pdf/f2/05/kjped-56-540.PMC3885790.pdf
"541 http://dx.doi.org/10.3345/kjp.2013.56.12.540Korean J Pediatr 2013;56(12):540-543 horizontal nystagmus, would result from brain parenchymal  lesion.",Non-OADS,/arxiv_data1/oa_pdf/f2/05/kjped-56-540.PMC3885790.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.540Lee KY , et al.",OADS,/arxiv_data1/oa_pdf/f2/05/kjped-56-540.PMC3885790.pdf
"543 http://dx.doi.org/10.3345/kjp.2013.56.12.540Korean J Pediatr 2013;56(12):540-543 Down syndrome, the majority of which are asymptomatic, with  estimates of symptomatic disease ranging from 1% to 2%12).",Non-OADS,/arxiv_data1/oa_pdf/f2/05/kjped-56-540.PMC3885790.pdf
"545 http://dx.doi.org/10.3345/kjp.2013.56.12.545Moyamoya syndrome occurred in a girl with an  inactive systemic lupus erythematosus Yun-Jin Lee, MD, Gyu Min Yeon, MD, Sang Ook Nam, MD, PhD, Su Yung Kim, MD, PhD Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National University School of Medicine, Yangsan, Korea We report the case of a 17-year-old Korean girl with systemic lupus erythematosus (SLE) who presented with  sudden weakness of the right-sided extremities and dysarthria.",Non-OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
"Key words: Moyamoya disease, Systemic lupus erythematosus, ChildCorresponding author: Su Yung Kim, MD, PhD Department of Pediatrics, Pusan National Univer - sity Children’s Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 626-770, KoreaTel: +82-55-360-3151Fax: +82-55-360-2181E-mail: suyung@pasan.ac.kr    Received: 6 October 2012 Revised: 3 January 2013Accepted: 9 May 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(12):545-549 http://dx.doi.org/10.3345/kjp.2013.56.12.545 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Moyamoya disease (MMD) is a cerebrovascular disorder of unknown etiology that  is recognized by bilateral progressive stenosis or occlusion of the terminal portions of  the internal carotid artery (ICA) and the development of an abnormal vascular network  or moyamoya vessels (MMVs) around the arterial occlusion1).",Non-OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.545Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
547 http://dx.doi.org/10.3345/kjp.2013.56.12.545Korean J Pediatr 2013;56(12):545-549 Discussion Our patient was a remarkable case of MMS in a 17-year-old  girl with SLE.,Non-OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.12.545Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
549 http://dx.doi.org/10.3345/kjp.2013.56.12.545Korean J Pediatr 2013;56(12):545-549 Acknowledgments This study was supported by a 2012 research grant from Pusan  National University Yangsan Hospital.,Non-OADS,/arxiv_data1/oa_pdf/9a/0b/kjped-56-545.PMC3885791.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003836).,Non-OADS,/arxiv_data1/oa_pdf/be/4c/bmjopen-2013-003836.PMC3885815.pdf
Ethics approval Ethical Committee of the University of Valencia in accordance with the Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm).,Non-OADS,/arxiv_data1/oa_pdf/be/4c/bmjopen-2013-003836.PMC3885815.pdf
Real Decreto 1066/2001 Telecomunicaciones/TelefoniaMovil/ RD1066_2001.pdf http://www.mityc.es/esES/OficinaVirtual/Documents/SE%20 41.,OADS,/arxiv_data1/oa_pdf/be/4c/bmjopen-2013-003836.PMC3885815.pdf
Jung Won Kwon (E-mail: kjwonpt@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/96/c8/jpts-25-1515.PMC3885828.pdf
Yuichi Takata (E-mail: takata@do- bunkyodai.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/17/e2/jpts-25-1519.PMC3885829.pdf
Ming Huo (E-mail: huoming8@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6b/78/jpts-25-1523.PMC3885830.pdf
Gun-Soo Han (E-mail: gunsoo@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/64/jpts-25-1525.PMC3885831.pdf
Soohee Park (E-mail: p334005@ honam.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2a/46/jpts-25-1529.PMC3885832.pdf
Byoung-Do Seo (E-mail: oksbd@ naver.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/59/dd/jpts-25-1533.PMC3885833.pdf
